0001477932-23-002547.txt : 20230414 0001477932-23-002547.hdr.sgml : 20230414 20230414135411 ACCESSION NUMBER: 0001477932-23-002547 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zerify, Inc. CENTRAL INDEX KEY: 0001285543 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 223827597 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55012 FILM NUMBER: 23820626 BUSINESS ADDRESS: STREET 1: 1090 KING GEORGES POST ROAD CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732 661 9641 MAIL ADDRESS: STREET 1: 1090 KING GEORGES POST ROAD CITY: EDISON STATE: NJ ZIP: 08837 FORMER COMPANY: FORMER CONFORMED NAME: StrikeForce Technologies Inc. DATE OF NAME CHANGE: 20050106 FORMER COMPANY: FORMER CONFORMED NAME: STRIKEFORCE TECHNOLOGIES INC DATE OF NAME CHANGE: 20040331 10-K 1 zrfy_10k.htm FORM 10-K zrfy_10k.htm

 

UNITED STATES

SECURITIES EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

 

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the fiscal year ended December 31, 2022

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from _________ to _________

 

ZERIFY, INC.

(Exact name of registrant as specified in its Charter)

 

 Wyoming

 

000-55012

 

 22-3827597

 (State or other jurisdiction of

 

(Commission

 

 (I.R.S. Employer

 incorporation or organization)

 

file number)

 

Identification No.)

 

1090 King Georges Post Road, Suite 603

Edison, NJ 08837

(Address of Principal Executive Offices)

 

(732) 661-9641

(Issuer’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

 

Name of each exchange on which registered

N/A

 

N/A

 

 Securities registered pursuant to Section 12(g) of the Exchange Act:

 

Common stock, $0.0001 par value

Title of Class

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐      Yes No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐     Yes No

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No☐

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such a shorter period that the registrant was required to submit and post such files). Yes ☒     No ☐

  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b–2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act. Yes      No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding at March 31, 2023

Common stock, $0.0001 par value

 

1,364,017,560

 

Class

 

Outstanding at March 31, 2023

Preferred stock, Series A, no par value

 

3

 

Class

 

Outstanding at March 31, 2023

Preferred stock, Series B, $0.10 par value

 

36,667

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. Solely for purposes of the foregoing calculation, all of the registrant’s directors and officers are deemed to be affiliates. This determination of affiliate status for this purpose does not reflect a determination that any persons are affiliates for any other purposes. $21,120,000 

 

Transitional Small Business Disclosure Format Yes ☐     No ☒

 

Documents Incorporated By Reference

 

None

 

 

 

 

ZERIFY, INC.

FORM 10-K ANNUAL REPORT

FOR THE FISCAL YEARS ENDED DECEMBER 31, 2022 AND 2021

TABLE OF CONTENTS

 

PART I

 

 

 

 

ITEM 1.

 

BUSINESS

 

 

4

 

ITEM 1A.

 

RISK FACTORS

 

 

15

 

ITEM 1B.

 

UNRESOLVED STAFF COMMENTS

 

 

22

 

ITEM 2.

 

PROPERTIES

 

 

22

 

ITEM 3.

 

LEGAL PROCEEDINGS

 

 

22

 

ITEM 4.

 

MINE SAFETY DISCLOSURES

 

 

22

 

PART II

 

 

 

 

ITEM 5.

 

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

 

23

 

ITEM 6.

 

SELECTED FINANCIAL DATA

 

 

24

 

ITEM 7.

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

25

 

ITEM 7A.

 

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

29

 

ITEM 8.

 

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

 

F-1

 

ITEM 9.

 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

 

30

 

ITEM 9A.

 

CONTROLS AND PROCEDURES

 

 

30

 

ITEM 9B.

 

OTHER INFORMATION

 

 

30

 

PART III

 

 

 

 

ITEM 10.

 

DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.

 

 

31

 

ITEM 11.

 

EXECUTIVE COMPENSATION

 

 

36

 

ITEM 12.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

 

38

 

ITEM 13.

 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

 

44

 

ITEM 14.

 

PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

 

46

 

PART IV

 

 

 

 

ITEM 15.

 

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

 

48

 

ITEM 16.

 

FORM 10-K/A SUMMARY

 

 

49

 

 

 

SIGNATURES

 

 

50

 

 

CERTIFICATIONS

 

Exhibit 31 –

 

Management certification

 

 

 

Exhibit 32 –

 

Sarbanes-Oxley Act

 

 
2

 

 

CAUTION REGARDING FORWARD-LOOKING INFORMATION

 

Included in this annual report are “forward-looking” statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) as well as historical information. Some of our statements under “Business”, “Properties”, “Legal Proceedings”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”,” the Notes to Consolidated Financial Statements” and elsewhere in this report constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe that the expectations reflected in these forward-looking statements are reasonable and achievable, we cannot assure you that the expectations reflected therein  will prove to be correct.  Additionally, because these statements involved risks and uncertainties,  . we cannot assure you that actual results will be consistent with these forward-looking statements Our actual results could differ materially from those anticipated in forward-looking statements as a result of certain factors, including matters described in the section titled “Risk Factors.” Forward-looking statements include those that use forward-looking terminology, such as the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “project,” “plan,” “will,” “shall,” “should,” and similar expressions, including when expressed  negatively. . We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.

 

Such risks include, among others, the following: international, national and local general economic and market conditions: our ability to sustain, manage or forecast our growth; material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the current inflation rate and supply chain disruptions; the implications and consequences of the COVID-19 pandemic on our business and on our clients’ business and on the effectiveness and distributions of vaccines and boosters, domestically and internationally, to limit the impact of COVID-19, changes to mask mandate policies and to transitioning from a pandemic to an endemic; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and prior filings.

 

Consequently, all the forward-looking statements made in this Form 10-K are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by management will be realized or, even if substantially realized, that they will have the expected consequences to or effects on our business operations. We undertake no obligation to update or revise these forward-looking statements, whether to reflect events or circumstances after the date initially filed or published, to reflect the occurrence of unanticipated events or otherwise.

 

Unless otherwise noted, references in this Form 10-K to “StrikeForce”, “Zerify”, “we”, “us”, “our”, “SFT”, “our company”, and the “Company” means Zerify, Inc (formally known as  StrikeForce Technologies, Inc.), a Wyoming corporation. 

 

 
3

Table of Contents

 

PART I

 

ITEM 1. BUSINESS

 

Executive Offices/Website

 

Our executive office is located at 1090 King Georges Post Road, Suite 603, Edison, NJ 08837. Our telephone number is (732) 661-9641. Our website is at www.zerify.com (formerly www.strikeforcetech.com) (we are not including the information contained in our website as part of, nor should the information be relied upon or incorporated by reference into this report on Form 10-K).

 

History

 

We are a software development and services company that offers a suite of integrated computer network security products using proprietary technology. StrikeForce Technical Services Corporation was incorporated in August 2001 in New Jersey. On September 3, 2004, we changed our name to StrikeForce Technologies, Inc. On November 15, 2010, we redomiciled to Wyoming. We initially conducted operations as an integrator and reseller of computer hardware and telecommunications equipment and services until December 2002.  In December 2002, and formally memorialized in September 2003, we acquired certain intellectual property rights and patent pending technology from NetLabs.com, Inc. (“Net Labs”), including the rights to further develop and sell Net-Labs’ principal technology. At such time, certain officers of NetLabs joined us as our officers and directors. 

 

Our ongoing strategy is developing and marketing our suite of network security products to the corporate, financial, healthcare, legal, government, technology, insurance, e-commerce and consumer sectors. Our goal is to grow our business through our globally expanding sales channel and internally generated sales, rather than by acquisitions. On June 14, 2022, our Board of Directors and the majority of our  outstanding votes  approved by  consent  to change our name from StrikeForce Technologies, Inc. to Zerify, Inc. We hold a 49% interest in BlockSafe Technologies, Inc., and, as of April 2021, we hold a 100% interest in Cybersecurity Risk Solutions, LLC. We conduct our operations from our corporate office in Edison, New Jersey.

 

We began our operations in 2001 as a reseller and integrator of computer hardware and iris biometric technology. Iris biometric technology is using your looking into your cell phone as a way to authenticate it is really you. From our inception through the first half of 2003, we derived the majority of our revenues as an integrator. In December 2002, upon the acquisition of the licensing rights to certain intellectual property and patent pending technology from NetLabs, we shifted our focus to developing and marketing our own suite of security products. Based upon our acquired licensing rights and additional research and development, we have developed various identification protection software products to protect computer networks from unauthorized access and to protect users from identity theft.

 

We completed the development of our ProtectID® platform at the end of June 2006, we completed the core development of our keyboard encryption and anti-keylogger product, GuardedID®, in December 2006, and we commenced deployment of our new mobile product, MobileTrust® into the mobile stores in 2015. We finished development of our SafeVchat™ Secure Video Conferencing and PrivacyLoK™ products at the end of 2020 and deployed SafeVchat™ beta testing by some by our clients and individuals through our resellers. SafeVchat™, in management’s estimation, is one of the most secure video conferencing products on the market. PrivacyLoK™ adds security to all video conferencing tools and runs in conjunction with other applications on the same computer. Our goal is to expand our revenue base via increased revenues from SafeVchat™ and PrivacyLoK™ in 2023, and beyond. All of the foregoing products are currently being sold and distributed.

 

The keystroke encryption technology we developed and use in our GuardedID® product is protected by three patents through the US Patent and Trademark Office. MobileTrust® has a patent throughout Europe, by the European Patent Office, as of June 2020 (See Intellectual Property Section beginning on page 11).

 

Our Product Targets, Pricing and Revenues

 

Our suite of products is targeted to the financial, e-commerce, corporate, government, healthcare, legal, insurance, technology and retail markets. We seek to locate customers in a variety of ways, including contracts with value added resellers and distributors (both inside the United States and internationally), direct sales calls initiated by our internal staff, exhibitions at security and technology trade shows, through the media, through consulting agreements, and through our agent relationships.  We generate sales revenue either as an Original Equipment Manufacturer (“OEM”) model, through a Hosting/License agreement, bundled with our other products or through direct purchase by distributors and resellers. We price our products for cloud consumer transactions based on the number of transactions in which our software products are utilized. We also price our products for business applications based on the number of users. These pricing models provide us with one-time, monthly, quarterly and annual recurring revenues with volume discounts.

 

 
4

Table of Contents

 

We generated all of our revenues of $103,000 for the year ended December 31, 2022 (compared to $193,000 for the year ended December 31, 2021), from the sales of our security products. The decrease in revenues was primarily due to a reduction in the sales of our products caused by the adverse economic conditions resulting from the ongoing COVID-19 pandemic.

 

Marketing/Market Demand

 

We market our products globally to financial service firms, healthcare related companies, legal services companies, e-commerce companies, automotive, government agencies, multi-level marketing groups, the enterprise market in general, and with virtual private network companies, as well as technology service companies and retail distributors that service all the above markets. We seek such sales through our own direct efforts, with emphasis on retail, through distributors, resellers and third-party agents internationally. We are also seeking to license the technology as original equipment with computer hardware and software manufacturers. We are engaged in multiple production installations and pilot projects with various distributors, resellers and direct customers primarily in the United States. Our GuardedID® product is also being sold directly to consumers, primarily through the Internet as well as distributors, resellers, third party agents, affiliates and potential OEM agreements by bundling GuardedID® with their products (providing a value-add and competitive advantage to their own products and offerings). Currently this is the most active market for us with multiple programs in production. We anticipate, but cannot guarantee, increases in revenues in fiscal 2023 (subject to the impairments to the economy caused by the ongoing COVID-19 pandemic and the degree to which the economy rebounds post-pandemic, and any domestic economic impact from the war in Ukraine), from these programs.

 

We have incurred substantial losses since our inception. Our products provide a cost-effective and technologically competitive solution to address the problems of network security and identity theft in general. Guidance for the Federal Financial Institutions Examination Council (“FFIEC”) regulations include the requirement for solutions that have Two-Factor Out-of-Band Authentication and products that stop keylogging malware, real time, which our management believes our proprietary products uniquely and directly address. This guidance went into effect as of January 1, 2012. Based on this requirement in the FFIEC update (published in June 2011 with enforcement commencing in January 2012), we have experienced a growing increase in sales orders and inquiries every year. However, there can be no assurance that our products will continue to gain acceptance and continue to grow in the commercial marketplace or that one of our competitors will not introduce technically superior products.

 

Because we are now experiencing a continual growing market demand (with growth temporarily curtailed by the economic consequences of the ongoing COVID-19 pandemic), we are developing a reseller and distribution channel as a strategy to generate, manage and fulfill demand for our products across market segments, minimizing the requirement for an increase in our staff as we grow our distributor market. We have minimized the concentration on our initial direct sales efforts as our distribution and reseller channels continue to grow internationally and will require appropriate levels of support.

 

Covid-19

 

In March 2020, the World Health Organization declared the spread of COVID-19 a pandemic. This outbreak continues to spread throughout the U.S. and around the world. As a result, authorities continue to implement numerous measures to try to contain the virus, including restrictions on travel, quarantines, shelter-in-place orders, business restrictions and complete shutdowns. We are not considered an “essential business” due to the industries and customers we serve. As of, and subsequent to, December 31, 2022, we have been following the recommendations of the CDC and state/local health authorities to minimize exposure risk for our team members during the pandemic, including the temporary closure of our corporate office and having our team members work remotely. During the second quarter of 2021, we reopened our corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. The COVID-19 pandemic has resulted in longer response times from potential new customers and certain existing customers. We cannot anticipate the effect that the impairments caused by the COVID-19 pandemic will have on our year end fiscal 2023 results, or the effectiveness and distributions of vaccines, boosters, and their distribution in 2023 and changes to mask mandate policies or the shift from a pandemic to an endemic. The pandemic has significantly impacted the economic conditions both in the United States and worldwide, with accelerated effects through the date of this Annual Report, as federal, state and local governments react to the public health crisis, creating significant uncertainties in both the worldwide and the United States economies. The situation is rapidly changing, including the onset of the ongoing most recent and anticipated wave of the virus caused by the B2 Omicron variant and the possibility of other variants over time, and additional impacts to our business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which, the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or office closure requirements. We will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition and liquidity, and our results presented herein are not necessarily indicative of the results to be expected for future periods in 2023, or beyond.

 

 
5

Table of Contents

  

Management believes that cyber security is a growing requirement as the pandemic continues and more people are working remotely as well as using digital forms on a regular basis. Consequently, the market demand, in our estimation, is increasing. However, we are also experiencing the impact of the pandemic. Currently our management has limited operating from our office location, which impedes our ability to take full advantage of the increasing market demand. Many of our current clients have experienced a dramatic slowdown in their business, limiting their ability to have the resources to pay for our services. We continue to generate  revenues and we anticipate, but cannot guarantee, our video conferencing tool, SafeVchat™, which provides authentication and security (using our existing products), will have gained acceptance in the market. Currently, we have companies doing beta testing. During the year ended December 31, 2022, we earned revenues of $10,000 from SafeVchat™ and PrivacyLoK™ and overall revenues of $103,000. We believe, but cannot assure, that our sales, partly as a consequence of the new work environment created by the ongoing pandemic and the need for our products, will significantly increase in fiscal 2023 and continue that substantial growth in 2024. We also are encouraged by the $65 billion dollars provided for broadband access to improve internet services that is in the recently enacted federal Infrastructure Bill of 2021, but cannot provide assurance as to how, or if, that will impact our products and services.

 

Regulation A Offerings

 

On May 11, 2021, our filing of an Offering Circular on Form 1-A, pursuant to Regulation A (File Number: 024-11512) was qualified by the Securities and Exchange Commission. We registered 150,000,000 shares of common stock for maximum proceeds of $7,065,000 (after deducting the maximum broker discount and costs of the offering). During the year ended December 31, 2021, we issued 119,666,450 shares of common stock to investors for cash proceeds of $5,602,158, net of fees and commission, pursuant to the May 2021 Offering Circular. In September 2021, we sold 50,000,000 warrant shares for $50,000 to two investors who purchased subscriptions through the Offering Circular. We also awarded 5,000,000 warrant shares to the broker who facilitated the Offering Circular. The warrants vest immediately and have a 5-year term with an exercise price of $0.05 per share.

 

On December 21, 2022, the Securities and Exchange Commission qualified our Regulation A Offering Circular on Form 1-A (File Number: 024-12026). We registered 222,222,222 Units consisting of five (5) shares of Common Stock and one (1)  common stock purchase warrants exercisable at $0.02 per share, at a price of $.0225 per Unit, for maximum proceeds of $5,000,000 (after deducting the maximum broker discount and costs of the offering). During the year ended December 31, 2022, we issued 40,100,000 common stock shares  in the Regulation A Offering in exchange for cash of $180,000, net of direct fees and commissions. As part of the Regulation A offering, we also issued warrants to certain investors and its placement agent to purchase 8,020,000 shares of common stock, which warrants vest immediately and have a 5-year term with an exercise price of $0.02 per share.

  

 
6

Table of Contents

 

Our Products

  

Zerify is a software development and services company. We own and are seeking to commercially market various identification protection software products that we developed to protect computer networks from unauthorized access, real time, and to protect network owners and users from cyber security attacks and data breaches. Our principal products ProtectID®, GuardedID®, MobileTrust® inclusive of our unique Zerify Meet (our Secure Video Conferencing Product) and Zerify Defender™ (our end-point security product)  are proprietary authentication and patented keystroke encryption technologies that are intended to eliminate unauthorized access to computer networks, securing video conferencing and all mobile devices, and to prevent unauthorized individuals from copying (logging) keystrokes and utilizing any video conference product. We are increasing our market for our suite of products in the financial services, e-commerce, corporate, healthcare, government and consumer sectors. Our cyber security products are as follows:

 

·

ProtectID® is our multi-patented authentication platform that uses “Out-of-Band” multi-factor in-house installation, cloud service technology, a hybrid to authenticate computer network users by a variety of methods including traditional passwords combined with a telephone, iPhone, Droid, Blackberry, PDA, multiple computer secure sessions, or a Push Authentication method which was implemented in the fourth quarter of 2017, biometric identification and encrypted devices such as tokens or smartcards as examples. The authentication procedure separates authentication information such as usernames from the pin/passwords or biometric information, which are then provided to or from the network’s host server across separate communication channels. The platform allows for corporate control and client choices, per their company’s security policies, which evolves over time with newly available and customer requested technologies.

·

GuardedID® creates a 256-bit AES encrypted real time separate pathway for information delivery from a keyboard to a targeted application on a local computer, preventing the use of spyware/malware to collect user information. This product provides keyboard encryption and helps prevent keylogging from occurring in real time, which helps prevent the number one threat to consumers and businesses in today’s market: keylogging software, which is stealth software embedded in web sites, emails, pictures, MP3 files, videos, USB’s or other software and hardware that, once unknowingly launched, secretly monitors and records all of a user’s keystrokes on the computer and sends the data to the cyber thief without the user’s awareness. Keylogging has been reported as the one of the major causes of major data breaches that occurred from 2010 to 2016, as reported in the 2010-2016 Verizon Data Breach Reports. (Patent No: 8,566,608, 8,732,483 and 8,973,107).

·

MobileTrust® is an advanced iPhone/iPad and Android device password vault that includes a strong password generator. MobileTrust® also provides for Mobile Multi-Factor One Time Password authentication, a secured browser and keystroke encryption between its virtual keyboard and secured browser, which is critical to all confidential online transactions and other features, which is now in production. This new feature for mobile devices, which helps prevent data breaches and stolen credentials is a critical and vital addition to all enterprise mobile users, as enterprises transition to “Bring Your Own Devices” (BYOD). (International European Patent No: Application #14763895.1)

·

GuardedID® Mobile SDK is a software development kit that provides developers our patent protected keystroke encryption protection for all Apple and Android mobile device’s secure keyboards, allowing our keystroke encryption software to be embedded in any mobile applications, utilizing DES 256 Encryption.

·

Zerify Meet™ is, in our estimation, one of the best and most secure video conferencing products in the marketplace and we believe at a time when it is most needed due to the remote workplace environment brought on by the work conditions arising from the consequences of the COVID-19 pandemic. The product is a two-factor authentication application, with out-of-band authentication capability, including push transactions to cell phones or a one-time passcode or fingerprint or facial capability, and only allows invitees to the conference to  gain access. Zerify Meet™ runs on any Apple or Android device and operates on any browser because it does not require an application. Zerify Meet™. The purchaser of  Zerify Meet™ also receives  Zerify Defender™.

 

 
7

Table of Contents

 

·

Zerify Defender™ is an end-point lock product that offers protective mechanisms that are far more encompassing than what other video conferencing platforms currently provide, such as camera locking, keyboard protection, clipboard protection, microphone protection and audio input/output locking. The application also runs on the user’s computer and protects all applications, not just video conferencing. The application is offered a part of our Zerify Meet™ product, or as a separate standalone application.

 

Our products sometimes include software and hardware that we contractually license from other vendors. These products include additional authentication and telecommunication software devices.

 

The ProtectID® Cloud Service can be hosted by our service provider (we have a strategic arrangement with a third party SAS70 hosting service) as well as the ProtectID® Out-of-Band and Multi-Factor Platform, which can be installed internally in a customer’s infrastructure or as a hybrid implementation. With the exception of our free redistributable Microsoft software components. ProtectID® is also part of our Zerify Meet™ product.

 

Factors that we consider important to our success include the following:

 

·

Our products address the needs of a broad variety of customers for authentication and cyber security overall.

 

 

·

For illustration (while historic), in 2011, it was reported that RSA Security’s data was breached from which Lockheed Martin and others were affected and lost millions of dollars. This event caused many companies to look to other means of two-factor authentication, such as Out-of-Band. The RSA Data Breach started with a keylogging virus which our GuardedID® product, management believes, would most likely have prevented.

 

 

·

The 2017 Verizon Data Breach report, published in April 2018, stated that 80% of all the data breaches they reported would not have occurred if the corporations used two factor authentications.

 

 

·

In February 2015, the New York Times reported that a Global Bank heist occurred in banks around the globe from a keylogger. This was the first known time that a large hack was reported that included a keylogger, which our management believes GuardedID® would have prevented. The article was noted as caused by keystroke encryption in a picture on the front page of the New York Times.

 

 

·

The Effectiveness of Our Products: Our products have been designed to provide, we believe, a high available level of security for computer networks and individual users. In particular, we believe that the now Patented “Out-of-Band” authentication process is an innovative technology that will greatly prevent unauthorized access to computer networks and will provide effective security products to drastically reduce the incidence of identity fraud for our customers. We have contractually commenced implementation of our products on a large global scale, yet there can be no assurance that they will function in all aspects as intended. Likewise, a high level of innovation characterizes the software industry and there can be no assurance that our competitors will not develop and introduce a superior product. The effective functioning of our products once deployed is an important factor in our future success.

 

 

·

Ability to Integrate our Software with Customer Environments: There are numerous operating systems that are used by computer networks. The ability of a software product to integrate with multiple operating systems is likely to be a significant factor in customer acceptance of particular products. Our ProtectID® operates on an independent Cloud Service platform and is also able to integrate with multiple operating systems and user interfaces for an in-house implementation. ProtectID® has been designed to use multiple authentication devices that are currently on the market (including, but not limited to, biometrics, key-fob tokens, iPhones, iPads, Androids, PDA’s, smart cards, face biometric, fingerprint and other mobile devices). Our ability to integrate our products with multiple existing and future technologies is currently a key factor in the growth of our product’s acceptance and is demonstrated by our success with recent clients and installations. Our GuardedID® product currently operates with Windows Internet Explorer (IE), Firefox, Chrome and Safari browsers and our upgraded Premium version works with almost all applications running on a Windows desktop platform, inclusive of Microsoft Office and the MAC. New features and functions for both products continue to be developed via our research and development. Our MobileTrust® and GuardedID®  work on all Apple and Android devices.

 

 

·

Relative Cost: We have attempted to design our products to provide a cost-effective suite of products for financial services, e-commerce, commercial, healthcare, government and direct-consumer customers. Our ability to offer our products at a competitive price is a key factor in the acceptance of our product as we have seen with many of our clients.

 

 
8

Table of Contents

 

Business Model

 

We are focusing primarily on developing sales through “channel” relationships by offering  our products through   other manufacturers, distributors, value-added resellers and agents, internationally. In 2016, we added and publicly announced additions to our global distribution sales channel, which provides additional presence for us in the United States, Canada, Europe and Africa. We continue to add additional channel partners, especially on the consumer side and developed a new retail business. We also sell our suite of security products directly from our Edison, New Jersey office, which also augments our channel partner relationships. It is our strategy that these “channel” relationships will provide the greater percentage of our revenues ongoing, as was the case in the past two years. Examples of the channel relationships that we are seeking include already established original equipment manufacturer (“OEM”) and bundled relationships with other security technology and software providers that would integrate or bundle the enhanced security capabilities of ProtectID®, GuardedID® into their own product lines, including Zerify Meet™ and Zerify Defender™ and our Zerify Meet™ API’s, thereby providing greater value to their clients. These would include providers of networking software and manufacturers of computer and telecommunications hardware and software that provide managed services, and multi-level marketing groups, as well as all markets interested in increasing the value of their products and packages, such as financial services software, anti-virus, government integrators and identity theft product companies. We contracted with various new distributors during 2020 and 2021, and we anticipate, but cannot guarantee an increase in revenues in 2023 (subject to the impairments caused by the ongoing COVID-19 pandemic and the degree to which the economy rebounds post-pandemic). However, in 2023 we anticipate some large increases based on current discussions starting.

 

We believe, but cannot guarantee, increased  revenues of Zerify Meet™, our secure Video Conferencing Tool, and Zerify Defender™, which adds five levels of security for Zerify Meet™. While the full effect of the increased use in remote access in employment due to COVID-19 is still undeterminable, it has become evident, in managements estimation, clear that people will be working remotely for a long time, perhaps with some hybrid level of permanence. In a February 2021 New York Times article, Google announced that they will no longer require that their employees to come into the attainment office, as stated in the New York Times, Video conference sales are projected to be over $100 billion, more than double of what was originally projected. We believe that SafeVchat™ and Zerify Defender™ are perfectly timed for introduction into the market and we anticipate, but cannot guarantee, our market share will grow over the next several years.

 

From our MobileTrust® security application, built with our sCloud registration process, we created and announced two additional products in 2020: our ProtectID® Mobile OTP (One Time Password) to be used with ProtectID®; and our GuardedID® Mobile keystroke encryption software development kit (SDK). Both products are now in production. With the creation of GuardedID® Mobile SDK, we now focus the sales of this software product to the development groups of our target markets for it to be added to their mobile applications. We are in discussions with many large-scale parties that are interested in this software, although no assurances can be provided as to acceptance and profitability. Management has already received requests for this software, as keystroke encryption malware grows and remains a major problem for the mobile-cyber security market, particularly with anti-virus products being viewed as non-effective against malware threats.

 

Our primary target markets include secure financial services such as banks and insurance companies, healthcare providers, legal services, government agencies through integrators, technology platforms, e-commerce-based services companies, telecommunications and cellular carriers, technology software companies, government agencies and consumers, especially for our mobile and keystroke encryption products and our secure video conferencing and end-point solutions We are focusing our concentration on cyber security and data breach strategic problem areas, such as where compliance with financial, healthcare, legal and government regulations are key and stolen passwords are used to acquire private information illegally. In 2020 and 2021, several of our channel partners had pilots and client implementations in place that are expected, although no assurances can be provided, to increase our revenues in 2023 (subject to the impairments caused by the ongoing COVID-19 pandemic and the degree to which the economy rebounds post-pandemic). There is no guarantee as to the timing and continued success of these efforts.

 

 
9

Table of Contents

 

Because we are now expecting a continual, recurring growing market demand, especially in the mobility and encryption retail markets, we continue to develop a reseller and distribution channel as a strategy to generate, manage and fulfill demand for our products across market segments, minimizing the requirement for an increase in our staff as we grow our distributor market. We continue to minimize the concentration on our initial direct sales efforts as our distribution and reseller channels continue to grow internationally and provide appropriate levels of sales and support to the growing Cyber Security market, especially with the new help with VationVentures.

 

We seek to generate revenues through recurring fees for Zerify Meet™ (inclusive of Zerify Defender™ and ProtectID®), Zerify Defender™, GuardedID® and ProtectID® based on client consumer usage in the financial, healthcare services and legal services markets, as well as enterprises in general. We provide our clients a choice of operating our ProtectID® software internally by licensing it or through our hosted Cloud Service or a hybrid that some clients have implemented and none of our competitors presently offer. GuardedID® requires a download on each and every computer it protects, whether for employees or consumers. We have four GuardedID® products, (i) a standard version which protects browser data entry only, (ii) a premium version which protects almost all the applications running under Microsoft Windows on the desktop, including Microsoft Office Suite and almost all applications running on the desktop, (iii) an Enterprise version which, in addition, provides the Enterprise administrative rights and the use of Microsoft’s Enterprise tools for the product’s deployment, and (iv) an Apple version for all the latest MAC operating systems and for the browsers and entire desktop. Our GuardedID® Mobile SDK (software development kit) is priced for the consumer through the appropriate mobile phone stores, as well as direct, distribution and OEM sales for higher volume enterprises, including volume discounts to the degree allowed by the telecommunications providers. We anticipate, but cannot guarantee, steadily increasing revenues from these product offerings.

 

Our management believes that our products provide a cost-effective and technologically competitive solution to address the increasing problems of network security and cyber security in general.

 

Marketing

 

Our multi-channel marketing strategy includes:

 

1. The addition of resellers, agents & distributors (our strategic sales channel) who distribute and resell our products and services to enterprise and commercial customers globally (technology and software product distributors, systems integrators, managed service companies, other security technology and software vendors, telecom companies, cyber security related product companies, etc.).

 

2. Application Service Provider (ASP) Partners: Our third-party service provides a hosting platform that facilitates faster implementations at competitive prices for our Cloud Service option

 

3. Original Equipment Manufacturers (OEM): SFT products are sold to other security technology vendors that integrate ProtectID®, GuardedID® and, now, GuardedID® Mobile SDK into their products (bundling) and services providing for monthly/annual increasing recurring revenues. They are also now able to sell and bundle Zerify Meet™ and Zerify Defender™.

 

4. Technology and other providers and resellers, agents and distributors are interested in purchasing and or selling our new SafeVchat™ and PrivacyLok™ products as secure video conferencing products

 

5. Outside Independent consultants selling our products for commission only, focusing on the video conferencing, healthcare, legal, travel and consumer markets

 

 
10

Table of Contents

 

Intellectual Property

 

In November 2010, we received notice that the United States Patent and Trademark Office (“USPTO”) had issued an official Notice of Allowance for the patent application for the technology relating to our ProtectID® product, titled “Multi-Channel Device Utilizing a Centralized Out-of-Band Authentication System”. In January 2011, we received notice that the USPTO issued to us Patent No. 7,870,599. This “Out-of-Band” Patent went through a USPTO Re-Examination process starting on August 16, 2011 and concluded on December 27, 2011, with all of our patent claims remaining intact and eight additional patent claims being added. Since 2011, we submitted additional continuation patents on the “Out-of-Band” Patent. The keystroke encryption technology we developed and use in our GuardedID® product is protected by three patents and one continuation pending.

 

In January 2013, we were assigned the entire right, title and interest in the “Out-of-Band” Patent from NetLabs, with the agreement of the developer, and the assignment was recorded with the USPTO.

 

In February 2013, we executed a retainer agreement with our patent attorneys to aggressively enforce our patent rights as “Out-of-Band Authentication” was becoming the standard for authenticating consumers in the financial market and for many SaaS application users (e.g., SalesForce, Quickbooks, etc.). In February 2013, our patent attorneys submitted a new “Out-of-Band” Patent continuation, which was granted.

 

In March 2013, our patent attorneys submitted a new “Methods and Apparatus for securing user input in a mobile device” Patent, which is now patent pending. Our MobileTrust® product is the invention supporting the patent pending.

 

In July 2013, we received notice that the USPTO had added 54 additional patent claims for our Out-of-Band patent we received in January 2011, by issuing to us Patent No. 8,484,698 thereby strengthening our position with clients and our current and potential lawsuits.

 

In October 2013, we received notice that the USPTO issued to us Patent No. 8,566,608 “Methods and apparatus for securing keystrokes from being intercepted between the keyboard and a browser.” This protects our GuardedID® product and the keystroke encryption portion of our MobileTrust® products.

 

In February 2014, we received a Notice of Allowance from the USPTO for our third patent relating to our “Multi-Channel Device Utilizing a Centralized Out-of-Band Authentication System” Patent No. 7,870,599. Upon receipt of this Out-of-Band patent we filed another continuation patent.

 

In March 2014, we received Notice of Allowance from the USPTO for our second patent and first continuation of our Keystroke Encryption patent, which only furthers our protection for all mobile devices when utilizing any keyboard for data entry. Upon receipt of this Notice, we also filed another continuation patent for Patent No. 8,566,608.

 

In April 2014, we were granted our third patent relating to our “Multi-Channel Device Utilizing a Centralized Out-of-Band Authentication System” Patent No. 8,713,701.

 

In September 2014, we filed an International Patent for MobileTrust® (PCT/US20114/029905).

 

In March 2015, we received our third patent from the USPTO, Patent No. 8,973,107, of our Keystroke Encryption patent. This enhances our position for our Keystroke Encryption product, GuardedID®, and our MobileTrust® product.

 

On March 28, 2013, we initiated patent litigation against PhoneFactor, Inc., a subsidiary of Microsoft Corporation, for alleged infringement of United States Patent No. 7,870,599 (the “‘599 Patent”). We filed a separate action against Microsoft Corporation based on its alleged infringement of the ‘599 Patent and two additional patents for out-of-band user authentication (U.S. Patent Nos.: 8,484,698 & 8,713,701). Both actions were filed in the U.S. District Court for the District of Delaware. On January 15, 2016, the litigation was settled and the parties executed a settlement agreement in the form of a Release and License Agreement. The terms and conditions of the Release and License Agreement are confidential except under limited conditions. As a consequence of the Release and License Agreement, the parties have moved to dismiss the action with prejudice, we have  licensed the patents to Microsoft Corporation, and we received a non-disclosable one-time lump sum payment.

 

 
11

Table of Contents

 

In June 2020, we were awarded an International European Patent, Application #14763895.1, for MobileTrust®. While the MobileTrust® International Patent was granted in Europe, the patent application in the United States was rejected.

 

Our patent attorneys filed our fourth, fifth and sixth “Out of Band” continuation patents. We currently have three patents granted to us for Out-of-Band ProtectID® (Patent Nos.: 7,870,599, 8,484,698 and 8,713,701). MobileTrust® is also covered by our GuardedID® patents. We cannot provide assurances that the latter patents will be granted in fiscal 2023.

 

We plan to continue our strategy to aggressively enforce the patent rights relating to our granted Keystroke Encryption patents that help protect our GuardedID® and MobileTrust® products. We were granted three related keystroke encryption patents for which we received the most recent patent on March 3, 2015 (Patent Nos.: 8,566,608, 8,732,483 and 8,973,107). In June 2020, we also received an International Patent in Europe for MobileTrust® (Patent Approved: Application #14763895.1).

 

We have four trademarks that have been approved and registered: GuardedID®, MobileTrust® and CryptoColor®. Also, BlockSafe Technologies, Inc. has one registered trademark: CyberDefender®. A portion of our software is licensed from third parties and the remainder is developed by our own team of developers while leveraging some external consultant expertise as necessitated. We rely upon confidentiality agreements signed by our employees, consultants, and third parties to protect the intellectual property rights.

 

Business Strategy

  

Our primary strategy throughout 2023 is to focus on the growth and support of our channel partners, including distributors, resellers and original equipment manufacturers (OEMs) (subject to the impairments caused by COVID-19). Our internal sales team targets potential direct sales in industries that management believes provides the greatest potential for short term sales. These include small to medium sized financial institutions, government agencies, e-commerce, healthcare, legal and enterprise businesses. We are also executing agreements with strategic resellers and distributors for marketing, selling and supporting our products internationally. We primarily work with distributors, resellers and agents to generate the bulk of our sales internationally, realizing that this strategy takes longer to nurture, however it is progressing well. We are starting to realize positive results, however slowly, with our sales channel and anticipate, but cannot guarantee, a successful fiscal 2023, through the sales channel and from our new mobile and GuardedID® MAC, ZerifyMeet™ and ZerifyDefender™ products with a concentration of sales already contracted. There can be no assurances, however, that we will succeed in implementing our sales strategy. Although management believes that there is an increasingly strong market for our products as the need for cyber security solutions increases globally, we have not generated substantial revenue from the sale of our products and there is no assurance we can secure a market sufficient to permit us to achieve profitability in fiscal 2023 (subject to the impairments caused by the ongoing COVID-19 pandemic and the degree to which the economy rebounds post-pandemic).

 

Most of the costs that we incur are related to salaries, professional fees, marketing, sales and research & design. Our operations presently require funding of approximately $220,000 per month. We expect that our monthly cash usage for operations will increase slightly due to contracted and anticipated increased volumes and adding some targeted channel marketing programs. We anticipate that the areas in which we will experience the greatest increase in operating expenses is in marketing, selling, product support, product research and new technology development in the growing cyber security market. We are committed to maintaining our current level of operating costs until we reach the level of revenues needed to absorb any potential increase in costs.

 

Competition

 

The software development and services market is characterized by innovation and competition. There are several well-established companies within the authentication market that offer network security systems in our product market and newer companies with emerging technologies. We believe that our multi-patented “Out-of-Band” multi-factor identity authentication platform is an innovative, secure, adaptable, competitively priced, integrated network authentication platform. The main features of ProtectID® include: an open architecture “Out-of-Band” platform for user authentication; operating system independence; biometric layering; soft mobile tokens; mobile authentication; secure website logon; Virtual Private Network (“VPN”) access; domain authentication; newly added Office 365 authentication and multi-level authentication. Unlike other techniques for increased network security, ProtectID® does not rely on a specific authentication device or method (e.g., phone, tokens, smart cards, digital certificates, soft mobile tokens, or biometrics, such as a retinal or fingerprint scan). Rather ProtectID® has been developed as an “open platform” that incorporates an unlimited number of authentication devices and methods. For example, once a user has been identified to a computer network, a system deploying our ProtectID® authentication system permits the “Out-of-Band” authentication of that user by a telephone, iPhone, iPad, PDA, email, hard token, SSL client software, a biometric device such as a voice biometric, or others, before that user is permitted to access the network. By using “Out-of-Band” authentication methods, management believes that ProtectID®, now protected through our ongoing litigation, with plans for additional litigation, provides a competitive product for customers with security requirements greater than typical name and password schemes for virtual private networks and computer systems with multiple users at remote locations, as examples. We also believe that our multi-patented keystroke encryption product, GuardedID®, offers an additional competitive edge for network security and e-commerce applications that should provide greater levels of security and the ability to evolve over time based on newer technologies when made available. There is less competition for the keystroke encryption product and there are no well-established companies in this space, which explains our current growth in pilots and sales for GuardedID®, especially relating to bundled channel partner programs. GuardedID® is critical to help prevent key logging viruses, one of the largest sources of cyberattacks and data breaches. GuardedID® also is protected with three patents.

 

 
12

Table of Contents

 

Our patented technologies are used in Zerify Meet™, our secure Video Conferencing Tool and Zerify Defender™, which adds five levels of security for Zerify Meet™ Premium, which we believe is more secure than Zoom, Teams and other competitors’ products available in the growing marketplace.

 

Although we believe that our suite of products offers competitive advantages, there is no assurance that any of these products will continue to increase its market share in the marketplace. Our competitors include established software and hardware companies that are likely to be better financed and to have established sales channels. Due to the high level of innovation in the software development industry, it is also possible that a competitor will introduce a product that provides a higher level of security than our products or which can be offered at prices that are more advantageous to the customer.

 

BlockSafe Technologies, Inc.

 

BlockSafe Technologies, Inc. (“BlockSafe”) was formed on December 1, 2017 in the State of Wyoming. BlockSafe is in the business of providing total cyber security solutions and has the licensee from us of our desktop anti-malware product called “GuardedID®” and our one-of-a-kind mobile application called “MobileTrust®”. BlockSafe is intended to be developed as an enterprise focused on using our licensed technology in the field of cryptocurrency and its use of blockchains. Small revenues have been generated to date, primarily due to the effects of the ongoing COVID-19 pandemic. There can be no assurances on the success of this project or any profitability arising from BlockSafe.

 

In prior years, the Company agreed to issue crypto currency tokens as part of its financing activities. As of December 31, 2022, no tokens have been developed or issued. There is no assurance as to whether, or at what amount, or on what terms, tokens will be available. Moreover, there can be no assurance how such technology will function, which could expose us to legal and regulatory issues. Cryptocurrency and its use of blockchains is still in the development stage and receiving mixed results. The Securities and Exchange Commission has, in its dissemination of information to the public, expressed that tokens in the United States would be treated as securities pursuant to the Howey Test. This standard has been adopted, in various forms, in numerous other jurisdictions. The European Union and China are contemplating their own form of cryptocurrency and Facebook Libra cryptocurrency recently lost the support of PayPal (see https://www.independent.co.uk/topic/cryptocurrency, which article is not incorporated by reference to this filing). On March 30, 2022, the Securities and Exchange Commission’s Division of Examinations announced its 2022 examination priorities which included the review of the use of crypto-assets as one of its top five priorities for review. This review and any regulatory rules and regulations arising from this review may impact the BlockSafe business. In addition, legal and regulatory developments could render the technology impermissible, which could have a material adverse effect on BlockSafe and us.

 

At December 31, 2022, noncontrolling interests represent 51% of BlockSafe. BlockSafe meets the definition of a variable interest entity (“VIE”) and based on the determination that we are the primary beneficiary of BlockSafe, we consolidated BlockSafe’s operating results, assets and liabilities. We and BlockSafe have a management agreement pursuant to which BlockSafe shall remit a management fee of $36,000 per month to us, and when BlockSafe reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to us, payable monthly over three years. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BlockSafe, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to our  general credit. .

 

 
13

Table of Contents

 

In June 2018, two members of our management team, George Waller, our Executive Vice President and Ramarao Pemmaraju, our Chief Technical Officer, were appointed to BlockSafe to serve as the Chief Executive Officer and Chief Technical Officer, respectively. Additionally, our Chief Executive Officer of Zerify, Mark L. Kay, also an appointee to the Board of Directors of BlockSafe, was appointed as Chairman and President of BlockSafe.

 

In 2018, our  consolidated subsidiary, BlockSafe, issued promissory notes to investors in the aggregate of $775,500. As part of each promissory note agreement BlockSafe agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined, to be issued by BlockSafe. In December 2018, BlockSafe agreed to issue 200,000 cryptocurrency tokens to an unrelated party for receipt of $50,000. In February 2019, the agreement was amended and the unrelated party is to receive an additional 100,000 tokens. No such tokens have been developed or issued as of December 31, 2022.

 

From February 2019 to March 2019, BlockSafe agreed to issue 450,000 cryptocurrency tokens and 56,250 restricted shares of BlockSafe common stock to four unrelated parties for receipt of $122,500. The tokens or restricted stock of BlockSafe have not been issued as of December 31, 2022.

 

From March to April 2019, five of the BlockSafe noteholders agreed to convert $295,500 of principal and $19,700 of accrued interest into 1,845,041 cryptocurrency tokens to be issued by BlockSafe. The tokens have not been issued as of December 31, 2022.

 

We have used the funds received from investors pursuant to the promissory notes for the efforts mentioned below to develop the Tokens and to develop an additional product and prepare it for sale. We currently do not require additional funds for the development efforts.

 

The steps we have taken to date in our efforts to develop tokens include completing a formal plan for the Tokens, obtaining professional advice regarding the legal implications of developing tokens, and we have a blockchain for our Tokens (BSAFE®). We have not yet finalized a budget for the development of Tokens, or hired a full development team, or completed the development of Tokens, and we have not developed any payment, trading, or custody platform or infrastructure related to the Tokens. The failure to develop or issue these Tokens as of December 31, 2022 does not constitute an event of default under the promissory notes. It should be noted however that the promissory notes were not repaid pursuant to their terms and are currently in default.

 

At December 31, 2021, our  consolidated subsidiary, BlockSafe, had recorded a financing obligation of $1,263,000 to be paid in tokens, as defined. At December 31, 2021 and through the date of this filing, BlockSafe. has not completed the development or issued any tokens. At December 31, 2022, as the development of the tokens has not been completed and tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe., through the issuance of tokens, or through other means if tokens are never issued.

 

We have stated to the note holders that once Zerify has the funds or BlockSafe sells the Tokens, the intent is to satisfy the outstanding balances as soon as possible. In the event that we are unable to satisfy the outstanding balances of the Notes, it could have a material adverse effect on our business, financial condition and results of operations.    

 

In March 2019, an increase of the authorized shares of BlockSafe’s common stock from one thousand (1,000) to one hundred million (100,000,000), $0.0001 par value, was ratified, effective upon the filing of an amendment to BlockSafe’s Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in March 2019.

 

 
14

Table of Contents

 

In March 2019, a 1:15,000 forward stock split of BlockSafe’s issued and outstanding shares of common stock was ratified, effective upon the filing of an amendment to BlockSafe’s Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in March 2019.

 

Cybersecurity Risk Solutions, LLC

 

On April 15, 2021, StrikeForce formally closed a Member Interest Purchase Agreement in which StrikeForce acquired the entire Member Interests of Cybersecurity Risk Solutions, LLC, a New Jersey limited liability company. In April 2021, we issued 500,000 shares of common stock with a fair value of $36,000, for the purchase of Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, we also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.

 

Cybersecurity Risk Solutions, LLC is a cybersecurity firm offering cyber, privacy & data protection services including a personal cyber risk assessment, the industry’s first cyber health score, report and custom action plan, as well as ongoing vulnerability scanning, hack monitoring and dark web intelligence monitoring. For more information, go to https://SecureCyberID.com (which website is expressly not included in this filing). Will Lynch, the prior sole member of Cybersecurity Risk Solutions, LLC was hired by StrikeForce as the Director of Channel Distribution and not as a Named Executive Officer. A Director of Channel Distribution develops, services, and grows relationships with clients. Mr. Lynch has an annual salary of $100,000 and will also receive 2% net of all Channel sales. Mr. Lynch reports to our Executive Vice President and Marketing Director.

 

Mr.Lynch, Director of Channel Distribution, tendered his resignation on December 2, 2022 and hasn’t been replaced at StrikeForce, now called Zerify. Cybersecurity Risk Solutions is still in business and selling its products.

 

Employees

 

As of fiscal year ended December 31, 2022, we had 16 employees and our relations with employees are good.

 

WHERE YOU CAN FIND MORE INFORMATION

 

You are advised to read this Form 10-K in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

 

ITEM 1A. RISK FACTORS

 

The risk factors required pursuant to Regulation S-K, Item 503(c) are not required for smaller reporting companies, however, we have determined to provide particular risk factors herein.  e. The risks and uncertainties described below are not the only ones facing us. Other events that we do not currently anticipate or that we currently deem immaterial also may affect our results of operations and financial condition. If any events described in the risk factors actually occur, our business, operating results, prospects and financial condition could be materially harmed. In connection with the forward-looking statements that appear elsewhere in this annual report, you should also carefully review the cautionary statement referred to under “Special Note Regarding Forward Looking Statements.” The forward-looking statements made in this report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

 

 
15

Table of Contents

 

SHOULD ONE OR MORE OF THE FOREGOING RISKS OR UNCERTAINTIES MATERIALIZE, OR SHOULD THE UNDERLYING ASSUMPTIONS OF OUR BUSINESS PROVE INCORRECT, ACTUAL RESULTS MAY DIFFER SIGNIFICANTLY FROM THOSE ANTICIPATED, BELIEVED, ESTIMATED, EXPECTED, INTENDED OR PLANNED.

 

OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM HAS EXPRESSED SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN, WHICH MAY HINDER OUR ABILITY TO OBTAIN FUTURE FINANCING.

 

We have yet to establish any history of profitable operations. For the year ended December 31, 2022, we incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000, and at December 31, 2022, we had a stockholders’ deficit of $14,855,000. Also, at December 31, 2022, we are in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors raise substantial doubt about our ability to continue as a going concern within one year of the date that these financial statements are issued. As a result, our independent registered public accounting firm included an explanatory paragraph in its report on our financial statements as of and for the year ended December 31, 2022 with respect to this uncertainty. This going concern opinion could materially limit our ability to raise additional funds through the issuance of new debt or equity securities and future reports on our financial statements may also include an explanatory paragraph with respect to our ability to continue as a going concern.

 

At December 31, 2022, we had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received proceeds of $813,000 on the sale of common shares and warrants (see Note 15 to the accompanying consolidated financial statements). We believe we have enough cash to sustain operations through June 30, 2023. Our ability to continue as a going concern is dependent upon our ability to continue to implement our business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of our strategy to increase revenues, there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon our ability to increase our customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

 

We completed the development of our ProtectID® platform at the end of June 2006, we completed the core development of our keyboard encryption and anti-keylogger product, GuardedID®, in December 2006 and commenced deployment of our new mobile product, MobileTrust® into the mobile stores in 2015. We completed GuardedID® in 2016 and SafeVchat™ and PrivacyLok™ in 2021. Presently, (except for Zerify Meet™ and PrivacyLok™ which are in beta testing although we already earned revenues from Zerify Meet™ and Zerify Defender™ in 2022), all of the products are being sold and distributed. Our suite of products is targeted to the financial, e-commerce, corporate, government, healthcare, legal, insurance, technology and retail markets. We seek to locate customers in a variety of ways. These primarily include contracts with value added resellers and distributors (both inside the United States and internationally), direct sales calls initiated by our internal staff, exhibitions at security and technology trade shows, through the media, through consulting agreements, and through our agent relationships. Our sales generate revenue either as an Original Equipment Manufacturer (“OEM”) model, through a Hosting/License agreement, bundled with other of our products or through direct purchase by distributors and resellers. We price our products for cloud consumer transactions based on the number of transactions in which our software products are utilized. We also price our products for business applications based on the number of users. These pricing models provide us with one-time, monthly, quarterly and annual recurring revenues with volume discounts. We are also generating revenues from annual maintenance contracts, renewal fees and expect, but cannot guarantee, an increase in revenues based upon the execution of various agreements that we have recently concluded, primarily in the retail and insurance sectors.

 

 
16

Table of Contents

 

WE WILL FACE INTENSE COMPETITION FROM OUR COMPETITORS THAT HAVE GREATER FINANCIAL, TECHNICAL AND MARKETING RESOURCES THAN WE DO. THESE COMPETITIVE FORCES MAY IMPACT OUR PROJECTED GROWTH AND ABILITY TO GENERATE REVENUES AND PROFITS, WHICH WOULD HAVE A NEGATIVE IMPACT ON OUR BUSINESS AND THE VALUE OF YOUR INVESTMENT.

 

We likely will face competition from alternate security software programs and services. As is typical of a new industry, demand and market acceptance for recently introduced services are subject to a high level of uncertainty and risk. In addition, the software industry is characterized by frequent innovation. As the market for computer security products evolves, it will be necessary for us to continually modify and enhance our existing products and develop new products. We believe that our competitors will enhance existing product lines and introduce new products. If we are unable to update our software to compete or to meet announced schedules for improvements and enhancements, it is likely that our sales will suffer and that potential customers will be lost to a competing company’s product.

 

Because the market for our services is new and evolving, it is difficult to predict the future growth rate, if any, and the size of this market. Substantial marketing activities have been implemented and will continue to be required to meet our revenue and profit goals. There can be no assurance we will be successful in such marketing efforts. There can be no assurance either that the market for our services will develop or become sustainable. Further, other companies may decide to provide services similar to ours. These companies may be better capitalized than us and we could face significant competition in pricing and services offered.

 

IF WE DO NOT ADEQUATELY PROTECT THE INTELLECTUAL PROPERTY RIGHTS, WE MAY EXPERIENCE A LOSS OF REVENUE AND OUR OPERATIONS MAY BE MATERIALLY IMPAIRED.

 

We rely upon confidentiality agreements signed by our employees, consultants and third parties to protect the intellectual property. These agreements generally provide that the individual must keep confidential and not disclose to other parties any confidential information developed or learned by the individual during the course of the individual’s relationship with us except in limited circumstances. These agreements generally also provide that we shall own all inventions conceived by the individual in the course of rendering services to us. These agreements may not effectively prevent disclosure of confidential information or result in the effective assignment to us of intellectual property and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information or other breaches of the agreements. In addition, others may independently discover trade secrets and proprietary information that have been licensed to us or that we own, and in such case we could not assert any trade secret rights against such party.

 

We cannot assure that we can adequately protect the intellectual property or successfully prosecute potential infringement of the intellectual property rights. Also, we cannot assure that others will not assert rights in, or ownership of, trademarks and other proprietary rights of ours or that we will be able to successfully resolve these types of conflicts to our satisfaction. Failure to protect the intellectual property rights would result in a loss of revenue and could adversely affect our operations and financial condition.

 

OUR INABILITY TO RETAIN OUR KEY EXECUTIVE OFFICERS WOULD IMPEDE OUR BUSINESS PLAN AND GROWTH STRATEGIES, WHICH COULD HAVE A NEGATIVE IMPACT ON OUR BUSINESS AND THE VALUE OF YOUR INVESTMENT.

 

Our success depends, to a critical extent, on the continued efforts and services of our Chief Executive Officer, Mark L. Kay, our Chief Technical Officer and Inventor, Ramarao Pemmaraju, our Chief Technical Officer, and our Executive Vice President and Head of Marketing, George Waller. Were we to lose any of our key executive officers, we would be forced to expend significant time and money in the pursuit of a replacement, which would result in both a delay in the implementation of our business plan and the diversion of limited working capital. We can give you no assurance that we can find satisfactory replacements for these key executive officers at all, or on terms that are not unduly expensive or burdensome. We do not currently carry key-man life insurance policies on any of our employees, which would assist us in recouping our costs in the event of the loss of those officers.

 

 
17

Table of Contents

 

THE INABILITY TO MANAGE OUR GROWTH COULD IMPEDE OUR ABILITY TO GENERATE REVENUES AND PROFITS AND TO OTHERWISE IMPLEMENT OUR BUSINESS PLAN AND GROWTH STRATEGIES, WHICH WOULD HAVE A NEGATIVE IMPACT ON OUR BUSINESS AND THE VALUE OF YOUR INVESTMENT.

 

We plan to grow rapidly, which will place strains on our management team and other of our resources to both implement more sophisticated managerial, operational and financial systems, procedures and controls and to hire, train and manage the personnel necessary to implement those functions. Our staff is currently comprised of ten people and we believe that in order for us to achieve our goals, it will be necessary to further expand our personnel, particularly in the area of sales, support services, technology development and client support. As we grow, we also expect to increase detailed and pertinent internal and administrative controls and procedures, require further product enhancements and customization of our existing products for specific clients, as well as enter new geographic markets. We do not presently have in place the corporate infrastructure common to larger organizations. We do not, for example, have a separate human resources department or purchasing department designed for a larger organization. Some of our key personnel do not have experience managing large numbers of personnel. Substantial expansion of our organization will require the acquisition of additional information systems and equipment, a larger physical space and formal management of human resources. It will require that we expand the number of people within our organization providing additional administrative support (or consider outsourcing) and to develop and implement additional internal controls appropriate for a larger organization. Our experience to date in managing the minimal growth has been positive, without product failures or breakdowns of internal controls. 

 

The time and costs to effectuate our business development process may place a significant strain on our management personnel, systems and resources, particularly given the limited amount of financial resources and skilled employees that may be available at the time. There can be no assurance that we will integrate and manage successfully new systems, controls and procedures for our business, or that our systems, controls, procedures, facilities and personnel, even if successfully integrated, will be adequate to support our projected future operations. There can be no assurance that any expenditure incurred during this expansion will ever be recouped. Any failure to implement and maintain such changes could have a material adverse effect on our business, financial condition and results of operations.

 

THE REGULATION OF PENNY STOCKS BY SEC AND FINRA (FINANCIAL INDUSTRY REGULATORY AUTHORITY, INC.) MAY DISCOURAGE THE TRADABILITY OF OUR SECURITIES AND THEREBY MAKE IT HARD FOR INVESTORS TO SELL THEIR SHARES AT THE TIME AND PRICES THEY MIGHT OTHERWISE EXPECT.

 

We are a “penny stock” company. We are subject to a Securities and Exchange Commission rule that imposes special sales practice requirements upon broker-dealers who sell such securities to persons other than established customers or accredited investors. For purposes of the rule, the phrase “accredited investors” means, in general terms, institutions with assets in excess of $5,000,000, or individuals having a net worth in excess of $1,000,000 or having an annual income that exceeds $200,000 (or that, when combined with a spouse’s income, exceeds $300,000). For transactions covered by the rule, the broker-dealer must make a special suitability determination of the purchaser and receive the purchaser’s written agreement to the transaction prior to the sale. Effectively, this discourages broker-dealers from executing trades in penny stocks. Consequently, the rule will affect the ability of purchasers in this offering to sell their securities in any market that might develop, because it imposes additional regulatory burdens on penny stock transactions.

 

In addition, the Securities and Exchange Commission has adopted a number of rules to regulate “penny stocks”. Such rules include Rules 3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, and 15g-9 under the Securities and Exchange Act of 1934, as amended. Because our securities constitute “penny stocks” within the meaning of the rules, the rules would apply to us and to our securities. The rules will further affect the ability of owners of shares to sell their securities in a market that might develop for them because it imposes additional regulatory burdens on penny stock transactions.

 

Shareholders should be aware that, according to the Securities and Exchange Commission Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, leaving investors with losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities.

 

 
18

Table of Contents

 

RULE 144 SALES IN THE FUTURE MAY HAVE A DEPRESSIVE EFFECT ON OUR STOCK PRICE AS AN INCREASE IN SUPPLY OF SHARES FOR SALE, WITH NO CORRESPONDING INCREASE IN DEMAND WILL CAUSE PRICES TO FALL.

 

All of the outstanding shares of common stock held by the present officers, directors, and affiliate stockholders are “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933, as amended. As restricted shares, these shares may be resold only pursuant to an effective registration statement or under the requirements of Rule 144 or other applicable exemptions from registration under the Act and as required under applicable state securities laws. Rule 144 provides in essence that a person who is an affiliate or officer or director who has held restricted securities for six months may, under certain conditions, sell every three months, in brokerage transactions, a number of shares that does not exceed the greater of 1.0% of a company’s outstanding common stock. There is no limit on the amount of restricted securities that may be sold by a non-affiliate after the owner has held the restricted securities for a period of six months if the company is a current reporting company under the 1934 Act. A sale under Rule 144 or under any other exemption from the Act, if available, or pursuant to subsequent registration of shares of common stock of present stockholders, may have a depressive effect upon the price of the common stock in any market that may develop.

 

FINRA SALES PRACTICE REQUIREMENTS MAY ALSO LIMIT A STOCKHOLDER’S ABILITY TO BUY AND SELL OUR STOCK.

 

In addition to the “penny stock” rules described above, the Financial Industry Regulatory Authority (FINRA) has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

 

BECAUSE WE ARE QUOTED ON THE OTCMARKETS.COM INSTEAD OF AN EXCHANGE OR NATIONAL QUOTATION SYSTEM, OUR INVESTORS MAY HAVE A MORE DIFFICULT TIME SELLING THEIR STOCK OR EXPERIENCE NEGATIVE VOLATILITY ON THE MARKET PRICE OF OUR STOCK.

 

Our common stock is traded on OTCMarkets.com. The OTCMarkets.com is often highly illiquid. There is a greater chance of volatility for securities that trade on the OTCMarkets.com as compared to a national exchange or quotation system. This volatility may be caused by a variety of factors, including the lack of readily available price quotations, the absence of consistent administrative supervision of bid and ask quotations, lower trading volume, and market conditions. Investors in our common stock may experience high fluctuations in the market price and volume of the trading market for our securities. These fluctuations, when they occur, have a negative effect on the market price for our securities. Accordingly, for the reasons above, our stockholders may not be able to realize a fair price from their shares when they determine to sell them or may have to hold them for a substantial period of time until the market for our common stock improves.

 

WE HAVE IDENTIFIED MATERIAL WEAKNESSES IN OUR DISCLOSURE CONTROLS AND PROCEDURES AND INTERNAL CONTROL OVER FINANCIAL REPORTING.

 

Maintaining effective internal control over financial reporting and effective disclosure controls and procedures are necessary for us to produce reliable financial statements. As discussed in Item 9A – “Controls and Procedures” of this Form 10-K, we have evaluated our internal control over financial reporting and our disclosure controls and procedures and concluded that they were not effective as of December 31, 2022.

 

 
19

Table of Contents

 

A material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses we identified are (1) We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us as of and for the year ended December 31, 2022. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness; (2) Our board of directors has no independent director or member with financial expertise which causes ineffective oversight of our external financial reporting and internal control over financial reporting; (3) We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

We are committed to remediating its material weaknesses as promptly as possible. Implementation of our  remediation plans has commenced and is being overseen by the board. However, there can be no assurance as to when these material weaknesses will be remediated or that additional material weaknesses will not arise in the future. Even effective internal control can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements. Any failure to remediate the material weaknesses, or the development of new material weaknesses in our internal control over financial reporting, could result in material misstatements in our financial statements, which in turn could have a material adverse effect on our financial condition and the trading price of our common stock and we could fail to meet our financial reporting obligations. We have identified weaknesses in our internal controls, and we cannot provide assurances that these weaknesses will be effectively remediated or that additional material weaknesses will not occur in the future.

 

If not remediated, our failure to establish and maintain effective disclosure controls and procedures and internal control over financial reporting could result in material misstatements in our financial statements and a failure to meet our reporting and financial obligations, each of which could have a material adverse effect on our financial condition and the trading price of our common stock.

 

VOLATILITY IN OUR COMMON SHARE PRICE MAY SUBJECT US TO SECURITIES LITIGATION, THEREBY DIVERTING OUR RESOURCES THAT MAY HAVE A MATERIAL EFFECT ON OUR PROFITABILITY AND RESULTS OF OPERATIONS.

 

As discussed in the preceding risk factors, the market for our common shares is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. In the past, plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may in the future be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and could divert management’s attention and resources.

 

COMPLIANCE WITH CHANGING REGULATION OF CORPORATE GOVERNANCE AND PUBLIC DISCLOSURE WILL RESULT IN ADDITIONAL EXPENSES AND POSE CHALLENGES FOR OUR MANAGEMENT TEAM.

 

Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules and regulations promulgated thereunder, the Sarbanes-Oxley Act and SEC regulations, have created uncertainty for public companies and significantly increased the costs and risks associated with accessing the U.S. public markets. In addition, the current federal administration has indicated significant regulatory modifications and we cannot foresee the impact of any revised regulations. Our management team will need to devote significant time and financial resources to comply with both existing and evolving standards for public companies, including the policies of the recently appointed Chairman of the SEC, which will lead to increased general and administrative expenses and a diversion of management time and attention from revenue generating activities to compliance activities.

 

 
20

Table of Contents

 

COVID-19.

 

We cannot, at this point, determine the extent to which ongoing COVID-19 pandemic will impact business or the economy as both are highly uncertain and cannot be predicted.

 

THE OUTBREAK OF THE CORONAVIRUS MAY NEGATIVELY IMPACT SOURCING AND MANUFACTURING OF THE PRODUCTS THAT WE SELL AS WELL AS CONSUMER SPENDING, WHICH COULD ADVERSELY AFFECT OUR BUSINESS, RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

In December 2019, a novel strain of coronavirus was reported to have surfaced in Wuhan, China, which has and is continuing to spread throughout China and other parts of the world, including the United States. On January 30, 2020, the World Health Organization declared the outbreak of the coronavirus disease (COVID-19) a “Public Health Emergency of International Concern.” On January 31, 2020, U.S. Health and Human Services Secretary Alex M. Azar II declared a public health emergency for the United States to aid the U.S. healthcare community in responding to COVID-19, and on March 11, 2020 the World Health Organization characterized the outbreak as a “pandemic”. The significant outbreak of COVID-19 has resulted in a widespread health crisis that could adversely affect the economies and financial markets worldwide, and could adversely affect our business, results of operations and financial condition.

 

In addition, we applied for funding pursuant to the Small Business Administration program. The Paycheck Protection Program provided forgivable funding for payroll and related costs as well as some non-payroll costs. We applied for funding and we received (on April 17, 2020) funding in the amount of $313,000. In June 2021, the April 2020 PPP loan of $313,000 was forgiven by the SBA. Pursuant to ASC 470, Debt, we recorded a gain of $313,000 to extinguish the PPP loan and accrued interest of $4,000. The Economic Injury Disaster Loan provides low-interest, long-term financing. We applied for funding and received (on May 18, 2020) funding in the amount of $150,000. In March 2021, we applied for funding and were approved for a second round of Paycheck Protection Program forgivable financing in the amount of $177,000. In November 2021, the March 2021 PPP loan of $177,000 was forgiven by the SBA. Pursuant to ASC 470, Debt, we recorded a gain of $177,000 to extinguish the PPP loan and accrued interest of $1,000.

 

THE OUTBREAK OF THE COVID-19 MAY ADVERSELY AFFECT OUR CUSTOMERS.

 

Further, such risks as described above could also adversely affect our customers’ financial condition, resulting in reduced spending for the merchandise we sell. Risks related to an epidemic, pandemic or other health crisis, such as COVID-19, could also lead to the complete or partial closure of one or more of our facilities or operations of our sourcing partners. The ultimate extent of the impact of any epidemic, pandemic or other health crisis on our business, financial condition and results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of such epidemic, pandemic or other health crisis and actions taken to contain or prevent their further spread, among others. These and other potential impacts of an epidemic, pandemic or other health crisis, such as COVID-19, could therefore materially and adversely affect our business, financial condition and results of operations.

 

An economic recession had set in from the pandemic in 2020 and continued into 2021. Some companies are not receiving payments and in turn, as a consequence of limited cash flow, are not prepared to purchase our products. COVID-19 has led to some of our customers and potential customers being stricken with the virus causing them to not be able to work for many weeks and therefore causing delays for us in our marketing decisions. This outbreak could decrease spending, adversely affect demand for our products, and harm our business and results of operations. It is not possible for us to predict the duration or magnitude of the adverse results of the outbreak or the timing and the degree to which economic recovery will be realized post-pandemic and, consequently, its effects on our business or results of operations, financial condition, or liquidity, at this time.

 

The global impact of COVID-19 and actions taken to reduce its spread continues to rapidly evolve and we will continue to monitor the situation and the effects on our business and operations closely. We do not yet know the full extent of potential impacts on our business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time. The length of time it may take for global vaccine distribution and more normal economic and operating conditions to resume remains uncertain and the economic recovery period could continue for a prolonged period even after the health risks of the pandemic subside. Given the uncertainty, we cannot reasonably estimate the impact on our future results of operations, cash flows or financial condition. To the extent the ongoing COVID-19 pandemic adversely affects our business and results of operations, it may also have the effect of heightening many of the other risks and uncertainties described in this “Risk Factors” section of this Annual Report. We will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition and liquidity, and our results presented herein are not necessarily indicative of the results to be expected for future years.

 

 
21

Table of Contents

  

THE OUTBREAK OF COVID-19 HAS RESULTED IN A WIDESPREAD HEALTH CRISIS THAT COULD ADVERSELY AFFECT THE ECONOMIES AND FINANCIAL MARKETS WORLDWIDE AND COULD EXPONENTIALLY INCREASE THE RISK FACTORS DESCRIBED IN OUR PRIOR FILINGS.

 

SHOULD ONE OR MORE OF THE FOREGOING RISKS OR UNCERTAINTIES MATERIALIZE, OR SHOULD THE UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY DIFFER SIGNIFICANTLY FROM THOSE ANTICIPATED, BELIEVED, ESTIMATED, EXPECTED, INTENDED OR PLANNED.

 

Special Note Regarding Forward-Looking Statements

 

This Annual Report contains forward-looking statements about our business, financial condition and prospects that reflect our management’s assumptions and good faith beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. If any of our assumptions should prove incorrect, or if any of the risks and uncertainties underlying such expectations should materialize, our actual results may differ materially from those indicated by the forward-looking statements.

 

The key factors that are not within our control and that may have a direct bearing on operating results include, but are not limited to, acceptance of our proposed services and the products we expect to market, our ability to establish a customer base, managements’ ability to raise capital in the future, the retention of key employees and changes in the regulation of our industry.

 

There may be other risks and circumstances that management may be unable to predict. When used in this filing, words such as, “believes,” “expects,” “intends,” “plans,” “anticipates,” “estimates” and similar expressions are intended to identify and qualify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

This Item is not applicable to us as we are not an accelerated filer, a large accelerated filer, or a well-seasoned issuer; however, we have not received written comments from the Commission staff regarding our periodic or current reports under the Securities Exchange Act of 1934 within the last 180 days before the end of our last fiscal year.

 

ITEM 2. PROPERTIES

 

We operate from leased offices located at 1090 King Georges Post Road, Suite #603, Edison, New Jersey 08837. We do not hold any material investments in other real or personal property other than office equipment. We paid a monthly base rent of $4,542 from February 2020 through January 2021 and $4,678 from February 2021 through January 2022. We paid a monthly base rent of $4,818 from February 2022 through January 2023 and currently paying $4,963 from February 2023 thru January 2024. Our leased offices are adequate for our needs.

 

ITEM 3. LEGAL PROCEEDINGS

 

Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant (U.S. District Court, District of New Jersey, Civil Action No. 2:22-cv-07258-MCA-AME)

  

On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”),  filed a stockholder derivative Complaint against the Company’s directors, Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their management of the Company.   Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint.  On March 10, 2023, the Defendants served a motion to dismiss the complaint  upon the Plaintiff.  The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023.   Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation.

 

Onstream Media Corporation

 

The Company is currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases.

 

The cases and their filing dates follow:

 

Case

 

Date Filed

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00191 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00192 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00193 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00194 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00195 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00196 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00197 (DWY)

 

September 9, 2022

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 
22

Table of Contents

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

(A) MARKET INFORMATION

 

Our registration statement on Form SB-2 was declared effective by the SEC in August 2005 and our shares were approved for listing on the OTC Bulletin Board by the Financial Industry Regulatory Authority (FINRA) in December 2005. Prior to December 2005, there was no public market for the common stock. Our common stock is currently quoted on the OTC Electronic Bulletin Board maintained by OTCMarkets.com (OTC: Pink) under the symbol “ZRFY”. The following sets forth high and low bid price quotations for each calendar quarter during the last fiscal years that trading occurred or quotations were available, calculated based on the result post-prior reverse splits of our common stock. Such quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

 

Quarter Ended:

 

Low:

 

 

High:

 

March 31, 2021

 

$0.0970

 

 

$0.1068

 

June 30, 2021

 

$0.0472

 

 

$0.0510

 

September 30, 2021

 

$0.0635

 

 

$0.0860

 

December 31, 2021

 

$0.0405

 

 

$0.0440

 

March 31, 2022

 

$0.0339

 

 

$0.0589

 

June 30, 2022

 

$0.0197

 

 

$0.0419

 

September 30, 2022

 

$0.0084

 

 

$0.0220

 

December 31, 2022

 

$0.0052

 

 

$0.0100

 

 

The closing bid price for our shares of common stock on March 9, 2023 was $.0055.

 

Our common stock is considered a low-priced security under the “Penny Stock” rules promulgated by the Securities and Exchange Commission. Under these rules, broker-dealers participating in transactions in these securities must first deliver a risk disclosure document which describes risks associated with these stocks, broker-dealers’ duties, customers’ rights and remedies, market and other information, and make suitability determinations approving the customers for these stock transactions based on financial situation, investment experience and objectives. Broker-dealers must also disclose these restrictions in writing, provide monthly account statements to customers, and obtain specific written consent of each customer. With these restrictions, the likely effect of designation as a low-priced stock is to decrease the willingness of broker-dealers to make a market for the stock, to decrease the liquidity of the stock and increase the transaction cost of sales and purchases of these stocks compared to other securities.

 

(B) HOLDERS

 

As of March 10, 2023, there were approximately 535 holders of the common stock on record with our transfer agent.

 

(C) DIVIDENDS

 

We have not previously paid any cash dividends on common stock and do not anticipate or contemplate paying dividends on common stock in the foreseeable future. Our present intention is to utilize all available funds to develop and expand our business. The only restrictions that limit the ability to pay dividends on common equity, or that are likely to do so in the future, are those restrictions imposed by law and those restrictions imposed under contractual obligation. Under Wyoming corporate law, no dividends or other distributions may be made which would render a company insolvent or reduce assets to less than the sum of liabilities plus the amount needed to satisfy outstanding liquidation preferences.

 

 
23

Table of Contents

 

Any future determination to pay cash dividends will be at the discretion of our board of directors, and will be dependent upon our financial condition, results of operations, capital requirements and other factors as our board may deem relevant at that time.

 

(D) RECENT ISSUANCES OF UNREGISTERED SECURITIES

 

During the year ended December 31, 2022, pursuant to our offering under Regulation A+, we issued 40,100,000 shares of common stock in exchange for cash of $180,000, net of direct fees and commissions.

 

During the year ended December 31, 2022, we issued 30,105,936 shares of its common stock for services, with a fair value of $423,000.

 

During the year ended December 31, 2022, we issued a total of 100,000,000 shares of common stock and received cash of $1,440,000, net of direct costs (see Note 11 to the accompanying consolidated financial statements).

 

Subsequent issuances

 

Subsequent to our year end of December 31, 2022 and  pursuant to the Company’s Qualified  Regulation A Offering, we issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, we also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, we sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

All of the above offerings and sales, except the afore-mentioned shares issued pursuant to a conversion of convertible notes, were made in reliance upon the exemption from registration under Rule 506 of Regulation D promulgated under the Securities Act of 1933 and/or Section 4(2) of the Securities Act of 1933, based on the following: (a) the investors confirmed to us that they were “accredited investors,” as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933 and had such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities; (b) there was no public offering or general solicitation with respect to the offering; (c) the investors were provided with certain disclosure materials and all other information requested with respect to us ; (d) where applicable, the investors acknowledged that all securities being purchased were “restricted securities” for purposes of the Securities Act of 1933, and agreed to transfer such securities only in a transaction registered under the Securities Act of 1933 or exempt from registration under the Securities Act; and (e) where applicable, a legend was placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequent registered under the Securities Act of 1933 or transferred in a transaction exempt from registration under the Securities Act of 1933.

 

Issuer Purchases of Equity Securities

 

None.

 

ITEM 6. Selected Financial Data.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required by this Item.

 

 
24

Table of Contents

 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following is management’s discussion and analysis (|MD&A”) of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

 

The following discussion and analysis should be read in conjunction with our financial statements and the related notes thereto and other financial information contained elsewhere in this Form 10-K.

 

Our MD&A is comprised of significant accounting estimates made in the normal course of its operations, overview of our business conditions, results of operations, liquidity and capital resources and contractual obligations. We did not have any off balance sheet arrangements as of December 31, 2021 or 2022.

 

The discussion and analysis of our financial condition and results of operations is based upon its financial statements, which have been prepared in accordance with generally accepted accounting principles generally accepted in the United States (or “GAAP”). The preparation of those financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities at the date of its financial statements. Actual results may differ from these estimates under different assumptions or conditions.

 

Background

 

We are a software development and services company that offers a suite of integrated computer network security products using proprietary technology. Our ongoing strategy is developing and marketing our suite of network security products to the corporate, financial, healthcare, legal, government, technology, insurance, e-commerce and consumer sectors. We plan to continue to grow our business primarily through our expanding sales channel and internally generated sales, rather than by acquisitions. We hold a 49% interest in BlockSafe Technologies, Inc., and, as of April 2021, we hold a 100% interest in Cybersecurity Risk Solutions, LLC.

 

In March 2020, the World Health Organization declared the spread of COVID-19 a pandemic. This outbreak continues to spread throughout the U.S. and around the world. As a result, authorities continue to implement numerous measures to try to contain the virus, including restrictions on travel, quarantines, shelter-in-place orders, business restrictions and complete shutdowns. We are not considered an “essential business” due to the industries and customers we serve. As of, and subsequent to, December 31, 2022, we have been following the recommendations of the CDC and state/local health authorities to minimize exposure risk for our team members during the pandemic, including the temporary closure of our corporate office and having our team members work remotely. During the second quarter of 2021, we reopened our corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. The COVID-19 pandemic has resulted in longer response times from potential new customers and certain existing customers. We cannot anticipate the effect that the impairments caused by the COVID-19 pandemic will have on our fiscal 2023 results, or the effectiveness and distributions of vaccines, boosters, and their distribution, changes to mask mandate policies and to transitioning from a pandemic to an endemic. The pandemic has significantly impacted the economic conditions both in the United States and worldwide, with accelerated effects through the date of this Annual Report, as federal, state and local governments react to the public health crisis, creating significant uncertainties in both the worldwide and the United States economies. The situation is rapidly changing, including the onset of the ongoing subsequent waves of the virus caused by the possibility of various variants over time, and additional impacts to our business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which, the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or office closure requirements. We will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition and liquidity, and our results presented herein are not necessarily indicative of the results to be expected for future periods in 2023, or beyond.

 

 
25

Table of Contents

 

During the year ended December 31, 2021, we believe the COVID-19 pandemic did impact our operating results as sales to customers were down 7% as compared from the year ended December 31, 2020. However, we have not observed any impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic. At this time, it is not possible for us to predict the duration or magnitude of the adverse results of the outbreak and its effects on our business or results of operations, financial condition, or liquidity.

 

We have been following the recommendations of health authorities to minimize exposure risk for our team members, including the temporary closure of our corporate office and having team members work remotely. Most customers and vendors have transitioned to electronic submission of invoices and payments.

 

Management believes that cyber security is a growing requirement as the pandemic continues, more people are working remotely as well as using digital forms on a regular basis. Consequently, the market demand, in our estimation, is increasing. However, we are also experiencing the impact of the ongoing pandemic. Currently our management is not working from our office location and impedes our ability to take full advantage of the increasing market demand. Many of our current clients have experienced a dramatic slowdown in their business, limiting their ability to have the resources to pay for our services. We still generate revenues and we anticipate, but cannot guarantee, we will have the resources to advance our secure video conferencing tool, Zerify Meet™ and Zerify Defender™, that provides authentication and encryption (using our existing products), for which we believe will have a great interest in the market. During the year ended December 31, 2022, we earned revenues of $10,000 from Zerify Meet™ and Zerify Defender™ and overall revenues of $103,000.

 

Our executive office is located at 1090 King Georges Post Road, Suite 603, Edison, NJ 08837. Our telephone number is (732) 661-9641. At December 31, 2021, we had 10 employees. Our website is www.zerify.com (formerly www.strikeforcetech.com) (we are not including the information contained in our website as part of, nor should the information be relied upon or incorporated by reference into, this report on Form 10-K/A).

 

Results of Operations

 

FOR THE YEAR ENDED DECEMBER 31, 2022 COMPARED TO THE YEAR ENDED DECEMBER 31, 2021

 

Revenues for the year ended December 31, 2022 were $103,000 compared to $193,000 for the year ended December 31, 2021, a decrease of $90,000 or 47%. The decrease in revenues was primarily due to a decrease in revenues relating to our ProtectID®, GuardedID® and MobileTrust® and Zerify™ Meet products, as affected by impairments related to the economic consequences of the COVID-19 pandemic. Revenues are derived from software and services.

 

Cost of revenues for the year ended December 31, 2022 was $34,000 compared to $27,000 for the year ended December 31, 2021, an increase of $7,000 or 26%. The increase in cost of revenues was primarily due to an increase in the fees related to our product offerings. Cost of revenues are fees and key fobs related to our revenues, and as a percentage of total revenues for the year ended December 31, 2022 was 33.0% compared to 14.0% for the year ended December 31, 2021.

 

Compensation, professional fees, and selling, general and administrative (collectively, “SGA”) expenses for the year ended December 31, 2022 were $7,711,000 compared to $9,448,000 for the year ended December 31, 2021, a decrease of $1,737,000. The decrease was due primarily to a decrease in stock-based compensation, offset by an increase in compensation/benefits expenses and professional fees. SG&A expenses consist primarily of salaries, benefits and overhead costs for executive and administrative personnel, insurance, fees for professional services, including consulting, legal, and accounting fees, plus travel costs and non-cash stock compensation expense for the issuance of stock options to employees and other general corporate expenses.

 

 
26

Table of Contents

 

Research and development expenses for the year ended December 31, 2022 were $580,000 compared to $566,000 for the year ended December 31, 2021, an increase of $14,000 or 2%. The increase was primarily due to an increase in salaries and benefits of the personnel conducting research and development. The salaries, benefits and overhead costs of personnel conducting research and development of our software products primarily comprises our research and development expenses.

 

For the year ended December 31, 2022, other expense was $607,000 as compared to other expense of $7,397,000 for the year ended December 31, 2021, a decrease in other expense of $6,790,000 or 91%. The decrease was primarily due to decreases in financing expense, interest expense, debt discount amortization, the change in the fair value of derivative liabilities and the loss on debt extinguishment.

 

Our net loss for the year ended December 31, 2022 was $8,829,000 compared to $17,245,000 for year ended December 31, 2021, a decrease of $8,416,000, or 49%. The decrease was primarily due to decreases in stock-based compensation, financing expense, interest expense, debt discount amortization, the change in the fair value of derivative liabilities and the loss on debt extinguishment, offset by increased compensation/benefits expenses and professional fees.   

 

Liquidity and Capital Resources

 

Our total current assets at December 31, 2022 were $212,000, as compared with $2,121,000 in total current assets at December 31, 2021, which included cash of $2,084,000. Additionally, we had a stockholders’ deficit in the amount of $14,855,000 at December 31, 2022 compared to a stockholders’ deficit of $11,589,000 at December 31, 2021. We have historically incurred recurring losses and have financed our operations through loans, principally from affiliated parties such as our directors, and from the proceeds of debt and equity financing. We financed our operations during the year ended December 31, 2022 primarily from the cash balance from the year ended December 31, 2021 and from proceeds of equity instruments and notes payable issued during fiscal 2022.

 

On August 12, 2022, our registration statement on Form S-1 was declared effective by the Securities and Exchange Commission. This registration statement registered 50,000,000 shares with underlying common stock purchase warrants. The common stock purchase warrants were exercised contemporaneously with the execution of exercise agreements. We received aggregate gross proceeds of $500,000 from the cash exercise of the common stock purchase warrants by the exercising holders and such holders, as a condition to exercising their common stock purchase warrants, were issued an aggregate of 50,000,000 shares of Common Stock and, as a condition to exercising the common stock purchase warrants early,  new common stock purchase warrants were issued to purchase an aggregate additional 50,000,000 shares of Common Stock.

 

Subsequent to December 31, 2022, pursuant to the Company’s Qualified Regulation A Offering, we issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, we also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, we sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

Going Concern

 

We have yet to establish any history of profitable operations. During the year ended December 31, 2022, we incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000, and at December 31, 2022, we had a stockholders’ deficit of $14,855,000. In addition, we are in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.

 

 
27

Table of Contents

 

At December 31, 2022, we had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received proceeds of $813,000 on the sale of common shares and warrants (see Note 15 to the accompanying consolidated financial statements). We believe we have enough cash to sustain operations through June 30, 2023. Our ability to continue as a going concern is dependent upon its ability to continue to implement our  business plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While we believe in the viability of its strategy to increase revenues, there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to us.    Even if we are able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

 

Changes in Authorized Shares and Forward Split of BlockSafe Shares

 

In April 2020, an increase of our  authorized common stock shares  from twelve billion (12,000,000,000) to seventeen billion (17,000,000,000), $0.0001 par value, was ratified, effective upon the filing of an amendment to our Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in April 2020.

 

In April 2020, our Board of Directors and the holders of a majority of the voting power approved a resolution to effectuate a 500:1 Reverse Stock Split resolution for a reduction in the authorized common stock from seventeen billion (17,000,000,000) to fourteen billion (14,000,000,000), $0.0001 par value. The amendment was adopted in June 2020.

 

In December 2020, a decrease of the authorized shares of our  common stock from fourteen billion (14,000,000,000) to four billion (4,000,000,000), $0.0001 par value, was ratified, effective upon the filing of an amendment to our Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in December 2020.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, result of operations, liquidity or capital expenditures.

 

Critical Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.

 

Revenue Recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

 
28

Table of Contents

 

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses and subscriptions of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. We recognize revenue from these arrangements ratably over the contractual service period. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

 

The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining a client contract.

 

Cost of revenue includes direct costs and fees related to the sale of our products.

 

Share-Based Payments

 

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

 

Recently Issued Accounting Pronouncements

 

Refer to Note 1 in the accompanying consolidated financial statements.

 

Additional Information

 

You are advised to read this Form 10-K in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

 
29

Table of Contents

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Please see pages F-1 through F-25.

 

Zerify, Inc.

Index to Financial Statements

 

Report of Independent Registered Public Accounting Firm PCAOB ID NO: 572

 

F-2

 

 

 

 

 

Consolidated Balance Sheets as of December 31, 2022 and 2021

 

F-4

 

 

 

 

 

Consolidated Statements of Operations for the years ended December 31, 2022 and 2021

 

F-5

 

 

 

 

 

Consolidated Statements of Changes in Stockholders’ Deficit for the years ended December 31, 2022 and 2021

 

F-6

 

 

 

 

 

Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021

 

F-7

 

 

 

 

 

Notes to Consolidated Financial Statements

 

F-8

 

 

 
F-1

Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

The Stockholders and Board of Directors of

Zerify, Inc.

Edison, NJ 

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Zerify, Inc. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders’ deficit, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”).  In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  As discussed in Note 1 to the financial statements, during the year ended December 31, 2022, the Company incurred a net loss and utilized cash in operations, and at December 31, 2022, had a stockholders' deficit.  In addition, $2,867,000 of notes payable were in default as of that date. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.  Management’s plans in regards to these matters are also described in Note 1.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on the Company’s financial statements based on our audits.  We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.  We believe that our audits provide a reasonable basis for our opinion.

  

 
F-2

Table of Contents

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

As discussed in Notes 11 and 12 to the consolidated financial statements, the Company issues stock options and stock warrants to certain officers, employees and consultants as compensation (the “Equity Awards”). The fair values of these Equity Awards were determined as of the grant date using a Black-Scholes option-pricing model (the “Black-Scholes Model”). The selection of the valuation methodology and assumptions utilized in the Black-Scholes Model are based, in part, upon assumptions for which management is required to use judgment, particularly the risk-free interest rate, volatility, and dividend yield.

 

We identified the valuation of the Equity Awards as a critical audit matter because of the significant judgments made by management to determine the grant date fair values. This required a high degree of auditor judgment and an increased expenditure of effort when performing audit procedures to evaluate the reasonableness of management’s valuation methodology and related assumptions, including the risk-free interest rate, volatility, and dividend yield.

 

Our audit procedures related to the determination of the fair values of the Equity Awards, including the valuation methodology and related assumptions such as the risk-free interest rate, volatility, and dividend yield, consisted of the following, among others: 

 

·

We obtained an understanding of management’s process over the valuation of the Equity Awards, including those over the determination of the valuation methodology and related assumptions, including the risk-free interest rate, volatility, and dividend yield.

·

We obtained and read the Equity Award agreements and management’s valuation analyses, including supporting schedules and related narrative information.

·

We evaluated management’s valuation methodology, including the selection of the model to determine the fair values of the Equity Awards.

·

We evaluated the reasonableness of management’s valuation assumptions and the underlying source information of significant valuation assumptions, including the risk-free interest rate, volatility, and dividend yield.

·

We assessed whether management’s calculations of the fair values were applied in accordance with the selected methodology, including testing the mathematical accuracy of the valuation analyses.

·

We developed independent estimates for the fair values of the Equity Awards based on assumptions utilized by the Company in its calculations.

 

We have served as the Company’s auditor since 2015. 

 

 

 

Weinberg & Company, P.A

Los Angeles, California

April 14, 2023

 

 
F-3

Table of Contents

 

ZERIFY, INC.

CONSOLIDATED BALANCE SHEET

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash (includes VIE balances of $1,000 and $1,000, respectively)

 

$192,000

 

 

$2,084,000

 

Accounts receivable, net

 

 

20,000

 

 

 

24,000

 

Prepaid expenses

 

 

-

 

 

 

13,000

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

212,000

 

 

 

2,121,000

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

36,000

 

 

 

-

 

Operating lease right-of-use asset

 

 

54,000

 

 

 

107,000

 

Other assets

 

 

11,000

 

 

 

12,000

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$313,000

 

 

$2,240,000

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively)

 

$1,160,000

 

 

$996,000

 

Convertible notes payable, net of discount of $96,000 and $0, respectively (including $895,000 and $895,000 in default)

 

 

1,282,000

 

 

 

1,398,000

 

Convertible notes payable – related parties

 

 

268,000

 

 

 

268,000

 

Notes payable, net of discount of $323,000 and $0, respectively (including $1,930,000 and $1,972,000 in default, respectively) (includes VIE balances of $285,000 and $310,000, respectively)

 

 

2,826,000

 

 

 

1,972,000

 

Notes payable – related parties

 

 

693,000

 

 

 

693,000

 

Accrued interest (including $1,557,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $134,000 and $120,000, respectively)

 

 

5,865,000

 

 

 

5,477,000

 

Contingent payment obligation

 

 

1,500,000

 

 

 

1,500,000

 

VIE Financing obligation

 

 

1,263,000

 

 

 

1,263,000

 

Operating lease liability, current portion

 

 

56,000

 

 

 

39,000

 

Derivative liability

 

 

112,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

15,025,000

 

 

 

13,606,000

 

 

 

 

 

 

 

 

 

 

Notes payable, long-term portion

 

 

142,000

 

 

 

150,000

 

Operating lease liability, long-term portion

 

 

1,000

 

 

 

73,000

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

15,168,000

 

 

 

13,829,000

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Deficit

 

 

 

 

 

 

 

 

Series A Preferred stock, no par value; 100 shares authorized; 3 shares issued and outstanding

 

 

987,000

 

 

 

987,000

 

Series B Preferred stock par value $0.10: 100,000,000 shares authorized; 36,667 shares issued and outstanding

 

 

4,000

 

 

 

4,000

 

Preferred stock series not designated par value $0.10: 10,000,000 shares authorized; none issued or outstanding

 

 

-

 

 

 

-

 

Common stock par value $0.0001: 4,000,000,000 shares authorized; 1,109,417,572 and 955,380,225 shares issued and outstanding, respectively

 

 

110,000

 

 

 

96,000

 

Additional paid-in capital

 

 

67,124,000

 

 

 

59,788,000

 

Accumulated deficit

 

 

(82,190,000 )

 

 

(71,595,000 )

Total Zerify, Inc. stockholders’ deficit

 

 

(13,965,000 )

 

 

(10,720,000 )

Noncontrolling interest in consolidated subsidiary

 

 

(890,000 )

 

 

(869,000 )

 

 

 

 

 

 

 

 

 

Total Stockholders’ Deficit

 

 

(14,855,000 )

 

 

(11,589,000 )

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Deficit

 

$313,000

 

 

$2,240,000

 

 

See accompanying notes to the consolidated financial statements.

 

 
F-4

Table of Contents

 

ZERIFY, INC.

 CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

 

For the Years Ended

December 31,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Revenue

 

$103,000

 

 

$193,000

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Cost of revenue 

 

 

34,000

 

 

 

27,000

 

Selling, general and administrative expenses

 

 

7,711,000

 

 

 

9,448,000

 

Research and development

 

 

580,000

 

 

 

566,000

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

8,325,000

 

 

 

10,041,000

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(8,222,000 )

 

 

(9,848,000 )

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

Interest  and financing expenses (including $121,000 and $121,000 to related parties)        

 

 

(516,000 )

 

 

(7,016,000 )

Debt discount amortization

 

 

(141,000 )

 

 

(52,000 )

Change in fair value of derivative liabilities

 

 

52,000

 

 

 

(219,000 )

Loss on extinguishment of debt, net

 

 

-

 

 

 

(109,000 )

Other expense

 

 

(2,000 )

 

 

(1,000 )

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

(607,000 )

 

 

(7,397,000 )

 

 

 

 

 

 

 

 

 

Net loss

 

 

(8,829,000 )

 

 

(17,245,000 )

Net loss attributable to noncontrolling interest 

 

 

21,000

 

 

 

46,000

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Zerify, Inc.

 

 

(8,808,000 )

 

 

(17,199,000 )

 

 

 

 

 

 

 

 

 

Deemed dividend to warrant holders

 

 

(1,787,000 )

 

 

-

 

 

 

 

 

 

 

 

 

 

Net loss to common stockholders

 

$(10,595,000 )

 

$(17,199,000 )

 

 

 

 

 

 

 

 

 

Net loss per common share 

 

 

 

 

 

 

 

 

-Basic and diluted

 

$(0.01 )

 

$(0.02 )

 

 

 

 

 

 

 

 

 

 Weighted average common shares outstanding

 

 

 

 

 

 

 

 

-Basic and diluted

 

 

1,001,263,673

 

 

 

868,770,818

 

 

See accompanying notes to the consolidated financial statements. 

 

 
F-5

Table of Contents

 

ZERIFY, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

 

 Series A Preferred

stock, no par

value

 

 

 Series B Preferred

stock, par value

$0.10

 

 

 Common stock,

par value $0.0001

 

 

Additional

Paid-in

 

 

Accumulated

 

 

Noncontrolling

 

 

Total

Stockholders’

 

 

 

 Shares

 

 

Amount

 

 

 Shares

 

 

Amount

 

 

 Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Interest

 

 

Deficit

 

Balance at January 1, 2020

 

 

3

 

 

$987,000

 

 

 

36,667

 

 

$4,000

 

 

 

718,263,338

 

 

$72,000

 

 

$39,814,000

 

 

$(54,396,000)

 

$(823,000)

 

$(14,342,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

119,666,450

 

 

 

12,000

 

 

 

5,356,000

 

 

 

-

 

 

 

-

 

 

 

5,368,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of common stock issued for services

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,365,138

 

 

 

1,000

 

 

 

180,000

 

 

 

-

 

 

 

-

 

 

 

181,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of vested options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,757,000

 

 

 

-

 

 

 

-

 

 

 

6,757,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of common stock issued as a financing cost

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

45,150,500

 

 

 

5,000

 

 

 

6,564,000

 

 

 

-

 

 

 

-

 

 

 

6,569,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued upon cashless exercise of warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

12,349,726

 

 

 

1,000

 

 

 

(1,000)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued upon cashless exercise of options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

39,955,655

 

 

 

3,000

 

 

 

(3,000)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued upon conversion of notes and accrued interest

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

16,168,589

 

 

 

2,000

 

 

 

1,033,000

 

 

 

-

 

 

 

-

 

 

 

1,035,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued upon conversion of debt settlement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

460,829

 

 

 

-

 

 

 

88,000

 

 

 

-

 

 

 

-

 

 

 

88,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(17,199,000)

 

 

(46,000)

 

 

(17,245,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 30, 2021

 

 

3

 

 

 

987,000

 

 

 

36,667

 

 

 

4,000

 

 

 

955,380,225

 

 

 

96,000

 

 

 

59,788,000

 

 

 

(71,595,000)

 

 

(869,000)

 

 

(11,589,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued upon exercise of warrants  for cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

100,000,000

 

 

 

10,000

 

 

 

1,430,000

 

 

 

-

 

 

 

-

 

 

 

1,440,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

40,100,000

 

 

 

3,000

 

 

 

177,000

 

 

 

-

 

 

 

-

 

 

 

180,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of  warrants granted for services

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

435,000

 

 

 

-

 

 

 

-

 

 

 

435,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants issued with notes payable accounted for as debt discount

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

260,000

 

 

 

-

 

 

 

-

 

 

 

260,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of common stock issued for services

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

30,105,936

 

 

 

3,000

 

 

 

420,000

 

 

 

 

 

 

 

 

 

 

 

423,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of vested options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,990,000

 

 

 

 

 

 

 

 

 

 

 

2,990,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deemed dividend to warrant holders

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,787,000

 

 

 

(1,787,000)

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of common stock and warrants

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 (16,168,589

)

 

 

(2,000)

 

 

(163,000)

 

 

 

 

 

 

 

 

(165,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,808,000)

 

 

(21,000)

 

 

(8,829,000

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2022

 

 

3

 

 

$987,000

 

 

 

36,667

 

 

$4,000

 

 

 

1,109,417,572

 

 

$110,000

 

 

$67,124,000

 

 

$(82,190,000)

 

$(890,000)

 

$(14,855,000)

 

See accompanying notes to the consolidated financial statements.

 

 
F-6

Table of Contents

 

ZERIFY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(8,829,000 )

 

$(17,245,000 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

3,000

 

 

 

4,000

 

Amortization of discount

 

 

141,000

 

 

 

52,000

 

Financing costs

 

 

64,000

 

 

 

-

 

Right-of-use asset

 

 

53,000

 

 

 

51,000

 

Fair value of common stock issued for services

 

 

423,000

 

 

 

181,000

 

Fair value of vested options and warrants

 

 

3,425,000

 

 

 

6,757,000

 

Fair value of common stock issued for financing services

 

 

-

 

 

 

6,569,000

 

Change in fair value of derivative liabilities

 

 

(52,000 )

 

 

219,000

 

Loss on extinguishment of debt

 

 

-

 

 

 

112,000

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

4,000

 

 

 

(4,000 )

Prepaid expenses and other assets

 

 

14,000

 

 

 

8,000

 

Accounts payable and accrued expenses

 

 

163,000

 

 

 

(14,000 )

Accrued interest

 

 

388,000

 

 

 

298,000

 

Operating lease liability

 

 

(55,000 )

 

 

(51,000 )

Net cash used in operating activities

 

 

(4,258,000 )

 

 

(3,063,000 )

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(39,000 )

 

 

-

 

Net cash used in investing  activities

 

 

(39,000 )

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from exercise of warrants

 

 

1,440,000

 

 

 

-

 

Proceeds from sale of common stock

 

 

180,000

 

 

 

5,368,000

 

Proceeds from sale of convertible notes

 

 

100,000

 

 

 

-

 

Proceeds from notes payable

 

 

1,075,000

 

 

 

177,000

 

Repayment of convertible note payable

 

 

(120,000 )

 

 

(40,000 )

Repayment of notes payable

 

 

(105,000 )

 

 

(231,000 )

Repurchase of common stock and warrants

 

 

(165,000 )

 

 

 

 

Repayment of convertible notes payable-related parties

 

 

-

 

 

 

(30,000 )

Repayment of notes payable-related parties

 

 

-

 

 

 

(259,000 )

Net cash provided by financing activities

 

 

2,405,000

 

 

 

4,985,000

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash

 

 

(1,892,000 )

 

 

1,922,000

 

 

 

 

 

 

 

 

 

 

Cash at beginning of the year

 

 

2,084,000

 

 

 

162,000

 

 

 

 

 

 

 

 

 

 

Cash at end of the year

 

$192,000

 

 

$2,084,000

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Interest paid

 

$8,000

 

 

$120,000

 

Income tax paid

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing transactions

 

 

 

 

 

 

 

 

Fair value of derivative upon issuance of convertible debt recorded as debt discount

 

$164,000

 

 

$-

 

Fair value of warrant recorded as debt discount

 

$260,000

 

 

$-

 

Common stock issued for conversion of notes and accrued interest

 

$-

 

 

$1,035,000

 

Common shares issued upon conversion of debt settlement

 

$-

 

 

$88,000

 

Warrants issued with convertible notes

 

$-

 

 

$-

 

 

See accompanying notes to the consolidated financial statements.

 

 
F-7

Table of Contents

 

ZERIFY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Note 1 – Organization and Summary of Significant Accounting Policies

 

Zerify, Inc. (formerly known as StrikeForce Technologies, Inc.) (the “Company”), a software development and services company, offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey.

 

On April 26, 2022, the Company applied for the Zerify trademark, ZERIFY™, which is intended to cover the categories of:

 

 

·

downloadable or recorded computer software for encryption;

 

 

 

 

·

downloadable or recorded computer software for cyber security assessment and protection;

 

 

 

 

·

anti-spyware software; downloadable or recorded computer application software for mobile devices, namely, software for protecting people from identity theft;

 

 

 

 

·

downloadable or recorded computer software for guarding users of computers and remote access devices from identity theft, featuring various software tools, namely, anti-keyboard logger and keyboard stroke encryption.

 

On June 14, 2022, the Company’s Board of Directors and by consent majority shareholder vote  approved  changing the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc.  The name change was made to  better reflect  the Company’s business plans centered around its   cyber security software products.  

 

On August 1, 2022,  FINRA approved the Company’s  Common Stock being quoted on the OTCQB Market under the symbol “ZRFY” (formerly “SFOR”).

 

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and  had a stockholders’ deficit of $14,855,000. Additionally,  at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.

 

 
F-8

Table of Contents

 

Basis of presentation and principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”).  The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers.  BST meets the definition of a variable interest entity (“VIE”)  because  the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation.

 

The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.

 

COVID-19

 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic,  which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and  disrupted  normal business operations.  The outbreak could   adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations.

 

During the years ended December 31, 2022 and 2021,  the COVID-19 pandemic did negatively impact the Company’s  operating results. For the years ended December 31, 2022, and 2021, the Company’s sales  decreased by 47%,  compared to the prior year, however, there have not been any impairments of the Company’s  assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot  predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.

 

The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.

 

Revenue Recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

 
F-9

Table of Contents

 

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

 

The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts.

 

Cost of revenue includes direct costs and fees related to the sale of our products.

 

The following tables present our revenue disaggregated by major product and service lines:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Software

 

$96,000

 

 

$193,000

 

Service

 

 

7,000

 

 

 

-

 

Total revenue

 

$103,000

 

 

$193,000

 

 

Accounts Receivable

 

Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively.

 

Property and Equipment

 

Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows:

 

 

 

Estimated

Useful Life

(Years)

 

 

 

 

 

Computer equipment

 

 

5

 

Computer software

 

 

3

 

Furniture and fixture

 

 

7

 

Office equipment

 

 

7

 

 

Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.

 

 
F-10

Table of Contents

 

Impairment of Long-lived Assets

 

The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Leases

 

The Company leases its  corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). 

 

Fair Value of Financial Instruments

 

The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use of observable market data if such data is available without undue cost and effort.

 

The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.

 

As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9).

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

 

 
F-11

Table of Contents

 

Stock-Based Compensation

 

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Loss per Share

 

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

150,633,001

 

 

 

83,133,001

 

Warrants to purchase common stock

 

 

362,729,077

 

 

 

68,981,234

 

Convertible notes

 

 

29,450,564

 

 

 

21

 

Convertible Series B Preferred stock

 

 

1,255,638

 

 

 

1,255,638

 

Total

 

 

544,068,280

 

 

 

153,369,894

 

 

Advertising, Sales and Marketing Costs

 

Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively.

 

Research and Development Costs

 

Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute  research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively.

 

 
F-12

Table of Contents

 

Concentrations

 

For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively.

 

The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.

 

Segments

 

The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. As a small business filer, ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Management ©s currently assessing the impact of adopting this standard on the Company’s financial statements and related disclosures.

 

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. The Company has elected early adoption of ASU 2021-04.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

 
F-13

Table of Contents

 

Note 2 – Property and Equipment

 

Property and equipment, stated at cost, less accumulated depreciation consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Computer equipment

 

$84,000

 

 

$82,000

 

Computer software

 

 

45,000

 

 

 

44,000

 

Furniture and fixtures

 

 

46,000

 

 

 

10,000

 

Office equipment

 

 

17,000

 

 

 

17,000

 

 

 

 

192,000

 

 

 

153,000

 

Less accumulated depreciation

 

 

(156,000 )

 

 

(153,000 )

 

 

$36,000

 

 

$-

 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $3,000 and $4,000, respectively.

 

Note 3 – Convertible Notes Payable

 

Convertible notes payable consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

 2021

 

Unsecured

 

 

 

 

 

 

(a) Convertible notes due to AL-Bank

 

$383,000

 

 

$503,000

 

(b) Convertible note with Diagonal Lending

 

 

100,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Unsecured

 

 

 

 

 

 

 

 

(c) Convertible notes with fixed conversion features, in default

 

 

895,000

 

 

 

895,000

 

Convertible notes payable

 

 

1,378,000

 

 

 

1,398,000

 

Less debt discount

 

 

(96,000 )

 

 

-

 

Total Convertible notes payable

 

$1,282,000

 

 

$1,398,000

 

 

(a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in prior fiscal years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a Denmark based financing institution. In September 2021, the Company executed a repayment agreement with AL-Bank requiring the Company to  make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in March 2025 (see Note 15), for a total of $400,000. Once the payments are made in full pursuant to  the repayment agreement, the remaining balance of $143,000 will  be forgiven and will be accounted for at that time. At December 31, 2021, the outstanding balance of convertible notes payable amounted to $503,000. During the year ended December 31, 2022, the Company made principal payments of $120,000. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $383,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock.

 

(b) On December 15, 2022, the Company issued a convertible note payable to 1800 Diagonal Lending LLC (“Diagonal Lending”) for  $100,000The note is unsecured, bears interest at a rate of 12%, or 22% on default, is due on December 15, 2023, and has a repayment penalty of 120% of the unpaid principal and unpaid interest if prepaid within 180 days of December 15, 2022. The convertible note payable is convertible into shares of the Company’s common stock at a conversion price of 65% of the two lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the 15 trading days immediately preceding the conversion date. As the ultimate determination of shares of common stock to be issued upon conversion of these debentures can exceed the current number of available authorized shares, the Company determined that the conversion features of these debentures are not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as a derivative liability (see Note 9).  Of the incurred derivative liability of $164,000 related to the conversion feature of the debentures, $100,000 was accounted as debt discount and the remaining $64,000 as financing costs. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $96,000. The convertible notes payable, including accrued interest are convertible to approximately 29,450,549 shares of the Company’s common stock.

 

 

 

 
F-14

Table of Contents

 

(c) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior fiscal years. At December 31, 2022 and December 31, 2021, the outstanding balance of unsecured convertible notes payable amounted to $895,000 and $895,000, respectively, and are deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.

 

Note 4 – Convertible Notes Payable – Related Parties

 

In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2023, as amended. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $268,000.

 

Note 5 – Notes Payable

 

Notes payable consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Unsecured

 

 

 

 

 

 

(a) Notes payable- $1,639,000 - in default

 

$1,639,000

 

 

$1,639,000

 

(b) Notes payable issued by BST - in default

 

 

286,000

 

 

 

310,000

 

(c) Note payable-EID loan

 

 

149,000

 

 

 

150,000

 

 

 

 

 

 

 

 

 

 

Secured

 

 

 

 

 

 

 

 

(d) Notes payable – October 2022

 

 

1,000,000

 

 

 

-

 

(e) Notes payable - in default

 

 

6,000

 

 

 

23,000

 

(f) Notes payable – July 2022

 

 

211,000

 

 

 

-

 

Total notes payable principal outstanding

 

 

3,291,000

 

 

 

2,122,000

 

Less debt discount

 

 

(323,000 )

 

 

-

 

Total notes payable

 

 

2,968,000

 

 

 

2,122,000

 

Less current portion of notes payable, net of discount

 

 

(2,826,000 )

 

 

(1,972,000 )

Long term notes payable

 

$142,000

 

 

$150,000

 

 

(a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable was $1,639,000, respectively, and are in default.

 

 
F-15

Table of Contents

 

 

(b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2022, the outstanding balance of the notes payable amounted to $310,000. During the year ended December 31, 2022, the Company made principal payments of $24,000. At December 31, 2022, the outstanding balance of the BlockSafe notes payable amounted to $286,000, and are in default.

 

(c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA)under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty-four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type.  During the year ended December 31, 2022, the Company made principal payments of $1,000. At December 31, 2022 and 2021, the outstanding balance of the EID loan amounted to $149,000 and $150,000, respectively. The Company was in compliance with the terms of the EID loan as of December 31, 2022.

 

(d) On October 26, 2022, the Company entered into a Securities Purchase Agreement  with Walleye Opportunities Master Fund Ltd., a Cayman Islands company (“Walleye”), whereby Walleye purchased a promissory note of the Company, in the aggregate principal amount of One Million Dollars ($1,000,000) (the “Note”), which is convertible by Walleye into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) upon an Event of Default .

 

On the Closing Date (specifically October 26, 2022), the Company received $800,000 which represented the principal of $1,000,000 less an original issue discount in the amount of $200,000 paid to Walleye. Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum. The Company shall have the right, exercisable on seven (7) Trading Days prior written notice to Walleye, to prepay the outstanding Principal Amount then due under this Note prior to any default. Walleye may demand immediate repayment in the event of  certain events, including a financing. In the event of default, Walleye shall have, as of and after any event of default, the option to cover the outstanding obligation of the Note time 120% at 90% of the lowest VWAP of the Common Stock on the date of the applicable conversion (the “Conversion Date”) or at any point during the four (4) Trading Day period immediately prior to the date of the applicable conversion.

 

In addition, on the Closing Date, Walleye received a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share which shall be earned in full as of the Closing Date of October 26, 2022. The  common stock purchase warrant has  a cashless exercise provision (unless there is a registration statement registering the underlying shares to the common stock purchase warrants).  As a result of these issuances and grants, the Company incurred the following (a) relative fair value of the warrants granted of $260,000; and (b) original issue discounts of $200,000 of the debentures for a total of $460,000 which was allocated as debt discount. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $323,000.

 

From October 26, 2022 until the Note is extinguished in its entirety, Walleye shall receive a right of participation and first right of refusal on subsequent financings as described in the Agreement.

 

On October 26, 2022, through a Security Agreement of the same date, the Company’s Subsidiaries (specifically BlockSafe Technologies, Inc. and Cyber Security Risk Solutions, LLC) agreed to guarantee and act as surety for payment of the Note.

 

At December 31, 2022, the outstanding balance of the note payable was $1,000,000.

 

(e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 37% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one unsecured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2021, the outstanding balance of the unsecured note agreements was $23,000. During the year ended December 31, 2022, the Company made principal payments of $17,000. At December 31, 2022, the outstanding balance of the secured notes payable was $6,000 and is in default.

 

 

 

  

 
F-16

Table of Contents

 

(f) In July 2022, the Company issued notes payable aggregating $275,000. The notes bear average interest rate of 51% per annum, each agreement secured by substantially all of the assets of the Company and maturing in January 2024.  During the year ended December 31, 2022, the Company made principal payments of $64,000.  At December 31, 2022, the outstanding balance of the secured notes payable was $211,000.

 

Note 6 – Notes Payable – Related Party

 

Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2023, as amended. The outstanding balance of these notes payable at December 31, 2022 and December 31, 2021 amounted to $693,000.

 

Note 7 – VIE Financing Obligation

 

The Company is in the process of developing Coins or Tokens which are envisioned as virtual currency. In fiscal 2018, the Company’s consolidated subsidiary, BlockSafe, issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined by promissory notes and subscription agreements that would be controlling with respect to any offer or sale of tokens to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000.

 

During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe.

 

At December 31, 2022 and December 31, 2021, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens.  At December 31, 2022 and through the date of filing, BlockSafe has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At December 31, 2022, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe, through the issuance of tokens, or through other means if tokens are never issued.

 

Note 8 – Contingent Payment Obligation

 

On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”) for financing of $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against alleged infringements of its patents. In exchange for the financing, the Funders are entitled to receive( after the payment of legal fees),  the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter.  The Funders are to be paid only  if the Company achieves recoveries of claim proceeds.  At December 31, 2022 and 2021, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if patent enforced claim proceeds are recovered.

 

 
F-17

Table of Contents

 

Note 9 – Derivative Financial Instruments

 

The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. During fiscal year 2022, the Company issued convertible debentures, and in accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

 

As of December 31, 2022, the derivative liabilities were valued using the Binomial pricing model and/or Black Scholes pricing model with the following assumptions:

 

 

 

At

December 31,

2022

 

 

Issued

December 15,

2022

 

 

At

December 31,

2021

 

 

 

 

 

 

 

 

 

Stock Price

 

$0.0055

 

 

$0.0075

 

 

$-

 

Exercise Price

 

$0.0034

 

 

$0.0034

 

 

$-

 

Expected Life (Years)

 

 

0.80

 

 

 

0.84

 

 

 

-

 

Volatility

 

 

 165

 

 

 159

 

 

 -

Dividend Yield

 

 

0%

 

 

0%

 

-

Risk-Free Interest Rate

 

 

4.73%

 

 

4.65%

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value:

 

 

 

 

 

 

 

 

 

 

 

 

Conversion feature

 

$112,000

 

 

$164,000

 

 

$-

 

 

The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.

 

At December 31, 2020, the balance of the derivative liabilities was $163,000.  During the year ended December 31, 2021, the corresponding convertible notes payable were converted to equity. Pursuant to current accounting guidelines, the Company determined the final fair value of the derivative liability which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At December 31, 2021, the Company has no more instruments accounted as derivative liabilities.

 

On December 15, 2022, the Company recognized derivative liabilities of $164,000 upon issuance of additional secured convertible debentures (see Note 5). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability on December 31, 2022 was $112,000, and as a result, recorded a change in fair value of $52,000 as a component of other income and expenses in the consolidated statements of operations.  At December 31, 2022, the balance of the derivative liabilities was $112,000

 

Note 10 – Operating Lease

 

In January 2019, the Company entered into a noncancelable operating lease for its office headquarters requiring payments of approximately $5,000 per month, payments increasing 3% each year, and ending on January 31, 2024. The Company determines if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases.

 

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

 

 
F-18

Table of Contents

 

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

 

 

 

Year ended

December 31,

2022

 

 

Year ended

December 31,

2021

 

Lease Cost

 

 

 

 

 

 

Operating lease cost (included in general and administration in the Company’s statement of operations)

 

$61,000

 

 

$56,000

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021

 

$58,000

 

 

$55,000

 

Weighted average remaining lease term – operating leases (in years)

 

 

1.1

 

 

 

2.1

 

Average discount rate – operating leases

 

 

10.0%

 

 

10.0%

 

The supplemental balance sheet information related to leases for the period is as follows:

 

 

 

At December 31, 2022

 

Operating leases

 

 

 

Long-term right-of-use assets

 

$54,000

 

 

 

 

 

 

Short-term operating lease liabilities

 

$56,000

 

Long-term operating lease liabilities

 

 

1,000

 

Total operating lease liabilities

 

$57,000

 

 

Maturities of the Company’s lease liabilities are as follows:

 

Year Ending

 

Operating

Leases

 

2023

 

 

58,000

 

2024

 

 

-

 

Total lease payments

 

 

58,000

 

Less: Imputed interest/present value discount

 

 

(1,000 )

Present value of lease liabilities

 

$57,000

 

 

Lease expenses were $61,000 and $56,000 during the years ended December 31, 2022 and 2021, respectively.

 

Note 11 – Stockholders’ Deficit

 

Preferred Stock

 

On October 21, 2010, the Company amended its Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10, the  designations, rights, and preferences  to be determined by the Board of Directors. On November 15, 2010, the Company changed its domicile from the State of New Jersey to the State of Wyoming.

 

In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation.

 

 
F-19

Table of Contents

 

The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding.

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock is  convertible into a number of common stock shares  equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

In February 2014, the Company’s Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time the Company receives a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to the Company’s common stock, the minimum price discount floor level is set at $0.005, as decided by the Company’s Board of Directors.

 

Series A Preferred Stock

 

In 2011, the Company issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in the aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of the total issued and outstanding shares of the Company’s common stock. This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to the shareholders of the Company. The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued.

 

At December 31, 2022 and 2021, there were 3 shares of Series A Preferred Stock outstanding. There were no issuances of Series A Preferred stock during fiscal 2022 and 2021.

 

Series B Preferred Stock

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

At December 31, 2022 and 2021, there were 36,667 shares of Series B Preferred Stock outstanding. There were no issuances of Series B Preferred stock during fiscal 2022 and 2021.

 

 
F-20

Table of Contents

 

Common Stock

 

Sale of Common Stock

 

During the year ended December 31, 2022,  pursuant to the Company’s Qualified Regulation A Offering, the Company issued 40,100,000 common stock shares  in exchange for cash of $180,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and its placement agent to purchase 8,020,000 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

During the year ended December 31, 2021, pursuant to the Company’s  offering under Regulation A, the Company issued 119,666,450 shares of common stock in exchange for cash of $5,368,000, net of direct fees and commission. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 55 million shares of common stock. The warrants are fully vested, exercisable at $0.05 per share and will expire in five years.

 

Common Stock Issued for Services

 

During the year ended December 31, 2022, the Company issued 30,105,936 shares of its common stock for services, with a fair value of $423,000.  The common shares were valued at the respective date of issuance. Included in this issuance were 2,500,000 and 10,000,000 shares issued to New to the Street in June and August of 2022 for services relating to a consulting agreement and were determined to have a fair value of $56,000 and $127,000, respectively.

 

During the year ended December 31, 2021, the Company issued 3,365,138 shares of its common stock for services, with a fair value of $181,000. The common stock shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.

 

Common Stock Issued on Conversion of Notes Payable and Accrued Interest

 

During the year ended December 31, 2021, the Company issued 16,168,589 shares of common stock with a fair value of $1,035,000 upon conversion of convertible notes payable and accrued interest.

 

Common Stock Issued on Settlement of Debt

 

During the year ended December 31, 2021, the Company issued 460,829 shares of common stock with a fair value of $88,000 as debt settlement.

 

Repurchase of common stock and warrants

 

In May 2022, the Company repurchased 16,168,589 shares of common stock and 605,476 shares of warrants from an investor for $165,000.  All shares repurchased by the Company were retired immediately upon acquisition. As of December 31, 2022, there are no shares held in treasury.

 

Warrants

 

The table below summarizes the Company’s warrant activities for the years ended December 31, 2021 and 2022:

 

 

 

Number of

Warrant Shares

 

 

Exercise Price Range

Per Share

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2020

 

 

27,405,475

 

 

$

 0.0045-2.90

 

 

$0.0117

 

Granted

 

 

55,000,000

 

 

 

0.05

 

 

 

0.05

 

Canceled/Expired

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(13,424,241 )

 

 

-

 

 

 

-

 

Balance, January 1, 2021

 

 

68,981,234

 

 

0.0045-2.90

 

 

 

0.0421

 

Granted

 

 

394,353,319

 

 

0.00450.05

 

 

 

0.011

 

Canceled/Expired

 

 

(605,476 )

 

0.00852.90

 

 

 

0.035

 

Exercised

 

 

(100,000,000 )

 

0.082.90

 

 

 

0.165

 

Balance, December 31, 2022

 

 

362,729,077

 

 

$

0.00450.75

 

 

$0.006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding and exercisable, December 31, 2022

 

 

362,729,077

 

 

$

 0.00450.75

 

 

$0.006

 

 

At December 31, 2022 and 2021, the intrinsic value of the warrants amounted to $13,000 and $473,000, respectively.

 

 
F-21

Table of Contents

 

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2022:

 

 

 

 

Warrants Outstanding and Exercisable

 

Range of Exercise Prices

 

 

Number

Outstanding

 

 

Average Remaining

Contractual Life (in years)

 

 

Weighted Average

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045

 

 

 

333,333,319

 

 

 

4.79

 

 

$0.0045

 

 

0.005

 

 

 

13,333,334

 

 

 

2.87

 

 

$0.005

 

 

0.02

 

 

 

11,020,000

 

 

 

4.85

 

 

 

0.02

 

 

0.05

 

 

 

5,000,000

 

 

 

3.72

 

 

 

0.50

 

 

0.75

 

 

 

42,424

 

 

 

1.93

 

 

 

0.75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045 - $0.75

 

 

 

362,729,077

 

 

 

4.05

 

 

$0.006

 

 

Exercise of Warrants

 

During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,334 warrant shares were exercised on a cashless basis in exchange for 12,349,726 common stock shares. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.

 

Modification, Exercise and Grant of Warrants

 

On May 5, 2022, the Company entered into an Inducement Offer to Exercise Common Stock Purchase Warrants Letter Agreements (the “Exercise Agreements”) with certain of the holders of the Existing Warrants, the Special Equities Opportunity Fund, LLC and Gregory Castaldo, to exercise existing warrants to purchase an aggregate of 50,000,000 shares of Common Stock (the “Exercising Holders”). Pursuant to the Exercise Agreements, the Exercising Holders and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holders would exercise their Existing Warrants (the “Investor Warrants”) for shares of Common Stock underlying such Existing Warrants (the “Exercised Shares”) at a reduced exercise price of $0.02 per share of Common Stock. In order to induce the Exercising Holders to cash exercise the Investor Warrants, the Exercise Agreements provide for the issuance of new warrants to purchase up to an aggregate of 50,000,000 shares of Common Stock (the “New Warrants”), with such New Warrants to be issued in an amount equal to the number of the Exercised Shares underlying any Investor Warrants. The New Warrants are exercisable after issuance, provide for a cashless exercise provision if the shares of Common Stock underlying the New Warrants are not registered and terminate on the date that is five years following the issuance of the New Warrants. The New Warrants have an exercise price per share of $0.05. The New Warrants and the shares of Common Stock issuable upon the exercise of the New Warrants are not being registered under the Securities Act of 1933 and are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act of 1933. The Exercised Shares are registered for resale on effective registration statements previously filed with the Securities and Exchange Commission. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $940,000, net of direct fees and commission.

 

In August 2022, the Company modified the exercise price of the warrants granted to the two investors/warrant holders in May 2022 from $0.05 per share to $0.01 per share. As a result of this modification, the warrant holders exercised 50,000,000 shares of warrants and the Company received $500,000 in cash and issued 50,000,000 shares of common stock.

 

As a result of these transactions, the Company issued a total of 100 million shares of common stock and received cash of $1,440,000, net of direct costs.

 

 
F-22

Table of Contents

 

Deemed Dividend to Warrant Holders

 

During the year ended December 31, 2022, the Company granted an aggregate of 150,000,000 warrants for services and financing activities that contained a provision requiring the Company to adjust the terms of the warrants when future financing events occur on more favorable terms. On December 21, 2022, and pursuant to the beneficial terms contained in the Company’s Qualified Regulation A Offering, the Company modified the 150,000,000 warrants by granting an additional 183,333,320 warrants and adjusting the warrant exercise from price from $0.01 per share to $0.0045 per share. Pursuant to current accounting guidelines, the Company recorded the incremental fair value of $1,787,000 as a deemed dividend.

 

Grant of Warrants for Services

 

On July 1,  2022, the Company granted warrants to a consultant, to purchase 3,000,000 shares of common stock for financing services rendered. The warrants are fully vested, exercisable at of $0.02 per share, will expire in 5 years and with an estimated fair value $63,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.02

 

Share Price

 

$0.02

 

Volatility %

 

 

233%

Risk Free Rate

 

 

2.88%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

On October 21,  2022, the Company granted warrants pursuant to a Financial Advisory Agreement, to purchase 50,000,000 shares of common stock for advisory services rendered. The warrants are fully vested, exercisable at of $0.01 per share, will expire in 5 years and with an estimated fair value $372,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.00752

 

Volatility %

 

 

224%

Risk Free Rate

 

 

4.34%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.

 

 
F-23

Table of Contents

 

Grants of Warrants on Issuance of Note Payable

 

Included in the issuance of a Note Payable to Walleye dated October 26, 2022 (see Note 5), Walleye received a grant of a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share, which shall be earned in full as of October 26, 2022. The estimated relative fair value of the warrants was determined to be $260,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.0079

 

Volatility %

 

 

268%

Risk Free Rate

 

 

4.41%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

Note 12 – Stock Options

 

In November 2012, the stockholders approved the 2012 Stock Option Plan for the Company’s employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000 and was increased to 400,000,000 in November 2017 by unanimous consent of the Board of Directors.

 

The table below summarizes the Company’s stock option activities for the years ended December 31, 2021 and 2022: 

 

 

 

 Number of

Options Shares

 

 

Exercise Price 

Range Per Share

 

 

Weighted Average Exercise Price

 

Balance, January 1, 2020

 

 

58,133,001

 

 

$

0.005-1,121,250,000

 

 

$0.03704

 

Granted

 

 

67,500,000

 

 

0.005-0.0375

 

 

 

0.0104

 

Exercised

 

 

(42,500,000)

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance, December 31, 2021

 

 

83,133,001

 

 

0.005-1,121,250,000

 

 

 

0.0274

 

Granted

 

 

67,500,000

 

 

 

0.0045

 

 

 

0.0045

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance outstanding, December 31, 2022

 

 

150,633,001

 

 

$

 0.0045-1,121,250,000

 

 

$0.0307

 

Balance exercisable, December 31, 2022

 

 

87,212,671

 

 

$

 0.0045-1,121,250,000

 

 

$0.0497

 

 

The following table summarizes information concerning the Company’s stock options as of December 31, 2022:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of

Exercise Prices

 

 

Number Outstanding

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

 Exercise

 Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

0.005

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

0.0045

 

 

 

67,500,000

 

 

 

9.97

 

 

 

0.0045

 

 

 

4,079,670

 

 

 

9.97

 

 

 

0.0045

 

$

0.0045 – 1,121,250,000

 

 

 

150,633,001

 

 

 

6.43

 

 

$0.0307

 

 

 

87,212,671

 

 

 

6.43

 

 

$0.0497

 

 

At December 31, 2022 and 2021, the intrinsic value of outstanding options was $76,000 and $3,225,000, respectively.

 

During the year ended December 31, 2022, the Company recorded an additional stock compensation expense of $2,958,000 to account for options granted in the prior year that vested. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.0045 per share, vest over six months, and expire in 10 years, with a total fair value of approximately $594,000. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 394%, (ii) discount rate of 3.79%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $32,000 to account for the fair value of options that vested during the period. As of December 31, 2022, the unamortized stock compensation amounted to approximately $562,000 which will be recognized in fiscal 2023.

 

 
F-24

Table of Contents

 

During the year ended December 31, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company  issued 39,955,655 shares of the Company’s common stock upon cashless exercise of 42,500,000 options. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share for 2,500,000 option shares and $0.0375 for 65,000,000 option shares, vest over six months, and expire in 10 years, with a total fair value of approximately $5,400,000 using the Black-Scholes Merton Option Pricing model. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 137%, (ii) discount rate of 1.46%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $368,000 to account for the fair value of options that vested during the period.

 

In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense.

 

Note 13 – Income Tax Provision

 

A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows for the year ended:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

 

 

 

 

 

 

Federal statutory income tax rate

 

 

21.0%

 

 

21.0%

State tax, net of federal benefit

 

 

7.0%

 

 

5.0%

 

 

 

 

 

 

 

 

 

Change in valuation allowance on net operating loss carry-forwards

 

 

(28.0 )

 

 

(26.0 )

 

 

 

 

 

 

 

 

 

Effective income tax rate

 

 

0.0%

 

 

0.0%

 

Deferred tax assets consist of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Net deferred tax assets:

 

 

 

 

 

 

Stock-based compensation

 

$3,776,000

 

 

$702,000

 

Private placement costs

 

 

394,000

 

 

 

366,000

 

Operating lease liability

 

 

16,000

 

 

 

42,000

 

Loss on extinguishment of debt

 

 

1,858,000

 

 

 

1,697,000

 

Net operating loss carryforwards

 

 

7,362,000

 

 

 

5,946,000

 

Deferred tax assets

 

 

13,406,000

 

 

 

8,753,000

 

Less valuation allowance

 

 

(13,406,000 )

 

 

(8,753,000 )

Total

 

 

-

 

 

 

-

 

 

The provisions of ASC Topic 740, Accounting for Income Taxes, require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2022 and 2021, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was more likely than not that the net deferred tax assets were not fully realizable. Accordingly, the Company established a full valuation allowance against its net deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.

 

 
F-25

Table of Contents

 

At December 31, 2022 and 2021, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal NOL purposes approximately $30.2 million and $26.5 million was available at December 31, 2022 and 2021. For state NOL purposes approximately $14.7 million and $13.2 million was available at December 31, 2022 and 2021, respectively. The Federal carryforwards expire on various dates through 2041 and the state carryforwards expire through 2041. Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation.

 

The Company’s operations are based in New Jersey and it is subject to Federal and New Jersey state income tax. Tax years after 2016 are open to examination by United States and state tax authorities.

 

The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. ASC 740 also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions. As of December 31, 2022 and 2021, no liability for unrecognized tax benefits was required to be recorded or disclosed.

 

Note 14 – Commitment and Contingencies

 

Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant (U.S. District Court, District of New Jersey, Civil Action No. 2:22-cv-07258-MCA-AME)

 

On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”),  filed a stockholder derivative Complaint against our  directors , Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their  management of us. Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint.  On March 10, 2023, the Defendants served a motion to dismiss the complaint  upon the Plaintiff.  The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023.   Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation.

 

Onstream Media Corporation

 

We are  currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases.

 

The cases and their filing dates follow:

 

Case

 

Date Filed

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00191 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00192 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00193 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00194 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00195 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00196 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00197 (DWY)

 

September 9, 2022

 

Note 15 – Subsequent Events

 

Subsequent to December 31, 2022, pursuant to the Company’s Qualified  Regulation A Offering, the Company issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, the Company sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

On February 23, 2023, the Company entered into an amendment to the AL-Bank note (see Note 3) that relieved the Company from its previously scheduled monthly payments for March and April 2023 by extending the maturity date of the note by an additional two months, or February and March of 2025. 

 

 
F-26

Table of Contents

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

We have no disclosure required by this Item.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

(a) Evaluation of Disclosure Controls and Procedures.

 

Regulations under the Securities Exchange Act of 1934 (the “Exchange Act”) require public companies to maintain “disclosure controls and procedures,” which are defined as controls and other procedures that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

We carried out an evaluation, with the participation of our management, including our Chief Executive Officer (“CEO”) and our Chief Financial Officer (CFO) of the effectiveness our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of December 31, 2022. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures are not effective at the reasonable assurance level due to the following material weaknesses:

 

1. We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us as of and for the year ended December 31, 2022. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

2. Our board of directors has no independent director or member with financial expertise which causes ineffective oversight of our external financial reporting and internal control over financial reporting.

 

3. We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

To address these material weaknesses, management performed additional analyses and other procedures to ensure that the financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

 

Remediation of Material Weaknesses

 

We intend to remediate the material weaknesses in our disclosure controls and procedures identified above by adding an independent director or member with financial expertise or hiring a full-time CFO with SEC reporting experience in the future when working capital permits and by working with our independent registered public accounting firm to refine our internal procedures.

 

(b) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter or during 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

On September 8, 2017, our retail distributor, WYNIT Distribution, LLC, filed for Chapter 11 bankruptcy protection in the Minnesota Bankruptcy Court (Bankruptcy Petition #17-42726). WYNIT serves a wide range of customers, including large national retailers such as Home Shopping Network, Office Depot/Max, Best Buy Canada, Staples and others as well as smaller independent resellers. Our Management has filed the appropriate forms, for our benefit, with the Minnesota Bankruptcy Court, but recognizes that we are an unsecured creditor. As of the date of this filing, the WYNIT Distribution, LLC, Chapter 11 bankruptcy is still proceeding.

 

 
30

Table of Contents

 

PART III 

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

 

DIRECTORS AND EXECUTIVE OFFICERS.

 

The following sets forth our executive officers and/or Directors, their ages, and all offices and positions held with us.

 

Name

 

Age

 

Position

Mark L. Kay

 

74

 

Chief Executive Officer and Chairman of the Board of Directors

Philip E. Blocker

 

66

 

Chief Financial Officer

Ramarao Pemmaraju

 

62

 

Chief Technical Officer and Director

George Waller

 

65

 

Executive Vice President and Marketing Director

 

Our Directors hold their offices until the next annual meeting of the shareholders and until their successors have been duly elected and qualified or until their earlier resignation, removal of office or death. Our executive officers are elected by the Board of Directors to serve until their successors are elected and qualified.

 

The following is a brief description of the business experience of our executive officers who are also the Directors and significant employees:

 

Mark L. Kay, Chief Executive Officer and Chairman of the Board of Directors

 

Mr. Kay joined us  as our CEO in May 2003 following his retirement at JPMorganChase & Co. In December 2008, a majority of the Board of Directors, by written consent, eliminated the position of our President, with those responsibilities being assumed by Mr. Kay. A majority of the Board of Directors also appointed Mr. Kay as the Chairman of the Board in December 2008. Prior to joining StrikeForce Mr. Kay was employed by JPMorganChase & Co. from August of 1977 until his retirement in December 2002, at which time he was a Managing Director of the firm. During his tenure with JPMorganChase & Co. Mr. Kay led strategic and corporate business groups with global teams up to approximately 1,000 people. His responsibilities also included Chief Operations Officer, Chief Information Officer, and Global Technology Auditor. Mr. Kay’s business concentrations were in securities (fixed income and equities), proprietary trading and treasury, global custody services, audit, cash management, corporate business services and web services. Prior to his employment with JPMorganChase & Co., Mr. Kay was a systems engineer at Electronic Data Services (EDS) for approximately five years from September 1972 through to August 1977. He holds a B.A. in Mathematics from CUNY.

 

Philip E. Blocker, Chief Financial Officer

 

Philip E. Blocker was appointed as our CEO in Oct 2011.  Mr. Blocker was CFO of MediaServ, a NYC based Internet software development company, in 2001. Prior to MediaServ, Mr. Blocker was a partner in POLARIS, a $25 million technology reseller, specializing in storage and high availability solutions. He is a Certified Public Accountant and has practical experience with taking private companies public.

 

 
31

Table of Contents

 

Ramarao Pemmaraju, Chief Technology Officer

 

Mr. Pemmaraju became our Chief Technology Officer (CTO) in July 2022 and is the inventor of the ProtectID® product. In May 1999 Mr. Pemmaraju co-founded NetLabs, which developed security software products. Mr. Pemmaraju concentrated his time on NetLabs from July 2001 through to July 2002. From June 2000 to July 2001 Mr. Pemmaraju was a systems architect and project leader for Coreon, an operations service provider in telecommunications. From October 1998 through May 2000, Mr. Pemmaraju was a systems engineer with Nexgen systems, an engineering consulting firm. Mr. Pemmaraju has over eighteen years’ experience in systems engineering and telecommunications. His specific expertise is in systems architecture, design and product development. Mr. Pemmaraju holds a M.S.E.E. from Rutgers University and a B.E. from Stevens Tech.

 

George Waller, Executive Vice President and Head of Marketing

 

Mr. Waller became our Vice President in charge of sales and marketing in June 2002. In July 2002, Mr. Waller became our CEO , a position he held until Mr. Kay joined us in May 2003. Since May 2003, Mr. Waller has been the Executive Vice President overseeing Sales, Marketing, Business Development and product development. From 2000 through June 2002, Mr. Waller was Vice President of business development for Infopro, an outsourcing software development firm. From 1999 to 2001, Mr. Waller was Vice President of sales and Marketing for Teachmeit.com-Incubation systems, Inc., a multifaceted computer company and sister company to Infopro. From 1997 through 1999, Mr. Waller was the Vice President of Internet Marketing for RX Remedy, an aggregator of medical content for online services. Previously, Mr. Waller was a Vice President of Connexus Corporation, a software integrator.

 

Family Relationships

 

There are no family relationships between any two or more of our directors or executive officers. There is no arrangement or understanding between any of our directors or executive officers and any other person pursuant to which any director or officer was or is to be selected as a director or officer, and there is no arrangement, plan or understanding as to whether non-management shareholders will exercise their voting rights to continue to elect the current board of directors. There are also no arrangements, agreements or understandings to our knowledge between non-management shareholders that may directly or indirectly participate in or influence the management of our affairs.

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, during the past five years, none of the following occurred with respect to a present or former director or executive officer of us: (1) any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (2) any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of any competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; and (4) being found by a court of competent jurisdiction (in a civil action), the SEC or the commodities futures trading commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated.

 

Board of Directors

 

Our By-laws provide that there must be no less than one and no more than seven directors, as determined by the Board of Directors. Our Board of Directors currently consists of three directors.

 

 
32

Table of Contents

 

Directors need not be our stockholders or residents of the State of Wyoming. Directors are elected for an annual term and generally hold office until the next Directors have been duly elected and qualified. A vacancy on the Board may be filled by the remaining Directors even though less than a quorum remains. A Director appointed to fill a vacancy remains a Director until his successor is elected by the Stockholders at the next annual meeting of Shareholder or until a special meeting is called to elect Directors.

 

Our executive officers are appointed by the Board of Directors.

 

During fiscal 2022, our Board of Directors met twelve times. The Board of Directors also uses written resolutions to deal with certain matters and, during fiscal 2022, twenty-two written resolutions were signed by a majority of the Directors.

 

Compensation of Directors

 

Our bylaws provide that, unless otherwise restricted by our certificate of incorporation, our Board of Directors has the authority to fix the compensation of directors. The directors may be paid their expenses, if any, related to attendance at each meeting of the board of directors and may be paid a fixed sum for attendance at each meeting of the board of directors or a stated salary as our director. Our bylaws further provide that no such payment will preclude any director from serving us in any other capacity and receiving compensation. Further, members of special or standing committees may be given compensation for attending committee meetings.

 

Committees

  

We have two committees: the Audit Committee and the Compensation Committee. At this time, there are no members of either Committee. Our Board of Directors performs the acts of the Committees. None of our current directors are deemed “independent” directors as that term is used by the national stock exchanges or have the requisite public company accounting background or expertise to be considered an “audit committee financial expert” as that term is defined under Regulation S-K promulgated under the Securities Act of 1933, as amended.

 

We anticipate that the principal functions of the Audit Committee will be to recommend the annual appointment of our auditors, the scope of the audit and the results of their examination, to review and approve any material accounting policy changes affecting our operating results and to review our internal control procedures.

 

We anticipate that our Compensation Committee will develop a Company-wide program covering all employees and that the goals of such program will be to attract, maintain, and motivate our employees. It is further anticipated that one of the aspects of the program will be to link an employee’s compensation to his or her performance, and that the grant of stock options or other awards related to the price of the common shares will be used in order to make an employee’s compensation consistent with shareholders’ gains. It is expected that salaries will be set competitively relative to the technology development industry and that individual experience and performance will be considered in setting salaries.

 

At present, executive and director compensation matters are determined by a majority vote of the board of directors.

 

We do not have a nominating committee. Historically our entire Board has selected nominees for election as directors. The Board believes this process has worked well thus far particularly since it has been the Board’s practice to require unanimity of Board members with respect to the selection of director nominees. In determining whether to elect a director or to nominate any person for election by our stockholders, the Board assesses the appropriate size of the Board of Directors, consistent with our bylaws, and whether any vacancies on the Board are expected due to retirement or otherwise. If vacancies are anticipated, or otherwise arise, the Board will consider various potential candidates to fill each vacancy. Candidates may come to the attention of the Board through a variety of sources, including from current members of the Board, stockholders, or other persons. The Board of Directors has not yet had the occasion to, but will, consider properly submitted proposed nominations by stockholders who are not our directors, officers, or employees on the same basis as candidates proposed by any other person.

 

 
33

Table of Contents

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than ten percent (10%) of our outstanding Common Stock, or the Reporting Persons, to file with the SEC initial reports of ownership on Form 3 and reports of changes in ownership of Common Stock on Forms 4 or 5. Such persons are required by SEC regulation to furnish us with copies of all such reports they file. Based solely on a review of Forms 3 and 4 furnished to us by the Reporting Persons or prepared on behalf of the Reporting Persons by us, we believe that the Reporting Persons have complied with reporting requirements applicable to them.

 

Involvement in Certain Legal Proceedings

 

None of the following events have occurred during the past ten years and are material to an evaluation of the ability or integrity of any of our directors or officers. :

 

 

1.

A petition under the Federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

2.

Such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

3.

Such person was the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities:

 

 

a.

Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

b.

Engaging in any type of business practice; or

 

c.

Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

 

 

4.

Such person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (f)(3)(i) of this section, or to be associated with persons engaged in any such activity;

 

5.

Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

6.

Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

 

7.

Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

 

a.

Any Federal or State securities or commodities law or regulation; or

 

b.

Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

 

c.

Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity.

 

 

8.

Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

 
34

Table of Contents

 

Code of Ethics

 

We have adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Our code of ethics contains standards that are reasonably designed to deter wrongdoing and to promote:

 

·

Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

 

·

Full, fair, accurate, timely, and understandable disclosure in reports and documents that we file with, or submits to, the Commission and in other public communications made by us;

 

· 

Compliance with applicable governmental laws, rules and regulations;

 

·

The prompt internal reporting of violations of the code to the board of directors or another appropriate person or persons; and

 

·

Accountability for adherence to the code.

 

Indemnification of Officers and Directors

 

As permitted by Wyoming law, our Articles of Incorporation provide that we will indemnify our directors and officers against expenses and liabilities they incur to defend, settle, or satisfy any civil or criminal action brought against them on account of their being or having been our directors or officers unless, in any such action, they are adjudged to have acted with gross negligence or willful misconduct.

 

Pursuant to the foregoing provisions, we have been informed that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in that Act and is, therefore, unenforceable.

 

Stockholder Communications with the Board

 

Stockholders who wish to communicate with the Board of Directors should send their communications to the Chairman of the Board at the address listed below. The Chairman of the Board is responsible for forwarding communications to the appropriate Board members.

 

Zerify, Inc.

1090 King George’s Post Road

Suite #603

Edison, NJ 08837

Attn: Mark L. Kay, Chairman

 

Shareholder Recommendations for Board Nominees

 

There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors.

 

 
35

Table of Contents

 

ITEM 11. EXECUTIVE COMPENSATION.

 

Summary Compensation Table

 

The following information is related to the compensation paid, distributed, or accrued by us for the fiscal years ended December 31, 2022 and 2021 to our Chief Executive Officer (principal executive officer) during the last fiscal year and the two other most highly compensated executive officers serving as of the end of the last fiscal year whose compensation exceeded $100,000 (the “Named Executive Officers”). The foregoing persons are collectively referred to in this Form 10-K as the “Named Executive Officers.” Compensation information is shown for the years ended December 31, 2022 and 2021:

 

 

 

 

 

 

 

 

 

 

Incentive Plan

 

 

Securities

 

 

Nonqualified Deferred

 

 

 

 

 

 

 

 

 

 

 

 

Stock

 

 

Option

 

 

Underlying

 

 

Compensation

 

 

All Other

 

 

 

Name/ Principal

 

 

Salary

 

 

Bonus

 

 

Awards

 

 

Awards

 

 

Options/SARs

 

 

Earnings

 

 

Compensation

 

 

Total

 

Position

 

Year

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mark L. Kay

 

2022

 

 

190,000

 

 

 

10,000

 

 

 

-

 

 

 

88,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

288,000

 

Chief Executive Officer

 

2021

 

 

161,000

 

 

 

10,000

 

 

 

-

 

 

 

670,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

841,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

George Waller

 

2022

 

 

190,000

 

 

 

10,000

 

 

 

-

 

 

 

88,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

288,000

 

Executive Vice President

 

2021

 

 

161,000

 

 

 

10,000

 

 

 

-

 

 

 

670,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

841,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ramarao Pemmeraju

 

2022

 

 

190,000

 

 

 

10,000

 

 

 

-

 

 

 

88,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

288,000

 

Chief Technology Officer

 

2021

 

 

161,000

 

 

 

10,000

 

 

 

-

 

 

 

2,729,000

(1)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,899,999

 

 

(1) For 2021, represents the incremental fair value related to the modification of stock options granted to Ramarao Pemmaraju, computed in accordance with FASB Topic 718. In February 2021, 7,000,000 unvested options granted in fiscal 2020 were modified and such options became fully vested.  Pursuant to current accounting guidelines, we remeasured the fair value of these options and determined their fair value to be $2,100,000.

 

On July 31, 2010, Philip E. Blocker was appointed as our Chief Financial Officer. Mr. Blocker is not our employee. He received fee payments of $2,000 in 2022 and $2,000 in 2021. Mr. Blocker received no option awards in 2022 or 2021.

 

 
36

Table of Contents

 

Outstanding Option Awards at Year End

 

The following table provides certain information regarding unexercised options to purchase common stock, stock options that have not vested, and equity-incentive plan awards outstanding at December 31, 2022 for each Named Executive Officer and/or Director: 

 

Outstanding Equity Awards At Fiscal Year-End Table

 

 

Option Awards

 

 

 

 

Stock Awards

 

Name

 

Number of Securities Underlying Unexercised Options

(#)

Exercisable

 

 

Number of Securities Underlying Unexercised Options

(#)

Unexercisable

 

 

Equity Incentive

 Plan

 Awards: Number of Securities Underlying Unexercised Unearned Options (#)

 

 

Option Exercise

 Price ($)

 

 

Option Expiration Date

 

Number

 of

Shares

 or Units

 of Stock

That

Have

Not

Vested (#)

 

 

Market

Value

 of

Shares

or

Units

of Stock

That

 Have

Not

Vested ($)

 

 

Equity Incentive

Plan

Awards: Number

 of

Unearned Shares,

 Units or Other

 Rights

 That

 Have Not

 Vested (#)

 

 

Equity Incentive

Plan

Awards: Market or Payout

Value of Unearned Shares,

 Units or Other

Rights That Have Not Vested ($)

 

Mark L. Kay

 

 

1

 

 

 

-

 

 

 

-

 

 

$1,121,250,000

 

 

01/03/23

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

72,000

 

 

 

-

 

 

 

-

 

 

$3.125

 

 

09/28/26

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.85

 

 

12/21/27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.05

 

 

12/17/29

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000,000

 

 

 

-

 

 

 

-

 

 

$0.0375

 

 

12/22/31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000,000

 

 

 

-

 

 

 

-

 

 

$0.005

 

 

12/18/30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

604,396

 

 

 

9,395,604

 

 

 

-

 

 

$0.0045

 

 

12/22/32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

George Waller

 

 

1

 

 

 

-

 

 

 

-

 

 

$1,121,250,000

 

 

01/03/23

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

72,000

 

 

 

-

 

 

 

-

 

 

$3.125

 

 

09/28/26

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.85

 

 

12/21/27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.05

 

 

12/17/29

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000,000

 

 

 

-

 

 

 

-

 

 

$0.0375

 

 

12/22/31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

604,396

 

 

 

9,395,604

 

 

 

-

 

 

$0.0045

 

 

12/22/32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ramarao Pemmaraju

 

 

1

 

 

 

-

 

 

 

-

 

 

$1,121,250,000

 

 

01/03/23

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

72,000

 

 

 

-

 

 

 

-

 

 

$3.125

 

 

09/28/26

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.85

 

 

12/21/27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,000

 

 

 

-

 

 

 

-

 

 

$2.05

 

 

12/17/29

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000,000

 

 

 

-

 

 

 

-

 

 

$0.0375

 

 

12/22/31

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

604,396

 

 

 

9,395,604

 

 

 

-

 

 

$0.0045

 

 

12/22/32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Option Exercises and Stock Vested Table

 

None.

 

Pension Benefits Table

 

None.

 

Non-Qualified Deferred Compensation Table

 

None.

 

All Other Compensation Table

 

None.

 

Perquisites Table

 

None.

 

Director Compensation

 

All three of our directors were also our executive officers through December 31, 2022. Our directors did not receive any separate compensation for serving as such during fiscal 2022.

 

Non-Director Compensation

 

In April 2021, Will Lynch was hired as the Director of Channel Distribution (a non-Executive Officer position). A Director of Channel Distribution develops, services, and grows relationships with clients. Mr. Lynch has an annual salary of $100,000 and will also receive 2% net of all Channel sales. Mr. Lynch reports to our Executive Vice President and Marketing Director.  Mr. Lynch, tendered his resignation on December 2, 2022 hasn’t been replaced at StrikeForce, now called Zerify. Cybersecurity Risk Solutions is still in business and selling its products.

 

 
37

Table of Contents

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 

 

Share Ownership of Certain Beneficial Owners

 

The following table sets forth certain information as of December 31, 2022, with respect to the shares of common stock beneficially owned by: (i) each director; (ii) each executive officer; (iii) all current executive officers (regardless of salary and bonus level) and directors as a group; and (iv) each person or entity known by us to beneficially own more than 5% of our outstanding common stock. The address for each director and executive officer is 1090 King Georges Post Road, Suite 603, Edison, New Jersey 08837. Unless otherwise indicated, the shareholders listed in the table below have sole voting and investment powers with respect to the shares indicated:

 

This table is based upon information obtained from our stock records.

 

NAME OF BENEFICIAL OWNER

 

AMOUNT OF OWNERSHIP(1)

 

 

PERCENTAGE OF CLASS(2) (excluding Preferred Stock (11)

 

Mark L. Kay

 

 

25,157,002

(3),(11)

 

 

1.5373

%

Ramarao Pemmaraju

 

 

41,971,457

(4),(5),(11)

 

 

2.5647

%

George Waller

 

 

26,574,354

(6),(7),(11)

 

 

1.6239

%

All directors and executive officers as a group (3 persons)

 

 

93,702,813

(8)

 

 

5.7259

%

NetLabs.com, Inc.

 

 

2

(9),(10)

 

 

0.00000012

%

 

 

(1)

A person is deemed to be the beneficial owner of securities that can be acquired by such person within 90 days from the date hereof.

 

 

 

 

(2)

 

Based on 1,092,417,572 shares of common stock outstanding as of December 31, 2022; also including 21 shares of common stock available upon the conversion of certain convertible loans, 1,255,638 shares of common stock available upon the conversion of Series B Preferred stock, 150,633,001 shares of common stock underlying common stock purchase options and 362,729,077 shares of common stock underlying warrants.

     

 

(3)

Includes 1 share of common stock available upon the conversion of certain convertible loans valued at $4,875,000,000,000 per share for $240,000 of convertibles and $3,656,250,000,000 per share for $28,000 of convertibles, 1 share of common stock underlying vested ten-year options valued at $1,121,250,000 per share, 72,000 shares of common stock underlying vested ten-year options valued at $3.125 per share, 20,000 shares of common stock underlying vested ten-year options valued at $2.85 per share, 20,000 shares of common stock underlying vested ten-year options valued at $2.05 per share, 10,000,000 shares of common stock underlying vested ten-year options valued at $0.0375 per share, and 5,000,000 shares of common stock underlying vested ten-year options valued at $0.0045 per share. Mark L. Kay, along with Ramarao Pemmaraju and George Waller each hold one share of Series A Preferred Shares which, collectively, allow the holders to vote up to 80% of the issued and outstanding shares of common and preferred stock; Mark Kay, along with Ramarao Pemmaraju and George Waller have irrevocably waived any conversion rights.

 

 
38

Table of Contents

 

 

(4)

Includes 1 share of common stock available upon the conversion of certain convertible loans valued at $4,875,000,000,000 per share for $25,000 of convertibles and $3,656,250,000,000 per share for $5,000 of convertibles, 2 shares of common stock underlying vested ten-year options valued at $1,121,250,000 per share, 116,000 shares of common stock underlying vested ten-year options valued at $3.125 per share, 30,000 shares of common stock underlying vested ten-year options valued at $2.85 per share, 30,000 shares of common stock underlying vested ten-year options valued at $2.05 per share,  15,000,000 shares of common stock underlying vested ten-year options valued at $0.0375 per share, and 7,500,000 shares of common stock underlying vested ten-year options valued at $0.0045 per share.  Of the total shares, 64,002 shares, consisting of 1 share of common stock available upon the conversion of certain convertible loans valued at $4,875,000,000,000 per share for $25,000 of convertibles and $3,656,250,000,000 per share for $5,000 of convertibles, 44,000 shares of common stock underlying vested ten-year options valued at $3.125 per share, 10,000 shares of common stock underlying vested ten-year options valued at $2.85 per share, 10,000 shares of common stock underlying vested ten-year options valued at $2.05 per share, 5,000,000 shares of common stock underlying vested ten-year options valued at $0.0375 per share, and 2,500,000 shares of common stock underlying vested ten-year options valued at $0.0045 per share are in the name of Sunita Pemmaraju who is a family member and spouse of Ramarao Pemmaraju. Mark L. Kay, along with Ramarao Pemmaraju and George Waller each hold one share of Series A Preferred Shares which, collectively, allow the holders to vote up to 80% of the issued and outstanding shares of common stock; Mark Kay, along with Ramarao Pemmaraju and George Waller have irrevocably waived any conversion rights.

 

 

(5)

Excludes shares owned by NetLabs.com, Inc. which is controlled by Ramarao Pemmaraju and another individual.

 

 

(6)

Includes 1 share listed in the name of Katherine LaRosa who is a spouse of George Waller.

 

 

(7)

Includes 1 share of common stock underlying vested ten-year options valued at $1,121,250,000 per share, 72,000 shares of common stock underlying vested ten-year options valued at $3.125 per share, 20,000 shares of common stock underlying vested ten-year options valued at $2.85 per share, 20,000 shares of common stock underlying vested ten-year options valued at $2.05 per share, 10,000,000 shares of common stock underlying vested ten-year options valued at $0.0375 per share, and 5,000,000 shares of common stock underlying vested ten-year options valued at $0.0045 per share. Mark Kay, along with Ramarao Pemmaraju and George Waller each hold one share of Series A Preferred Shares which, collectively, allow the holders to vote up to 80% of the issued and outstanding shares of common stock; Mark Kay, along with Ramarao Pemmaraju and George Waller have irrevocably waived any conversion rights.

 

 

(8)

Includes 2 shares of common stock available upon the conversion of certain convertible loans valued at $4,875,000,000,000 per share for $265,000 of convertibles and $3,656,250,000,000 per share for $33,000 of convertibles, 4 shares of common stock underlying vested ten-year options valued at $1,121,250,000 per share, 260,000 shares of common stock underlying vested ten-year options valued at $3.125 per share, 70,000 shares of common stock underlying vested ten-year options valued at $2.85 per share, 70,000 shares of common stock underlying vested ten-year options valued at $2.05 per share, 35,000,000 shares of common stock underlying vested ten-year options valued at $0.0375 per share, and 17,500,000 shares of common stock underlying vested ten-year options valued at $0.0045 per share. Excludes the Series A Preferred Shares: Mark L. Kay, along with Ramarao Pemmaraju and George Waller, each hold one share of Series A Preferred Shares which, collectively, allow the holders to vote up to 80% of the issued and outstanding shares of common stock; Mark Kay, along with Ramarao Pemmaraju and George Waller, have irrevocably waived any conversion rights.

 

 

 

 

(9)

Ramarao Pemmaraju controls NetLabs.com, Inc. along with another individual.

 

 

(10)

Includes 1 share of common stock underlying vested ten-year options valued at $975,000,000 per share.

 

 

(11)

Mark Kay, along with Ramarao Pemmaraju and George Waller hold 3 shares of preferred stock. The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock.

 

 
39

Table of Contents

 

DESCRIPTION OF SECURITIES

 

Equity Incentive Plan Information

 

The following table sets forth as of December 31, 2022, the total number of shares of our common stock which may be issued upon the exercise of outstanding stock options and other rights under compensation plans approved by the shareholders, and under compensation plans not approved by the shareholders. The table also sets forth the weighted average purchase price per share of the shares subject to those options, and the number of shares available for future issuance under those plans.

 

Plan Category

 

Number of securities to be issued upon exercise of outstanding options

 

 

Weighted-average exercise price of outstanding option

 

 

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

 

Equity compensation plans approved by security holders

 

 

150,633,001

 

 

$0.0307

 

 

 

182,500,000

 

Equity compensation plans not approved by security holders

 

 

N/A

 

 

$N/A

 

 

 

N/A

 

Total

 

 

150,633,001

 

 

$0.0307

 

 

 

182,500,174

 

 

2012 Stock Option Plan

 

In November 2012, the stockholders approved the 2012 Stock Option Plan for our employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000.

 

The number of shares authorized for issuance under the Incentive Plan was increased to 200,000,000 in September 2016 by unanimous consent of our Board of Directors.

 

The number of shares authorized for issuance under the Incentive Plan was increased to 400,000,000 in November 2017 by unanimous consent of our Board of Directors.

 

In December 2020, we awarded options to purchase 57,500,000 shares of our common stock to our management team and employees, exercisable at $0.005 per share, expiring ten (10) years from the date of grant and vesting over a six-month period.

 

In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, we remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense. We also recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, we also issued 17,208,335 shares of our common stock upon cashless exercise of 17,500,000 options.

 

 
40

Table of Contents

 

In July 2021, we issued 13,557,693 shares of our common stock upon cashless exercise of 15,000,000 options.

 

In September 2021, we issued 9,189,627 shares of the Company’s common stock upon cashless exercise of 10,000,000 options.

 

In October 2021, we awarded options to purchase 2,500,000 shares of our common stock to our management team and employees, exercisable at $0.005 per share, expiring ten (10) years from the date of grant and vesting over a six-month period.

 

In December 2021, we awarded options to purchase 65,000,000 shares of our common stock to our management team and employees, exercisable at $0.0375 per share, expiring ten (10) years from the date of grant and vesting over a six-month period.

 

The 2012 Stock Option Plan will terminate on October 5, 2022, the ten-year anniversary of its effective date (ratified by the shareholders on November 16, 2012). However, awards granted before the termination of the 2012 Stock Option Plan may extend beyond that date in accordance with their terms.

 

The 2022 Omnibus Equity Compensation Plan

 

In January 20, 2023, the stockholders approved the 2022 Omnibus Equity Compensation Plan for our employees, effective October 4, 2022. The number of shares authorized for issuance under the plan was 250,000,000.

 

In December 2022, we awarded options to purchase 67,500,000 shares of our common stock to our management team and employees, exercisable at $0.045 per share, expiring ten (10) years from the date of grant and vesting over a six-month period.

 

General

 

Common Stock

 

The shares of our common stock presently outstanding, and any shares of our common stock issues upon exercise of stock options and/or common stock purchase warrants, will be fully paid and non-assessable. Each holder of common stock is entitled to one vote for each share owned on all matters voted upon by shareholders, and a majority vote is required for all actions to be taken by shareholders. In the event we liquidate, dissolve or wind-up our operations, the holders of the common stock are entitled to share equally and ratably in our assets, if any, remaining after the payment of all our debts and liabilities and the liquidation preference of any shares of preferred stock that may then be outstanding. The common stock has no preemptive rights, no cumulative voting rights, and no redemption, sinking fund, or conversion provisions. Since the holders of common stock do not have cumulative voting rights, holders of more than 50% of the outstanding shares can elect all of our Directors, and the holders of the remaining shares, by themselves, cannot elect any Directors. Holders of common stock are entitled to receive dividends, if and when declared by the Board of Directors, out of funds legally available for such purpose, subject to the dividend and liquidation rights of any preferred stock that may then be outstanding.

 

In April 2020, an increase of the authorized shares of our common stock from twelve billion (12,000,000,000) to seventeen billion (17,000,000,000), $0.0001 par value, was ratified, effective upon the filing of an amendment to our Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in April 2020.

 

On April 13, 2020, our Board of Directors and the holders of a majority of the voting power approved a resolution to effectuate a 500:1 Reverse Stock Split a resolution for a Reduction in Authorized from seventeen billion (17,000,000,000) Common Stock down to fourteen billion (14,000,000,000) Common Stock, $0.0001 par value. The amendment was adopted in June 2020.

 

On November 13, 2020, our filing of an Offering Circular on Form 1-A, pursuant to Regulation A (File Number: 024-11267) was qualified by the Securities and Exchange Commission. The Company registered 668,449,198 shares of common stock maximum proceeds of $2,315,000 (after deducting the maximum broker discount and costs of the offering).

 

 
41

Table of Contents

 

In December 2020, a decrease of the authorized shares of our common stock from fourteen billion (14,000,000,000) to four billion (4,000,000,000), $0.0001 par value, was ratified, effective upon the filing of an amendment to our Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in December 2020.

 

Preferred Stock

 

On October 21, 2010, we amended our Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10. The designations, rights, and preferences of such preferred stock are to be determined by the Board of Directors. On November 15, 2010, we changed our domicile from the  New Jersey to  Wyoming.

 

In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation.

 

The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding.

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of us , such liquidation rights to be paid from our  assets  not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to our shareholders for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by our Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

In February 2014, our Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time we receive a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to our common stock, the minimum price discount floor level is set at $0.005, as decided by our Board of Directors.

 

Series A Preferred Stock

 

In 2011, we issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of our total issued and outstanding common stock shares. . This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to our shareholders.  The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued.

 

Series B Preferred Stock

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up, such liquidation rights are to be paid from our assets not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to our shareholders for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by our Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

 
42

Table of Contents

 

As of December 31, 2022, there were 36,667 shares of Series B Preferred Stock issued and outstanding, 20,000 of which convert to common shares at a 25% market discount and 16,667 of which convert to common shares at a 30% market discount.

 

All of the above offerings and sales, except the afore-mentioned shares issued pursuant to a conversion of convertible notes, were made in reliance upon the exemption from registration under Rule 506 of Regulation D promulgated under the Securities Act of 1933 and/or Section 4(2) of the Securities Act of 1933, based on the following: (a) the investors confirmed to us that they were “accredited investors,” as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933 and had such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities; (b) there was no public offering or general solicitation with respect to the offering; (c) the investors were provided with certain disclosure materials and all other information as requested ; (d) where applicable, the investors acknowledged that all securities being purchased were “restricted securities” for purposes of the Securities Act of 1933, and agreed to transfer such securities only in a transaction registered under the Securities Act of 1933 or exempt from registration under the Securities Act; and (e) where applicable, a legend was placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequent registered under the Securities Act of 1933 or transferred in a transaction exempt from registration under the Securities Act of 1933.

 

Voting Rights 

 

Each holder of Common Stock is entitled to one vote for each share of Common Stock held on all matters submitted to a vote of stockholders.

 

The three shares of the issued and outstanding shares of the Series A preferred stock have voting rights equal to eighty percent of the total issued and outstanding shares of our common stock.

 

Dividends 

 

Subject to preferences that may be applicable to any then-outstanding shares of Preferred Stock, if any, and any other restrictions, holders of Common Stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. We and our predecessors have not declared any dividends in the past. Further, we do not presently contemplate that there will be any future payment of any dividends on Common Stock.

 

Amendment of our Bylaws

 

Our bylaws may be adopted, amended or repealed by the affirmative vote of a majority of our outstanding shares. Subject to applicable law, our bylaws also may be adopted, amended or repealed by our Board of Directors.

 

Transfer Agent

 

Our transfer agent is Worldwide Stock Transfer, LLC. Their address is One University Plaza, Suite 505, Hackensack, NJ 07601.

 

 
43

Table of Contents

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

None of the following parties has, since our date of incorporation, had any material interest, direct or indirect, in any transaction with us or in any presently proposed transaction that has or will materially affect us:

 

·

Any of our directors or officers, except as described below;

 

· 

Any person proposed as a nominee for election as a director;

 

· 

Any person who beneficially owns, directly or indirectly, shares carrying more than 5% of the voting rights attached to our outstanding shares of common stock;

 

· 

Any of our promoters;

 

· 

Any relative or spouse of any of the foregoing persons who has the same house address as such person.

 

BlockSafe Technologies, Inc.

 

BlockSafe Technologies, Inc. (“BlockSafe”) was formed on December 1, 2017 in Wyoming. BlockSafe is in the business of providing total cyber security solutions and is the licensee from our company of our desktop anti-malware product called “GuardedID®” and a one-of-a-kind mobile application called “MobileTrust®”. BlockSafe is intended to be developed as an enterprise focusing on using our licensed technology in the field of cryptocurrency and its use of blockchains. BlockSafe has limited revenues to date as it is still in the developmental stage. There can be no assurances on the success of this project or any profitability arising from BlockSafe.

 

As of December 31, 2022, no tokens have been developed or issued. There is no assurance as to whether, or at what amount, or on what terms, tokens will be available. Moreover, there can be no assurance how such technology will function, which could expose us to legal and regulatory issues. Cryptocurrency and its use of blockchains is still in the development stage and receiving mixed results. The Securities and Exchange Commission has, in its dissemination of information to the public, expressed that tokens in the United States would be treated as securities pursuant to the Howey Test. This standard has been adopted, in various forms, in numerous other jurisdictions. The European Union and China are contemplating their own form of cryptocurrency and Facebook Libra cryptocurrency recently lost the support of PayPal (see https://www.independent.co.uk/topic/cryptocurrency, which article is not incorporated by reference to this filing). On March 30, 2022, the Securities and Exchange Commission’s Division of Examinations announced its 2022 examination priorities which included the review of the use of crypto-assets as one of its top five priorities for review. This review and any regulatory rules and regulations arising from this review may impact the BlockSafe business. In addition, legal and regulatory developments could render the technology impermissible, which could have a material adverse effect on BlockSafe and us.

 

In June 2018, two members of our management team, George Waller, our Executive Vice President and Ramarao Pemmaraju, our Chief Technical Officer, were appointed to BlockSafe to serve as the Chief Executive Officer and Chief Technical Officer, respectively. Additionally, our Chief Executive Officer of StrikeForce, Mark L. Kay, also an appointee to the Board of Directors of BlockSafe, was appointed as Chairman and President of BlockSafe.

 

BlockSafe is owned 49% by the Company and 31% is owned by three of our executive officers.  BlockSafe meets the definition of a variable interest entity (“VIE”) and based on the determination that we are the primary beneficiary of BlockSafe, we consolidated BlockSafe’s operating results, assets and liabilities. Intercompany balances and transactions have been eliminated in consolidation. At December 31, 2022, noncontrolling interests represents 51% of BlockSafe that we do not directly own. We and BlockSafe have a management agreement pursuant to which BlockSafe shall remit a management fee of $36,000 per month to us and when BlockSafe reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to us and payable monthly over three years. The management fee is currently eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BlockSafe, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to our general credit.  

 

 
44

Table of Contents

 

Cybersecurity Risk Solutions, LLC

 

On April 15, 2021, StrikeForce formally closed a Member Interest Purchase Agreement in which StrikeForce acquired the entire Member Interests of Cybersecurity Risk Solutions, LLC, a New Jersey limited liability company. In April 2021, we issued 500,000 shares of common stock with a fair value of $36,000, for the purchase of Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, we also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.

 

Cybersecurity Risk Solutions, LLC is a cybersecurity firm offering cyber, privacy & data protection services including a personal cyber risk assessment, the industry’s first cyber health score, report and custom action plan, as well as ongoing vulnerability scanning, hack monitoring and dark web intelligence monitoring. For more information, go to https://SecureCyberID.com (which website is expressly not included in this filing). Will Lynch, the prior sole member of Cybersecurity Risk Solutions, LLC was hired by StrikeForce as the Director of Channel Distribution and not as a Named Executive Officer. A Director of Channel Distribution develops, services, and grows relationships with clients. Mr. Lynch has an annual salary of $100,000 and will also receive 2% net of all Channel sales..  Mr. Lynch, tendered his resignation on December 2, 2022  and hasn’t been replaced at StrikeForce, now called Zerify. Cybersecurity Risk Solutions is still in business and selling its products.

 

RELATED PARTY CONVERTIBLE NOTES

 

In previous years, we issued convertible notes to related parties/officers in exchange for cash and/or services rendered. The notes are unsecured and are due on December 31, 2023, as amended. As of December 31, 2022, the outstanding balance of the notes payable amounted to $268,000.

 

During the year ended December 31, 2021, convertible notes payable aggregating $30,000 were repaid. In addition, the remaining noteholder also agreed to extend the maturity date to December 31, 2022 with no changes to the other terms of the notes payable.

 

At December 31, 2020, accrued interest due on the convertible notes to related parties was $625,000. During the year ended December 31, 2021, interest of $68,000 was accrued, and accrued interest of $64,000 was subsequently repaid. The outstanding balance of these convertible notes at December 31, 2022 and December 31, 2021 amounted to $693,000 and $693,000, respectively.

 

RELATED PARTY PROMISSORY NOTES

 

Notes payable-related parties promissory notes represent notes payable to our Chief Executive Officer ranging in interest rates of 0% per annum to 8% per annum. The notes are unsecured and have extended due dates of December 31, 2023.

 

At December 31, 2022 and 2021, the balance of notes payable-related parties totaled $693,000 which are all due to our Chief Executive Officer.

 

DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

 

Wyoming corporation law provides that:

 

·

a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful;

 

 
45

Table of Contents

 

·

a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper; and

 

 

·

to the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding, or in defense of any claim, issue or matter therein, the corporation shall indemnify him against expenses, including attorneys’ fees, actually and reasonably incurred by him in connection with the defense.

 

Our articles of incorporation require us to indemnify our directors and officers against all damages incurred in connection with our business to the fullest extent provided or allowed by law.

 

Our bylaws provide that we will advance all expenses incurred to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suite or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was our director or officer, or is or was serving at our request as a director or executive officer of another company, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request. This advancement of expenses is to be made upon receipt of an undertaking by or on behalf of such person to repay said amounts should it be ultimately determined that the person was not entitled to be indemnified under our bylaws or otherwise.

 

Our bylaws also provide that no advance shall be made by us to any officer in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made: (a) by the board of directors by a majority vote of a quorum consisting of directors who were not parties to the proceeding; or (b) if such quorum is not obtainable, or, even if obtainable, a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to our best interests.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Commission this indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Fees billed by Weinberg & Company, P.A. for the fiscal years ended December 31, 2022 and 2021 related to the Company’s audit services were approved by the Audit Committee and paid by the Company.

 

The following table shows the audit fees incurred for fiscal year 2022 and 2021:

 

 

 

 2022

 

 

 2021

 

Audit fees (1)

 

$132,500

 

 

$107,500

 

Audit related fees (2)

 

 

-

 

 

 

-

 

Tax fees (3)

 

 

-

 

 

 

-

 

Total

 

$132,500

 

 

$107,500

 

 

 
46

Table of Contents

 

(1)

Audit Fees – This category includes the audit of our annual financial statements, review of financial statements included in our quarterly reports and services that are normally provided by the independent registered public accounting firm in connection with engagements for those years and services that are normally provided by our independent registered public accounting firm in connection with statutory audits and SEC regulatory filings or engagements.

 

 

(2)

Audit-Related Fees – This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees”.

 

 

(3)

Tax Fees – This category consists of professional services rendered by our independent registered public accounting firm for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.

  

The Board of Directors has reviewed and discussed, with our management and independent registered public accounting firm, our audited financial statements contained in our Annual Report on Form 10-K for our 2022 fiscal year. The Board has also discussed with the auditors the matters required to be discussed pursuant to SAS No. 61 (Codification of Statements on Auditing Standards, AU Section 380), which includes, among other items, matters related to the conduct of the audit of our financial statements.

 

The Board has received and reviewed the written disclosures and the letter from the independent registered public accounting firm required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees) and has discussed with its auditors its independence from us. The Board has considered whether the provision of services other than audit services is compatible with maintaining auditor independence.

 

Based on the review and discussions referred to above, the Board approved the inclusion of the audited financial statements be included in our Annual Report on Form 10-K for our 2022 fiscal year for filing with the SEC.

 

Pre-Approval Policies

 

The Board’s policy is to pre-approve all audit services and all permitted non-audit services (including the fees and terms thereof) to be provided by our independent registered public accounting firm; provided, however, pre-approval requirements for non-audit services are not required if all such services (1) do not aggregate to more than five percent of total revenues paid by us to our accountant in the fiscal year when services are provided; (2) were not recognized as non-audit services at the time of the engagement; and (3) are promptly brought to the attention of the Board and approved prior to the completion of the audit.

 

The Board pre-approved all fees described above.

 

 
47

Table of Contents

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

Exhibit

Number

 

Description

1.1

 

Placement Agreement dated July 7, 2020, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (23)

1.2

 

Addendum to Placement Agreement dated November 11, 2020, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (25)

1.3

 

Addendum to Placement Agreement dated April 20, 2021, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (28)

3.1

 

Amended and Restated Certificate of Incorporation of StrikeForce Technologies, Inc. (1)

3.2

 

By-laws of StrikeForce Technologies, Inc. (1)

3.3

 

Amended By-laws of StrikeForce Technologies, Inc. (2)

3.4

 

Amended By-laws of StrikeForce Technologies, Inc. (3)

3.5

 

Articles of Amendment of StrikeForce Technologies, Inc. (2)

3.6

 

Amendments to Articles of Incorporation (6)

3.7

 

Amendments to Articles of Incorporation (7)

3.8

 

Registration of Classes of Securities (8)

3.9

 

Amendments to Articles of Incorporation (9)

3.10

 

Registration of Classes of Securities (10)

3.11

 

Amendments to Articles of Incorporation (11)

3.12

 

Registration of Classes of Securities (12)

3.13

 

Amendments to Articles of Incorporation (13)

3.14

 

Amendments to Articles of Incorporation (14)

3.15

 

Amendments to Articles of Incorporation (15)

3.16

 

Amendments to Articles of Incorporation (16)

3.17

 

Amendments to Articles of Incorporation (17)

3.18

 

Amendments to Articles of Incorporation (18)

3.19

 

Amendments to Articles of Incorporation (22)

3.20

 

Amendments to Articles of Incorporation (26)

4.1

 

Form of Subscription Agreement (25)

4.2

 

Form of Convertible Promissory Note-Related Party (24)

4.3

 

Form of Promissory Note-Related Party (24)

10.1

 

Employment Agreement dated as of May 20, 2003, by and between StrikeForce Technologies, Inc. and Mark L. Kay (1)

10.2

 

Irrevocable Waiver of Conversion Rights of Mark L. Kay (4)

10.3

 

Irrevocable Waiver of Conversion Rights of Ramarao Pemmaraju (4)

10.4

 

Irrevocable Waiver of Conversion Rights of George Waller (4)

10.5

 

CFO Consultant Agreement with Philip E. Blocker (4)

10.6

 

2012 Stock Option Plan (5)

10.7

 

Asset Purchase Agreement between StrikeForce Technologies, Inc. and Cyber Safety, Inc., dated August 24, 2015 (18)

10.8

 

Amendment to the Asset Purchase Agreement and Distributor and Reseller Agreement between StrikeForce Technologies, Inc. and Cyber Safety, Inc. (19)

10.9

 

Execution of Litigation Funding Agreement (20)

10.10

 

BlockSafe Technologies, Inc. Intellectual Property License Agreement (21)

10.11

 

BlockSafe Technologies, Inc. Management Agreement (21)

10.12

 

BlockSafe Technologies, Inc. Amended Management Agreement (21)

10.13

 

Software License and Development Agreement, amendment two, by and between StrikeForce Technologies, Inc. and Intersections, Inc., dated October 1, 2010 (24)

 

 
48

Table of Contents

 

10.14

 

Form of Settlement and Exchange Agreement (26)

10.15

 

Cybersecurity Risk Solutions LLC Member Interest Purchase Agreement, dated April 15, 2021 (27)

21.1

 

List of Ownership Interests

31.1

 

Certification by Chief Executive Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (29)

31.2

 

Certification by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (29)

32.1

 

Certification by Chief Executive Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (29)

32.2

 

Certification by Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (29)

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). (29)

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document. (29)

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document. (29)

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document. (29)

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document. (29)

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document. (29)

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). (29)

 

(1)

Filed as an exhibit to the Registrant’s Form SB-2 dated as of May 11, 2005 and incorporated herein by reference.

(2)

Filed as an exhibit to the Registrant’s Form 8-K dated February 4, 2011 and incorporated herein by reference.

(3)

Filed as an exhibit to the Registrant’s Form 10-Q dated December 13, 2010 and incorporated herein by reference.

(4)

Filed as an exhibit to the Registrant’s Form S-1/A dated July 31, 2012 and incorporated herein by reference.

(5)

Filed in conjunction with the Registrant’s Form 14A filed October 5, 2012 and incorporated herein by reference.

(6)

Filed as an exhibit to the Registrant’s Form 8-K dated February 5, 2013 and incorporated herein by reference.

(7)

Filed as an exhibit to the Registrant’s Form 8-K dated May 14, 2013 and incorporated herein by reference.

(8)

Filed as an exhibit to the Registrant’s Form 8-A dated July 29, 2013 and incorporated herein by reference.

(9)

Filed as an exhibit to the Registrant’s Form 8-K dated August 22, 2013 and incorporated herein by reference.

(10)

Filed as an exhibit to the Registrant’s Form 8-A dated October 3, 2013 and incorporated herein by reference.

(11)

Filed as an exhibit to the Registrant’s Form 8-K dated October 3, 2013 and incorporated herein by reference.

(12)

Filed as an exhibit to the Registrant’s Form 8-A dated December 31, 2013 and incorporated herein by reference.

(13)

Filed as an exhibit to the Registrant’s Form 8-K dated December 31, 2013 and incorporated herein by reference.

(14)

Filed as an exhibit to the Registrant’s Form 8-K dated March 18, 2014 and incorporated herein by reference.

(15)

Filed as an exhibit to the Registrant’s Form 8-K dated December 22, 2014 and incorporated herein by reference.

(16)

Filed as an exhibit to the Registrant’s Form 8-K dated February 13, 2015 and incorporated herein by reference.

(17)

Filed as an exhibit to the Registrant’s Form 8-K dated August 4, 2015 and incorporated herein by reference.

(18)

Filed as an exhibit to the Registrant’s Form 8-K dated August 24, 2015 and incorporated herein by reference.

(19)

Filed as an exhibit to the Registrant’s Form 8-K dated February 2, 2016 and incorporated herein by reference.

(20)

Filed as an exhibit to the Registrant’s Form 8-K dated September 11, 2017 and incorporated herein by reference.

(21)

Filed as an exhibit to the Registrant’s Form 10-Q dated June 30, 2018 and incorporated herein by reference.

(22)

Filed as an exhibit to the Registrant’s Form 8-K dated June 25, 2020 and incorporated herein by reference.

(23)

Filed as an exhibit to the Registrant’s Form 1-A dated July 13, 2020 and incorporated herein by reference.

(24)

Filed as an exhibit to the Registrant’s Form 1-A.1 dated September 11, 2020 and incorporated herein by reference.

(25)

Filed as an exhibit to the Registrant’s Form 1-A.1 dated November 12, 2020 and incorporated herein by reference.

(26)

Filed as an exhibit to the Registrant’s Form 8-K dated February 8, 2021 and incorporated herein by reference.

(27)

Filed as an exhibit to the Registrant’s Form 8-K dated April 19, 2021 and incorporated herein by reference.

(28)

Filed as an exhibit to the Registrant’s Form 1A/A- dated April 26, 2021 and incorporated herein by reference.

(29)

Filed herewith.

  

ITEM 16.  FORM 10-K/A SUMMARY 

 

Not applicable.

 

 
49

Table of Contents

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ZERIFY, INC.

 

 

 

 

Dated: April 14, 2023

By:

/s/ Mark L. Kay

 

 

Mark L. Kay

 

 

 

Chief Executive Officer

 

 

Dated: April 14, 2023

By:

/s/ Philip E. Blocker

 

Philip E. Blocker

 

 

 

Chief Financial Officer and

 

 

 

Principal Accounting Officer

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Mark L. Kay

 

Director

 

April 14, 2023 

Name: Mark L. Kay

 

 

 

 

 

 

 

 

 

/s/ Ramarao Pemmaraju

 

Director

 

April 14, 2023 

Name: Ramarao Pemmaraju

 

 

 

 

 

 

 

 

 

/s/ George Waller

 

Director

 

April 14, 2023 

Name: George Waller

 

 

 

 

 

 
50

 

EX-21.1 2 zrfy_ex211.htm LIST OF OWNERSHIP INTERESTS zrfy_ex21.htm

EXHIBIT 21.1

 

BlockSafe Technologies, Inc.: 49% holder.

 

Cybersecurity Risk Solutions, LLC: 100% holder.

EX-31.1 3 zrfy_ex311.htm CERTIFICATION zrfy_ex311.htm

EXHIBIT 31.1

CERTIFICATION

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Mark L. Kay, certify that:

 

1.

I have reviewed this annual report on Form 10-K of Zerify, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 14, 2023

 

 

 

 

/s/ Mark L. Kay

 

Mark L. Kay, Chief Executive Officer

 

 

EX-31.2 4 zrfy_ex312.htm CERTIFICATION zrfy_ex312.htm

EXHIBIT 31.2

CERTIFICATION

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Philip E. Blocker, certify that:

 

1.

I have reviewed this annual report on Form 10-K of Zerify, Inc.; 

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 14, 2023

 

 

/s/ Philip E. Blocker 

 

 

Philip E. Blocker, Chief Financial Officer

 

 

EX-32.1 5 zrfy_ex321.htm CERTIFICATION zrfy_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Zerify, Inc. (the "Company") on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark L. Kay, our Chief Executive Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2001, that:

 

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: April 14, 2023

 

/s/ Mark L. Kay

Mark L. Kay,

Chief Executive Officer

EX-32.2 6 zrfy_ex322.htm CERTIFICATION zrfy_ex322.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Zerify, Inc. (the "Company") on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Philip E. Blocker, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2001, that:

 

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: April 14, 2023

 

/s/ Philip E. Blocker

Philip E. Blocker

Chief Financial Officer

 

EX-101.SCH 7 zrfy-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Convertible Notes Payable Related Parties link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Notes Payable Related Parties link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - VIE Financing Obligation link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Contingent Payment Obligation link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Operating Lease link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - Stockholders Deficit link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - Stock Options link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Income Tax Provision link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Operating Lease (Tables) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - Stockholders Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - Stock Options (Tables) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - Income Tax Provision (Tables) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - Commitment and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - Organization and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - Convertible Notes Payable - Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - Notes Payable Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - VIE Financing Obligation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - Contingent Payment Obligation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - Derivative Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - Derivative Financial Instruments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - Operating Lease (Details) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - Operating Lease (Details 1) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - Operating Lease (Details 2) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - Operating Lease (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - Stockholders Deficit (Details) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - Stockholders Deficit (Details 1) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - Stockholders Deficit (Details 2) link:presentationLink link:calculationLink link:definitionLink 000056 - Disclosure - Stockholders Deficit (Details 3) link:presentationLink link:calculationLink link:definitionLink 000057 - Disclosure - Stockholders Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000058 - Disclosure - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 000059 - Disclosure - Stock Options (Details 1) link:presentationLink link:calculationLink link:definitionLink 000060 - Disclosure - Stock Options (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000061 - Disclosure - Income Tax Provision (Details) link:presentationLink link:calculationLink link:definitionLink 000062 - Disclosure - Income Tax Provision (Details 1) link:presentationLink link:calculationLink link:definitionLink 000063 - Disclosure - Income Tax Provision (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000064 - Disclosure - Commitment and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 000065 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 8 zrfy-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Entity Incorporation State Country Code Entity File Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12g Title Entity Interactive Data Current Auditor Firm Id Auditor Location Auditor Name CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Class of Stock [Axis] Series B Preferred Stock [Member] Series A Preferred Stock [Member] ASSETS Current Assets: Cash (includes VIE balances of $1,000 and $1,000, respectively) Accounts receivable, net Prepaid expenses Total current assets [Assets, Current] Property and equipment, net Operating lease right-of-use asset Other assets Total Assets [Assets] LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively) Convertible notes payable, net of discount of $96,000 and $0, respectively (including $895,000 and $895,000 in default) Convertible notes payable - related parties Notes payable, net of discount of $323,000 and $0, respectively (including $1,930,000 and $1,972,000 in default, respectively) (includes VIE balances of $285,000 and $310,000, respectively) Notes payable - related parties Accrued interest (including $1,557,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $134,000 and $120,000, respectively) Contingent payment obligation VIE Financing obligation Operating lease liability, current portion Derivative liability Total current liabilities [Liabilities, Current] Notes payable, long-term portion Operating lease liability, long-term portion Total Liabilities [Liabilities] Commitments and Contingencies Stockholders' Deficit Preferred stock, Value Common stock par value $0.0001: 4,000,000,000 shares authorized; 1,109,417,572 and 955,380,225 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total Zerify, Inc. stockholders' deficit [Stockholders' Equity Attributable to Parent] Noncontrolling interest in consolidated subsidiary Total Stockholders' Deficit [Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest] Total Liabilities and Stockholders' Deficit [Liabilities and Equity] Current Assets Cash VIE Current Liabilities VIE Balance of Accounts Payables and Accrued Liabilities Allowance on convertible notes payable Convertible notes payable, default Notes payable VIE Allowance on notes payable Notes payable, default Accrued Interest VIE Accrued interest due to related parties Stockholders' Deficit [Stockholders' Deficit] Preferred Stock, share par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Revenue Operating expenses: Cost of revenue Selling, general and administrative expenses Research and development Total operating expenses [Operating Expenses] Loss from operations [Operating Income (Loss)] Other income (expense): Interest and financing expenses (including $121,000 and $121,000 to related parties) [Financing Interest Expense] Debt discount amortization [Amortization of Debt Discount (Premium)] Change in fair value of derivative liabilities Loss on extinguishment of debt, net Other expense [Other Expenses] Other income (expense), net [Other Nonoperating Income (Expense)] Net loss [Net Income (Loss) Attributable to Parent] Net loss attributable to noncontrolling interest [Net Income (Loss) Attributable to Noncontrolling Interest] Net loss attributable to Zerify, Inc. [Income (Loss) Attributable to Parent, before Tax] Deemed dividend to warrant holders [Dividends] Net loss to common stockholders [Net Income (Loss) Available to Common Stockholders, Basic] Net loss per common share -Basic and diluted Weighted average common shares outstanding -Basic and diluted [-Basic and diluted] CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statement Equity Components [Axis] Series A Preferred Stock Series B Preferred Stock Common Stock Additional Paid-In Capital Accumulated Deficit Noncontrolling Interest Balance, shares [Shares, Issued] Balance, amount Common stock issued for cash, shares Common stock issued for cash, amount Fair value of common stock issued for services, shares Fair value of common stock issued for services, amount Fair value of vested options Fair value of common stock issued as a financing cost, shares Fair value of common stock issued as a financing cost, amount Common stock issued upon cashless exercise of warrants, shares Common stock issued upon cashless exercise of warrants, amount Common stock issued upon cashless exercise of options, shares Common stock issued upon cashless exercise of options, amount Common stock issued upon conversion of notes and accrued interest, shares Common stock issued upon conversion of notes and accrued interest, amount Common stock issued upon conversion of debt settlement, shares Common stock issued upon conversion of debt settlement, amount Net loss Common stock issued upon exercise of warrants for cash, shares Common stock issued upon exercise of warrants for cash, amount Fair value of warrants granted for services Fair value of warrants issued with notes payable accounted for as debt discount Deemed dividend to warrant holders [Deemed dividend to warrant holders] Repurchase of common stock and warrants, shares Repurchase of common stock and warrants, amount Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS Cash flows from operating activities: Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Amortization of discount Financing costs Right-of-use asset Fair value of common stock issued for services Fair value of vested options and warrants Fair value of common stock issued for financing services Change in fair value of derivative liabilities [Derivative, Gain (Loss) on Derivative, Net] Loss on extinguishment of debt Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and other assets Accounts payable and accrued expenses Accrued interest Operating lease liability Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash flows from investing activities: Purchases of property and equipment [Payments to Acquire Property, Plant, and Equipment] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash flows from financing activities: Proceeds from exercise of warrants Proceeds from sale of common stock Proceeds from sale of convertible notes Proceeds from notes payable Repayment of convertible note payable [Repayments of Convertible Debt] Repayment of notes payable [Repayments of Notes Payable] Repurchase of common stock and warrants [Payments for Repurchase of Common Stock] Repayment of convertible notes payable-related parties [Repayment of convertible notes payable-related parties] Repayment of notes payable-related parties [Repayments of Related Party Debt] Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net increase (decrease) in cash [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash at beginning of the year [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents] Cash at end of the year Supplemental disclosure of cash flow information: Interest paid Income tax paid Supplemental disclosure of non-cash investing and financing transactions Fair value of derivative upon issuance of convertible debt recorded as debt discount Fair value of warrant recorded as debt discount Common stock issued for conversion of notes and accrued interest Common shares issued upon conversion of debt settlement Warrants issued with convertible notes Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Property and Equipment Property and Equipment Property, Plant and Equipment [Table Text Block] Convertible Notes Payable Convertible Notes Payable [Convertible Notes Payable] Convertible Notes Payable Related Parties Convertable Notes Payable - Related Parties Notes Payable Notes Payable Debt Disclosure [Text Block] Notes Payable Related Parties Notes Payable - Related Parties VIE Financing Obligation VIE Financing Obligation Legal Matters and Contingencies [Text Block] Contingent Payment Obligation Contingent Payment Obligation [Contingent Payment Obligation] Derivative Financial Instruments Derivative Financial Instruments Financial Instruments Disclosure [Text Block] Operating Lease Operating Lease [Operating Lease] Stockholders Deficit Stockholders' Deficit Shareholders' Equity and Share-Based Payments [Text Block] Stock Options Stock Options Fair Value, Option [Text Block] Income Tax Provision Income Tax Provision Income Tax Disclosure [Text Block] Commitment and Contingencies Commitment and Contingencies Commitments and Contingencies Disclosure [Text Block] Subsequent Events Subsequent Events Schedule of Subsequent Events [Table Text Block] Going Concern Basis of presentation and principles of consolidation COVID-19 Use of Estimates Revenue Recognition Accounts Receivable Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Impairment of Long-lived Assets Income Taxes Leases Fair Value of Financial Instruments Derivative Financial Instruments Derivatives, Policy [Policy Text Block] Stock-Based Compensation Loss per share Advertising, Sales and Marketing Costs Research and Development Costs Concentrations Segments Recent Accounting Pronouncements Schedule of Revenue Recognition Schedule of Property and Equipment Schedule of earning per share Schedule of property and equipment, stated at cost, less accumulated depreciation Schedule of convertible notes payable Schedule of notes payable Schedule of derivative liability Schedule of lease expense and supplemental cash flow information Schedule of supplemental balance sheet information Schedule of maturities Schedule of stock warrants activity Schedule of warrants outstanding and exercisable Schedule grants of warrants on issuance of note Payable Schedule of grant of warrants for services Schedule of stock options plan Schedule of stock option outstanding and exercisable Schedule of reconcilliation of fedral statutory income tax rate Schedule of deferred tax assets and liabilities Schedule of Onstream Media Corporation cases and their filing dates Product and Service [Axis] Software [Member] Service [Member] Total revenue Property Plant And Equipment By Type Axis Computer equipment [Member] Computer software [Member] Furniture and fixtures [Member] Office equipment [Member] Estimated Useful Life (Years) Options to purchase common stock Warrants to purchase common stock Convertible notes Convertible Series B Preferred stock Total [Total] Related Party Transactions By Related Party Axis Major Customers Axis Concentration Risk By Benchmark Axis BST [Member] One customer [Member] Revenues [Member] Two customer [Member] Three customer [Member] Accounts Receivable [Member] Net loss Net cash used in operating activities [Proceeds from Operating Activities] Total Stockholders' Deficit Notes payable aggregate amount Cash on hand Proceeds on the sale of common shares and warrants Sales deacreased percentage Allowance for doubtful debts Derivative liabilities Advertising, sales and marketing costs Research and development costs Ownership interest held by company Ownership interest held by three executive officers Management fee per month Financing milestone, amount Monthly management fee Concentration Risk, Percentage Property and equipment gross Less accumulated depreciation [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Property and equipment net Depreciation expense Secured (a) Convertible notes due to AL-Bank Unsecured (b) Convertible note with Diagonal Lending (c) Convertible notes with fixed conversion features, in default Total convertible notes principal outstanding Debt discount Convertible notes, net of discount Award Date Axis Short Term Debt Type Axis 2005 Through 2007 [Member] Convertible Notes Payable [Member] 2005 [Member] Unamortized debt discount Debt discount [Debt discount] Maturity date description Convertible notes payable, outstanding balance (a) DART/Citco Global, in default Proceeds from convertible notes payable Common stock shares issued upon conversion of debt Derivative liability [Derivative Liability] Financing costs Repayment penalty percentage Conversion price percentage Interest rate decriptions Interest rate Total [Total 1] Monyhly payment Remaining balance Principal payments Chief Executive Officer [Member] Due date Interest rate [Debt Instrument, Interest Rate, Stated Percentage] Convertible notes payable, outstanding balance Unsecured notes payable-in default (a) Notes payable- $1,639,000 - in default (b) Notes payable issued by BST - in default Secured notes payable (c) Note payable-EID loan (d) Notes payable - October 2022 (e) Notes payable - in default (f) Notes payable - July 2022 Total notes payable principal outstanding Debt discount Notes payable Less current portion of notes payable Long term notes payable Debt Instrument Axis Plan Name [Axis] Range [Axis] Long-Term Debt, Type [Axis] One Note [Member] EID Loan [Member] Note Payable Two [Member] Notes Payable [Member] Promissory Note [Member] Securities Purchase Agreement [Member] Walleye Opportunities Master Fund Ltd [Member] Maximum [Member] Minimum [Member] Unsecured [Member] Warrants granted Original issue discounts Total debentures Unamortized debt discount Notes payable, outstanding balance Principal payment Principal payments of promissory notes Amount recieved Interest rate decriptions Outstanding secured notes payable Note issued Interest rate of notes Amount payables Extinguished as debt settlement obligation transaction Description about issuance of note payable Common stock purchase of warrant Warrant exercisble price Purchased promissory note aggregate principal amount Common stock, par value Notes payable, outstanding balance [Notes payable, outstanding balance] Loan borrowed amount Interest rate on loan Monthly payment on loan, description Notes payable issue Notes payable issue maturity date Notes payable Volume weighted average price of common stock Minimum [Member] Maximum [Member] Notes payable - related parties Due date Interest rate [Debt, Weighted Average Interest Rate] Interest rate Related Party Transaction Axis Promissory note - various parties [Member] Related Party [Member] Unsecured Convertible Notes Payable [Member] Financing obligation Tokens issued to unrelated parties Financing obligation description Promissory note issued to unrelated parties Litigation funding agreement [Member] Therium Inc. and VGL Capital, LLC [Member] Contingent payment obligation [Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset] Gross proceeds Contingent obligation, description Stock Price Exercise Price Expected life (in years) Volatility Dividend Yield Risk-free interest rate Fair Value: Conversion feature Net change in the fair value of derivative liabilities Derivative liability Extinguishment of derivative liabilities Lease Cost Operating lease cost (included in general and administration in the Company's statement of operations) Other Information Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021 Weighted average remaining lease term - operating leases (in years) Average discount rate - operating leases Operating leases Long-term right-of-use assets Short-term operating lease liabilities Long-term operating lease liabilities Total operating lease liabilities 2023 2024 Total lease payment Less: Imputed interest/present value discount [Lessee, Operating Lease, Liability, Undiscounted Excess Amount] Present value of lease liabilities Operating lease payments, monthly Operating lease, description Lease expenses Minimum [Member] [Minimum [Member]] Maximum [Member] [Maximum [Member]] Number of Warrant Shares Number of warrants Beginning balance [Class of Warrant or Right, Outstanding] Number of warrants Granted Number of warrant shares, Canceled/Expired [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period] Number of warrants Exercised Number of warrants Outstsnding Ending Number of warrants exercisable Ending Exercise price range per share, Granted Weighted Average Exercise Price Weighted Average Exercise Price Beginning Balance Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Canceled/Expired Weighted Average Exercise Price, Exercised Weighted Average Exercise Price Outstanding Ending Balacce Weighted Average Exercise Price Exercisable Ending Balacce Exercise Price Range Per Share, Beginning balance Exercise Price Range Per Share, Exercised Exercise Price Range Per Share, Canceled/Expired Exercise Price Range Per Share Outstanding Ending Exercise Price Range Per Share Exercisable Ending balance Exercise Price Range Per Share Exercisable Ending balance [Exercise Price Range Per Share Exercisable Ending balance] Class Of Warrant Or Right Axis Warrant [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Total [Member] Warrant Total [Member] [Warrant Total [Member]] Average Remaining Contractual Life (in years) Weighted Average Exercise Price [Weighted Average Exercise Price] Number Outstanding Range of Exercise Prices Warrant Services [Member] Exercise Prices Share price Volatility [Volatility] Risk Free Rate Expected term (yrs.) Dividend Rate Warrant Note Payable [Member] Exercise Prices Share price Volatility Risk Free Rate Expected term (yrs.) Dividend Rate Warrant Total [Member] October, 21 2010 [Member] November 2020 [Member] Common Class Shares [Member] Grant of Warrants For Servicesl [Member] Warrant Holder [Member] Common Shares issued for cash Shares issued for cash value Deemed dividend Cash recieved Issued shares of stock warrants granted Preferred stock, shares authorized Shares issued for cash value, direct fees and commission Preferred stock, per share Warrants exercisable price Preferred stock, shares outstanding Warrants issued to purchase common shares Number of Warrants exercised Vested, exercisable price Purchase shares of common stock for financing services Additional warrants Warrant exercised, share Estimated fair value Common stock issued upon warrant exercised Warrants exercisable expire term Common stock issued Common stock issued [Common stock issued] Fair value of common stock issued Intrinsic value of warrants Warrants issued to purchase common stock Warrants issued to purchase common stock exercisable price Warrants issued to purchase common stock expiration period Common stock issued for service, share Common stock issued for service, share Common stock issued for service, value Stock issued for business purchase, shares Stock issued for business purchase, value Common stock issued upon conversion of convertible notes payable and accrued interest, share Shares of warrants Common stock issued upon conversion of convertible notes payable and accrued interest, value Common stock issued for debt settlement, share Common stock issued for debt settlement, value Additional shares of preferred stock Preferred stock, shares designated Aggregate amount Preferred stock value Preferred stock, descriptions Initial price of preferred stock Stock options Number of Options Shares, Beginning balance [Number of Options Shares, Beginning balance] Number of Options Shares, Granted Number of Options Shares, Exercised Number of Options Shares, Ending balance Number of Options Shares exercisable Ending Weighted Average Exercise Price [Weighted Average Exercise Price 1] Weighted Average Exercises Price Beginning Balance Weighted Average Exercise Price, Granted [Weighted Average Exercise Price, Granted] Weighted Average Exercise Price Outstanding Ending Balacce [Weighted Average Exercise Price Outstanding Ending Balacce] Weighted Average Exercise Price Exercisable Ending Balacce [Weighted Average Exercise Price Exercisable Ending Balacce] Exercise Price Range Per Share, Beginning balance [Exercise Price Range Per Share, Beginning balance] Exercise Price Range Per Share ,Granted Exercise Price Range Per Share Exercisable Ending balance Exercise Price Range Per Share, Ending balance Financial Instrument Axis Option Exercisable [Member] Exercise Prices Two [Member] Exercise Prices Three [Member] Options Outstanding [Member] Exercise Prices Four [Member] Exercise Prices Five [Member] Exercise Prices One [Member] Option Exercisable [Member] [Option Exercisable [Member]] Exercise Prices Six [Member] Exercise Prices Six [Member] [Exercise Prices Six [Member]] Weighted average exercise price [Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price] Weighted average remaining contractual life (years) Number of warrants outstanding Number of warrants exercisable Weighted average exercise price Stock Option [Member] February 2021 [Member] Option shares Exercise price Share based compensation Unamortized stock compensation Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Total fair value Intrinsic value of outstanding options Stock compensation expense, Additional Common stock, shares issued upon cashless exercise of options Options, Grants in Period Discount rate Volatility rate Options, exercised during period Options outstanding, estimated life Stock option granted Federal statutory income tax rate State tax, net of federal benefit Change in valuation allowance on net operating loss carry-forwards Effective income tax rate Income Tax Authority Axis Income Tax Provision [Member] Stock-based compensation Private placement costs Operating lease liability Loss on extinguishment of debt [Loss on extinguishment of debt] Net operating loss carryforwards Gross deferred tax assets Net deferred tax assets Less valuation allowance Tax Credit Carryforward Axis Federal [Member] State [Member] Net operating loss carry-forwards Carryforwards expiry year Onstream Media Corporation V Zerify Inc [Member] Onstream Media Corporation V Zerify Inc One [Member] Onstream Media Corporation V Zerify Inc Two [Member] Onstream Media Corporation V Zerify Inc Three [Member] Onstream Media Corporation V Zerify Inc Four [Member] Onstream Media Corporation V Zerify Inc Five [Member] Onstream Media Corporation V Zerify Inc Six [Member] Date of filing Common Stocks [Member] Qualified Regulation A Offering [Member] Certain Investors [Member] Private Placement Under Rule Regulation D [Member] Issued shares of common stock in exchange for cash Issued warrants to purchase shares of common stock Issued shares of common stock Warrants fully vested, exercisable Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increa Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. EX-101.CAL 9 zrfy-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 10 zrfy-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 11 zrfy-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 31, 2023
Jun. 30, 2022
Cover [Abstract]      
Entity Registrant Name ZERIFY, INC.    
Entity Central Index Key 0001285543    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2022    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Entity Common Stock Shares Outstanding   1,364,017,560  
Entity Public Float     $ 21,120,000
Document Annual Report true    
Document Transition Report false    
Entity Incorporation State Country Code WY    
Entity File Number 000-55012    
Entity Tax Identification Number 22-3827597    
Entity Address Address Line 1 1090 King Georges Post Road    
Entity Address Address Line 2 Suite 603    
Entity Address City Or Town Edison    
Entity Address State Or Province NJ    
Entity Address Postal Zip Code 08837    
City Area Code 732    
Local Phone Number 661-9641    
Security 12g Title Common stock, $0.0001 par value    
Entity Interactive Data Current Yes    
Auditor Firm Id 572    
Auditor Location Los Angeles, California    
Auditor Name Weinberg & Company, P.A    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash (includes VIE balances of $1,000 and $1,000, respectively) $ 192,000 $ 2,084,000
Accounts receivable, net 20,000 24,000
Prepaid expenses 0 13,000
Total current assets 212,000 2,121,000
Property and equipment, net 36,000 0
Operating lease right-of-use asset 54,000 107,000
Other assets 11,000 12,000
Total Assets 313,000 2,240,000
Current Liabilities:    
Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively) 1,160,000 996,000
Convertible notes payable, net of discount of $96,000 and $0, respectively (including $895,000 and $895,000 in default) 1,282,000 1,398,000
Convertible notes payable - related parties 268,000 268,000
Notes payable, net of discount of $323,000 and $0, respectively (including $1,930,000 and $1,972,000 in default, respectively) (includes VIE balances of $285,000 and $310,000, respectively) 2,826,000 1,972,000
Notes payable - related parties 693,000 693,000
Accrued interest (including $1,557,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $134,000 and $120,000, respectively) 5,865,000 5,477,000
Contingent payment obligation 1,500,000 1,500,000
VIE Financing obligation 1,263,000 1,263,000
Operating lease liability, current portion 56,000 39,000
Derivative liability 112,000 0
Total current liabilities 15,025,000 13,606,000
Notes payable, long-term portion 142,000 150,000
Operating lease liability, long-term portion 1,000 73,000
Total Liabilities 15,168,000 13,829,000
Stockholders' Deficit    
Preferred stock, Value 0 0
Common stock par value $0.0001: 4,000,000,000 shares authorized; 1,109,417,572 and 955,380,225 shares issued and outstanding, respectively 110,000 96,000
Additional paid-in capital 67,124,000 59,788,000
Accumulated deficit (82,190,000) (71,595,000)
Total Zerify, Inc. stockholders' deficit (13,965,000) (10,720,000)
Noncontrolling interest in consolidated subsidiary (890,000) (869,000)
Total Stockholders' Deficit (14,855,000) (11,589,000)
Total Liabilities and Stockholders' Deficit 313,000 2,240,000
Series B Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock, Value 4,000 4,000
Series A Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock, Value $ 987,000 $ 987,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash VIE $ 1,000 $ 1,000
Current Liabilities    
VIE Balance of Accounts Payables and Accrued Liabilities 4,000 2,000
Allowance on convertible notes payable 96,000 0
Convertible notes payable, default 895,000 895,000
Notes payable VIE 285,000 310,000
Allowance on notes payable 323,000 0
Notes payable, default 1,930,000 1,972,000
Accrued Interest VIE 134,000 120,000
Accrued interest due to related parties $ 1,557,000 $ 1,497,000
Stockholders' Deficit    
Preferred Stock, share par value $ 0.10 $ 0.10
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares par value $ 0.0001 $ 0.0001
Common stock, shares authorized 4,000,000,000 4,000,000,000
Common stock, shares issued 1,109,417,572 955,380,225
Common stock, shares outstanding 1,109,417,572 955,380,225
Series B Preferred Stock [Member]    
Stockholders' Deficit    
Preferred Stock, share par value $ 0.10 $ 0.10
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, shares issued 36,667 36,667
Preferred stock, shares outstanding 36,667 36,667
Series A Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock, shares authorized 100 100
Preferred stock, shares issued 3 3
Preferred stock, shares outstanding 3 3
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 103,000 $ 193,000
Operating expenses:    
Cost of revenue 34,000 27,000
Selling, general and administrative expenses 7,711,000 9,448,000
Research and development 580,000 566,000
Total operating expenses 8,325,000 10,041,000
Loss from operations (8,222,000) (9,848,000)
Other income (expense):    
Interest and financing expenses (including $121,000 and $121,000 to related parties) (516,000) (7,016,000)
Debt discount amortization (141,000) (52,000)
Change in fair value of derivative liabilities 52,000 (219,000)
Loss on extinguishment of debt, net 0 (109,000)
Other expense (2,000) (1,000)
Other income (expense), net (607,000) (7,397,000)
Net loss (8,829,000) (17,245,000)
Net loss attributable to noncontrolling interest 21,000 46,000
Net loss attributable to Zerify, Inc. (8,808,000) (17,199,000)
Deemed dividend to warrant holders (1,787,000) 0
Net loss to common stockholders $ (10,595,000) $ (17,199,000)
Net loss per common share    
-Basic and diluted $ (0.01) $ (0.02)
Weighted average common shares outstanding    
-Basic and diluted 1,001,263,673 868,770,818
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Balance, shares at Dec. 31, 2020   3 36,667 718,263,338      
Balance, amount at Dec. 31, 2020 $ (14,342,000) $ 987,000 $ 4,000 $ 72,000 $ 39,814,000 $ (54,396,000) $ (823,000)
Common stock issued for cash, shares       119,666,450      
Common stock issued for cash, amount 5,368,000 0 0 $ 12,000 5,356,000 0 0
Fair value of common stock issued for services, shares       3,365,138      
Fair value of common stock issued for services, amount 181,000 0 0 $ 1,000 180,000 0 0
Fair value of vested options 6,757,000 0 0 $ 0 6,757,000 0 0
Fair value of common stock issued as a financing cost, shares       45,150,500      
Fair value of common stock issued as a financing cost, amount 6,569,000 0 0 $ 5,000 6,564,000 0 0
Common stock issued upon cashless exercise of warrants, shares       12,349,726      
Common stock issued upon cashless exercise of warrants, amount 0 0 0 $ 1,000 (1,000) 0 0
Common stock issued upon cashless exercise of options, shares       39,955,655      
Common stock issued upon cashless exercise of options, amount 0 0 0 $ 3,000 (3,000) 0 0
Common stock issued upon conversion of notes and accrued interest, shares       16,168,589      
Common stock issued upon conversion of notes and accrued interest, amount 1,035,000 0 0 $ 2,000 1,033,000 0 0
Common stock issued upon conversion of debt settlement, shares       460,829      
Common stock issued upon conversion of debt settlement, amount 88,000 0 0 $ 0 88,000 0 0
Net loss (17,245,000) $ 0 $ 0 $ 0 0 (17,199,000) (46,000)
Balance, shares at Dec. 31, 2021   3 36,667 955,380,225      
Balance, amount at Dec. 31, 2021 (11,589,000) $ 987,000 $ 4,000 $ 96,000 59,788,000 (71,595,000) (869,000)
Common stock issued for cash, shares       40,100,000      
Common stock issued for cash, amount 180,000 0 0 $ 3,000 177,000 0 0
Fair value of common stock issued for services, shares       30,105,936      
Fair value of common stock issued for services, amount 423,000 0 0 $ 3,000 420,000    
Fair value of vested options 2,990,000       2,990,000    
Net loss (8,829,000) 0       (8,808,000) (21,000)
Common stock issued upon exercise of warrants for cash, shares       100,000,000      
Common stock issued upon exercise of warrants for cash, amount 1,440,000 0 0 $ 10,000 1,430,000 0 0
Fair value of warrants granted for services 435,000 0 0 0 435,000 0 0
Fair value of warrants issued with notes payable accounted for as debt discount 260,000 $ 0 $ 0 $ 0 260,000 0 0
Deemed dividend to warrant holders 0       1,787,000 (1,787,000)  
Repurchase of common stock and warrants, shares       (16,168,589)      
Repurchase of common stock and warrants, amount (165,000)     $ (2,000) (163,000)    
Balance, shares at Dec. 31, 2022   3 36,667 1,109,417,572      
Balance, amount at Dec. 31, 2022 $ (14,855,000) $ 987,000 $ 4,000 $ 110,000 $ 67,124,000 $ (82,190,000) $ (890,000)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (8,829,000) $ (17,245,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 3,000 4,000
Amortization of discount 141,000 52,000
Financing costs 64,000 0
Right-of-use asset 53,000 51,000
Fair value of common stock issued for services 423,000 181,000
Fair value of vested options and warrants 3,425,000 6,757,000
Fair value of common stock issued for financing services 0 6,569,000
Change in fair value of derivative liabilities (52,000) 219,000
Loss on extinguishment of debt 0 112,000
Changes in operating assets and liabilities:    
Accounts receivable 4,000 (4,000)
Prepaid expenses and other assets 14,000 8,000
Accounts payable and accrued expenses 163,000 (14,000)
Accrued interest 388,000 298,000
Operating lease liability (55,000) (51,000)
Net cash used in operating activities (4,258,000) (3,063,000)
Cash flows from investing activities:    
Purchases of property and equipment (39,000) 0
Net cash used in investing activities (39,000) 0
Cash flows from financing activities:    
Proceeds from exercise of warrants 1,440,000 0
Proceeds from sale of common stock 180,000 5,368,000
Proceeds from sale of convertible notes 100,000 0
Proceeds from notes payable 1,075,000 177,000
Repayment of convertible note payable (120,000) (40,000)
Repayment of notes payable (105,000) (231,000)
Repurchase of common stock and warrants (165,000)  
Repayment of convertible notes payable-related parties 0 (30,000)
Repayment of notes payable-related parties 0 (259,000)
Net cash provided by financing activities 2,405,000 4,985,000
Net increase (decrease) in cash (1,892,000) 1,922,000
Cash at beginning of the year 2,084,000 162,000
Cash at end of the year 192,000 2,084,000
Supplemental disclosure of cash flow information:    
Interest paid 8,000 120,000
Income tax paid 0 0
Supplemental disclosure of non-cash investing and financing transactions    
Fair value of derivative upon issuance of convertible debt recorded as debt discount 164,000 0
Fair value of warrant recorded as debt discount 260,000 0
Common stock issued for conversion of notes and accrued interest 0 1,035,000
Common shares issued upon conversion of debt settlement 0 88,000
Warrants issued with convertible notes $ 0 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Organization and Summary of Significant Accounting Policies  
Organization and Summary of Significant Accounting Policies

Note 1 – Organization and Summary of Significant Accounting Policies

 

Zerify, Inc. (formerly known as StrikeForce Technologies, Inc.) (the “Company”), a software development and services company, offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey.

 

On April 26, 2022, the Company applied for the Zerify trademark, ZERIFY™, which is intended to cover the categories of:

 

 

·

downloadable or recorded computer software for encryption;

 

 

 

 

·

downloadable or recorded computer software for cyber security assessment and protection;

 

 

 

 

·

anti-spyware software; downloadable or recorded computer application software for mobile devices, namely, software for protecting people from identity theft;

 

 

 

 

·

downloadable or recorded computer software for guarding users of computers and remote access devices from identity theft, featuring various software tools, namely, anti-keyboard logger and keyboard stroke encryption.

 

On June 14, 2022, the Company’s Board of Directors and by consent majority shareholder vote  approved  changing the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc.  The name change was made to  better reflect  the Company’s business plans centered around its   cyber security software products.  

 

On August 1, 2022,  FINRA approved the Company’s  Common Stock being quoted on the OTCQB Market under the symbol “ZRFY” (formerly “SFOR”).

 

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and  had a stockholders’ deficit of $14,855,000. Additionally,  at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.

Basis of presentation and principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”).  The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers.  BST meets the definition of a variable interest entity (“VIE”)  because  the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation.

 

The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.

 

COVID-19

 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic,  which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and  disrupted  normal business operations.  The outbreak could   adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations.

 

During the years ended December 31, 2022 and 2021,  the COVID-19 pandemic did negatively impact the Company’s  operating results. For the years ended December 31, 2022, and 2021, the Company’s sales  decreased by 47%,  compared to the prior year, however, there have not been any impairments of the Company’s  assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot  predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.

 

The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.

 

Revenue Recognition

 

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

 

The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts.

 

Cost of revenue includes direct costs and fees related to the sale of our products.

 

The following tables present our revenue disaggregated by major product and service lines:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Software

 

$96,000

 

 

$193,000

 

Service

 

 

7,000

 

 

 

-

 

Total revenue

 

$103,000

 

 

$193,000

 

 

Accounts Receivable

 

Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively.

 

Property and Equipment

 

Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows:

 

 

 

Estimated

Useful Life

(Years)

 

 

 

 

 

Computer equipment

 

 

5

 

Computer software

 

 

3

 

Furniture and fixture

 

 

7

 

Office equipment

 

 

7

 

 

Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.

Impairment of Long-lived Assets

 

The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Leases

 

The Company leases its  corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). 

 

Fair Value of Financial Instruments

 

The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use of observable market data if such data is available without undue cost and effort.

 

The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.

 

As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9).

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

Stock-Based Compensation

 

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Loss per Share

 

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

150,633,001

 

 

 

83,133,001

 

Warrants to purchase common stock

 

 

362,729,077

 

 

 

68,981,234

 

Convertible notes

 

 

29,450,564

 

 

 

21

 

Convertible Series B Preferred stock

 

 

1,255,638

 

 

 

1,255,638

 

Total

 

 

544,068,280

 

 

 

153,369,894

 

 

Advertising, Sales and Marketing Costs

 

Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively.

 

Research and Development Costs

 

Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute  research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively.

Concentrations

 

For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively.

 

The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.

 

Segments

 

The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. As a small business filer, ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Management ©s currently assessing the impact of adopting this standard on the Company’s financial statements and related disclosures.

 

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. The Company has elected early adoption of ASU 2021-04.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment
12 Months Ended
Dec. 31, 2022
Property and Equipment  
Property and Equipment

Note 2 – Property and Equipment

 

Property and equipment, stated at cost, less accumulated depreciation consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Computer equipment

 

$84,000

 

 

$82,000

 

Computer software

 

 

45,000

 

 

 

44,000

 

Furniture and fixtures

 

 

46,000

 

 

 

10,000

 

Office equipment

 

 

17,000

 

 

 

17,000

 

 

 

 

192,000

 

 

 

153,000

 

Less accumulated depreciation

 

 

(156,000 )

 

 

(153,000 )

 

 

$36,000

 

 

$-

 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $3,000 and $4,000, respectively.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable
12 Months Ended
Dec. 31, 2022
Convertible Notes Payable  
Convertible Notes Payable

Note 3 – Convertible Notes Payable

 

Convertible notes payable consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

 2021

 

Unsecured

 

 

 

 

 

 

(a) Convertible notes due to AL-Bank

 

$383,000

 

 

$503,000

 

(b) Convertible note with Diagonal Lending

 

 

100,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Unsecured

 

 

 

 

 

 

 

 

(c) Convertible notes with fixed conversion features, in default

 

 

895,000

 

 

 

895,000

 

Convertible notes payable

 

 

1,378,000

 

 

 

1,398,000

 

Less debt discount

 

 

(96,000 )

 

 

-

 

Total Convertible notes payable

 

$1,282,000

 

 

$1,398,000

 

 

(a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in prior fiscal years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a Denmark based financing institution. In September 2021, the Company executed a repayment agreement with AL-Bank requiring the Company to  make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in March 2025 (see Note 15), for a total of $400,000. Once the payments are made in full pursuant to  the repayment agreement, the remaining balance of $143,000 will  be forgiven and will be accounted for at that time. At December 31, 2021, the outstanding balance of convertible notes payable amounted to $503,000. During the year ended December 31, 2022, the Company made principal payments of $120,000. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $383,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock.

 

(b) On December 15, 2022, the Company issued a convertible note payable to 1800 Diagonal Lending LLC (“Diagonal Lending”) for  $100,000.  The note is unsecured, bears interest at a rate of 12%, or 22% on default, is due on December 15, 2023, and has a repayment penalty of 120% of the unpaid principal and unpaid interest if prepaid within 180 days of December 15, 2022. The convertible note payable is convertible into shares of the Company’s common stock at a conversion price of 65% of the two lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the 15 trading days immediately preceding the conversion date. As the ultimate determination of shares of common stock to be issued upon conversion of these debentures can exceed the current number of available authorized shares, the Company determined that the conversion features of these debentures are not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as a derivative liability (see Note 9).  Of the incurred derivative liability of $164,000 related to the conversion feature of the debentures, $100,000 was accounted as debt discount and the remaining $64,000 as financing costs. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $96,000. The convertible notes payable, including accrued interest are convertible to approximately 29,450,549 shares of the Company’s common stock.

(c) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior fiscal years. At December 31, 2022 and December 31, 2021, the outstanding balance of unsecured convertible notes payable amounted to $895,000 and $895,000, respectively, and are deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable Related Parties
12 Months Ended
Dec. 31, 2022
Convertible Notes Payable Related Parties  
Convertable Notes Payable - Related Parties

Note 4 – Convertible Notes Payable – Related Parties

 

In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2023, as amended. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $268,000.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable
12 Months Ended
Dec. 31, 2022
Notes Payable  
Notes Payable

Note 5 – Notes Payable

 

Notes payable consisted of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Unsecured

 

 

 

 

 

 

(a) Notes payable- $1,639,000 - in default

 

$1,639,000

 

 

$1,639,000

 

(b) Notes payable issued by BST - in default

 

 

286,000

 

 

 

310,000

 

(c) Note payable-EID loan

 

 

149,000

 

 

 

150,000

 

 

 

 

 

 

 

 

 

 

Secured

 

 

 

 

 

 

 

 

(d) Notes payable – October 2022

 

 

1,000,000

 

 

 

-

 

(e) Notes payable - in default

 

 

6,000

 

 

 

23,000

 

(f) Notes payable – July 2022

 

 

211,000

 

 

 

-

 

Total notes payable principal outstanding

 

 

3,291,000

 

 

 

2,122,000

 

Less debt discount

 

 

(323,000 )

 

 

-

 

Total notes payable

 

 

2,968,000

 

 

 

2,122,000

 

Less current portion of notes payable, net of discount

 

 

(2,826,000 )

 

 

(1,972,000 )

Long term notes payable

 

$142,000

 

 

$150,000

 

 

(a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable was $1,639,000, respectively, and are in default.

 

(b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2022, the outstanding balance of the notes payable amounted to $310,000. During the year ended December 31, 2022, the Company made principal payments of $24,000. At December 31, 2022, the outstanding balance of the BlockSafe notes payable amounted to $286,000, and are in default.

 

(c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA)under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty-four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type.  During the year ended December 31, 2022, the Company made principal payments of $1,000. At December 31, 2022 and 2021, the outstanding balance of the EID loan amounted to $149,000 and $150,000, respectively. The Company was in compliance with the terms of the EID loan as of December 31, 2022.

 

(d) On October 26, 2022, the Company entered into a Securities Purchase Agreement  with Walleye Opportunities Master Fund Ltd., a Cayman Islands company (“Walleye”), whereby Walleye purchased a promissory note of the Company, in the aggregate principal amount of One Million Dollars ($1,000,000) (the “Note”), which is convertible by Walleye into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) upon an Event of Default .

 

On the Closing Date (specifically October 26, 2022), the Company received $800,000 which represented the principal of $1,000,000 less an original issue discount in the amount of $200,000 paid to Walleye. Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum. The Company shall have the right, exercisable on seven (7) Trading Days prior written notice to Walleye, to prepay the outstanding Principal Amount then due under this Note prior to any default. Walleye may demand immediate repayment in the event of  certain events, including a financing. In the event of default, Walleye shall have, as of and after any event of default, the option to cover the outstanding obligation of the Note time 120% at 90% of the lowest VWAP of the Common Stock on the date of the applicable conversion (the “Conversion Date”) or at any point during the four (4) Trading Day period immediately prior to the date of the applicable conversion.

 

In addition, on the Closing Date, Walleye received a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share which shall be earned in full as of the Closing Date of October 26, 2022. The  common stock purchase warrant has  a cashless exercise provision (unless there is a registration statement registering the underlying shares to the common stock purchase warrants).  As a result of these issuances and grants, the Company incurred the following (a) relative fair value of the warrants granted of $260,000; and (b) original issue discounts of $200,000 of the debentures for a total of $460,000 which was allocated as debt discount. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $323,000.

 

From October 26, 2022 until the Note is extinguished in its entirety, Walleye shall receive a right of participation and first right of refusal on subsequent financings as described in the Agreement.

 

On October 26, 2022, through a Security Agreement of the same date, the Company’s Subsidiaries (specifically BlockSafe Technologies, Inc. and Cyber Security Risk Solutions, LLC) agreed to guarantee and act as surety for payment of the Note.

 

At December 31, 2022, the outstanding balance of the note payable was $1,000,000.

 

(e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 37% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one unsecured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2021, the outstanding balance of the unsecured note agreements was $23,000. During the year ended December 31, 2022, the Company made principal payments of $17,000. At December 31, 2022, the outstanding balance of the secured notes payable was $6,000 and is in default.

(f) In July 2022, the Company issued notes payable aggregating $275,000. The notes bear average interest rate of 51% per annum, each agreement secured by substantially all of the assets of the Company and maturing in January 2024.  During the year ended December 31, 2022, the Company made principal payments of $64,000.  At December 31, 2022, the outstanding balance of the secured notes payable was $211,000.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable Related Parties
12 Months Ended
Dec. 31, 2022
Notes Payable Related Parties  
Notes Payable - Related Parties

Note 6 – Notes Payable – Related Party

 

Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2023, as amended. The outstanding balance of these notes payable at December 31, 2022 and December 31, 2021 amounted to $693,000.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
VIE Financing Obligation
12 Months Ended
Dec. 31, 2022
VIE Financing Obligation  
VIE Financing Obligation

Note 7 – VIE Financing Obligation

 

The Company is in the process of developing Coins or Tokens which are envisioned as virtual currency. In fiscal 2018, the Company’s consolidated subsidiary, BlockSafe, issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined by promissory notes and subscription agreements that would be controlling with respect to any offer or sale of tokens to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000.

 

During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe.

 

At December 31, 2022 and December 31, 2021, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens.  At December 31, 2022 and through the date of filing, BlockSafe has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At December 31, 2022, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe, through the issuance of tokens, or through other means if tokens are never issued.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Contingent Payment Obligation
12 Months Ended
Dec. 31, 2022
Contingent Payment Obligation  
Contingent Payment Obligation

Note 8 – Contingent Payment Obligation

 

On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”) for financing of $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against alleged infringements of its patents. In exchange for the financing, the Funders are entitled to receive( after the payment of legal fees),  the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter.  The Funders are to be paid only  if the Company achieves recoveries of claim proceeds.  At December 31, 2022 and 2021, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if patent enforced claim proceeds are recovered.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2022
Derivative Financial Instruments  
Derivative Financial Instruments

Note 9 – Derivative Financial Instruments

 

The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. During fiscal year 2022, the Company issued convertible debentures, and in accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

 

As of December 31, 2022, the derivative liabilities were valued using the Binomial pricing model and/or Black Scholes pricing model with the following assumptions:

 

 

 

At

December 31,

2022

 

 

Issued

December 15,

2022

 

 

At

December 31,

2021

 

 

 

 

 

 

 

 

 

Stock Price

 

$0.0055

 

 

$0.0075

 

 

$-

 

Exercise Price

 

$0.0034

 

 

$0.0034

 

 

$-

 

Expected Life (Years)

 

 

0.80

 

 

 

0.84

 

 

 

-

 

Volatility

 

 

 165

 

 

 159

 

 

 -

Dividend Yield

 

 

0%

 

 

0%

 

-

Risk-Free Interest Rate

 

 

4.73%

 

 

4.65%

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value:

 

 

 

 

 

 

 

 

 

 

 

 

Conversion feature

 

$112,000

 

 

$164,000

 

 

$-

 

 

The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.

 

At December 31, 2020, the balance of the derivative liabilities was $163,000.  During the year ended December 31, 2021, the corresponding convertible notes payable were converted to equity. Pursuant to current accounting guidelines, the Company determined the final fair value of the derivative liability which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At December 31, 2021, the Company has no more instruments accounted as derivative liabilities.

 

On December 15, 2022, the Company recognized derivative liabilities of $164,000 upon issuance of additional secured convertible debentures (see Note 5). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability on December 31, 2022 was $112,000, and as a result, recorded a change in fair value of $52,000 as a component of other income and expenses in the consolidated statements of operations.  At December 31, 2022, the balance of the derivative liabilities was $112,000. 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease
6 Months Ended
Jun. 30, 2021
Operating Lease  
Operating Lease

Note 10 – Operating Lease

 

In January 2019, the Company entered into a noncancelable operating lease for its office headquarters requiring payments of approximately $5,000 per month, payments increasing 3% each year, and ending on January 31, 2024. The Company determines if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases.

 

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

 

 

 

Year ended

December 31,

2022

 

 

Year ended

December 31,

2021

 

Lease Cost

 

 

 

 

 

 

Operating lease cost (included in general and administration in the Company’s statement of operations)

 

$61,000

 

 

$56,000

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021

 

$58,000

 

 

$55,000

 

Weighted average remaining lease term – operating leases (in years)

 

 

1.1

 

 

 

2.1

 

Average discount rate – operating leases

 

 

10.0%

 

 

10.0%

 

The supplemental balance sheet information related to leases for the period is as follows:

 

 

 

At December 31, 2022

 

Operating leases

 

 

 

Long-term right-of-use assets

 

$54,000

 

 

 

 

 

 

Short-term operating lease liabilities

 

$56,000

 

Long-term operating lease liabilities

 

 

1,000

 

Total operating lease liabilities

 

$57,000

 

 

Maturities of the Company’s lease liabilities are as follows:

 

Year Ending

 

Operating

Leases

 

2023

 

 

58,000

 

2024

 

 

-

 

Total lease payments

 

 

58,000

 

Less: Imputed interest/present value discount

 

 

(1,000 )

Present value of lease liabilities

 

$57,000

 

 

Lease expenses were $61,000 and $56,000 during the years ended December 31, 2022 and 2021, respectively.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit
12 Months Ended
Dec. 31, 2022
Stockholders Deficit  
Stockholders' Deficit

Note 11 – Stockholders’ Deficit

 

Preferred Stock

 

On October 21, 2010, the Company amended its Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10, the  designations, rights, and preferences  to be determined by the Board of Directors. On November 15, 2010, the Company changed its domicile from the State of New Jersey to the State of Wyoming.

 

In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation.

The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding.

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock is  convertible into a number of common stock shares  equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

In February 2014, the Company’s Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time the Company receives a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to the Company’s common stock, the minimum price discount floor level is set at $0.005, as decided by the Company’s Board of Directors.

 

Series A Preferred Stock

 

In 2011, the Company issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in the aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of the total issued and outstanding shares of the Company’s common stock. This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to the shareholders of the Company. The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued.

 

At December 31, 2022 and 2021, there were 3 shares of Series A Preferred Stock outstanding. There were no issuances of Series A Preferred stock during fiscal 2022 and 2021.

 

Series B Preferred Stock

 

The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.

 

At December 31, 2022 and 2021, there were 36,667 shares of Series B Preferred Stock outstanding. There were no issuances of Series B Preferred stock during fiscal 2022 and 2021.

Common Stock

 

Sale of Common Stock

 

During the year ended December 31, 2022,  pursuant to the Company’s Qualified Regulation A Offering, the Company issued 40,100,000 common stock shares  in exchange for cash of $180,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and its placement agent to purchase 8,020,000 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

During the year ended December 31, 2021, pursuant to the Company’s  offering under Regulation A, the Company issued 119,666,450 shares of common stock in exchange for cash of $5,368,000, net of direct fees and commission. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 55 million shares of common stock. The warrants are fully vested, exercisable at $0.05 per share and will expire in five years.

 

Common Stock Issued for Services

 

During the year ended December 31, 2022, the Company issued 30,105,936 shares of its common stock for services, with a fair value of $423,000.  The common shares were valued at the respective date of issuance. Included in this issuance were 2,500,000 and 10,000,000 shares issued to New to the Street in June and August of 2022 for services relating to a consulting agreement and were determined to have a fair value of $56,000 and $127,000, respectively.

 

During the year ended December 31, 2021, the Company issued 3,365,138 shares of its common stock for services, with a fair value of $181,000. The common stock shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.

 

Common Stock Issued on Conversion of Notes Payable and Accrued Interest

 

During the year ended December 31, 2021, the Company issued 16,168,589 shares of common stock with a fair value of $1,035,000 upon conversion of convertible notes payable and accrued interest.

 

Common Stock Issued on Settlement of Debt

 

During the year ended December 31, 2021, the Company issued 460,829 shares of common stock with a fair value of $88,000 as debt settlement.

 

Repurchase of common stock and warrants

 

In May 2022, the Company repurchased 16,168,589 shares of common stock and 605,476 shares of warrants from an investor for $165,000.  All shares repurchased by the Company were retired immediately upon acquisition. As of December 31, 2022, there are no shares held in treasury.

 

Warrants

 

The table below summarizes the Company’s warrant activities for the years ended December 31, 2021 and 2022:

 

 

 

Number of

Warrant Shares

 

 

Exercise Price Range

Per Share

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2020

 

 

27,405,475

 

 

$

 0.0045-2.90

 

 

$0.0117

 

Granted

 

 

55,000,000

 

 

 

0.05

 

 

 

0.05

 

Canceled/Expired

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(13,424,241 )

 

 

-

 

 

 

-

 

Balance, January 1, 2021

 

 

68,981,234

 

 

0.0045-2.90

 

 

 

0.0421

 

Granted

 

 

394,353,319

 

 

0.0045 – 0.05

 

 

 

0.011

 

Canceled/Expired

 

 

(605,476 )

 

0.0085 – 2.90

 

 

 

0.035

 

Exercised

 

 

(100,000,000 )

 

0.08 – 2.90

 

 

 

0.165

 

Balance, December 31, 2022

 

 

362,729,077

 

 

$

0.0045 – 0.75

 

 

$0.006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding and exercisable, December 31, 2022

 

 

362,729,077

 

 

$

 0.0045 – 0.75

 

 

$0.006

 

 

At December 31, 2022 and 2021, the intrinsic value of the warrants amounted to $13,000 and $473,000, respectively.

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2022:

 

 

 

 

Warrants Outstanding and Exercisable

 

Range of Exercise Prices

 

 

Number

Outstanding

 

 

Average Remaining

Contractual Life (in years)

 

 

Weighted Average

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045

 

 

 

333,333,319

 

 

 

4.79

 

 

$0.0045

 

 

0.005

 

 

 

13,333,334

 

 

 

2.87

 

 

$0.005

 

 

0.02

 

 

 

11,020,000

 

 

 

4.85

 

 

 

0.02

 

 

0.05

 

 

 

5,000,000

 

 

 

3.72

 

 

 

0.50

 

 

0.75

 

 

 

42,424

 

 

 

1.93

 

 

 

0.75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045 - $0.75

 

 

 

362,729,077

 

 

 

4.05

 

 

$0.006

 

 

Exercise of Warrants

 

During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,334 warrant shares were exercised on a cashless basis in exchange for 12,349,726 common stock shares. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.

 

Modification, Exercise and Grant of Warrants

 

On May 5, 2022, the Company entered into an Inducement Offer to Exercise Common Stock Purchase Warrants Letter Agreements (the “Exercise Agreements”) with certain of the holders of the Existing Warrants, the Special Equities Opportunity Fund, LLC and Gregory Castaldo, to exercise existing warrants to purchase an aggregate of 50,000,000 shares of Common Stock (the “Exercising Holders”). Pursuant to the Exercise Agreements, the Exercising Holders and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holders would exercise their Existing Warrants (the “Investor Warrants”) for shares of Common Stock underlying such Existing Warrants (the “Exercised Shares”) at a reduced exercise price of $0.02 per share of Common Stock. In order to induce the Exercising Holders to cash exercise the Investor Warrants, the Exercise Agreements provide for the issuance of new warrants to purchase up to an aggregate of 50,000,000 shares of Common Stock (the “New Warrants”), with such New Warrants to be issued in an amount equal to the number of the Exercised Shares underlying any Investor Warrants. The New Warrants are exercisable after issuance, provide for a cashless exercise provision if the shares of Common Stock underlying the New Warrants are not registered and terminate on the date that is five years following the issuance of the New Warrants. The New Warrants have an exercise price per share of $0.05. The New Warrants and the shares of Common Stock issuable upon the exercise of the New Warrants are not being registered under the Securities Act of 1933 and are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act of 1933. The Exercised Shares are registered for resale on effective registration statements previously filed with the Securities and Exchange Commission. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $940,000, net of direct fees and commission.

 

In August 2022, the Company modified the exercise price of the warrants granted to the two investors/warrant holders in May 2022 from $0.05 per share to $0.01 per share. As a result of this modification, the warrant holders exercised 50,000,000 shares of warrants and the Company received $500,000 in cash and issued 50,000,000 shares of common stock.

 

As a result of these transactions, the Company issued a total of 100 million shares of common stock and received cash of $1,440,000, net of direct costs.

Deemed Dividend to Warrant Holders

 

During the year ended December 31, 2022, the Company granted an aggregate of 150,000,000 warrants for services and financing activities that contained a provision requiring the Company to adjust the terms of the warrants when future financing events occur on more favorable terms. On December 21, 2022, and pursuant to the beneficial terms contained in the Company’s Qualified Regulation A Offering, the Company modified the 150,000,000 warrants by granting an additional 183,333,320 warrants and adjusting the warrant exercise from price from $0.01 per share to $0.0045 per share. Pursuant to current accounting guidelines, the Company recorded the incremental fair value of $1,787,000 as a deemed dividend.

 

Grant of Warrants for Services

 

On July 1,  2022, the Company granted warrants to a consultant, to purchase 3,000,000 shares of common stock for financing services rendered. The warrants are fully vested, exercisable at of $0.02 per share, will expire in 5 years and with an estimated fair value $63,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.02

 

Share Price

 

$0.02

 

Volatility %

 

 

233%

Risk Free Rate

 

 

2.88%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

On October 21,  2022, the Company granted warrants pursuant to a Financial Advisory Agreement, to purchase 50,000,000 shares of common stock for advisory services rendered. The warrants are fully vested, exercisable at of $0.01 per share, will expire in 5 years and with an estimated fair value $372,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.00752

 

Volatility %

 

 

224%

Risk Free Rate

 

 

4.34%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.

Grants of Warrants on Issuance of Note Payable

 

Included in the issuance of a Note Payable to Walleye dated October 26, 2022 (see Note 5), Walleye received a grant of a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share, which shall be earned in full as of October 26, 2022. The estimated relative fair value of the warrants was determined to be $260,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:

 

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.0079

 

Volatility %

 

 

268%

Risk Free Rate

 

 

4.41%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options
12 Months Ended
Dec. 31, 2022
Stock Options  
Stock Options

Note 12 – Stock Options

 

In November 2012, the stockholders approved the 2012 Stock Option Plan for the Company’s employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000 and was increased to 400,000,000 in November 2017 by unanimous consent of the Board of Directors.

 

The table below summarizes the Company’s stock option activities for the years ended December 31, 2021 and 2022: 

 

 

 

 Number of

Options Shares

 

 

Exercise Price 

Range Per Share

 

 

Weighted Average Exercise Price

 

Balance, January 1, 2020

 

 

58,133,001

 

 

$

0.005-1,121,250,000

 

 

$0.03704

 

Granted

 

 

67,500,000

 

 

0.005-0.0375

 

 

 

0.0104

 

Exercised

 

 

(42,500,000)

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance, December 31, 2021

 

 

83,133,001

 

 

0.005-1,121,250,000

 

 

 

0.0274

 

Granted

 

 

67,500,000

 

 

 

0.0045

 

 

 

0.0045

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance outstanding, December 31, 2022

 

 

150,633,001

 

 

$

 0.0045-1,121,250,000

 

 

$0.0307

 

Balance exercisable, December 31, 2022

 

 

87,212,671

 

 

$

 0.0045-1,121,250,000

 

 

$0.0497

 

 

The following table summarizes information concerning the Company’s stock options as of December 31, 2022:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of

Exercise Prices

 

 

Number Outstanding

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

 Exercise

 Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

0.005

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

0.0045

 

 

 

67,500,000

 

 

 

9.97

 

 

 

0.0045

 

 

 

4,079,670

 

 

 

9.97

 

 

 

0.0045

 

$

0.0045 – 1,121,250,000

 

 

 

150,633,001

 

 

 

6.43

 

 

$0.0307

 

 

 

87,212,671

 

 

 

6.43

 

 

$0.0497

 

 

At December 31, 2022 and 2021, the intrinsic value of outstanding options was $76,000 and $3,225,000, respectively.

 

During the year ended December 31, 2022, the Company recorded an additional stock compensation expense of $2,958,000 to account for options granted in the prior year that vested. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.0045 per share, vest over six months, and expire in 10 years, with a total fair value of approximately $594,000. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 394%, (ii) discount rate of 3.79%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $32,000 to account for the fair value of options that vested during the period. As of December 31, 2022, the unamortized stock compensation amounted to approximately $562,000 which will be recognized in fiscal 2023.

During the year ended December 31, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company  issued 39,955,655 shares of the Company’s common stock upon cashless exercise of 42,500,000 options. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share for 2,500,000 option shares and $0.0375 for 65,000,000 option shares, vest over six months, and expire in 10 years, with a total fair value of approximately $5,400,000 using the Black-Scholes Merton Option Pricing model. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 137%, (ii) discount rate of 1.46%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $368,000 to account for the fair value of options that vested during the period.

 

In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Income Tax Provision
12 Months Ended
Dec. 31, 2022
Income Tax Provision  
Income Tax Provision

Note 13 – Income Tax Provision

 

A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows for the year ended:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

 

 

 

 

 

 

 

Federal statutory income tax rate

 

 

21.0%

 

 

21.0%

State tax, net of federal benefit

 

 

7.0%

 

 

5.0%

 

 

 

 

 

 

 

 

 

Change in valuation allowance on net operating loss carry-forwards

 

 

(28.0 )

 

 

(26.0 )

 

 

 

 

 

 

 

 

 

Effective income tax rate

 

 

0.0%

 

 

0.0%

 

Deferred tax assets consist of the following:

 

 

 

December 31,

2022

 

 

December 31,

2021

 

Net deferred tax assets:

 

 

 

 

 

 

Stock-based compensation

 

$3,776,000

 

 

$702,000

 

Private placement costs

 

 

394,000

 

 

 

366,000

 

Operating lease liability

 

 

16,000

 

 

 

42,000

 

Loss on extinguishment of debt

 

 

1,858,000

 

 

 

1,697,000

 

Net operating loss carryforwards

 

 

7,362,000

 

 

 

5,946,000

 

Deferred tax assets

 

 

13,406,000

 

 

 

8,753,000

 

Less valuation allowance

 

 

(13,406,000 )

 

 

(8,753,000 )

Total

 

 

-

 

 

 

-

 

 

The provisions of ASC Topic 740, Accounting for Income Taxes, require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2022 and 2021, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was more likely than not that the net deferred tax assets were not fully realizable. Accordingly, the Company established a full valuation allowance against its net deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.

At December 31, 2022 and 2021, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal NOL purposes approximately $30.2 million and $26.5 million was available at December 31, 2022 and 2021. For state NOL purposes approximately $14.7 million and $13.2 million was available at December 31, 2022 and 2021, respectively. The Federal carryforwards expire on various dates through 2041 and the state carryforwards expire through 2041. Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation.

 

The Company’s operations are based in New Jersey and it is subject to Federal and New Jersey state income tax. Tax years after 2016 are open to examination by United States and state tax authorities.

 

The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. ASC 740 also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions. As of December 31, 2022 and 2021, no liability for unrecognized tax benefits was required to be recorded or disclosed.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Commitment and Contingencies
12 Months Ended
Dec. 31, 2022
Commitment and Contingencies  
Commitment and Contingencies

Note 14 – Commitment and Contingencies

 

Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant (U.S. District Court, District of New Jersey, Civil Action No. 2:22-cv-07258-MCA-AME)

 

On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”),  filed a stockholder derivative Complaint against our  directors , Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their  management of us. Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint.  On March 10, 2023, the Defendants served a motion to dismiss the complaint  upon the Plaintiff.  The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023.   Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation.

 

Onstream Media Corporation

 

We are  currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases.

 

The cases and their filing dates follow:

 

Case

 

Date Filed

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00191 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00192 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00193 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00194 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00195 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00196 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00197 (DWY)

 

September 9, 2022

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events  
Subsequent Events

Note 15 – Subsequent Events

 

Subsequent to December 31, 2022, pursuant to the Company’s Qualified  Regulation A Offering, the Company issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, the Company sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.

 

On February 23, 2023, the Company entered into an amendment to the AL-Bank note (see Note 3) that relieved the Company from its previously scheduled monthly payments for March and April 2023 by extending the maturity date of the note by an additional two months, or February and March of 2025. 

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Organization and Summary of Significant Accounting Policies  
Going Concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and  had a stockholders’ deficit of $14,855,000. Additionally,  at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.

Basis of presentation and principles of consolidation

The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”).  The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers.  BST meets the definition of a variable interest entity (“VIE”)  because  the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation.

 

The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.

COVID-19

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic,  which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and  disrupted  normal business operations.  The outbreak could   adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations.

 

During the years ended December 31, 2022 and 2021,  the COVID-19 pandemic did negatively impact the Company’s  operating results. For the years ended December 31, 2022, and 2021, the Company’s sales  decreased by 47%,  compared to the prior year, however, there have not been any impairments of the Company’s  assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot  predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.

 

The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.

Revenue Recognition

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

 

The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts.

 

Cost of revenue includes direct costs and fees related to the sale of our products.

 

The following tables present our revenue disaggregated by major product and service lines:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Software

 

$96,000

 

 

$193,000

 

Service

 

 

7,000

 

 

 

-

 

Total revenue

 

$103,000

 

 

$193,000

 

Accounts Receivable

Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively.

Property and Equipment

Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows:

 

 

 

Estimated

Useful Life

(Years)

 

 

 

 

 

Computer equipment

 

 

5

 

Computer software

 

 

3

 

Furniture and fixture

 

 

7

 

Office equipment

 

 

7

 

 

Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.

Impairment of Long-lived Assets

The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets.

Income Taxes

The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Leases

The Company leases its  corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). 

Fair Value of Financial Instruments

The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use of observable market data if such data is available without undue cost and effort.

 

The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.

 

As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9).

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

Stock-Based Compensation

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation – Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

Loss per share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

 

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

150,633,001

 

 

 

83,133,001

 

Warrants to purchase common stock

 

 

362,729,077

 

 

 

68,981,234

 

Convertible notes

 

 

29,450,564

 

 

 

21

 

Convertible Series B Preferred stock

 

 

1,255,638

 

 

 

1,255,638

 

Total

 

 

544,068,280

 

 

 

153,369,894

 

Advertising, Sales and Marketing Costs

Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively.

Research and Development Costs

Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute  research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively.

Concentrations

For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively.

 

The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.

Segments

The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. As a small business filer, ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Management ©s currently assessing the impact of adopting this standard on the Company’s financial statements and related disclosures.

 

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. The Company has elected early adoption of ASU 2021-04.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Organization and Summary of Significant Accounting Policies  
Schedule of Revenue Recognition

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Software

 

$96,000

 

 

$193,000

 

Service

 

 

7,000

 

 

 

-

 

Total revenue

 

$103,000

 

 

$193,000

 

Schedule of Property and Equipment

 

 

Estimated

Useful Life

(Years)

 

 

 

 

 

Computer equipment

 

 

5

 

Computer software

 

 

3

 

Furniture and fixture

 

 

7

 

Office equipment

 

 

7

 

Schedule of earning per share

 

 

Years Ended

December 31,

 

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

150,633,001

 

 

 

83,133,001

 

Warrants to purchase common stock

 

 

362,729,077

 

 

 

68,981,234

 

Convertible notes

 

 

29,450,564

 

 

 

21

 

Convertible Series B Preferred stock

 

 

1,255,638

 

 

 

1,255,638

 

Total

 

 

544,068,280

 

 

 

153,369,894

 

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2022
Property and Equipment  
Schedule of property and equipment, stated at cost, less accumulated depreciation

 

 

December 31,

2022

 

 

December 31,

2021

 

Computer equipment

 

$84,000

 

 

$82,000

 

Computer software

 

 

45,000

 

 

 

44,000

 

Furniture and fixtures

 

 

46,000

 

 

 

10,000

 

Office equipment

 

 

17,000

 

 

 

17,000

 

 

 

 

192,000

 

 

 

153,000

 

Less accumulated depreciation

 

 

(156,000 )

 

 

(153,000 )

 

 

$36,000

 

 

$-

 

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Tables)
12 Months Ended
Dec. 31, 2022
Convertible Notes Payable  
Schedule of convertible notes payable

 

 

December 31,

2022

 

 

December 31,

 2021

 

Unsecured

 

 

 

 

 

 

(a) Convertible notes due to AL-Bank

 

$383,000

 

 

$503,000

 

(b) Convertible note with Diagonal Lending

 

 

100,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Unsecured

 

 

 

 

 

 

 

 

(c) Convertible notes with fixed conversion features, in default

 

 

895,000

 

 

 

895,000

 

Convertible notes payable

 

 

1,378,000

 

 

 

1,398,000

 

Less debt discount

 

 

(96,000 )

 

 

-

 

Total Convertible notes payable

 

$1,282,000

 

 

$1,398,000

 

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Tables)
12 Months Ended
Dec. 31, 2022
Notes Payable  
Schedule of notes payable

 

 

December 31,

2022

 

 

December 31,

2021

 

Unsecured

 

 

 

 

 

 

(a) Notes payable- $1,639,000 - in default

 

$1,639,000

 

 

$1,639,000

 

(b) Notes payable issued by BST - in default

 

 

286,000

 

 

 

310,000

 

(c) Note payable-EID loan

 

 

149,000

 

 

 

150,000

 

 

 

 

 

 

 

 

 

 

Secured

 

 

 

 

 

 

 

 

(d) Notes payable – October 2022

 

 

1,000,000

 

 

 

-

 

(e) Notes payable - in default

 

 

6,000

 

 

 

23,000

 

(f) Notes payable – July 2022

 

 

211,000

 

 

 

-

 

Total notes payable principal outstanding

 

 

3,291,000

 

 

 

2,122,000

 

Less debt discount

 

 

(323,000 )

 

 

-

 

Total notes payable

 

 

2,968,000

 

 

 

2,122,000

 

Less current portion of notes payable, net of discount

 

 

(2,826,000 )

 

 

(1,972,000 )

Long term notes payable

 

$142,000

 

 

$150,000

 

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Financial Instruments  
Schedule of derivative liability

 

 

At

December 31,

2022

 

 

Issued

December 15,

2022

 

 

At

December 31,

2021

 

 

 

 

 

 

 

 

 

Stock Price

 

$0.0055

 

 

$0.0075

 

 

$-

 

Exercise Price

 

$0.0034

 

 

$0.0034

 

 

$-

 

Expected Life (Years)

 

 

0.80

 

 

 

0.84

 

 

 

-

 

Volatility

 

 

 165

 

 

 159

 

 

 -

Dividend Yield

 

 

0%

 

 

0%

 

-

Risk-Free Interest Rate

 

 

4.73%

 

 

4.65%

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value:

 

 

 

 

 

 

 

 

 

 

 

 

Conversion feature

 

$112,000

 

 

$164,000

 

 

$-

 

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease (Tables)
12 Months Ended
Dec. 31, 2022
Operating Lease  
Schedule of lease expense and supplemental cash flow information

 

 

Year ended

December 31,

2022

 

 

Year ended

December 31,

2021

 

Lease Cost

 

 

 

 

 

 

Operating lease cost (included in general and administration in the Company’s statement of operations)

 

$61,000

 

 

$56,000

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021

 

$58,000

 

 

$55,000

 

Weighted average remaining lease term – operating leases (in years)

 

 

1.1

 

 

 

2.1

 

Average discount rate – operating leases

 

 

10.0%

 

 

10.0%
Schedule of supplemental balance sheet information

 

 

At December 31, 2022

 

Operating leases

 

 

 

Long-term right-of-use assets

 

$54,000

 

 

 

 

 

 

Short-term operating lease liabilities

 

$56,000

 

Long-term operating lease liabilities

 

 

1,000

 

Total operating lease liabilities

 

$57,000

 

Schedule of maturities

Year Ending

 

Operating

Leases

 

2023

 

 

58,000

 

2024

 

 

-

 

Total lease payments

 

 

58,000

 

Less: Imputed interest/present value discount

 

 

(1,000 )

Present value of lease liabilities

 

$57,000

 

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders Deficit  
Schedule of stock warrants activity

 

 

Number of

Warrant Shares

 

 

Exercise Price Range

Per Share

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2020

 

 

27,405,475

 

 

$

 0.0045-2.90

 

 

$0.0117

 

Granted

 

 

55,000,000

 

 

 

0.05

 

 

 

0.05

 

Canceled/Expired

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(13,424,241 )

 

 

-

 

 

 

-

 

Balance, January 1, 2021

 

 

68,981,234

 

 

0.0045-2.90

 

 

 

0.0421

 

Granted

 

 

394,353,319

 

 

0.0045 – 0.05

 

 

 

0.011

 

Canceled/Expired

 

 

(605,476 )

 

0.0085 – 2.90

 

 

 

0.035

 

Exercised

 

 

(100,000,000 )

 

0.08 – 2.90

 

 

 

0.165

 

Balance, December 31, 2022

 

 

362,729,077

 

 

$

0.0045 – 0.75

 

 

$0.006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding and exercisable, December 31, 2022

 

 

362,729,077

 

 

$

 0.0045 – 0.75

 

 

$0.006

 

Schedule of warrants outstanding and exercisable

 

 

 

Warrants Outstanding and Exercisable

 

Range of Exercise Prices

 

 

Number

Outstanding

 

 

Average Remaining

Contractual Life (in years)

 

 

Weighted Average

Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045

 

 

 

333,333,319

 

 

 

4.79

 

 

$0.0045

 

 

0.005

 

 

 

13,333,334

 

 

 

2.87

 

 

$0.005

 

 

0.02

 

 

 

11,020,000

 

 

 

4.85

 

 

 

0.02

 

 

0.05

 

 

 

5,000,000

 

 

 

3.72

 

 

 

0.50

 

 

0.75

 

 

 

42,424

 

 

 

1.93

 

 

 

0.75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.0045 - $0.75

 

 

 

362,729,077

 

 

 

4.05

 

 

$0.006

 

Schedule grants of warrants on issuance of note Payable

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.0079

 

Volatility %

 

 

268%

Risk Free Rate

 

 

4.41%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%
Schedule of grant of warrants for services

 

 

Assumptions

 

Exercise Price

 

$0.02

 

Share Price

 

$0.02

 

Volatility %

 

 

233%

Risk Free Rate

 

 

2.88%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%

 

 

Assumptions

 

Exercise Price

 

$0.01

 

Share Price

 

$0.00752

 

Volatility %

 

 

224%

Risk Free Rate

 

 

4.34%

Expected Term (yrs.)

 

 

5

 

Dividend Rate

 

 

0%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Stock Options  
Schedule of stock options plan

 

 

 Number of

Options Shares

 

 

Exercise Price 

Range Per Share

 

 

Weighted Average Exercise Price

 

Balance, January 1, 2020

 

 

58,133,001

 

 

$

0.005-1,121,250,000

 

 

$0.03704

 

Granted

 

 

67,500,000

 

 

0.005-0.0375

 

 

 

0.0104

 

Exercised

 

 

(42,500,000)

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance, December 31, 2021

 

 

83,133,001

 

 

0.005-1,121,250,000

 

 

 

0.0274

 

Granted

 

 

67,500,000

 

 

 

0.0045

 

 

 

0.0045

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

Balance outstanding, December 31, 2022

 

 

150,633,001

 

 

$

 0.0045-1,121,250,000

 

 

$0.0307

 

Balance exercisable, December 31, 2022

 

 

87,212,671

 

 

$

 0.0045-1,121,250,000

 

 

$0.0497

 

Schedule of stock option outstanding and exercisable

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of

Exercise Prices

 

 

Number Outstanding

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Average

Remaining Contractual

Life (in

years)

 

 

Weighted

Average

 Exercise

 Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

 

1

 

 

 

0.01

 

 

$1,121,250,000

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

 

518,000

 

 

 

4.04

 

 

 

3.0000

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

 

115,000

 

 

 

6.97

 

 

 

2.0000

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

 

65,000,000

 

 

 

8.98

 

 

 

0.0375

 

 

0.005

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

 

17,500,000

 

 

 

8.08

 

 

 

0.0050

 

 

0.0045

 

 

 

67,500,000

 

 

 

9.97

 

 

 

0.0045

 

 

 

4,079,670

 

 

 

9.97

 

 

 

0.0045

 

$

0.0045 – 1,121,250,000

 

 

 

150,633,001

 

 

 

6.43

 

 

$0.0307

 

 

 

87,212,671

 

 

 

6.43

 

 

$0.0497

 

XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Income Tax Provision (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Provision  
Schedule of reconcilliation of fedral statutory income tax rate

 

 

December 31,

2022

 

 

December 31,

2021

 

 

 

 

 

 

 

 

Federal statutory income tax rate

 

 

21.0%

 

 

21.0%

State tax, net of federal benefit

 

 

7.0%

 

 

5.0%

 

 

 

 

 

 

 

 

 

Change in valuation allowance on net operating loss carry-forwards

 

 

(28.0 )

 

 

(26.0 )

 

 

 

 

 

 

 

 

 

Effective income tax rate

 

 

0.0%

 

 

0.0%
Schedule of deferred tax assets and liabilities

 

 

December 31,

2022

 

 

December 31,

2021

 

Net deferred tax assets:

 

 

 

 

 

 

Stock-based compensation

 

$3,776,000

 

 

$702,000

 

Private placement costs

 

 

394,000

 

 

 

366,000

 

Operating lease liability

 

 

16,000

 

 

 

42,000

 

Loss on extinguishment of debt

 

 

1,858,000

 

 

 

1,697,000

 

Net operating loss carryforwards

 

 

7,362,000

 

 

 

5,946,000

 

Deferred tax assets

 

 

13,406,000

 

 

 

8,753,000

 

Less valuation allowance

 

 

(13,406,000 )

 

 

(8,753,000 )

Total

 

 

-

 

 

 

-

 

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Commitment and Contingencies (Tables)
12 Months Ended
Dec. 31, 2022
Commitment and Contingencies  
Schedule of Onstream Media Corporation cases and their filing dates

Case

 

Date Filed

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00191 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00192 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00193 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00194 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00195 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00196 (DWY)

 

September 9, 2022

Onstream Media Corporation v. Zerify Inc.

Case No. 22-cv-00197 (DWY)

 

September 9, 2022

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Total revenue $ 103,000 $ 193,000
Software [Member]    
Total revenue 96,000 193,000
Service [Member]    
Total revenue $ 7,000 $ 0
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Details 1)
12 Months Ended
Dec. 31, 2022
Computer equipment [Member]  
Estimated Useful Life (Years) 5 years
Computer software [Member]  
Estimated Useful Life (Years) 3 years
Furniture and fixtures [Member]  
Estimated Useful Life (Years) 7 years
Office equipment [Member]  
Estimated Useful Life (Years) 7 years
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Details 2) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Organization and Summary of Significant Accounting Policies    
Options to purchase common stock 150,633,001 83,133,001
Warrants to purchase common stock 362,729,077 68,981,234
Convertible notes 29,450,564 21
Convertible Series B Preferred stock 1,255,638 1,255,638
Total 544,068,280 153,369,894
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 15, 2022
Dec. 31, 2020
Net loss $ (8,829,000) $ (17,245,000)    
Net cash used in operating activities 4,258,000      
Total Stockholders' Deficit (14,855,000) $ (11,589,000)   $ (14,342,000)
Notes payable aggregate amount 2,825,000      
Cash on hand 192,000      
Proceeds on the sale of common shares and warrants $ 813,000      
Sales deacreased percentage 47.00% 47.00%    
Allowance for doubtful debts $ 20,000 $ 20,000    
Derivative liabilities 112,000 0 $ 164,000 $ 163,000
Advertising, sales and marketing costs 313,000 103,000    
Research and development costs $ 580,000 $ 566,000    
One customer [Member] | Revenues [Member]        
Concentration Risk, Percentage 39.00% 36.00%    
One customer [Member] | Accounts Receivable [Member]        
Concentration Risk, Percentage 10.00% 65.00%    
Two customer [Member] | Revenues [Member]        
Concentration Risk, Percentage 34.00% 32.00%    
Two customer [Member] | Accounts Receivable [Member]        
Concentration Risk, Percentage   14.00%    
Three customer [Member] | Revenues [Member]        
Concentration Risk, Percentage   19.00%    
BST [Member]        
Ownership interest held by company 49.00%      
Ownership interest held by three executive officers 31.00%      
Management fee per month $ 36,000      
Financing milestone, amount 1,000,000      
Monthly management fee $ 140,000      
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property and equipment gross $ 192,000 $ 153,000
Less accumulated depreciation (156,000) (153,000)
Property and equipment net 36,000 0
Computer equipment [Member]    
Property and equipment gross 84,000 82,000
Computer software [Member]    
Property and equipment gross 45,000 44,000
Furniture and fixtures [Member]    
Property and equipment gross 46,000 10,000
Office equipment [Member]    
Property and equipment gross $ 17,000 $ 17,000
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property and Equipment    
Depreciation expense $ 3,000 $ 4,000
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Secured    
(a) Convertible notes due to AL-Bank $ 383,000 $ 503,000
Unsecured    
(b) Convertible note with Diagonal Lending 100,000 0
(c) Convertible notes with fixed conversion features, in default 895,000 895,000
Total convertible notes principal outstanding 1,378,000 1,398,000
Debt discount (96,000) 0
Convertible notes, net of discount $ 1,282,000 $ 1,398,000
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Unamortized debt discount $ 323,000  
Debt discount (323,000) $ 0
Proceeds from convertible notes payable 100,000 0
Financing costs 64,000 0
Convertible Notes Payable [Member]    
Unamortized debt discount 96,000  
Debt discount 100,000  
Convertible notes payable, outstanding balance $ 100,000  
Common stock shares issued upon conversion of debt 29,450,549  
Derivative liability $ 164,000  
Financing costs $ 64,000  
Repayment penalty percentage 120.00%  
Conversion price percentage 65.00%  
Interest rate decriptions The note is unsecured, bears interest at a rate of 12%, or 22% on default  
2005 Through 2007 [Member]    
Maturity date description due on various dates from March 2008 to March 2015, and are currently in default  
Convertible notes payable, outstanding balance $ 895,000 895,000
Proceeds from convertible notes payable $ 895,000  
Interest rate decriptions The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum  
2005 [Member]    
Convertible notes payable, outstanding balance $ 383,000 503,000
(a) DART/Citco Global, in default $ 543,000  
Interest rate 7.50%  
Total   $ 400,000
Monyhly payment $ 10,000  
Remaining balance 143,000  
Principal payments $ 120,000  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable - Related Parties (Details Narrative) - Chief Executive Officer [Member] - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Due date Dec. 31, 2023  
Interest rate 8.00%  
Convertible notes payable, outstanding balance $ 268,000 $ 268,000
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Unsecured notes payable-in default    
(a) Notes payable- $1,639,000 - in default $ 1,639,000 $ 1,639,000
(b) Notes payable issued by BST - in default 286,000 310,000
Secured notes payable    
(c) Note payable-EID loan 149,000 150,000
(d) Notes payable - October 2022 1,000,000 0
(e) Notes payable - in default 6,000 23,000
(f) Notes payable - July 2022 211,000 0
Total notes payable principal outstanding 3,291,000 2,122,000
Debt discount (323,000) 0
Notes payable 2,968,000 2,122,000
Less current portion of notes payable (2,826,000) (1,972,000)
Long term notes payable $ 142,000 $ 150,000
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 15, 2020
Oct. 26, 2022
Jul. 31, 2022
Dec. 31, 2022
Dec. 31, 2019
Dec. 31, 2021
Warrants granted   $ 260,000        
Original issue discounts   200,000        
Total debentures   460,000        
Unamortized debt discount       $ 323,000    
Notes payable, outstanding balance       $ 286,000    
Common stock, par value       $ 0.0001   $ 0.0001
Notes payable       $ 2,968,000   $ 2,122,000
Walleye Opportunities Master Fund Ltd [Member]            
Original issue discounts   200,000        
Notes payable, outstanding balance       1,000,000    
Principal payments of promissory notes   1,000,000        
Amount recieved   $ 800,000        
Description about issuance of note payable   Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum        
Common stock purchase of warrant   50,000,000        
Warrant exercisble price   $ 0.01        
Walleye Opportunities Master Fund Ltd [Member] | Maximum [Member]            
Volume weighted average price of common stock   120.00%        
Walleye Opportunities Master Fund Ltd [Member] | Minimum [Member]            
Volume weighted average price of common stock   90.00%        
EID Loan [Member]            
Principal payment       1,000    
Notes payable, outstanding balance       149,000   $ 150,000
Loan borrowed amount $ 150,000          
Interest rate on loan 3.75%          
Monthly payment on loan, description Monthly principal and interest payments of $250 per month          
Promissory Note [Member] | Securities Purchase Agreement [Member] | Walleye Opportunities Master Fund Ltd [Member]            
Purchased promissory note aggregate principal amount   $ 1,000,000        
Common stock, par value   $ 0.0001        
One Note [Member]            
Notes payable, outstanding balance       $ 310,000    
Principal payment         $ 319,000  
Interest rate decriptions       The notes are unsecured, bearing interest at a rate of 8% per annum    
Outstanding secured notes payable       $ 6,000    
Note issued         $ 468,000  
Interest rate of notes         8.00% 37.00%
Amount payables       24,000    
One Note [Member] | Unsecured [Member]            
Notes payable, outstanding balance       23,000    
Amount payables       17,000    
Extinguished as debt settlement obligation transaction         $ 21,000  
Note Payable Two [Member]            
Principal payment       64,000    
Interest rate of notes     51.00%      
Notes payable issue     $ 275,000      
Notes payable issue maturity date     January 2024      
Notes payable       211,000    
Notes Payable [Member]            
Notes payable, outstanding balance       $ 1,639,000   $ 1,639,000
Interest rate decriptions       The notes are unsecured, bear interest at a rate of 8% through 14% per annum    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable Related Parties (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Notes payable - related parties $ 693,000 $ 693,000
Chief Executive Officer [Member]    
Due date Dec. 31, 2023  
Interest rate 8.00%  
Chief Executive Officer [Member] | Minimum [Member]    
Interest rate 0.00%  
Chief Executive Officer [Member] | Maximum [Member]    
Interest rate 10.00%  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
VIE Financing Obligation (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2021
Financing obligation $ 1,263,000     $ 1,263,000
Unsecured Convertible Notes Payable [Member]        
Tokens issued to unrelated parties     $ 50,000  
Promissory note issued to unrelated parties     $ 776,000  
Promissory note - various parties [Member] | Related Party [Member]        
Financing obligation   $ 315,000    
Tokens issued to unrelated parties   $ 122,000    
BST [Member]        
Financing obligation $ 1,263,000      
Financing obligation description as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100%      
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Contingent Payment Obligation (Details Narrative) - USD ($)
12 Months Ended
Sep. 06, 2017
Dec. 31, 2022
Contingent payment obligation   $ 1,500,000
Litigation funding agreement [Member] | Therium Inc. and VGL Capital, LLC [Member]    
Contingent payment obligation $ 1,500,000  
Gross proceeds $ 1,500,000  
Contingent obligation, description the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Details) - USD ($)
12 Months Ended
Dec. 15, 2022
Dec. 31, 2022
Dec. 31, 2021
Derivative Financial Instruments      
Stock Price $ 0.0075 $ 0.0055 $ 0
Exercise Price $ 0.0034 $ 0.0034 $ 0
Expected life (in years) 10 months 2 days 9 months 18 days  
Volatility 159.00% 165.00%  
Dividend Yield 0.00% 0.00%  
Risk-free interest rate 4.65% 4.73%  
Fair Value:      
Conversion feature $ 164,000 $ 112,000 $ 0
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Financial Instruments (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 15, 2022
Derivative Financial Instruments        
Net change in the fair value of derivative liabilities $ 52,000 $ 219,000    
Derivative liability 112,000 0 $ 163,000 $ 164,000
Extinguishment of derivative liabilities $ 112,000 $ 382,000 $ 382,000  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Lease Cost    
Operating lease cost (included in general and administration in the Company's statement of operations) $ 61,000 $ 56,000
Other Information    
Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021 $ 58,000 $ 55,000
Weighted average remaining lease term - operating leases (in years) 1 year 1 month 6 days 2 years 1 month 6 days
Average discount rate - operating leases 10.00% 10.00%
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Operating leases    
Long-term right-of-use assets $ 54,000 $ 107,000
Short-term operating lease liabilities 56,000 39,000
Long-term operating lease liabilities 1,000 $ 73,000
Total operating lease liabilities $ 57,000  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease (Details 2)
Dec. 31, 2022
USD ($)
Operating Lease  
2023 $ 58,000
2024 0
Total lease payment 58,000
Less: Imputed interest/present value discount (1,000)
Present value of lease liabilities $ 57,000
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Operating Lease      
Operating lease payments, monthly $ 5,000    
Operating lease, description payments increasing 3% each year, and ending on January 31, 2024    
Lease expenses   $ 61,000 $ 56,000
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of Warrant Shares    
Number of warrants Beginning balance 68,981,234 27,405,475
Number of warrants Granted 394,353,319 55,000,000
Number of warrant shares, Canceled/Expired (605,476)  
Number of warrants Exercised (100,000,000) (13,424,241)
Number of warrants Outstsnding Ending 362,729,077 68,981,234
Number of warrants exercisable Ending 362,729,077  
Exercise price range per share, Granted $ 0.0045 $ 0.05
Weighted Average Exercise Price    
Weighted Average Exercise Price Beginning Balance 0.0421 0.0117
Weighted Average Exercise Price, Granted 0.011 0.05
Weighted Average Exercise Price, Canceled/Expired 0.035  
Weighted Average Exercise Price, Exercised 0.165  
Weighted Average Exercise Price Outstanding Ending Balacce 0.006 0.0421
Weighted Average Exercise Price Exercisable Ending Balacce 0.006  
Exercise Price Range Per Share Exercisable Ending balance 0.0045 1,121,250,000
Minimum [Member]    
Number of Warrant Shares    
Exercise price range per share, Granted   0.005
Weighted Average Exercise Price    
Weighted Average Exercise Price, Granted 0.0045  
Exercise Price Range Per Share, Beginning balance 0.0045 0.0045
Exercise Price Range Per Share, Exercised 0.08  
Exercise Price Range Per Share, Canceled/Expired 0.0085  
Exercise Price Range Per Share Outstanding Ending 0.0045 0.0045
Exercise Price Range Per Share Exercisable Ending balance 0.0045  
Maximum [Member]    
Number of Warrant Shares    
Exercise price range per share, Granted   0.0375
Weighted Average Exercise Price    
Weighted Average Exercise Price, Granted 0.05  
Exercise Price Range Per Share, Beginning balance 2.90 2.90
Exercise Price Range Per Share, Exercised 2.90  
Exercise Price Range Per Share, Canceled/Expired 2.90  
Exercise Price Range Per Share Outstanding Ending 0.75 $ 2.90
Exercise Price Range Per Share Exercisable Ending balance 1,121,250,000  
Exercise Price Range Per Share Exercisable Ending balance $ 0.75  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Details 1)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Warrant [Member]  
Average Remaining Contractual Life (in years) 4 years 9 months 14 days
Weighted Average Exercise Price $ 0.0045
Number Outstanding | shares 333,333,319
Range of Exercise Prices $ 0.0045
Warrant One [Member]  
Average Remaining Contractual Life (in years) 2 years 10 months 13 days
Weighted Average Exercise Price $ 0.005
Number Outstanding | shares 13,333,334
Range of Exercise Prices $ 0.005
Warrant Two [Member]  
Average Remaining Contractual Life (in years) 4 years 10 months 6 days
Weighted Average Exercise Price $ 0.02
Number Outstanding | shares 11,020,000
Range of Exercise Prices $ 0.02
Warrant Three [Member]  
Average Remaining Contractual Life (in years) 3 years 8 months 19 days
Weighted Average Exercise Price $ 0.50
Number Outstanding | shares 5,000,000
Range of Exercise Prices $ 0.05
Warrant Four [Member]  
Average Remaining Contractual Life (in years) 1 year 11 months 4 days
Weighted Average Exercise Price $ 0.75
Number Outstanding | shares 42,424
Range of Exercise Prices $ 0.75
Warrant Total [Member]  
Average Remaining Contractual Life (in years) 4 years 18 days
Weighted Average Exercise Price $ 0.006
Number Outstanding | shares 362,729,077
Warrant Total [Member] | Maximum [Member]  
Range of Exercise Prices $ 0.75
Warrant Total [Member] | Minimum [Member]  
Range of Exercise Prices $ 0.0045
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Details 2) - Warrant Services [Member] - $ / shares
1 Months Ended
Oct. 21, 2022
Jul. 31, 2022
Exercise Prices $ 0.01 $ 0.02
Share price $ 0.00752 $ 0.02
Volatility 224.00% 233.00%
Risk Free Rate 4.34% 2.88%
Expected term (yrs.) 5 years 5 years
Dividend Rate 0.00% 0.00%
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Details 3) - Warrant Note Payable [Member]
1 Months Ended
Oct. 26, 2022
$ / shares
Exercise Prices $ 0.01
Share price $ 0.0079
Volatility 268.00%
Risk Free Rate 4.41%
Expected term (yrs.) 5 years
Dividend Rate 0.00%
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders Deficit (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 05, 2022
Jan. 10, 2011
Oct. 26, 2022
Oct. 21, 2022
Aug. 31, 2022
Jul. 31, 2022
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2019
Common Shares issued for cash         50,000,000     50,000,000    
Shares issued for cash value               $ 1,440,000    
Deemed dividend               $ 1,787,000 $ 0  
Cash recieved         $ 500,000          
Issued shares of stock warrants granted               100,000,000    
Preferred stock, shares authorized               10,000,000 10,000,000  
Preferred stock, per share               $ 0.10 $ 0.10  
Warrants exercisable price $ 0.02       $ 0.01     $ 0.05    
Preferred stock, shares outstanding               0 0  
Purchase shares of common stock for financing services               150,000,000    
Common stock issued upon warrant exercised                 12,349,726  
Common stock issued                 45,150,500  
Common stock issued                 45,150,500  
Common stock issued for service, share                 6,569,000  
Common stock issued for service, value               $ 423,000 $ 181,000  
Preferred stock value               $ 0 $ 0  
October, 21 2010 [Member]                    
Preferred stock, shares authorized               10,000,000    
Preferred stock, per share               $ 0.10    
Additional shares of preferred stock               10,000,000    
Warrant Total [Member]                    
Issued shares of stock warrants granted 50,000,000                  
Shares issued for cash value, direct fees and commission $ 940,000                  
Warrants exercisable price $ 0.02             $ 0.05    
Warrants issued to purchase common shares               50,000,000    
Number of Warrants exercised                 90,908 90,908
Warrant exercised, share                 13,333,333  
Common stock issued upon warrant exercised                 12,349,726  
Fair value of common stock issued                 $ 6,569,000  
Intrinsic value of warrants               $ 13,000 $ 473,000  
Warrant Note Payable [Member]                    
Vested, exercisable price     $ 0.01              
Estimated fair value     $ 260,000              
Grant of Warrants For Servicesl [Member]                    
Vested, exercisable price       $ 0.01   $ 0.02        
Purchase shares of common stock for financing services       50,000,000   3,000,000        
Estimated fair value       $ 372,000   $ 63,000        
Warrants exercisable expire term       5 years   5 years        
Warrant Holder [Member]                    
Deemed dividend               $ 1,787,000    
Warrants exercisable price               $ 0.0045    
Vested, exercisable price               $ 0.01    
Purchase shares of common stock for financing services               150,000,000    
Additional warrants               183,333,320    
Series B Preferred Stock [Member]                    
Preferred stock, shares authorized               100,000,000 100,000,000  
Preferred stock, per share               $ 0.10 $ 0.10  
Preferred stock, shares outstanding               36,667 36,667  
Preferred stock, shares designated   100,000,000                
Aggregate amount   $ 987,000                
Preferred stock value   $ 329,000           $ 4,000 $ 4,000  
Preferred stock, descriptions   such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share           such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share    
Initial price of preferred stock   $ 2.50           $ 2.50    
Common Class Shares [Member] | November 2020 [Member]                    
Common Shares issued for cash               40,100,000 119,666,450  
Shares issued for cash value               $ 180,000 $ 5,368,000  
Warrants issued to purchase common stock               8,020,000 55,000,000  
Warrants issued to purchase common stock exercisable price                 $ 0.005  
Warrants issued to purchase common stock expiration period               five years five years  
Common stock issued for service, share               30,105,936 3,365,138  
Common stock issued for service, value               $ 423,000 $ 181,000  
Stock issued for business purchase, shares         10,000,000   2,500,000   500,000  
Stock issued for business purchase, value         $ 127,000   $ 56,000   $ 36,000  
Common stock issued upon conversion of convertible notes payable and accrued interest, share 16,168,589               16,168,589  
Shares of warrants 605,476                  
Common stock issued upon conversion of convertible notes payable and accrued interest, value                 $ 1,035,000  
Common stock issued for debt settlement, share                 460,829  
Common stock issued for debt settlement, value $ 165,000               $ 88,000  
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Stock options    
Number of Options Shares, Beginning balance 83,133,001 58,133,001
Number of Options Shares, Granted 67,500,000 67,500,000
Number of Options Shares, Exercised   (42,500,000)
Number of Options Shares, Ending balance 150,633,001 83,133,001
Number of Options Shares exercisable Ending 87,212,671  
Weighted Average Exercise Price    
Weighted Average Exercises Price Beginning Balance $ 0.0274 $ 0.03704
Weighted Average Exercise Price, Granted 0.0045 0.0104
Weighted Average Exercise Price Outstanding Ending Balacce 0.0307 0.0274
Weighted Average Exercise Price Exercisable Ending Balacce 0.0497  
Exercise Price Range Per Share, Beginning balance 0.005 0.005
Exercise Price Range Per Share ,Granted 0.0045 0.05
Exercise Price Range Per Share Exercisable Ending balance 0.0045 1,121,250,000
Exercise Price Range Per Share, Ending balance 0.0045 0.005
Minimum [Member]    
Weighted Average Exercise Price    
Exercise Price Range Per Share ,Granted   0.005
Exercise Price Range Per Share Exercisable Ending balance 0.0045  
Maximum [Member]    
Weighted Average Exercise Price    
Exercise Price Range Per Share, Beginning balance 1,121,250,000 1,121,250,000
Exercise Price Range Per Share ,Granted   $ 0.0375
Exercise Price Range Per Share Exercisable Ending balance $ 1,121,250,000  
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details 1)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Option Exercisable [Member]  
Weighted average exercise price | $ / shares $ 0.0497
Weighted average remaining contractual life (years) 6 years 5 months 4 days
Number of warrants exercisable | shares 87,212,671
Option Exercisable [Member] | Exercise Prices Two [Member]  
Weighted average exercise price | $ / shares $ 3.0000
Weighted average remaining contractual life (years) 4 years 14 days
Number of warrants exercisable | shares 518,000
Option Exercisable [Member] | Exercise Prices Three [Member]  
Weighted average exercise price | $ / shares $ 2.0000
Weighted average remaining contractual life (years) 6 years 11 months 19 days
Number of warrants exercisable | shares 115,000
Option Exercisable [Member] | Exercise Prices Four [Member]  
Weighted average exercise price | $ / shares $ 0.0375
Weighted average remaining contractual life (years) 8 years 11 months 23 days
Number of warrants exercisable | shares 65,000,000
Option Exercisable [Member] | Exercise Prices One [Member]  
Weighted average remaining contractual life (years) 3 days
Number of warrants exercisable | shares 1
Weighted average exercise price | $ / shares $ 1,121,250,000
Option Exercisable [Member] | Exercise Prices Six [Member]  
Weighted average exercise price | $ / shares $ 0.0045
Weighted average remaining contractual life (years) 9 years 11 months 19 days
Number of warrants exercisable | shares 67,500,000
Options Outstanding [Member]  
Weighted average remaining contractual life (years) 6 years 5 months 4 days
Number of warrants outstanding | shares 150,633,001
Weighted average exercise price | $ / shares $ 0.0307
Options Outstanding [Member] | Exercise Prices Two [Member]  
Weighted average remaining contractual life (years) 4 years 14 days
Number of warrants outstanding | shares 518,000
Weighted average exercise price | $ / shares $ 3.0000
Options Outstanding [Member] | Exercise Prices Three [Member]  
Weighted average remaining contractual life (years) 6 years 11 months 19 days
Number of warrants outstanding | shares 115,000
Weighted average exercise price | $ / shares $ 2.0000
Options Outstanding [Member] | Exercise Prices Four [Member]  
Weighted average exercise price | $ / shares $ 0.0375
Weighted average remaining contractual life (years) 8 years 11 months 23 days
Number of warrants outstanding | shares 65,000,000
Options Outstanding [Member] | Exercise Prices Five [Member]  
Weighted average exercise price | $ / shares $ 0.0050
Weighted average remaining contractual life (years) 8 years 29 days
Number of warrants exercisable | shares 17,500,000
Options Outstanding [Member] | Exercise Prices One [Member]  
Weighted average remaining contractual life (years) 3 days
Number of warrants outstanding | shares 1
Weighted average exercise price | $ / shares $ 1,121,250,000
Option Exercisable [Member] | Exercise Prices Five [Member]  
Weighted average remaining contractual life (years) 8 years 29 days
Number of warrants outstanding | shares 17,500,000
Weighted average exercise price | $ / shares $ 0.0050
Option Exercisable [Member] | Exercise Prices Six [Member]  
Weighted average remaining contractual life (years) 9 years 11 months 19 days
Number of warrants outstanding | shares 4,079,670
Weighted average exercise price | $ / shares $ 0.0045
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Nov. 30, 2017
Share based compensation $ 2,958,000 $ 32,000  
Unamortized stock compensation $ 562,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 400,000,000   100,000,000
Total fair value $ 3,425,000 $ 6,757,000  
Options, Grants in Period 67,500,000 67,500,000  
Stock Option [Member]      
Option shares 2,500,000    
Exercise price $ 0.0045 $ 0.005  
Total fair value $ 594,000    
Intrinsic value of outstanding options $ 76,000 $ 3,225,000  
Stock compensation expense, Additional   $ 2,712,000  
Common stock, shares issued upon cashless exercise of options   39,955,655  
Options, Grants in Period   67,500,000  
Discount rate 3.79% 1.46%  
Volatility rate 394.00% 137.00%  
Options, exercised during period   42,500,000  
Options outstanding, estimated life 10 years 10 years  
Stock Option [Member] | February 2021 [Member]      
Share based compensation $ 3,675,000 $ 368,000  
Options outstanding, estimated life 10 years    
Stock option granted 12,250,000    
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Income Tax Provision (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Provision    
Federal statutory income tax rate 21.00% 21.00%
State tax, net of federal benefit 7.00% 5.00%
Change in valuation allowance on net operating loss carry-forwards (28.00%) (26.00%)
Effective income tax rate 0.00% 0.00%
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Income Tax Provision (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Operating lease liability $ 57,000  
Income Tax Provision [Member]    
Stock-based compensation 3,776,000 $ 702,000
Private placement costs 394,000 366,000
Operating lease liability 16,000 42,000
Loss on extinguishment of debt 1,858,000 1,697,000
Net operating loss carryforwards 7,362,000 5,946,000
Gross deferred tax assets 13,406,000 8,753,000
Net deferred tax assets 0 0
Less valuation allowance $ (13,406,000) $ (8,753,000)
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Income Tax Provision (Details Narrative) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Federal [Member]    
Net operating loss carry-forwards $ 30.2 $ 26.5
Carryforwards expiry year 2041  
State [Member]    
Net operating loss carry-forwards $ 14.7 $ 13.2
Carryforwards expiry year 2041  
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Commitment and Contingencies (Details)
12 Months Ended
Dec. 31, 2022
Onstream Media Corporation V Zerify Inc [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc One [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Two [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Three [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Four [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Five [Member]  
Date of filing Sep. 09, 2022
Onstream Media Corporation V Zerify Inc Six [Member]  
Date of filing Sep. 09, 2022
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details Narrative)
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Qualified Regulation A Offering [Member] | Certain Investors [Member]  
Issued warrants to purchase shares of common stock 35,319,999
Warrants fully vested, exercisable | $ / shares $ 0.02
Private Placement Under Rule Regulation D [Member] | Certain Investors [Member]  
Warrants fully vested, exercisable | $ / shares $ 0.02
Common Stocks [Member] | Qualified Regulation A Offering [Member]  
Issued shares of common stock in exchange for cash | $ $ 795,000
Issued shares of common stock 176,599,998
Common Stocks [Member] | Private Placement Under Rule Regulation D [Member]  
Issued shares of common stock in exchange for cash | $ $ 18,000
Issued shares of common stock 78,000,000
XML 77 zrfy_10k_htm.xml IDEA: XBRL DOCUMENT 0001285543 2022-01-01 2022-12-31 0001285543 zrfy:PrivatePlacementUnderRuleRegulationDMember zrfy:CertainInvestorsMember 2022-12-31 0001285543 zrfy:PrivatePlacementUnderRuleRegulationDMember zrfy:IssuanceOfCommonStockMember 2022-01-01 2022-12-31 0001285543 zrfy:QualifiedRegulationAOfferingMember zrfy:CertainInvestorsMember 2022-12-31 0001285543 zrfy:QualifiedRegulationAOfferingMember zrfy:IssuanceOfCommonStockMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncSixMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncFiveMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncFourMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncThreeMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncTwoMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncOneMember 2022-01-01 2022-12-31 0001285543 zrfy:OnstreamMediaCorporationVZerifyIncMember 2022-01-01 2022-12-31 0001285543 zrfy:StateMember 2022-01-01 2022-12-31 0001285543 zrfy:FederalMember 2022-01-01 2022-12-31 0001285543 zrfy:StateMember 2022-12-31 0001285543 zrfy:StateMember 2021-12-31 0001285543 zrfy:FederalMember 2022-12-31 0001285543 zrfy:FederalMember 2021-12-31 0001285543 zrfy:IncomeTaxProvisionMember 2022-12-31 0001285543 zrfy:IncomeTaxProvisionMember 2021-12-31 0001285543 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001285543 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001285543 2017-11-30 0001285543 zrfy:FebruaryTwoThousandTwentyOneMember us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001285543 zrfy:FebruaryTwoThousandTwentyOneMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001285543 us-gaap:StockOptionMember 2021-12-31 0001285543 us-gaap:StockOptionMember 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesOneMember 2022-12-31 0001285543 zrfy:OptionExercisablesMember zrfy:ExercisePricesSixMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember 2022-12-31 0001285543 zrfy:OptionExercisablesMember zrfy:ExercisePricesFiveMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesThreeMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesTwoMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesOneMember 2022-12-31 0001285543 zrfy:OptionExercisableMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesFourMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesFSixMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesFiveMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisablesMember zrfy:ExercisePricesSixMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisablesMember zrfy:ExercisePricesFiveMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesFourMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesThreeMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesThreeMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesTwoMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesOneMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesTwoMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesOneMember 2022-01-01 2022-12-31 0001285543 zrfy:OptionExercisableMember 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesFSixMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesFiveMember 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesFourMember 2022-12-31 0001285543 zrfy:OptionsOutstandingMember zrfy:ExercisePricesFourMember 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesThreeMember 2022-12-31 0001285543 zrfy:OptionExercisableMember zrfy:ExercisePricesTwoMember 2022-12-31 0001285543 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001285543 us-gaap:SeriesBPreferredStockMember 2011-01-01 2011-01-10 0001285543 us-gaap:SeriesBPreferredStockMember 2011-01-10 0001285543 zrfy:NovemberTwentyZeroTwentyMember zrfy:CommonClassSharesMember 2022-05-01 2022-05-05 0001285543 zrfy:NovemberTwentyZeroTwentyMember zrfy:CommonClassSharesMember 2022-08-01 2022-08-31 0001285543 zrfy:NovemberTwentyZeroTwentyMember zrfy:CommonClassSharesMember 2022-06-01 2022-06-30 0001285543 zrfy:NovemberTwentyZeroTwentyMember zrfy:CommonClassSharesMember 2022-01-01 2022-12-31 0001285543 zrfy:NovemberTwentyZeroTwentyMember zrfy:CommonClassSharesMember 2021-01-01 2021-12-31 0001285543 zrfy:WarrantsMember 2022-12-31 0001285543 zrfy:WarrantsMember 2021-12-31 0001285543 zrfy:WarrantsMember 2019-01-01 2019-12-31 0001285543 zrfy:GrantWarrantsForServicesMember 2022-10-01 2022-10-21 0001285543 zrfy:GrantWarrantsForServicesMember 2022-07-01 2022-07-31 0001285543 zrfy:WarrantsMember 2021-01-01 2021-12-31 0001285543 2022-05-01 2022-05-05 0001285543 zrfy:TwentyOneOctoberTwentyZeroTenMember 2022-12-31 0001285543 zrfy:WarrantsMember 2022-05-01 2022-05-05 0001285543 2022-08-31 0001285543 zrfy:WarrantHolderMember 2022-01-01 2022-12-31 0001285543 2022-08-01 2022-08-31 0001285543 zrfy:WarrantNotePayableMember 2022-10-01 2022-10-26 0001285543 zrfy:WarrantServicesMember 2022-07-01 2022-07-31 0001285543 zrfy:WarrantServicesMember 2022-10-01 2022-10-21 0001285543 zrfy:WarrantsMember zrfy:MaximumsMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantsFourMember zrfy:MinimumsMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantsMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantFourMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantThreeMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantTwoMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantOneMember 2022-01-01 2022-12-31 0001285543 zrfy:WarrantInMember 2022-01-01 2022-12-31 0001285543 zrfy:MaximumsMember 2021-01-01 2021-12-31 0001285543 zrfy:MaximumsMember 2022-01-01 2022-12-31 0001285543 zrfy:MinimumsMember 2021-01-01 2021-12-31 0001285543 zrfy:MinimumsMember 2022-01-01 2022-12-31 0001285543 2019-01-01 2019-01-31 0001285543 2020-01-01 2020-12-31 0001285543 2022-12-15 0001285543 2022-12-01 2022-12-15 0001285543 zrfy:LitigationFundingAgreementMember zrfy:TheriumIncAndVGLCapitalLLCMember 2017-09-01 2017-09-06 0001285543 zrfy:PromissoryNoteVariousPartiesMember zrfy:RelatedPartyMember 2019-01-01 2019-12-31 0001285543 zrfy:UnsecuredConvertibleNotesPayableMember 2018-01-01 2018-12-31 0001285543 zrfy:PromissoryNoteVariousPartiesMember zrfy:RelatedPartyMember 2019-12-31 0001285543 srt:MaximumMember zrfy:ChiefExecutiveOfficersMember 2022-12-31 0001285543 srt:MinimumMember zrfy:ChiefExecutiveOfficersMember 2022-12-31 0001285543 zrfy:NotesPayableMember 2022-01-01 2022-12-31 0001285543 zrfy:NotesPayableMember 2022-12-31 0001285543 zrfy:NotesPayableMember 2021-12-31 0001285543 srt:MinimumMember zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-01 2022-10-26 0001285543 srt:MaximumMember zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-01 2022-10-26 0001285543 zrfy:NotePayableTwoMember 2022-12-31 0001285543 zrfy:NotePayableTwoMember 2022-07-01 2022-07-31 0001285543 zrfy:NotePayableTwoMember 2022-07-31 0001285543 zrfy:EidLoanMember 2020-05-01 2020-05-15 0001285543 zrfy:EidLoanMember 2021-12-31 0001285543 zrfy:EidLoanMember 2022-12-31 0001285543 zrfy:NotePayableTwoMember 2022-01-01 2022-12-31 0001285543 zrfy:EidLoanMember 2022-01-01 2022-12-31 0001285543 zrfy:PromissoryNoteMember zrfy:SecuritiesPurchaseAgreementMember zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-26 0001285543 zrfy:PromissoryNoteMember zrfy:SecuritiesPurchaseAgreementMember zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-01 2022-10-26 0001285543 zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-26 0001285543 us-gaap:UnsecuredDebtMember zrfy:OneNoteMember 2019-01-01 2019-12-31 0001285543 us-gaap:UnsecuredDebtMember zrfy:OneNoteMember 2022-01-01 2022-12-31 0001285543 zrfy:OneNoteMember 2021-12-31 0001285543 zrfy:OneNoteMember 2019-12-31 0001285543 zrfy:OneNoteMember 2022-01-01 2022-12-31 0001285543 zrfy:OneNoteMember 2022-12-31 0001285543 zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-12-31 0001285543 us-gaap:UnsecuredDebtMember zrfy:OneNoteMember 2022-12-31 0001285543 zrfy:WalleyeOpportunitiesMasterFundLtdMember 2022-10-01 2022-10-26 0001285543 zrfy:OneNoteMember 2019-01-01 2019-12-31 0001285543 2022-10-26 0001285543 2022-10-01 2022-10-26 0001285543 zrfy:ChiefExecutiveOfficersMember 2021-12-31 0001285543 zrfy:ChiefExecutiveOfficersMember 2022-12-31 0001285543 zrfy:ChiefExecutiveOfficersMember 2022-01-01 2022-12-31 0001285543 zrfy:TwentyZeroFiveMember 2022-01-01 2022-12-31 0001285543 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001285543 zrfy:TwentyZeroFiveThroughTwentyZeroFiveMember 2022-12-31 0001285543 zrfy:TwentyZeroFiveMember 2021-12-31 0001285543 zrfy:TwentyZeroFiveMember 2022-12-31 0001285543 zrfy:TwentyZeroFiveThroughTwentyZeroFiveMember 2021-12-31 0001285543 zrfy:TwentyZeroFiveThroughTwentyZeroFiveMember 2022-01-01 2022-12-31 0001285543 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001285543 us-gaap:OfficeEquipmentMember 2022-12-31 0001285543 us-gaap:OfficeEquipmentMember 2021-12-31 0001285543 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001285543 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001285543 zrfy:ComputerSoftwareMember 2022-12-31 0001285543 zrfy:ComputerSoftwareMember 2021-12-31 0001285543 us-gaap:ComputerEquipmentMember 2022-12-31 0001285543 us-gaap:ComputerEquipmentMember 2021-12-31 0001285543 zrfy:TwoCustomerMember us-gaap:AccountsReceivableMember 2021-01-01 2021-12-31 0001285543 zrfy:OneCustomerMember us-gaap:AccountsReceivableMember 2021-01-01 2021-12-31 0001285543 zrfy:OneCustomerMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001285543 zrfy:ThreeCustomerMember zrfy:RevenuesMember 2021-01-01 2021-12-31 0001285543 zrfy:TwoCustomerMember zrfy:RevenuesMember 2021-01-01 2021-12-31 0001285543 zrfy:OneCustomerMember zrfy:RevenuesMember 2021-01-01 2021-12-31 0001285543 zrfy:TwoCustomerMember zrfy:RevenuesMember 2022-01-01 2022-12-31 0001285543 zrfy:OneCustomerMember zrfy:RevenuesMember 2022-01-01 2022-12-31 0001285543 zrfy:BSTMember 2022-01-01 2022-12-31 0001285543 zrfy:BSTMember 2022-12-31 0001285543 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001285543 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001285543 zrfy:ComputerSoftwareMember 2022-01-01 2022-12-31 0001285543 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001285543 us-gaap:ServiceMember 2021-01-01 2021-12-31 0001285543 zrfy:SoftwareMember 2021-01-01 2021-12-31 0001285543 us-gaap:ServiceMember 2022-01-01 2022-12-31 0001285543 zrfy:SoftwareMember 2022-01-01 2022-12-31 0001285543 2021-01-01 2021-06-30 0001285543 us-gaap:NoncontrollingInterestMember 2022-12-31 0001285543 us-gaap:RetainedEarningsMember 2022-12-31 0001285543 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001285543 us-gaap:CommonStockMember 2022-12-31 0001285543 zrfy:SeriesBPreferredStocksMember 2022-12-31 0001285543 zrfy:SeriesAPreferredStocksMember 2022-12-31 0001285543 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001285543 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001285543 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001285543 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001285543 zrfy:SeriesBPreferredStocksMember 2022-01-01 2022-12-31 0001285543 zrfy:SeriesAPreferredStocksMember 2022-01-01 2022-12-31 0001285543 us-gaap:NoncontrollingInterestMember 2021-12-31 0001285543 us-gaap:RetainedEarningsMember 2021-12-31 0001285543 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001285543 us-gaap:CommonStockMember 2021-12-31 0001285543 zrfy:SeriesBPreferredStocksMember 2021-12-31 0001285543 zrfy:SeriesAPreferredStocksMember 2021-12-31 0001285543 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001285543 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001285543 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001285543 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001285543 zrfy:SeriesBPreferredStocksMember 2021-01-01 2021-12-31 0001285543 zrfy:SeriesAPreferredStocksMember 2021-01-01 2021-12-31 0001285543 2020-12-31 0001285543 us-gaap:NoncontrollingInterestMember 2020-12-31 0001285543 us-gaap:RetainedEarningsMember 2020-12-31 0001285543 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001285543 us-gaap:CommonStockMember 2020-12-31 0001285543 zrfy:SeriesBPreferredStocksMember 2020-12-31 0001285543 zrfy:SeriesAPreferredStocksMember 2020-12-31 0001285543 2021-01-01 2021-12-31 0001285543 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001285543 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001285543 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001285543 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001285543 2021-12-31 0001285543 2022-12-31 0001285543 2023-03-31 0001285543 2022-06-30 iso4217:USD shares iso4217:USD shares pure 0001285543 false --12-31 FY 2022 0.10 10000000 0 0 0 0 0.0001 4000000000 955380225 1109417572 100 3 3 3 0.10 100000000 36667 36667 0.47 268000 1639000 1263000 0.0421 0.0045 2.90 83133001 0.0274 0.005 10-K true 2022-12-31 false ZERIFY, INC. WY 000-55012 22-3827597 1090 King Georges Post Road Suite 603 Edison NJ 08837 732 661-9641 Common stock, $0.0001 par value No No Yes Yes Non-accelerated Filer true false false 1364017560 21120000 572 Weinberg & Company, P.A Los Angeles, California 1000 1000 192000 2084000 20000 24000 0 13000 212000 2121000 36000 0 54000 107000 11000 12000 313000 2240000 4000 2000 1160000 996000 96000 0 895000 895000 1282000 1398000 268000 268000 323000 0 1930000 1972000 285000 310000 2826000 1972000 693000 693000 1557000 1497000 134000 120000 5865000 5477000 1500000 1500000 1263000 1263000 56000 39000 112000 0 15025000 13606000 142000 150000 1000 73000 15168000 13829000 100 3 987000 987000 0.10 100000000 36667 4000 4000 0.10 10000000 0 0 0.0001 4000000000 1109417572 955380225 110000 96000 67124000 59788000 -82190000 -71595000 -13965000 -10720000 -890000 -869000 -14855000 -11589000 313000 2240000 103000 193000 34000 27000 7711000 9448000 580000 566000 8325000 10041000 -8222000 -9848000 516000 7016000 141000 52000 52000 -219000 0 -109000 2000 1000 -607000 -7397000 -8829000 -17245000 -21000 -46000 -8808000 -17199000 1787000 0 -10595000 -17199000 -0.01 -0.02 1001263673 868770818 3 987000 36667 4000 718263338 72000 39814000 -54396000 -823000 -14342000 0 0 119666450 12000 5356000 0 0 5368000 0 0 3365138 1000 180000 0 0 181000 0 0 0 6757000 0 0 6757000 0 0 45150500 5000 6564000 0 0 6569000 0 0 12349726 1000 -1000 0 0 0 0 0 39955655 3000 -3000 0 0 0 0 0 16168589 2000 1033000 0 0 1035000 0 0 460829 0 88000 0 0 88000 0 0 0 0 -17199000 -46000 -17245000 3 987000 36667 4000 955380225 96000 59788000 -71595000 -869000 -11589000 0 0 100000000 10000 1430000 0 0 1440000 0 0 40100000 3000 177000 0 0 180000 0 0 0 435000 0 0 435000 0 0 0 260000 0 0 260000 0 0 30105936 3000 420000 423000 2990000 2990000 1787000 -1787000 0 -16168589 -2000 -163000 -165000 0 -8808000 -21000 -8829000 3 987000 36667 4000 1109417572 110000 67124000 -82190000 -890000 -14855000 8829000 17245000 3000 4000 141000 52000 64000 0 53000 51000 423000 181000 3425000 6757000 0 6569000 -52000 219000 0 112000 4000 -4000 14000 8000 163000 -14000 388000 298000 -55000 -51000 -4258000 -3063000 39000 0 -39000 0 1440000 0 180000 5368000 100000 0 1075000 177000 120000 40000 105000 231000 165000 0 30000 0 259000 2405000 4985000 -1892000 1922000 2084000 162000 192000 2084000 8000 120000 0 0 164000 0 260000 0 0 1035000 0 88000 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 1 – Organization and Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Zerify, Inc. (formerly known as StrikeForce Technologies, Inc.) (the “Company”), a software development and services company, offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 26, 2022, the Company applied for the Zerify trademark, ZERIFY™, which is intended to cover the categories of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">downloadable or recorded computer software for encryption;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">downloadable or recorded computer software for cyber security assessment and protection;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">anti-spyware software; downloadable or recorded computer application software for mobile devices, namely, software for protecting people from identity theft;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">downloadable or recorded computer software for guarding users of computers and remote access devices from identity theft, featuring various software tools, namely, anti-keyboard logger and keyboard stroke encryption.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 14, 2022, the Company’s Board of Directors and by consent majority shareholder vote  approved  changing the Company’s name from StrikeForce Technologies, Inc. to Zerify, Inc.  The name change was made to  better reflect  the Company’s business plans centered around its   cyber security software products.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 1, 2022,  FINRA approved the Company’s  Common Stock being quoted on the OTCQB Market under the symbol “ZRFY” (formerly “SFOR”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Going Concern</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and  had a stockholders’ deficit of $14,855,000. Additionally,  at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Basis of presentation and principles of consolidation</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”).  The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers.  BST meets the definition of a variable interest entity (“VIE”)  because  the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">COVID-19</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic,  which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and  disrupted  normal business operations.  The outbreak could   adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the years ended December 31, 2022 and 2021,  the COVID-19 pandemic did negatively impact the Company’s  operating results. For the years ended December 31, 2022, and 2021, the Company’s sales  decreased by 47%,  compared to the prior year, however, there have not been any impairments of the Company’s  assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot  predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Use of Estimates</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Revenue Recognition</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <em>Revenue from Contracts with Customers</em>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of revenue includes direct costs and fees related to the sale of our products. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables present our revenue disaggregated by major product and service lines:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">103,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Accounts Receivable</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Property and Equipment</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Useful Life </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Impairment of Long-lived Assets</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Income Taxes</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Leases</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leases its  corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Fair Value of Financial Instruments</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1—Quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3—Unobservable inputs based on the Company’s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is required to use of observable market data if such data is available without undue cost and effort.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Derivative Financial Instruments</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Stock-Based Compensation</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, <em>Compensation – Stock Compensation </em>(Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Loss per Share</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options to purchase common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,633,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83,133,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants to purchase common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,981,234</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,450,564</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Series B Preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">544,068,280</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">153,369,894</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em><span style="text-decoration:underline">Advertising, Sales and Marketing Costs</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Research and Development Costs</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute  research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Concentrations</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Segments</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Recent Accounting Pronouncements</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In June 2016, the FASB issued ASU No. 2016-13, <em>Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). </em>The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. As a small business filer, ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Management ©s currently assessing the impact of adopting this standard on the Company’s financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In May 2021, the FASB issued ASU 2021-04, <em>“Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).”</em> The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. The Company has elected early adoption of ASU 2021-04.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. In the fiscal year ended December 31, 2022, the Company incurred a net loss of $8,829,000 and used cash in operating activities of $4,258,000 and  had a stockholders’ deficit of $14,855,000. Additionally,  at December 31, 2022, the Company is in default on notes payable and convertible notes payable in the aggregate amount of $2,825,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022, the Company had cash on hand in the amount of $192,000. Subsequent to December 31, 2022, we received net proceeds of $813,000 on the sale of common shares and warrants (see Note 15). The Company believes it has enough cash to sustain operations through June 30, 2023. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business plan. Currently, the Company plan to increase revenues includes selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers, of which there are no assurances of success. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. Additionally, the Company is at risk of the unavailability of financing and even if available, not on satisfactory terms. and which may contain undue restrictions on its operations or cause substantial dilution from financing.</p> -8829000 4258000 -14855000 2825000 192000 813000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The consolidated financial statements include the accounts of the Company and its subsidiary, BlockSafe Technologies, Inc. (“BST”).  The Company owns 49% of BST and 31% is owned by three of the Company’s executive officers.  BST meets the definition of a variable interest entity (“VIE”)  because  the Company is the primary beneficiary of BST. BST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company and BST have a management agreement pursuant to which BST is required shall remit a monthly management fee of $36,000 to the Company; when BST reaches $1,000,000 in financing, BST will owe the Company an additional monthly management fee of approximately $140,000 for a three year period. The management fee is eliminated in consolidation. At December 31, 2022 and 2021, the amount of VIE cash on the accompanying consolidated balance sheets can be used only to settle obligations of BST. The amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the Company’s general creditors.</p> 0.49 0.31 36000 1000000 140000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic,  which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally, and  disrupted  normal business operations.  The outbreak could   adversely affect demand for the Company’s products and negatively impact the Company’s business and results of operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the years ended December 31, 2022 and 2021,  the COVID-19 pandemic did negatively impact the Company’s  operating results. For the years ended December 31, 2022, and 2021, the Company’s sales  decreased by 47%,  compared to the prior year, however, there have not been any impairments of the Company’s  assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. the Company cannot  predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has been following the recommendations of health authorities to minimize exposure risk for its team members during the pandemic, including the temporary closure of its corporate office and having team members work remotely. During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.</p> 0.47 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of Accounting Standards Codification (ASC) 606, <em>Revenue from Contracts with Customers</em>. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust®, Zerify Meet™ and Zerify Defender™ products. The Company recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. To date, the Company has not incurred incremental costs in obtaining customer contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cost of revenue includes direct costs and fees related to the sale of our products. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables present our revenue disaggregated by major product and service lines:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">103,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">103,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">193,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 96000 193000 7000 0 103000 193000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivable consist of trade amounts due from customers and are recorded at invoiced amounts. The Company maintains an allowance for doubtful accounts receivable based upon our business customers’ financial condition and payment history, and our historical collection experience and expected collectability of accounts receivable. If the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded. At December 31, 2022 and 2021, the allowance for doubtful accounts was $20,000 and $20,000, respectively. </p> 20000 20000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and equipment are recorded at cost less accumulated depreciation and amortization. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Useful Life </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expenditures for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2022 and 2021, the Company did not recognize any impairment for its property and equipment.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Estimated </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Useful Life </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixture</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> P5Y P3Y P7Y P7Y <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company reviews its property and equipment, right-of-use assets, and other long-lived assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. For the years ended December 31, 2022 and 2021, the Company had no impairment of long-lived assets. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for income taxes using the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company leases its  corporate office space under a lease agreement with monthly payments over a period of 60 months. Pursuant to ASC 842, Leases, lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets (see Note 10). </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1—Quoted prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3—Unobservable inputs based on the Company’s assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is required to use of observable market data if such data is available without undue cost and effort.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2022, the Company’s balance sheet includes Level 3 liabilities comprised of the fair value of embedded derivative liabilities of $112,000 (see Note 9). </p> 112000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using the trinomial/binomial valuation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, <em>Compensation – Stock Compensation </em>(Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options to purchase common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,633,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83,133,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants to purchase common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,981,234</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,450,564</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Series B Preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">544,068,280</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">153,369,894</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Options to purchase common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,633,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83,133,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Warrants to purchase common stock </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,981,234</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,450,564</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible Series B Preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,255,638</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">544,068,280</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">153,369,894</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 150633001 83133001 362729077 68981234 29450564 21 1255638 1255638 544068280 153369894 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Advertising, sales and marketing costs are expensed as incurred and are included in sales and marketing expenses. For the years ended December 31, 2022 and 2021, advertising, sales and marketing expenses were $313,000 and $103,000, respectively. </p> 313000 103000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Costs incurred for research and development are expensed as incurred. The salaries, benefits, and overhead costs of personnel conducting research and development of the Company’s software products constitute  research and development expenses. Purchased materials that do not have an alternative future use are also expensed. For the years ended December 31, 2022 and 2021, research and development costs were $580,000 and $566,000, respectively. </p> 580000 566000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the year ended December 31, 2022, sales to two customers comprised 39% and 34% of revenues, respectively. For the year ended December 31, 2021, sales to three customers comprised 36%, 32% and 19% of revenues, respectively. At December 31, 2022, no customer comprised more than 10% of accounts receivable. At December 31, 2021, two customers comprised 65% and 14% of accounts receivable, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.</p> 0.39 0.34 0.36 0.32 0.19 0.10 0.65 0.14 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company operates in one segment for the development and distribution of our software products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In June 2016, the FASB issued ASU No. 2016-13, <em>Credit Losses – Measurement of Credit Losses on Financial Instruments (“ASC 326”). </em>The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. As a small business filer, ASU 2020-06 will be effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Management ©s currently assessing the impact of adopting this standard on the Company’s financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In May 2021, the FASB issued ASU 2021-04, <em>“Earnings Per Share (Topic 260), Debt–- Modifications and Extinguishments (Subtopic 470-50), Compensation–- Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).”</em> The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. Transition is prospective. The Company has elected early adoption of ASU 2021-04.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2 – Property and Equipment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and equipment, stated at cost, less accumulated depreciation consisted of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">84,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">82,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">44,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixtures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">192,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">153,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(156,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(153,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">36,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense for the years ended December 31, 2022 and 2021 was $3,000 and $4,000, respectively.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">84,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">82,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer software</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">44,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Furniture and fixtures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">192,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">153,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(156,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(153,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">36,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 84000 82000 45000 44000 46000 10000 17000 17000 192000 153000 156000 153000 36000 0 3000 4000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3 – Convertible Notes Payable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Convertible notes payable consisted of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a) Convertible notes due to AL-Bank</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">383,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">503,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(b) Convertible note with Diagonal Lending </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(c) Convertible notes with fixed conversion features, in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">895,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">895,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,378,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,398,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(96,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,282,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,398,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(a) During fiscal 2005, the Company issued notes payable to DART/Citco Global in the aggregate of $543,000. The notes bear interest at an average rate of 7.5% per annum and matured in December 2010. The aggregate notes are convertible by the note holder into less than one share of the Company’s common stock based on a fixed conversion price adjusted for applicable reverse stock splits that occurred in prior fiscal years. In fiscal 2009, the note holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. In August 2021, the notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a Denmark based financing institution. In September 2021, the Company executed a repayment agreement with AL-Bank requiring the Company to  make monthly payments of $10,000 to AL-Bank, starting in October 2021 and ending in March 2025 (see Note 15), for a total of $400,000. Once the payments are made in full pursuant to  the repayment agreement, the remaining balance of $143,000 will  be forgiven and will be accounted for at that time. At December 31, 2021, the outstanding balance of convertible notes payable amounted to $503,000. During the year ended December 31, 2022, the Company made principal payments of $120,000. At December 31, 2022, the outstanding balance of the unsecured convertible notes payable amounted to $383,000. The convertible notes payable, including accrued interest are convertible to approximately two shares of the Company’s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(b) On December 15, 2022, the Company issued a convertible note payable to 1800 Diagonal Lending LLC (“Diagonal Lending”) for  $100,000.  The note is unsecured, bears interest at a rate of 12%, or 22% on default, is due on December 15, 2023, and has a repayment penalty of 120% of the unpaid principal and unpaid interest if prepaid within 180 days of December 15, 2022. The convertible note payable is convertible into shares of the Company’s common stock at a conversion price of 65% of the two lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the 15 trading days immediately preceding the conversion date. As the ultimate determination of shares of common stock to be issued upon conversion of these debentures can exceed the current number of available authorized shares, the Company determined that the conversion features of these debentures are not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as a derivative liability (see Note 9).  Of the incurred derivative liability of $164,000 related to the conversion feature of the debentures, $100,000 was accounted as debt discount and the remaining $64,000 as financing costs. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $96,000. The convertible notes payable, including accrued interest are convertible to approximately 29,450,549 shares of the Company’s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(c) During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits that occurred in prior fiscal years. At December 31, 2022 and December 31, 2021, the outstanding balance of unsecured convertible notes payable amounted to $895,000 and $895,000, respectively, and are deemed in default. The convertible notes payable, including accrued interest are convertible to approximately thirteen shares of the Company’s common stock.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a) Convertible notes due to AL-Bank</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">383,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">503,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(b) Convertible note with Diagonal Lending </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(c) Convertible notes with fixed conversion features, in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">895,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">895,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,378,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,398,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(96,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,282,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,398,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 383000 503000 100000 0 895000 895000 1378000 1398000 -96000 0 1282000 1398000 543000 0.075 10000 400000 143000 503000 120000 383000 100000 The note is unsecured, bears interest at a rate of 12%, or 22% on default 1.20 0.65 164000 100000 64000 96000 29450549 895000 The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum due on various dates from March 2008 to March 2015, and are currently in default 895000 895000 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 4 – Convertible Notes Payable – Related Parties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In prior years, the Company issued unsecured convertible notes to its Chief Executive Officer (CEO) in exchange for cash and/or services rendered. The notes have a compounded interest rate of 8% per annum and will mature on December 31, 2023, as amended. The aggregate notes are convertible by the note holders into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable amounted to $268,000.</p> 0.08 2023-12-31 268000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5 – Notes Payable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Notes payable consisted of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a) Notes payable- $1,639,000 - in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,639,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,639,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b) Notes payable issued by BST - in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">286,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">310,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c) Note payable-EID loan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">149,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Secured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d) Notes payable – October 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(e) Notes payable - in default </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(f) Notes payable – July 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">211,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total notes payable principal outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,291,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,122,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(323,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total notes payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,968,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,122,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less current portion of notes payable, net of discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,826,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,972,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Long term notes payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">142,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">(a) In previous years, the Company issued notes payable in exchange for cash. The notes are unsecured, bear interest at a rate of 8% through 14% per annum and matured starting in fiscal 2011 up to November 2021. At December 31, 2022 and December 31, 2021, the outstanding balance of the notes payable was $1,639,000, respectively, and are in default.</p>  <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(b) In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2022, the outstanding balance of the notes payable amounted to $310,000. During the year ended December 31, 2022, the Company made principal payments of $24,000. At December 31, 2022, the outstanding balance of the BlockSafe notes payable amounted to $286,000, and are in default.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(c) On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the Small Business Administration (SBA)under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $250 per month are deferred for twenty-four months and will commence in June 2022. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type.  During the year ended December 31, 2022, the Company made principal payments of $1,000. At December 31, 2022 and 2021, the outstanding balance of the EID loan amounted to $149,000 and $150,000, respectively. The Company was in compliance with the terms of the EID loan as of December 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(d) On October 26, 2022, the Company entered into a Securities Purchase Agreement  with Walleye Opportunities Master Fund Ltd., a Cayman Islands company (“Walleye”), whereby Walleye purchased a promissory note of the Company, in the aggregate principal amount of One Million Dollars ($1,000,000) (the “Note”), which is convertible by Walleye into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) upon an Event of Default . </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">On the Closing Date (specifically October 26, 2022), the Company received $800,000 which represented the principal of $1,000,000 less an original issue discount in the amount of $200,000 paid to Walleye. Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum. The Company shall have the right, exercisable on seven (7) Trading Days prior written notice to Walleye, to prepay the outstanding Principal Amount then due under this Note prior to any default. Walleye may demand immediate repayment in the event of  certain events, including a financing. In the event of default, Walleye shall have, as of and after any event of default, the option to cover the outstanding obligation of the Note time 120% at 90% of the lowest VWAP of the Common Stock on the date of the applicable conversion (the “Conversion Date”) or at any point during the four (4) Trading Day period immediately prior to the date of the applicable conversion.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">In addition, on the Closing Date, Walleye received a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share which shall be earned in full as of the Closing Date of October 26, 2022. The  common stock purchase warrant has  a cashless exercise provision (unless there is a registration statement registering the underlying shares to the common stock purchase warrants).  As a result of these issuances and grants, the Company incurred the following (a) relative fair value of the warrants granted of $260,000; and (b) original issue discounts of $200,000 of the debentures for a total of $460,000 which was allocated as debt discount. The debt discount is being amortized to interest expense over the term of the corresponding debentures. As of December 31, 2022, the unamortized debt discount was $323,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">From October 26, 2022 until the Note is extinguished in its entirety, Walleye shall receive a right of participation and first right of refusal on subsequent financings as described in the Agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">On October 26, 2022, through a Security Agreement of the same date, the Company’s Subsidiaries (specifically BlockSafe Technologies, Inc. and Cyber Security Risk Solutions, LLC) agreed to guarantee and act as surety for payment of the Note.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">At December 31, 2022, the outstanding balance of the note payable was $1,000,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(e) In fiscal 2019 and 2020, the Company issued notes payable aggregating $468,000. The notes bear interest at a rate starting from 8% to 37% per annum, each agreement secured by substantially all of the assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of $319,000, and one unsecured note of $21,000 was extinguished as part of a debt settlement obligation transaction. At December 31, 2021, the outstanding balance of the unsecured note agreements was $23,000. During the year ended December 31, 2022, the Company made principal payments of $17,000. At December 31, 2022, the outstanding balance of the secured notes payable was $6,000 and is in default. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">(f) In July 2022, the Company issued notes payable aggregating $275,000. The notes bear average interest rate of 51% per annum, each agreement secured by substantially all of the assets of the Company and maturing in January 2024.  During the year ended December 31, 2022, the Company made principal payments of $64,000.  At December 31, 2022, the outstanding balance of the secured notes payable was $211,000.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unsecured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a) Notes payable- $1,639,000 - in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,639,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,639,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(b) Notes payable issued by BST - in default</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">286,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">310,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(c) Note payable-EID loan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">149,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Secured </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(d) Notes payable – October 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(e) Notes payable - in default </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(f) Notes payable – July 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">211,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total notes payable principal outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,291,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,122,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(323,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total notes payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,968,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,122,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less current portion of notes payable, net of discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,826,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,972,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Long term notes payable </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">142,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">150,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1639000 1639000 286000 310000 149000 150000 1000000 0 6000 23000 211000 0 3291000 2122000 -323000 0 2968000 2122000 2826000 1972000 142000 150000 The notes are unsecured, bear interest at a rate of 8% through 14% per annum 1639000 The notes are unsecured, bearing interest at a rate of 8% per annum 310000 24000 286000 150000 0.0375 Monthly principal and interest payments of $250 per month 1000 149000 150000 1000000 0.0001 800000 1000000 200000 Walleye received a seven (7) month note, with no interest and, only in the event of a default (after the Maturity Date) of twelve percent (12%) per annum 1.20 0.90 50000000 0.01 260000 200000 460000 323000 1000000 468000 0.08 0.37 319000 21000 23000 17000 6000 275000 0.51 January 2024 64000 211000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6 – Notes Payable – Related Party</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Notes payable-related party notes represent unsecured notes payable to the Company’s Chief Executive Officer (CEO) ranging in interest rates of 0% per annum to 10% per annum and will mature on December 31, 2023, as amended. The outstanding balance of these notes payable at December 31, 2022 and December 31, 2021 amounted to $693,000. </p> 0 0.10 2023-12-31 693000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7 – VIE Financing Obligation </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is in the process of developing Coins or Tokens which are envisioned as virtual currency. In fiscal 2018, the Company’s consolidated subsidiary, BlockSafe, issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined by promissory notes and subscription agreements that would be controlling with respect to any offer or sale of tokens to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and December 31, 2021, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens.  At December 31, 2022 and through the date of filing, BlockSafe has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At December 31, 2022, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of $1,263,000 is a liability to be settled by BlockSafe, through the issuance of tokens, or through other means if tokens are never issued. </p> 776000 50000 122000 315000 1263000 as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% 1263000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8 – Contingent Payment Obligation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”) for financing of $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against alleged infringements of its patents. In exchange for the financing, the Funders are entitled to receive( after the payment of legal fees),  the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter.  The Funders are to be paid only  if the Company achieves recoveries of claim proceeds.  At December 31, 2022 and 2021, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if patent enforced claim proceeds are recovered.</p> 1500000 1500000 the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter 1500000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9 – Derivative Financial Instruments</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. During fiscal year 2022, the Company issued convertible debentures, and in accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2022, the derivative liabilities were valued using the Binomial pricing model and/or Black Scholes pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Issued </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 15,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="4" style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0055</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0075</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0034</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0034</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Life (Years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.84</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 165</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 159</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> -</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-Free Interest Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.73</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.65</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Conversion feature</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">112,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">164,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2020, the balance of the derivative liabilities was $163,000.  During the year ended December 31, 2021, the corresponding convertible notes payable were converted to equity. Pursuant to current accounting guidelines, the Company determined the final fair value of the derivative liability which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At December 31, 2021, the Company has no more instruments accounted as derivative liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 15, 2022, the Company recognized derivative liabilities of $164,000 upon issuance of additional secured convertible debentures (see Note 5). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability on December 31, 2022 was $112,000, and as a result, recorded a change in fair value of $52,000 as a component of other income and expenses in the consolidated statements of operations.  At December 31, 2022, the balance of the derivative liabilities was $112,000.  </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Issued </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 15,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="4" style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0055</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0075</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0034</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0034</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Life (Years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.80</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.84</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 165</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 159</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> -</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-Free Interest Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.73</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.65</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Conversion feature</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">112,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">164,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.0055 0.0075 0 0.0034 0.0034 0 P0Y9M18D P0Y10M2D 1.65 1.59 0 0 0.0473 0.0465 112000 164000 0 163000 382000 219000 382000 164000 112000 52000 112000 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Note 10 – Operating Lease</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In January 2019, the Company entered into a noncancelable operating lease for its office headquarters requiring payments of approximately $5,000 per month, payments increasing 3% each year, and ending on January 31, 2024. The Company determines if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the related liabilities are presented as lease liabilities in our consolidated balance sheets pursuant to ASC 842, Leases.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The components of lease expense and supplemental cash flow information related to leases for the period are as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Lease Cost</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease cost (included in general and administration in the Company’s statement of operations)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">61,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Other Information</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average remaining lease term – operating leases (in years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Average discount rate – operating leases</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">The supplemental balance sheet information related to leases for the period is as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At December 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Operating leases</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term right-of-use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">54,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Short-term operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">57,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Maturities of the Company’s lease liabilities are as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Year Ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Leases</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total lease payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: Imputed interest/present value discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Present value of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">57,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease expenses were $61,000 and $56,000 during the years ended December 31, 2022 and 2021, respectively.</p> 5000 payments increasing 3% each year, and ending on January 31, 2024 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year ended</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Lease Cost</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease cost (included in general and administration in the Company’s statement of operations)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">61,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Other Information</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average remaining lease term – operating leases (in years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Average discount rate – operating leases</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 61000 56000 58000 55000 P1Y1M6D P2Y1M6D 0.100 0.100 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>At December 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Operating leases</span></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term right-of-use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">54,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Short-term operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-term operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total operating lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">57,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 54000 56000 1000 57000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Year Ending</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Operating </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Leases</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total lease payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: Imputed interest/present value discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Present value of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">57,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 58000 0 58000 1000 57000 61000 56000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 11 – Stockholders’ Deficit</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Preferred Stock</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 21, 2010, the Company amended its Articles of Incorporation in New Jersey to authorize 10,000,000 shares of preferred stock, par value $0.10, the  designations, rights, and preferences  to be determined by the Board of Directors. On November 15, 2010, the Company changed its domicile from the State of New Jersey to the State of Wyoming.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to the 10,000,000 shares of preferred stock authorized on October 21, 2010, on January 10, 2011, 100 shares of preferred stock were designated as Series A Preferred Stock and 100,000,000 shares were designated as Series B Preferred Stock. The bylaws under the Wyoming Incorporation were amended to reflect the rights and preferences of each additional new designation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series A Preferred Stock collectively has voting rights equal to eighty percent of the total current issued and outstanding shares of common stock. If at least one share of Series A Preferred Stock is outstanding, the aggregate shares of Series A Preferred Stock shall have voting rights equal to the number of shares of common stock equal to four times the sum of the total number of shares of common stock issued and outstanding, plus the number of shares of Series B Preferred Stock (or other designated preferred stock) which are issued and outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock is  convertible into a number of common stock shares  equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In February 2014, the Company’s Board of Directors amended the conversion feature of the Series B Preferred Stock, to permit conversion to common shares at a 40% market discount to current market value at the time the Company receives a conversion request. Current market value is defined as the average of the immediately prior five trading day’s closing prices. Additionally, when Series B Preferred Stock shares convert to the Company’s common stock, the minimum price discount floor level is set at $0.005, as decided by the Company’s Board of Directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Series A Preferred Stock</span></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2011, the Company issued three shares of non-convertible Series A Preferred Stock valued at $329,000 per share, or $987,000 in the aggregate to three members of the management team. The Series A Preferred Stock are convertible into four times the total number of common shares plus the total number of shares of Series B preferred stock issued and outstanding at the time of conversion and have voting rights equal to eighty percent of the total issued and outstanding shares of the Company’s common stock. This effectively provided the management team, upon retention of their Series A Preferred Stock, voting control on matters presented to the shareholders of the Company. The shareholders of the Series A Preferred Stock have each irrevocably waived their conversion rights relating to the Series A Preferred Stock issued.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and 2021, there were 3 shares of Series A Preferred Stock outstanding. There were no issuances of Series A Preferred stock during fiscal 2022 and 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="text-decoration:underline">Series B Preferred Stock</span></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Series B Preferred Stock has preferential liquidation rights in the event of any liquidation, dissolution or winding up of the Company, such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share. The Series B Preferred Stock shall be convertible to a number of shares of common stock equal to the price of the Series B Preferred Stock divided by the par value of the Series B Preferred Stock. The option to convert the shares of Series B Preferred Stock may not be exercised until three months following the issuance of the Series B Preferred Stock to the recipient shareholder. The Series B Preferred Stock shall have ten votes on matters presented to the shareholders of the Company for one share of Series B Preferred Stock held. The initial price of the Series B Preferred Stock shall be $2.50, (subject to adjustment by the Company’s Board of Directors) until such time, if ever, the Series B Preferred Stock are listed on a secondary and/or public exchange. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and 2021, there were 36,667 shares of Series B Preferred Stock outstanding. There were no issuances of Series B Preferred stock during fiscal 2022 and 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Sale of Common Stock </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2022,  pursuant to the Company’s Qualified Regulation A Offering, the Company issued 40,100,000 common stock shares  in exchange for cash of $180,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and its placement agent to purchase 8,020,000 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, pursuant to the Company’s  offering under Regulation A, the Company issued 119,666,450 shares of common stock in exchange for cash of $5,368,000, net of direct fees and commission. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 55 million shares of common stock. The warrants are fully vested, exercisable at $0.05 per share and will expire in five years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Common Stock Issued for Services</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2022, the Company issued 30,105,936 shares of its common stock for services, with a fair value of $423,000.  The common shares were valued at the respective date of issuance. Included in this issuance were 2,500,000 and 10,000,000 shares issued to New to the Street in June and August of 2022 for services relating to a consulting agreement and were determined to have a fair value of $56,000 and $127,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, the Company issued 3,365,138 shares of its common stock for services, with a fair value of $181,000. The common stock shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Common Stock Issued on Conversion of Notes Payable and Accrued Interest</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, the Company issued 16,168,589 shares of common stock with a fair value of $1,035,000 upon conversion of convertible notes payable and accrued interest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Common Stock Issued on Settlement of Debt</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, the Company issued 460,829 shares of common stock with a fair value of $88,000 as debt settlement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Repurchase of common stock and warrants</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In May 2022, the Company repurchased 16,168,589 shares of common stock and 605,476 shares of warrants from an investor for $165,000.  All shares repurchased by the Company were retired immediately upon acquisition. As of December 31, 2022, there are no shares held in treasury.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the Company’s warrant activities for the years ended December 31, 2021 and 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrant Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Range</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">27,405,475</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-2.90 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0117</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.05</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.05</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canceled/Expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(13,424,241 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,981,234</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045-2.90</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0421</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">394,353,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 0.05</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.011</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canceled/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(605,476 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0085 – 2.90</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.035</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(100,000,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.08 – 2.90</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.165</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 0.75 </p></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.006</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance outstanding and exercisable, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045 – 0.75</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.006</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and 2021, the intrinsic value of the warrants amounted to $13,000 and $473,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants Outstanding and Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range of Exercise Prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Remaining </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual Life (in years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">333,333,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.79</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0045</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13,333,334</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.87</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.005</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.02</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">11,020,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.85</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.02</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.05</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.72</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.75</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">42,424</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1.93</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.75</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: black 3px double;">$</td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 - $0.75 </p></td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">362,729,077</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">4.05</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">0.006</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Exercise of Warrants</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,334 warrant shares were exercised on a cashless basis in exchange for 12,349,726 common stock shares. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em><span style="text-decoration:underline">Modification, Exercise and Grant of Warrants</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 5, 2022, the Company entered into an Inducement Offer to Exercise Common Stock Purchase Warrants Letter Agreements (the “Exercise Agreements”) with certain of the holders of the Existing Warrants, the Special Equities Opportunity Fund, LLC and Gregory Castaldo, to exercise existing warrants to purchase an aggregate of 50,000,000 shares of Common Stock (the “Exercising Holders”). Pursuant to the Exercise Agreements, the Exercising Holders and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holders would exercise their Existing Warrants (the “Investor Warrants”) for shares of Common Stock underlying such Existing Warrants (the “Exercised Shares”) at a reduced exercise price of $0.02 per share of Common Stock. In order to induce the Exercising Holders to cash exercise the Investor Warrants, the Exercise Agreements provide for the issuance of new warrants to purchase up to an aggregate of 50,000,000 shares of Common Stock (the “New Warrants”), with such New Warrants to be issued in an amount equal to the number of the Exercised Shares underlying any Investor Warrants. The New Warrants are exercisable after issuance, provide for a cashless exercise provision if the shares of Common Stock underlying the New Warrants are not registered and terminate on the date that is five years following the issuance of the New Warrants. The New Warrants have an exercise price per share of $0.05. The New Warrants and the shares of Common Stock issuable upon the exercise of the New Warrants are not being registered under the Securities Act of 1933 and are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act of 1933. The Exercised Shares are registered for resale on effective registration statements previously filed with the Securities and Exchange Commission. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $940,000, net of direct fees and commission.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2022, the Company modified the exercise price of the warrants granted to the two investors/warrant holders in May 2022 from $0.05 per share to $0.01 per share. As a result of this modification, the warrant holders exercised 50,000,000 shares of warrants and the Company received $500,000 in cash and issued 50,000,000 shares of common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a result of these transactions, the Company issued a total of 100 million shares of common stock and received cash of $1,440,000, net of direct costs.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em><span style="text-decoration:underline">Deemed Dividend to Warrant Holders</span></em></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2022, the Company granted an aggregate of 150,000,000 warrants for services and financing activities that contained a provision requiring the Company to adjust the terms of the warrants when future financing events occur on more favorable terms. On December 21, 2022, and pursuant to the beneficial terms contained in the Company’s Qualified Regulation A Offering, the Company modified the 150,000,000 warrants by granting an additional 183,333,320 warrants and adjusting the warrant exercise from price from $0.01 per share to $0.0045 per share. Pursuant to current accounting guidelines, the Company recorded the incremental fair value of $1,787,000 as a deemed dividend.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Grant of Warrants for Services</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 1,  2022, the Company granted warrants to a consultant, to purchase 3,000,000 shares of common stock for financing services rendered. The warrants are fully vested, exercisable at of $0.02 per share, will expire in 5 years and with an estimated fair value $63,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">233</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.88</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 21,  2022, the Company granted warrants pursuant to a Financial Advisory Agreement, to purchase 50,000,000 shares of common stock for advisory services rendered. The warrants are fully vested, exercisable at of $0.01 per share, will expire in 5 years and with an estimated fair value $372,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00752</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">224</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.34</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,908 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Grants of Warrants on Issuance of Note Payable</span></em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Included in the issuance of a Note Payable to Walleye dated October 26, 2022 (see Note 5), Walleye received a grant of a five year Fifty Million (50,000,000) common stock purchase warrants, exercisable at $0.01 per share, which shall be earned in full as of October 26, 2022. The estimated relative fair value of the warrants was determined to be $260,000 using the Black-Scholes-Merton option pricing model with the assumptions as set forth in the table below:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0079</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">268</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.41</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 10000000 0.10 10000000 100000000 such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share 2.50 0.005 329000 987000 such liquidation rights to be paid from the assets of the Company not delegated to parties with greater priority at $1.00 per share or, in the event an aggregate subscription by a single subscriber of the Series B Preferred Stock is greater than $100,000,000, $0.997 per share 2.50 36667 40100000 180000 8020000 0.02 five years 119666450 5368000 55000000 0.05 five years 30105936 423000 2500000 10000000 56000 127000 3365138 181000 500000 36000 16168589 1035000 460829 88000 16168589 605476 165000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrant Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price Range</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">27,405,475</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-2.90 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0117</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.05</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.05</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canceled/Expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(13,424,241 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">68,981,234</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045-2.90</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0421</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">394,353,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 0.05</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.011</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canceled/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(605,476 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0085 – 2.90</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.035</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(100,000,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.08 – 2.90</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.165</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 0.75 </p></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.006</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance outstanding and exercisable, December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">362,729,077</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045 – 0.75</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.006</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 27405475 0.0045 2.90 0.0117 55000000 0.05 0.05 -13424241 68981234 0.0045 2.90 0.0421 394353319 0.0045 0.05 0.011 605476 0.0085 2.90 0.035 -100000000 0.08 2.90 0.165 362729077 0.0045 0.75 0.006 362729077 0.0045 0.75 0.006 13000 473000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants Outstanding and Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range of Exercise Prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Remaining </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual Life (in years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">333,333,319</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.79</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0045</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13,333,334</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.87</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.005</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.02</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">11,020,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.85</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.02</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.05</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.72</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.50</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.75</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">42,424</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1.93</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.75</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="BORDER-BOTTOM: black 3px double;">$</td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 - $0.75 </p></td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">362,729,077</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">4.05</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">0.006</td><td style="BORDER-BOTTOM: black 3px double; PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.0045 333333319 P4Y9M14D 0.0045 0.005 13333334 P2Y10M13D 0.005 0.02 11020000 P4Y10M6D 0.02 0.05 5000000 P3Y8M19D 0.50 0.75 42424 P1Y11M4D 0.75 0.0045 0.75 362729077 P4Y18D 0.006 12349726 90908 45150500 6569000 50000000 0.02 50000000 50000000 940000 0.05 0.01 50000000 500000 50000000 100000000 1440000 150000000 150000000 183333320 0.01 0.0045 1787000 3000000 0.02 P5Y 63000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">233</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.88</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.00752</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">224</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.34</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 0.02 0.02 2.33 0.0288 P5Y 0 50000000 0.01 P5Y 372000 0.01 0.00752 2.24 0.0434 P5Y 0 13333333 12349726 90908 45150500 6569000 50000000 0.01 260000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Assumptions</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share Price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0079</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility %</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">268</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk Free Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.41</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected Term (yrs.)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend Rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 0.01 0.0079 2.68 0.0441 P5Y 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 12 – Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2012, the stockholders approved the 2012 Stock Option Plan for the Company’s employees, effective January 3, 2013. The number of shares authorized for issuance under the plan was 100,000,000 and was increased to 400,000,000 in November 2017 by unanimous consent of the Board of Directors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The table below summarizes the Company’s stock option activities for the years ended December 31, 2021 and 2022: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,133,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;">$</td><td style="width:12%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-1,121,250,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.03704</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">67,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-0.0375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0104</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(42,500,000</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">83,133,001</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-1,121,250,000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0274</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">67,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0045</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0045</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance outstanding, December 31, 2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">150,633,001</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-1,121,250,000 </p></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0307</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance exercisable, December 31, 2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">87,212,671</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-1,121,250,000 </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0497</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table summarizes information concerning the Company’s stock options as of December 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number Outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (in </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (in </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,121,250,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1,121,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1,121,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.0000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">518,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.04</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">518,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.04</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.0000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">115,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">6.97</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">115,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">6.97</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">65,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.98</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0375</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">65,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.98</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0375</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">17,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.08</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0050</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">17,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.08</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0050</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">67,500,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">9.97</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0045</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">4,079,670</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">9.97</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0045</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td>$</td><td style="BORDER-BOTTOM: 3px double;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 1,121,250,000 </p></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">150,633,001</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">6.43</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0307</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">87,212,671</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">6.43</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0497</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and 2021, the intrinsic value of outstanding options was $76,000 and $3,225,000, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2022, the Company recorded an additional stock compensation expense of $2,958,000 to account for options granted in the prior year that vested. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.0045 per share, vest over six months, and expire in 10 years, with a total fair value of approximately $594,000. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 394%, (ii) discount rate of 3.79%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $32,000 to account for the fair value of options that vested during the period. As of December 31, 2022, the unamortized stock compensation amounted to approximately $562,000 which will be recognized in fiscal 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended December 31, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company  issued 39,955,655 shares of the Company’s common stock upon cashless exercise of 42,500,000 options. The Company also granted options to purchase an aggregate of 67,500,000 shares of its common stock to employees. The options have an exercise price of $0.005 per share for 2,500,000 option shares and $0.0375 for 65,000,000 option shares, vest over six months, and expire in 10 years, with a total fair value of approximately $5,400,000 using the Black-Scholes Merton Option Pricing model. The fair value of the options was determined using a Black-Scholes Merton Option Pricing model based on the following assumptions: (i) volatility rate of 137%, (ii) discount rate of 1.46%, (iii) zero expected dividend yield, and (iv) expected life of 10.00 years. The Company recognized stock compensation expense of $368,000 to account for the fair value of options that vested during the period. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense.</p> 100000000 400000000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range Per Share</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, January 1, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58,133,001</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;">$</td><td style="width:12%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-1,121,250,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.03704</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">67,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-0.0375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0104</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(42,500,000</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">83,133,001</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005-1,121,250,000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0274</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">67,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0045</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0045</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance outstanding, December 31, 2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">150,633,001</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-1,121,250,000 </p></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0307</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance exercisable, December 31, 2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">87,212,671</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 0.0045-1,121,250,000 </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0497</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 58133001 0.005 1121250000 0.03704 67500000 0.005 0.0375 0.0104 -42500000 83133001 0.005 1121250000 0.0274 67500000 0.0045 0.0045 150633001 0.0045 1121250000 0.0307 87212671 0.0045 1121250000 0.0497 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Prices</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number Outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (in </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (in </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>years)</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,121,250,000</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1,121,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">0.01</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:5%;vertical-align:bottom;text-align:right;">1,121,250,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.0000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">518,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.04</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">518,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.04</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.0000</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">115,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">6.97</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">115,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">6.97</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.0000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0375</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">65,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.98</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0375</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">65,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.98</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0375</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.005</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">17,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.08</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0050</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">17,500,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">8.08</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0050</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">67,500,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">9.97</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0045</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">4,079,670</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">9.97</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">0.0045</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td>$</td><td style="BORDER-BOTTOM: 3px double;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.0045 – 1,121,250,000 </p></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">150,633,001</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">6.43</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0307</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">87,212,671</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">6.43</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">0.0497</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1 P0Y3D 1121250000 1 P0Y3D 1121250000 518000 P4Y14D 3.0000 518000 P4Y14D 3.0000 115000 P6Y11M19D 2.0000 115000 P6Y11M19D 2.0000 65000000 P8Y11M23D 0.0375 65000000 P8Y11M23D 0.0375 17500000 P8Y29D 0.0050 17500000 P8Y29D 0.0050 67500000 P9Y11M19D 0.0045 4079670 P9Y11M19D 0.0045 150633001 P6Y5M4D 0.0307 87212671 P6Y5M4D 0.0497 76000 3225000 2958000 0.0045 P10Y 594000 3.94 0.0379 P10Y 32000 562000 2712000 39955655 42500000 67500000 0.005 2500000 1.37 0.0146 P10Y 368000 12250000 3675000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 13 – Income Tax Provision</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income tax provision is as follows for the year ended:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Federal statutory income tax rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">State tax, net of federal benefit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in valuation allowance on net operating loss carry-forwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(26.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Effective income tax rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deferred tax assets consist of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,776,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">702,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Private placement costs </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">394,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">366,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease liability </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on extinguishment of debt </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,858,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,697,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net operating loss carryforwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,362,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,946,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,406,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,753,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(13,406,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(8,753,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The provisions of ASC Topic 740, Accounting for Income Taxes, require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2022 and 2021, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was more likely than not that the net deferred tax assets were not fully realizable. Accordingly, the Company established a full valuation allowance against its net deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2022 and 2021, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal NOL purposes approximately $30.2 million and $26.5 million was available at December 31, 2022 and 2021. For state NOL purposes approximately $14.7 million and $13.2 million was available at December 31, 2022 and 2021, respectively. The Federal carryforwards expire on various dates through 2041 and the state carryforwards expire through 2041. Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s operations are based in New Jersey and it is subject to Federal and New Jersey state income tax. Tax years after 2016 are open to examination by United States and state tax authorities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. ASC 740 also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions. As of December 31, 2022 and 2021, no liability for unrecognized tax benefits was required to be recorded or disclosed.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Federal statutory income tax rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">State tax, net of federal benefit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in valuation allowance on net operating loss carry-forwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(28.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(26.0 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Effective income tax rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 0.210 0.210 0.070 0.050 -0.280 -0.260 0.000 0.000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net deferred tax assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,776,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">702,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Private placement costs </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">394,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">366,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease liability </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">42,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on extinguishment of debt </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,858,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,697,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net operating loss carryforwards</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,362,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,946,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,406,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,753,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(13,406,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(8,753,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3776000 702000 394000 366000 16000 42000 1858000 1697000 7362000 5946000 13406000 8753000 -13406000 -8753000 0 0 30200000 26500000 14700000 13200000 2041 2041 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 14 – Commitment and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em><span style="text-decoration:underline">Constantino Zanfardino, Derivatively on Behalf of Nominal Defendant Zerify, Inc., formerly known as Strikeforce Technologies, Inc. v. Mark L. Kay, Ramarao Pemmaraju and George Waller, Defendants, and Zerify, Inc. formerly known as Strikeforce Technologies, Inc., Nominal Defendant</span></em><em> (U.S. District Court, District of New Jersey, Civil Action No. 2:22-cv-07258-MCA-AME</em>)</p><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 13, 2022, a claimed stockholder, Constantino Zanfardino (“Plaintiff”),  filed a stockholder derivative Complaint against our  directors , Mark L. Kay, Ramarao Pemmaraju and George Waller (collectively, “Defendants”). Plaintiff asserts claims against each of the Defendants for breach of fiduciary duty, waste of corporate assets and unjust enrichment resulting from Defendants’ alleged wrongdoing in their  management of us. Through the litigation, Plaintiff seeks judgment against each of the Defendants in favor of the Company. On March 3, 2023, the Defendants’ filed a Memorandum of Law in Support of their Motion to Dismiss Plaintiff’s Complaint.  On March 10, 2023, the Defendants served a motion to dismiss the complaint  upon the Plaintiff.  The Plaintiff’s opposition to the Defendants’ motion to dismiss is due on May 9, 2023.   Defendants are vigorously defending this litigation. At this time, it is not possible to estimate the ultimate outcome of this litigation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>Onstream Media Corporation</em></p><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are  currently engaged in several patent litigations brought by Onstream Media Corporation in the United States District Court, District of Wyoming. The parties are currently in negotiations to resolve all of the pending cases.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The cases and their filing dates follow:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Case</strong></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Date Filed</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00191 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00192 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00193 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00194 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00195 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00196 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00197 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Case</strong></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Date Filed</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00191 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00192 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00193 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00194 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00195 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00196 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Onstream Media Corporation v. Zerify Inc.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Case No. 22-cv-00197 (DWY)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 9, 2022</p></td></tr></tbody></table> 2022-09-09 2022-09-09 2022-09-09 2022-09-09 2022-09-09 2022-09-09 2022-09-09 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 15 – Subsequent Events</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to December 31, 2022, pursuant to the Company’s Qualified  Regulation A Offering, the Company issued 176,599,998 shares of common stock in exchange for cash of $795,000, net of direct fees and commissions. As part of the offering, the Company also issued warrants to certain investors and placement agent to purchase 35,319,999 shares of common stock. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to December 31, 2022, pursuant to our private placement under Rule 506(b) of Regulation D, the Company sold 78,000,000 warrants to purchase shares of common stock in exchange for cash of $18,000, net of direct fees and commissions. The warrants are fully vested, exercisable at $0.02 per share and will expire in five years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 23, 2023, the Company entered into an amendment to the AL-Bank note (see Note 3) that relieved the Company from its previously scheduled monthly payments for March and April 2023 by extending the maturity date of the note by an additional two months, or February and March of 2025.  </p> 176599998 795000 35319999 0.02 78000000 18000 0.02 EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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l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end XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 206 422 1 false 81 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://zrfy.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://zrfy.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://zrfy.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://zrfy.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 000007 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 7 false false R8.htm 000008 - Disclosure - Property and Equipment Sheet http://zrfy.com/role/PropertyAndEquipment Property and Equipment Notes 8 false false R9.htm 000009 - Disclosure - Convertible Notes Payable Notes http://zrfy.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 9 false false R10.htm 000010 - Disclosure - Convertible Notes Payable Related Parties Notes http://zrfy.com/role/ConvertibleNotesPayableRelatedParties Convertible Notes Payable Related Parties Notes 10 false false R11.htm 000011 - Disclosure - Notes Payable Notes http://zrfy.com/role/NotesPayable Notes Payable Notes 11 false false R12.htm 000012 - Disclosure - Notes Payable Related Parties Notes http://zrfy.com/role/NotesPayableRelatedParties Notes Payable Related Parties Notes 12 false false R13.htm 000013 - Disclosure - VIE Financing Obligation Sheet http://zrfy.com/role/VieFinancingObligation VIE Financing Obligation Notes 13 false false R14.htm 000014 - Disclosure - Contingent Payment Obligation Sheet http://zrfy.com/role/ContingentPaymentObligation Contingent Payment Obligation Notes 14 false false R15.htm 000015 - Disclosure - Derivative Financial Instruments Sheet http://zrfy.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 15 false false R16.htm 000016 - Disclosure - Operating Lease Sheet http://zrfy.com/role/OperatingLease Operating Lease Notes 16 false false R17.htm 000017 - Disclosure - Stockholders Deficit Sheet http://zrfy.com/role/StockholdersDeficit Stockholders Deficit Notes 17 false false R18.htm 000018 - Disclosure - Stock Options Sheet http://zrfy.com/role/StockOptions Stock Options Notes 18 false false R19.htm 000019 - Disclosure - Income Tax Provision Sheet http://zrfy.com/role/IncomeTaxProvision Income Tax Provision Notes 19 false false R20.htm 000020 - Disclosure - Commitment and Contingencies Sheet http://zrfy.com/role/CommitmentAndContingencies Commitment and Contingencies Notes 20 false false R21.htm 000021 - Disclosure - Subsequent Events Sheet http://zrfy.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 000022 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies 22 false false R23.htm 000023 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables Organization and Summary of Significant Accounting Policies (Tables) Tables http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies 23 false false R24.htm 000024 - Disclosure - Property and Equipment (Tables) Sheet http://zrfy.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://zrfy.com/role/PropertyAndEquipment 24 false false R25.htm 000025 - Disclosure - Convertible Notes Payable (Tables) Notes http://zrfy.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://zrfy.com/role/ConvertibleNotesPayable 25 false false R26.htm 000026 - Disclosure - Notes Payable (Tables) Notes http://zrfy.com/role/NotesPayableTables Notes Payable (Tables) Tables http://zrfy.com/role/NotesPayable 26 false false R27.htm 000027 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://zrfy.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://zrfy.com/role/DerivativeFinancialInstruments 27 false false R28.htm 000028 - Disclosure - Operating Lease (Tables) Sheet http://zrfy.com/role/OperatingLeaseTables Operating Lease (Tables) Tables http://zrfy.com/role/OperatingLease 28 false false R29.htm 000029 - Disclosure - Stockholders Deficit (Tables) Sheet http://zrfy.com/role/StockholdersDeficitTables Stockholders Deficit (Tables) Tables http://zrfy.com/role/StockholdersDeficit 29 false false R30.htm 000030 - Disclosure - Stock Options (Tables) Sheet http://zrfy.com/role/StockOptionsTables Stock Options (Tables) Tables http://zrfy.com/role/StockOptions 30 false false R31.htm 000031 - Disclosure - Income Tax Provision (Tables) Sheet http://zrfy.com/role/IncomeTaxProvisionTables Income Tax Provision (Tables) Tables http://zrfy.com/role/IncomeTaxProvision 31 false false R32.htm 000032 - Disclosure - Commitment and Contingencies (Tables) Sheet http://zrfy.com/role/CommitmentAndContingenciesTables Commitment and Contingencies (Tables) Tables http://zrfy.com/role/CommitmentAndContingencies 32 false false R33.htm 000033 - Disclosure - Organization and Summary of Significant Accounting Policies (Details) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails Organization and Summary of Significant Accounting Policies (Details) Details http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 000034 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 1) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1 Organization and Summary of Significant Accounting Policies (Details 1) Details http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 000035 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 2) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2 Organization and Summary of Significant Accounting Policies (Details 2) Details http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 000036 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative) Sheet http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Organization and Summary of Significant Accounting Policies (Details Narrative) Details http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 000037 - Disclosure - Property and Equipment (Details) Sheet http://zrfy.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://zrfy.com/role/PropertyAndEquipmentTables 37 false false R38.htm 000038 - Disclosure - Property and Equipment (Details Narrative) Sheet http://zrfy.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://zrfy.com/role/PropertyAndEquipmentTables 38 false false R39.htm 000039 - Disclosure - Convertible Notes Payable (Details) Notes http://zrfy.com/role/ConvertibleNotesPayableDetails Convertible Notes Payable (Details) Details http://zrfy.com/role/ConvertibleNotesPayableTables 39 false false R40.htm 000040 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://zrfy.com/role/ConvertibleNotesPayableTables 40 false false R41.htm 000041 - Disclosure - Convertible Notes Payable - Related Parties (Details Narrative) Notes http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative Convertible Notes Payable - Related Parties (Details Narrative) Details 41 false false R42.htm 000042 - Disclosure - Notes Payable (Details) Notes http://zrfy.com/role/NotesPayableDetails Notes Payable (Details) Details http://zrfy.com/role/NotesPayableTables 42 false false R43.htm 000043 - Disclosure - Notes Payable (Details Narrative) Notes http://zrfy.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://zrfy.com/role/NotesPayableTables 43 false false R44.htm 000044 - Disclosure - Notes Payable Related Parties (Details Narrative) Notes http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative Notes Payable Related Parties (Details Narrative) Details http://zrfy.com/role/NotesPayableRelatedParties 44 false false R45.htm 000045 - Disclosure - VIE Financing Obligation (Details Narrative) Sheet http://zrfy.com/role/VieFinancingObligationDetailsNarrative VIE Financing Obligation (Details Narrative) Details http://zrfy.com/role/VieFinancingObligation 45 false false R46.htm 000046 - Disclosure - Contingent Payment Obligation (Details Narrative) Sheet http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative Contingent Payment Obligation (Details Narrative) Details http://zrfy.com/role/ContingentPaymentObligation 46 false false R47.htm 000047 - Disclosure - Derivative Financial Instruments (Details) Sheet http://zrfy.com/role/DerivativeFinancialInstrumentsDetails Derivative Financial Instruments (Details) Details http://zrfy.com/role/DerivativeFinancialInstrumentsTables 47 false false R48.htm 000048 - Disclosure - Derivative Financial Instruments (Details Narrative) Sheet http://zrfy.com/role/DerivativeFinancialInstrumentsDetailsNarrative Derivative Financial Instruments (Details Narrative) Details http://zrfy.com/role/DerivativeFinancialInstrumentsTables 48 false false R49.htm 000049 - Disclosure - Operating Lease (Details) Sheet http://zrfy.com/role/OperatingLeaseDetails Operating Lease (Details) Details http://zrfy.com/role/OperatingLeaseTables 49 false false R50.htm 000050 - Disclosure - Operating Lease (Details 1) Sheet http://zrfy.com/role/OperatingLeaseDetails1 Operating Lease (Details 1) Details http://zrfy.com/role/OperatingLeaseTables 50 false false R51.htm 000051 - Disclosure - Operating Lease (Details 2) Sheet http://zrfy.com/role/OperatingLeaseDetails2 Operating Lease (Details 2) Details http://zrfy.com/role/OperatingLeaseTables 51 false false R52.htm 000052 - Disclosure - Operating Lease (Details Narrative) Sheet http://zrfy.com/role/OperatingLeaseDetailsNarrative Operating Lease (Details Narrative) Details http://zrfy.com/role/OperatingLeaseTables 52 false false R53.htm 000053 - Disclosure - Stockholders Deficit (Details) Sheet http://zrfy.com/role/StockholdersDeficitDetails Stockholders Deficit (Details) Details http://zrfy.com/role/StockholdersDeficitTables 53 false false R54.htm 000054 - Disclosure - Stockholders Deficit (Details 1) Sheet http://zrfy.com/role/StockholdersDeficitDetails1 Stockholders Deficit (Details 1) Details http://zrfy.com/role/StockholdersDeficitTables 54 false false R55.htm 000055 - Disclosure - Stockholders Deficit (Details 2) Sheet http://zrfy.com/role/StockholdersDeficitDetails2 Stockholders Deficit (Details 2) Details http://zrfy.com/role/StockholdersDeficitTables 55 false false R56.htm 000056 - Disclosure - Stockholders Deficit (Details 3) Sheet http://zrfy.com/role/StockholdersDeficitDetails3 Stockholders Deficit (Details 3) Details http://zrfy.com/role/StockholdersDeficitTables 56 false false R57.htm 000057 - Disclosure - Stockholders Deficit (Details Narrative) Sheet http://zrfy.com/role/StockholdersDeficitDetailsNarrative Stockholders Deficit (Details Narrative) Details http://zrfy.com/role/StockholdersDeficitTables 57 false false R58.htm 000058 - Disclosure - Stock Options (Details) Sheet http://zrfy.com/role/StockOptionsDetails Stock Options (Details) Details http://zrfy.com/role/StockOptionsTables 58 false false R59.htm 000059 - Disclosure - Stock Options (Details 1) Sheet http://zrfy.com/role/StockOptionsDetails1 Stock Options (Details 1) Details http://zrfy.com/role/StockOptionsTables 59 false false R60.htm 000060 - Disclosure - Stock Options (Details Narrative) Sheet http://zrfy.com/role/StockOptionsDetailsNarrative Stock Options (Details Narrative) Details http://zrfy.com/role/StockOptionsTables 60 false false R61.htm 000061 - Disclosure - Income Tax Provision (Details) Sheet http://zrfy.com/role/IncomeTaxProvisionDetails Income Tax Provision (Details) Details http://zrfy.com/role/IncomeTaxProvisionTables 61 false false R62.htm 000062 - Disclosure - Income Tax Provision (Details 1) Sheet http://zrfy.com/role/IncomeTaxProvisionDetails1 Income Tax Provision (Details 1) Details http://zrfy.com/role/IncomeTaxProvisionTables 62 false false R63.htm 000063 - Disclosure - Income Tax Provision (Details Narrative) Sheet http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative Income Tax Provision (Details Narrative) Details http://zrfy.com/role/IncomeTaxProvisionTables 63 false false R64.htm 000064 - Disclosure - Commitment and Contingencies (Details) Sheet http://zrfy.com/role/CommitmentAndContingenciesDetails Commitment and Contingencies (Details) Details http://zrfy.com/role/CommitmentAndContingenciesTables 64 false false R65.htm 000065 - Disclosure - Subsequent Events (Details Narrative) Sheet http://zrfy.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://zrfy.com/role/SubsequentEvents 65 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. zrfy_10k.htm 1 [dq-0542-Deprecated-Concept] Concept WorkersCompensationDiscountAmount in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. zrfy_10k.htm 1 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 29 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesOutstanding, us-gaap:ConvertibleNotesPayable, us-gaap:NotesAndLoansPayable, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:PreferredStockSharesOutstanding, zrfy:ExercisePriceRangePerShareBeginningBalance, zrfy:ExercisePriceRangePerShareOutstandingEnding, zrfy:FinancingObligationNet, zrfy:NumberOfOptionsSharesBeginningBalance, zrfy:SalesDeacreasedPercentage, zrfy:WeightedAverageExercisePriceBeginningBalance, zrfy:WeightedAverageExercisesPriceBeginningBalance - zrfy_10k.htm 1 zrfy_10k.htm zrfy-20221231.xsd zrfy-20221231_cal.xml zrfy-20221231_def.xml zrfy-20221231_lab.xml zrfy-20221231_pre.xml zrfy_ex211.htm zrfy_ex311.htm zrfy_ex312.htm zrfy_ex321.htm zrfy_ex322.htm http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "zrfy_10k.htm": { "axisCustom": 0, "axisStandard": 18, "baseTaxonomies": { "http://fasb.org/srt/2022": 2, "http://fasb.org/us-gaap/2022": 557, "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 206, "dts": { "calculationLink": { "local": [ "zrfy-20221231_cal.xml" ] }, "definitionLink": { "local": [ "zrfy-20221231_def.xml" ] }, "inline": { "local": [ "zrfy_10k.htm" ] }, "labelLink": { "local": [ "zrfy-20221231_lab.xml" ] }, "presentationLink": { "local": [ "zrfy-20221231_pre.xml" ] }, "schema": { "local": [ "zrfy-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 593, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 20, "http://xbrl.sec.gov/dei/2022": 5, "http://zrfy.com/20221231": 8, "total": 33 }, "keyCustom": 178, "keyStandard": 244, "memberCustom": 65, "memberStandard": 16, "nsprefix": "zrfy", "nsuri": "http://zrfy.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://zrfy.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ConvertableNotesPayableRelatedPartiesDisclosureTextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - Convertible Notes Payable Related Parties", "menuCat": "Notes", "order": "10", "role": "http://zrfy.com/role/ConvertibleNotesPayableRelatedParties", "shortName": "Convertible Notes Payable Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ConvertableNotesPayableRelatedPartiesDisclosureTextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - Notes Payable", "menuCat": "Notes", "order": "11", "role": "http://zrfy.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:NotesPayableRelatedPartiestabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - Notes Payable Related Parties", "menuCat": "Notes", "order": "12", "role": "http://zrfy.com/role/NotesPayableRelatedParties", "shortName": "Notes Payable Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:NotesPayableRelatedPartiestabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - VIE Financing Obligation", "menuCat": "Notes", "order": "13", "role": "http://zrfy.com/role/VieFinancingObligation", "shortName": "VIE Financing Obligation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:Note7ContingentPaymentObligation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Contingent Payment Obligation", "menuCat": "Notes", "order": "14", "role": "http://zrfy.com/role/ContingentPaymentObligation", "shortName": "Contingent Payment Obligation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:Note7ContingentPaymentObligation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Derivative Financial Instruments", "menuCat": "Notes", "order": "15", "role": "http://zrfy.com/role/DerivativeFinancialInstruments", "shortName": "Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:OperatingLeasetextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - Operating Lease", "menuCat": "Notes", "order": "16", "role": "http://zrfy.com/role/OperatingLease", "shortName": "Operating Lease", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2021-01-01to2021-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:OperatingLeasetextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - Stockholders Deficit", "menuCat": "Notes", "order": "17", "role": "http://zrfy.com/role/StockholdersDeficit", "shortName": "Stockholders Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueOptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - Stock Options", "menuCat": "Notes", "order": "18", "role": "http://zrfy.com/role/StockOptions", "shortName": "Stock Options", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueOptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - Income Tax Provision", "menuCat": "Notes", "order": "19", "role": "http://zrfy.com/role/IncomeTaxProvision", "shortName": "Income Tax Provision", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://zrfy.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - Commitment and Contingencies", "menuCat": "Notes", "order": "20", "role": "http://zrfy.com/role/CommitmentAndContingencies", "shortName": "Commitment and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "21", "role": "http://zrfy.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "22", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Organization and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMilestoneMethodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "23", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Organization and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMilestoneMethodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "24", "role": "http://zrfy.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "zrfy:ConvertibleNotesPayableTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - Convertible Notes Payable (Tables)", "menuCat": "Tables", "order": "25", "role": "http://zrfy.com/role/ConvertibleNotesPayableTables", "shortName": "Convertible Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "zrfy:ConvertibleNotesPayableTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - Notes Payable (Tables)", "menuCat": "Tables", "order": "26", "role": "http://zrfy.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - Derivative Financial Instruments (Tables)", "menuCat": "Tables", "order": "27", "role": "http://zrfy.com/role/DerivativeFinancialInstrumentsTables", "shortName": "Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - Operating Lease (Tables)", "menuCat": "Tables", "order": "28", "role": "http://zrfy.com/role/OperatingLeaseTables", "shortName": "Operating Lease (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleOfStockWarrantsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - Stockholders Deficit (Tables)", "menuCat": "Tables", "order": "29", "role": "http://zrfy.com/role/StockholdersDeficitTables", "shortName": "Stockholders Deficit (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleOfStockWarrantsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:CashAtVariableInterestEntity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:CashAtVariableInterestEntity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - Stock Options (Tables)", "menuCat": "Tables", "order": "30", "role": "http://zrfy.com/role/StockOptionsTables", "shortName": "Stock Options (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - Income Tax Provision (Tables)", "menuCat": "Tables", "order": "31", "role": "http://zrfy.com/role/IncomeTaxProvisionTables", "shortName": "Income Tax Provision (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - Commitment and Contingencies (Tables)", "menuCat": "Tables", "order": "32", "role": "http://zrfy.com/role/CommitmentAndContingenciesTables", "shortName": "Commitment and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - Organization and Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "33", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "Organization and Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:RevenueRecognitionMilestoneMethodTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_SoftwareMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 1)", "menuCat": "Details", "order": "34", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "shortName": "Organization and Summary of Significant Accounting Policies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_us-gaap_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:OptionsToPurchaseCommonStock", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - Organization and Summary of Significant Accounting Policies (Details 2)", "menuCat": "Details", "order": "35", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2", "shortName": "Organization and Summary of Significant Accounting Policies (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:OptionsToPurchaseCommonStock", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "36", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Organization and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromOperatingActivities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - Property and Equipment (Details)", "menuCat": "Details", "order": "37", "role": "http://zrfy.com/role/PropertyAndEquipmentDetails", "shortName": "Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - Property and Equipment (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://zrfy.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "Property and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "zrfy:ConvertibleNotesPayableTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:ConvertibleNotesDueToBankInDefault", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - Convertible Notes Payable (Details)", "menuCat": "Details", "order": "39", "role": "http://zrfy.com/role/ConvertibleNotesPayableDetails", "shortName": "Convertible Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConvertibleDebtTableTextBlock", "zrfy:ConvertibleNotesPayableTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:ConvertibleNotesDueToBankInDefault", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://zrfy.com/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "zrfy:CostOfRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000040 - Disclosure - Convertible Notes Payable (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "shortName": "Convertible Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "zrfy:ConvertibleNotesPayableTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_us-gaap_ConvertibleNotesPayableMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "zrfy:NotesPayableRelatedPartiestabletextblock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_ChiefExecutiveOfficersMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000041 - Disclosure - Convertible Notes Payable - Related Parties (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "shortName": "Convertible Notes Payable - Related Parties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "zrfy:ConvertableNotesPayableRelatedPartiesDisclosureTextblock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_ChiefExecutiveOfficersMember", "decimals": "0", "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NotesPayableInDefault", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000042 - Disclosure - Notes Payable (Details)", "menuCat": "Details", "order": "42", "role": "http://zrfy.com/role/NotesPayableDetails", "shortName": "Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NotesPayableInDefault", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-26", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000043 - Disclosure - Notes Payable (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://zrfy.com/role/NotesPayableDetailsNarrative", "shortName": "Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-26", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000044 - Disclosure - Notes Payable Related Parties (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative", "shortName": "Notes Payable Related Parties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "zrfy:NotesPayableRelatedPartiestabletextblock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_srt_MinimumMember_zrfy_ChiefExecutiveOfficersMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:FinancingObligationNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000045 - Disclosure - VIE Financing Obligation (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://zrfy.com/role/VieFinancingObligationDetailsNarrative", "shortName": "VIE Financing Obligation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:FinancingObligationNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "zrfy:Note7ContingentPaymentObligation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000046 - Disclosure - Contingent Payment Obligation (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "shortName": "Contingent Payment Obligation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "zrfy:Note7ContingentPaymentObligation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-12-01to2022-12-15", "decimals": "INF", "first": true, "lang": null, "name": "zrfy:StockPrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000047 - Disclosure - Derivative Financial Instruments (Details)", "menuCat": "Details", "order": "47", "role": "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails", "shortName": "Derivative Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-12-01to2022-12-15", "decimals": "INF", "first": true, "lang": null, "name": "zrfy:StockPrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NetChangeInTheFairValueOfDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000048 - Disclosure - Derivative Financial Instruments (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://zrfy.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "shortName": "Derivative Financial Instruments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NetChangeInTheFairValueOfDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000049 - Disclosure - Operating Lease (Details)", "menuCat": "Details", "order": "49", "role": "http://zrfy.com/role/OperatingLeaseDetails", "shortName": "Operating Lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2020-12-31_zrfy_SeriesAPreferredStocksMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2020-12-31_zrfy_SeriesAPreferredStocksMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000050 - Disclosure - Operating Lease (Details 1)", "menuCat": "Details", "order": "50", "role": "http://zrfy.com/role/OperatingLeaseDetails1", "shortName": "Operating Lease (Details 1)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfMaturitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000051 - Disclosure - Operating Lease (Details 2)", "menuCat": "Details", "order": "51", "role": "http://zrfy.com/role/OperatingLeaseDetails2", "shortName": "Operating Lease (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfMaturitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "zrfy:OperatingLeasetextblock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2019-01-01to2019-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000052 - Disclosure - Operating Lease (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://zrfy.com/role/OperatingLeaseDetailsNarrative", "shortName": "Operating Lease (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "zrfy:OperatingLeasetextblock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2019-01-01to2019-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfStockWarrantsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000053 - Disclosure - Stockholders Deficit (Details)", "menuCat": "Details", "order": "53", "role": "http://zrfy.com/role/StockholdersDeficitDetails", "shortName": "Stockholders Deficit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfStockWarrantsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfStockWarrantsOutstandingAndExercisableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_WarrantInMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000054 - Disclosure - Stockholders Deficit (Details 1)", "menuCat": "Details", "order": "54", "role": "http://zrfy.com/role/StockholdersDeficitDetails1", "shortName": "Stockholders Deficit (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfStockWarrantsOutstandingAndExercisableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_WarrantInMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-21_zrfy_WarrantServicesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantExercisePriceIncrease", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000055 - Disclosure - Stockholders Deficit (Details 2)", "menuCat": "Details", "order": "55", "role": "http://zrfy.com/role/StockholdersDeficitDetails2", "shortName": "Stockholders Deficit (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-21_zrfy_WarrantServicesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantExercisePriceIncrease", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleGrantsOfWarrantsOnIssuanceOfNotePayableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-26_zrfy_WarrantNotePayableMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantExercisePriceIncrease", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000056 - Disclosure - Stockholders Deficit (Details 3)", "menuCat": "Details", "order": "56", "role": "http://zrfy.com/role/StockholdersDeficitDetails3", "shortName": "Stockholders Deficit (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleGrantsOfWarrantsOnIssuanceOfNotePayableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-10-01to2022-10-26_zrfy_WarrantNotePayableMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WarrantExercisePriceIncrease", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-08-01to2022-08-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:SharesIssuedForCash", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000057 - Disclosure - Stockholders Deficit (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://zrfy.com/role/StockholdersDeficitDetailsNarrative", "shortName": "Stockholders Deficit (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-08-01to2022-08-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:SharesIssuedForCash", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NumberOfOptionsSharesBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000058 - Disclosure - Stock Options (Details)", "menuCat": "Details", "order": "58", "role": "http://zrfy.com/role/StockOptionsDetails", "shortName": "Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "zrfy:NumberOfOptionsSharesBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_OptionExercisableMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000059 - Disclosure - Stock Options (Details 1)", "menuCat": "Details", "order": "59", "role": "http://zrfy.com/role/StockOptionsDetails1", "shortName": "Stock Options (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_OptionExercisableMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000060 - Disclosure - Stock Options (Details Narrative)", "menuCat": "Details", "order": "60", "role": "http://zrfy.com/role/StockOptionsDetailsNarrative", "shortName": "Stock Options (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000061 - Disclosure - Income Tax Provision (Details)", "menuCat": "Details", "order": "61", "role": "http://zrfy.com/role/IncomeTaxProvisionDetails", "shortName": "Income Tax Provision (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "zrfy:ScheduleOfSupplementalBalanceSheetInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000062 - Disclosure - Income Tax Provision (Details 1)", "menuCat": "Details", "order": "62", "role": "http://zrfy.com/role/IncomeTaxProvisionDetails1", "shortName": "Income Tax Provision (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_IncomeTaxProvisionMember", "decimals": "0", "lang": null, "name": "zrfy:StockBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_FederalMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000063 - Disclosure - Income Tax Provision (Details Narrative)", "menuCat": "Details", "order": "63", "role": "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative", "shortName": "Income Tax Provision (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_FederalMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "zrfy:ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_OnstreamMediaCorporationVZerifyIncMember", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:FilingDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000064 - Disclosure - Commitment and Contingencies (Details)", "menuCat": "Details", "order": "64", "role": "http://zrfy.com/role/CommitmentAndContingenciesDetails", "shortName": "Commitment and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "zrfy:ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31_zrfy_OnstreamMediaCorporationVZerifyIncMember", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:FilingDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_CertainInvestorsMember_zrfy_QualifiedRegulationAOfferingMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000065 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://zrfy.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "AsOf2022-12-31_zrfy_CertainInvestorsMember_zrfy_QualifiedRegulationAOfferingMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - Organization and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies", "shortName": "Organization and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "8", "role": "http://zrfy.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Convertible Notes Payable", "menuCat": "Notes", "order": "9", "role": "http://zrfy.com/role/ConvertibleNotesPayable", "shortName": "Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "zrfy_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "zrfy:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 81, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Security 12g Title" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://zrfy.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "srt_CommercialPaperAverageRatePaid": { "auth_ref": [ "r433", "r435" ], "lang": { "en-us": { "role": { "documentation": "Average rate paid on commercial paper.", "label": "Volume weighted average price of common stock" } } }, "localname": "CommercialPaperAverageRatePaid", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r232", "r449", "r497", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Major Customers Axis" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r255", "r256", "r257", "r258", "r305", "r404", "r420", "r431", "r432", "r447", "r450", "r457", "r494", "r536", "r537", "r538", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r255", "r256", "r257", "r258", "r305", "r404", "r420", "r431", "r432", "r447", "r450", "r457", "r494", "r536", "r537", "r538", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "verboseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r232", "r449", "r497", "r544" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers." } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r230", "r405", "r448", "r456", "r489", "r490", "r497", "r543" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r230", "r405", "r448", "r456", "r489", "r490", "r497", "r543" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services." } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r255", "r256", "r257", "r258", "r303", "r305", "r314", "r315", "r316", "r380", "r404", "r420", "r431", "r432", "r447", "r450", "r457", "r488", "r494", "r537", "r538", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r255", "r256", "r257", "r258", "r303", "r305", "r314", "r315", "r316", "r380", "r404", "r420", "r431", "r432", "r447", "r450", "r457", "r488", "r494", "r537", "r538", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses (includes VIE balances of $4,000 and $2,000, respectively)" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r233", "r234" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r66", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "[Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment]", "negatedLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term - operating leases (in years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r455" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r318", "r319", "r320", "r479", "r480", "r481", "r527" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising, Sales and Marketing Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r31", "r44", "r120", "r290" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "[Amortization of Debt Discount (Premium)]", "negatedLabel": "Debt discount amortization" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r290", "r362", "r445", "r446", "r473" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r136", "r161", "r181", "r215", "r224", "r228", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r344", "r348", "r354", "r455", "r492", "r493", "r533" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r155", "r166", "r181", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r344", "r348", "r354", "r455", "r492", "r493", "r533" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date Axis" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/StockOptionsDetailsNarrative", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/StockOptionsDetailsNarrative", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": { "auth_ref": [ "r342", "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.", "label": "[Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset]", "verboseLabel": "Contingent payment obligation" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r46", "r157", "r436" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash (includes VIE balances of $1,000 and $1,000, respectively)" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r40", "r46", "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents]", "periodEndLabel": "Cash at end of the year", "periodStartLabel": "Cash at beginning of the year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r40", "r119" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "totalLabel": "Net increase (decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r467" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash on hand" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash investing and financing transactions" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r162", "r163", "r164", "r181", "r199", "r200", "r203", "r204", "r207", "r208", "r240", "r259", "r261", "r262", "r263", "r266", "r267", "r295", "r296", "r297", "r298", "r300", "r354", "r433", "r466", "r475", "r482" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r79", "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class Of Warrant Or Right Axis" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant exercisble price", "verboseLabel": "Warrants fully vested, exercisable" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Issued warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "[Class of Warrant or Right, Outstanding]", "periodEndLabel": "Number of warrants Outstsnding Ending", "periodStartLabel": "Number of warrants Beginning balance" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommercialPaper": { "auth_ref": [ "r2", "r126", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.", "label": "Note issued" } } }, "localname": "CommercialPaper", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r68", "r253", "r254", "r428", "r491" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitment and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/CommitmentAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r479", "r480", "r527" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, shares par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r75" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r455" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock par value $0.0001: 4,000,000,000 shares authorized; 1,109,417,572 and 955,380,225 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r56", "r57", "r116", "r117", "r232", "r427" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r56", "r57", "r116", "r117", "r232", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark Axis" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockDescription": { "auth_ref": [ "r48", "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Preferred stock, descriptions" } } }, "localname": "ConversionOfStockDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Schedule of convertible notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r5", "r128", "r137", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible notes payable, outstanding balance", "verboseLabel": "Convertible notes payable, outstanding balance" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, net of discount of $96,000 and $0, respectively (including $895,000 and $895,000 in default)", "verboseLabel": "Convertible notes, net of discount" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r3", "r127", "r134", "r145" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentRate": { "auth_ref": [ "r48", "r50" ], "lang": { "en-us": { "role": { "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.", "label": "Conversion price percentage" } } }, "localname": "DebtConversionConvertedInstrumentRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r73", "r180", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r284", "r291", "r292", "r294" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Principal payments" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r3", "r4", "r5", "r127", "r128", "r134", "r184", "r268", "r269", "r270", "r271", "r272", "r274", "r280", "r281", "r282", "r283", "r285", "r286", "r287", "r288", "r289", "r290", "r363", "r442", "r443", "r444", "r445", "r446", "r476" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument Axis" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Conversion feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r121", "r122", "r268", "r363", "r443", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Notes payable aggregate amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Management fee per month" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r20", "r121", "r287" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r20", "r269" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "[Debt Instrument, Interest Rate, Stated Percentage]", "terseLabel": "Interest rate", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Interest rate decriptions", "verboseLabel": "Interest rate decriptions" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r167", "r442", "r528" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Due date", "verboseLabel": "Due date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Maturity date description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r23", "r184", "r268", "r269", "r270", "r271", "r272", "r274", "r280", "r281", "r282", "r283", "r285", "r286", "r287", "r288", "r289", "r290", "r363", "r442", "r443", "r444", "r445", "r446", "r476" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r120", "r122", "r495" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Unamortized debt discount", "verboseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "[Debt, Weighted Average Interest Rate]", "verboseLabel": "Interest rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "The per share price that the individual must pay to acquire shares under the deferred compensation arrangement.", "label": "Exercise Price" } } }, "localname": "DeferredCompensationArrangementWithIndividualExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued pursuant to the terms of a deferred compensation arrangement.", "label": "Additional warrants" } } }, "localname": "DeferredCompensationArrangementWithIndividualSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r100", "r525" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r44", "r64" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows", "http://zrfy.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r526" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "[Derivative, Gain (Loss) on Derivative, Net]", "verboseLabel": "Change in fair value of derivative liabilities" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentDetailAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentDetailAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r168", "r169", "r353", "r438" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "[Derivative Liability]", "verboseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r168" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liability", "terseLabel": "Derivative liability", "verboseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/DerivativeFinancialInstrumentsDetailsNarrative", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r107", "r108", "r109", "r110", "r112", "r183" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "verboseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r78", "r132" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "[Dividends]", "negatedLabel": "Deemed dividend to warrant holders", "verboseLabel": "Deemed dividend" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r54", "r55" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r182", "r326", "r337" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Federal statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Deficit" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r75", "r152", "r173", "r174", "r175", "r185", "r186", "r187", "r189", "r194", "r196", "r206", "r241", "r302", "r318", "r319", "r320", "r334", "r335", "r351", "r356", "r357", "r358", "r359", "r360", "r361", "r371", "r421", "r422", "r423" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r44", "r74" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair value of vested options and warrants", "verboseLabel": "Total fair value" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value:" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionTextBlock": { "auth_ref": [ "r118", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.", "label": "Fair Value, Option [Text Block]", "verboseLabel": "Stock Options" } } }, "localname": "FairValueOptionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptions" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r238", "r239", "r242", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r293", "r299", "r350", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r441", "r484", "r485", "r486", "r545", "r546", "r547", "r548", "r549", "r550", "r551" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument Axis" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "Derivative Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VIE Financing Obligation" } } }, "localname": "FinancialLiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FinancingInterestExpense": { "auth_ref": [ "r27" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services.", "label": "[Financing Interest Expense]", "negatedLabel": "Interest and financing expenses (including $121,000 and $121,000 to related parties)" } } }, "localname": "FinancingInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r111" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Change in fair value of derivative liabilities" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r44", "r71", "r72" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r28", "r175" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "[Income (Loss) Attributable to Parent, before Tax]", "totalLabel": "Net loss attributable to Zerify, Inc." } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority Axis" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Provision" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r182", "r327", "r328", "r332", "r336", "r338", "r339", "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Tax Provision" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvision" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r172", "r324", "r325", "r328", "r329", "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r41", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income tax paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Amount payables" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r43" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r43" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r43" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued interest" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r472", "r531" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r43" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r474" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest (including $1,557,000 and $1,497,000 due to related parties, respectively) (includes VIE balances of $134,000 and $120,000, respectively)" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r44" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Fair value of common stock issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeasesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating leases" } } }, "localname": "LeasesOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "verboseLabel": "VIE Financing Obligation" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/VieFinancingObligation" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Total lease payment" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "[Lessee, Operating Lease, Liability, Undiscounted Excess Amount]", "negatedLabel": "Less: Imputed interest/present value discount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r17", "r181", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r345", "r348", "r349", "r354", "r439", "r492", "r533", "r534" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r130", "r141", "r455", "r477", "r487", "r529" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total Liabilities and Stockholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r156", "r181", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r345", "r348", "r349", "r354", "r455", "r492", "r533", "r534" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r5", "r128", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Total debentures" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r23" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, long-term portion", "verboseLabel": "Long term notes payable" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable" } } }, "localname": "LongtermConvertibleDebtCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r23", "r70" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable Related Parties" } } }, "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r123" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Monthly management fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising, sales and marketing costs" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r25", "r129", "r140", "r181", "r240", "r259", "r261", "r262", "r263", "r266", "r267", "r354" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest in consolidated subsidiary" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r179" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r179" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "[Net Cash Provided by (Used in) Investing Activities]", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r40", "r42", "r45" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r26", "r45", "r131", "r143", "r154", "r170", "r171", "r175", "r181", "r188", "r190", "r191", "r192", "r193", "r195", "r196", "r201", "r215", "r223", "r227", "r229", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r352", "r354", "r440", "r492" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/ConsolidatedStatementsOfOperations", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r103", "r105", "r170", "r171", "r195", "r196", "r470" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "[Net Income (Loss) Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r190", "r191", "r192", "r193", "r197", "r198", "r202", "r204", "r215", "r223", "r227", "r229", "r440" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "[Net Income (Loss) Available to Common Stockholders, Basic]", "totalLabel": "Net loss to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r101", "r302", "r479", "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansPayable": { "auth_ref": [ "r5", "r128", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Notes payable, outstanding balance" } } }, "localname": "NotesAndLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r48", "r49", "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Notes payable issue" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r5", "r128", "r138" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes payable", "verboseLabel": "Notes payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetails", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable" } } }, "localname": "NotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable, net of discount of $323,000 and $0, respectively (including $1,930,000 and $1,972,000 in default, respectively) (includes VIE balances of $285,000 and $310,000, respectively)", "negatedLabel": "Less current portion of notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r13", "r123", "r478" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes payable - related parties", "verboseLabel": "Notes payable - related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r215", "r223", "r227", "r229", "r440" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r367", "r454" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost (included in general and administration in the Company's statement of operations)" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r530" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Lease expenses" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": { "auth_ref": [ "r205", "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.", "label": "Operating lease payments, monthly" } } }, "localname": "OperatingLeaseLeaseIncomeLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total operating lease liabilities", "terseLabel": "Operating lease liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1", "http://zrfy.com/role/OperatingLeaseDetails1", "http://zrfy.com/role/OperatingLeaseDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r365" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liability, current portion", "verboseLabel": "Short-term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/OperatingLeaseDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r365" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, long-term portion", "verboseLabel": "Long-term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/OperatingLeaseDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r364" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset", "verboseLabel": "Long-term right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/OperatingLeaseDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r473" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r368", "r454" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Average discount rate - operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carry-forwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionIndexedToIssuersEquityIndexedShares": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The number of issuer's shares to which the option contract is indexed.", "label": "Option shares" } } }, "localname": "OptionIndexedToIssuersEquityIndexedShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Basis of presentation and principles of consolidation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r52", "r53", "r61", "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Organization and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r124", "r135", "r160" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r30", "r144" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "[Other Expenses]", "negatedLabel": "Other expense" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r32" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "[Other Nonoperating Income (Expense)]", "totalLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r37" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "[Payments for Repurchase of Common Stock]", "negatedLabel": "Repurchase of common stock and warrants" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r39" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Financing costs", "verboseLabel": "Financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows", "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r34" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "[Payments to Acquire Property, Plant, and Equipment]", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Dividend Rate", "verboseLabel": "Dividend Rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r295" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, share par value", "verboseLabel": "Preferred stock, per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r6", "r295" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r455" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, Value", "verboseLabel": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r165", "r251", "r252", "r437" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r36" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from sale of convertible notes", "verboseLabel": "Proceeds from convertible notes payable" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows", "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r35" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Warrants granted" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r36" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOperatingActivities": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total amount of cash received from operating activities during the current period.", "label": "[Proceeds from Operating Activities]", "verboseLabel": "Net cash used in operating activities" } } }, "localname": "ProceedsFromOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndCollectionOfOtherReceivables": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale and collection of receivables classified as other.", "label": "Proceeds on the sale of common shares and warrants" } } }, "localname": "ProceedsFromSaleAndCollectionOfOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r471" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r154", "r170", "r171", "r178", "r181", "r188", "r195", "r196", "r215", "r223", "r227", "r229", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r343", "r346", "r347", "r352", "r354", "r418", "r440", "r452", "r453", "r470", "r492" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type Axis" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r65", "r158" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r67", "r142", "r419", "r455" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "verboseLabel": "Property and equipment net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r67", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated Useful Life (Years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r177", "r243" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Allowance for doubtful debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r304", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails", "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r151", "r372", "r373", "r532" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction Axis" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r304", "r372", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r532" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party Axis" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails", "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r38" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "[Repayments of Convertible Debt]", "negatedLabel": "Repayment of convertible note payable" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r38" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "[Repayments of Notes Payable]", "negatedLabel": "Repayment of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r38" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "[Repayments of Related Party Debt]", "negatedLabel": "Repayment of notes payable-related parties" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r94", "r147", "r542" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "verboseLabel": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r78", "r139", "r424", "r425", "r455" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r152", "r185", "r186", "r187", "r189", "r194", "r196", "r241", "r318", "r319", "r320", "r334", "r335", "r351", "r421", "r423" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionAllowances": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for sales allowances.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionAllowances", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of consideration recognized during the period for the milestone or milestones.", "label": "Financing milestone, amount" } } }, "localname": "RevenueRecognitionMilestoneMethodRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionMilestoneMethodTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the entity's accounting policy for the recognition of revenue under the milestone method. Includes: (1) a description of the overall arrangement; (2) a description of each milestone and related contingent consideration; (3) a determination of whether each milestone is considered substantive; (4) the factors that the entity considered in determining whether the milestone or milestones are substantive; and (5) the amount of consideration recognized during the period for the milestone or milestones.", "label": "Schedule of Revenue Recognition" } } }, "localname": "RevenueRecognitionMilestoneMethodTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r176", "r181", "r213", "r214", "r222", "r225", "r226", "r230", "r231", "r232", "r240", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r354", "r418", "r492" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue", "verboseLabel": "Total revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of lease expense and supplemental cash flow information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OperatingLeaseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of notes payable" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of derivative liability" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of earning per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of reconcilliation of fedral statutory income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation.", "label": "Schedule of Property and Equipment" } } }, "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r83", "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock option outstanding and exercisable" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of stock options plan" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "Schedule of Subsequent Events [Table Text Block]", "verboseLabel": "Subsequent Events" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredLongtermDebtCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Secured" } } }, "localname": "SecuredLongtermDebtCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r221", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segments" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r468", "r469", "r496" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r468", "r469", "r496" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Average Remaining Contractual Life (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period]", "negatedLabel": "Number of warrant shares, Canceled/Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Stock option granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options Shares, Granted", "verboseLabel": "Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Canceled/Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r306", "r311", "r312", "r313", "r314", "r317", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Range of Exercise Prices" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Number of warrants exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Number of warrants outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Exercise price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "[Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price]", "verboseLabel": "Weighted average exercise price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Weighted average exercise price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life (years)", "verboseLabel": "Options outstanding, estimated life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r80", "r93" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "verboseLabel": "Stockholders' Deficit" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtInterestRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage increase in the stated interest rate on a short-term debt instrument.", "label": "Interest rate on loan" } } }, "localname": "ShortTermDebtInterestRateIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.", "label": "Interest rate of notes" } } }, "localname": "ShortTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short Term Debt Type Axis" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShorttermDebtAverageOutstandingAmount": { "auth_ref": [ "r433", "r434" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, average borrowings during the period.", "label": "Remaining balance" } } }, "localname": "ShorttermDebtAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r162", "r163", "r164", "r181", "r199", "r200", "r203", "r204", "r207", "r208", "r240", "r259", "r261", "r262", "r263", "r266", "r267", "r295", "r296", "r297", "r298", "r300", "r354", "r433", "r466", "r475", "r482" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r75", "r152", "r173", "r174", "r175", "r185", "r186", "r187", "r189", "r194", "r196", "r206", "r241", "r302", "r318", "r319", "r320", "r334", "r335", "r351", "r356", "r357", "r358", "r359", "r360", "r361", "r371", "r421", "r422", "r423" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails", "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/IncomeTaxProvisionDetails1", "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/PropertyAndEquipmentDetails", "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockOptionsDetailsNarrative", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r185", "r186", "r187", "r206", "r405" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails", "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/IncomeTaxProvisionDetails1", "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative", "http://zrfy.com/role/NotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/PropertyAndEquipmentDetails", "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockOptionsDetailsNarrative", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative", "http://zrfy.com/role/SubsequentEventsDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r81", "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share based compensation" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r6", "r7", "r78" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock issued for business purchase, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r6", "r7", "r75", "r76", "r78" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Issued shares of common stock" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Fair value of common stock issued for services, shares", "verboseLabel": "Common stock issued for service, share" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r75", "r78" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued for cash, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r6", "r7", "r75", "r78", "r308" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Common stock issued upon cashless exercise of options, shares", "verboseLabel": "Options, exercised during period" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r24", "r75", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock issued for business purchase, value" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r24", "r75", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Issued shares of common stock in exchange for cash" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Fair value of common stock issued for services, amount", "verboseLabel": "Common stock issued for service, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r7", "r75", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued for cash, amount" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r24", "r75", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Common stock issued upon cashless exercise of options, amount" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Stock Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r62", "r455", "r477", "r487", "r529" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "totalLabel": "Total Zerify, Inc. stockholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r101", "r102", "r104", "r152", "r153", "r174", "r185", "r186", "r187", "r189", "r194", "r241", "r302", "r318", "r319", "r320", "r334", "r335", "r351", "r356", "r357", "r361", "r371", "r422", "r423", "r477", "r487", "r529" ], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "[Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total Stockholders' Deficit", "verboseLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets", "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit", "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward Axis" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward." } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r148", "r149", "r150", "r235", "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r238", "r239", "r293", "r299", "r350", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r484", "r485", "r486", "r545", "r546", "r547", "r548", "r549", "r550", "r551" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1", "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured [Member]" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UnsecuredLongtermDebtCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unsecured" } } }, "localname": "UnsecuredLongtermDebtCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r58", "r59", "r60", "r209", "r210", "r211", "r212" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantExercisePriceIncrease": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.", "label": "Exercise Prices", "verboseLabel": "Exercise Prices" } } }, "localname": "WarrantExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "perShareItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Warrant Shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WorkersCompensationDiscountAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current year monetary amount of the change in worker's compensation reserve liability resulting from the discount applied to reduce the reserve to present value.", "label": "Unamortized stock compensation" } } }, "localname": "WorkersCompensationDiscountAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_AccruedInterestDueToRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued interest due to related parties" } } }, "localname": "AccruedInterestDueToRelatedParties", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_AccruedInterestVie": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Interest VIE" } } }, "localname": "AccruedInterestVie", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_AdditionalSharesOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional shares of preferred stock" } } }, "localname": "AdditionalSharesOfPreferredStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_AggregateAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Aggregate amount" } } }, "localname": "AggregateAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_AllowanceOnConvertibleNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Allowance on convertible notes payable" } } }, "localname": "AllowanceOnConvertibleNotesPayable", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_AllowanceOnNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Allowance on notes payable" } } }, "localname": "AllowanceOnNotesPayable", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_AssetCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetCurrentAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "zrfy_AssumptionOfExpectedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected term (yrs.)", "verboseLabel": "Expected term (yrs.)" } } }, "localname": "AssumptionOfExpectedTerm", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "durationItemType" }, "zrfy_AssumptionOfSharePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share price", "verboseLabel": "Share price" } } }, "localname": "AssumptionOfSharePrices", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "perShareItemType" }, "zrfy_AssumptionOfVolatility": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Volatility]", "terseLabel": "Volatility", "verboseLabel": "Volatility" } } }, "localname": "AssumptionOfVolatility", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "percentItemType" }, "zrfy_BConvertibleNotesWithFixedConversionFeatures": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(b) Convertible note with Diagonal Lending" } } }, "localname": "BConvertibleNotesWithFixedConversionFeatures", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_BSTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BST [Member]" } } }, "localname": "BSTMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_CConvertibleNotesWithAdjustableConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "(c) Convertible notes with fixed conversion features, in default" } } }, "localname": "CConvertibleNotesWithAdjustableConversionFeature", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_COVIDNinteenPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COVID-19" } } }, "localname": "COVIDNinteenPolicyTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "zrfy_CarryforwardsExpiryYear": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Carryforwards expiry year" } } }, "localname": "CarryforwardsExpiryYear", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_CashAtVariableInterestEntity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash VIE" } } }, "localname": "CashAtVariableInterestEntity", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2022 and 2021" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_CashRecieved": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash recieved" } } }, "localname": "CashRecieved", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_CertainInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Certain Investors [Member]" } } }, "localname": "CertainInvestorsMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_ChangeInValuationAllowanceOnNetOperatingLossCarryForwards": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increa", "label": "Change in valuation allowance on net operating loss carry-forwards" } } }, "localname": "ChangeInValuationAllowanceOnNetOperatingLossCarryForwards", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "percentItemType" }, "zrfy_ChiefExecutiveOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficersMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableRelatedPartiesDetailsNarrative", "http://zrfy.com/role/NotesPayableRelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_CommitmentAndContingenciesabstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitment and Contingencies" } } }, "localname": "CommitmentAndContingenciesabstract", "nsuri": "http://zrfy.com/20221231", "xbrltype": "stringItemType" }, "zrfy_CommonClassSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class Shares [Member]" } } }, "localname": "CommonClassSharesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_CommonSharesIssuedUponConversionOfDebtSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common shares issued upon conversion of debt settlement" } } }, "localname": "CommonSharesIssuedUponConversionOfDebtSettlement", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued" } } }, "localname": "CommonStockIssued", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedForConversionOfNotesAndAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for conversion of notes and accrued interest" } } }, "localname": "CommonStockIssuedForConversionOfNotesAndAccruedInterest", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedForDebtSettlementShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for debt settlement, share" } } }, "localname": "CommonStockIssuedForDebtSettlementShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedForDebtSettlementValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for debt settlement, value" } } }, "localname": "CommonStockIssuedForDebtSettlementValue", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedForServiceShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for service, share" } } }, "localname": "CommonStockIssuedForServiceShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Common stock issued]", "verboseLabel": "Common stock issued" } } }, "localname": "CommonStockIssuedShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponCashlessExerciseOfWarrantsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon cashless exercise of warrants, amount" } } }, "localname": "CommonStockIssuedUponCashlessExerciseOfWarrantsAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedUponCashlessExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon cashless exercise of warrants, shares" } } }, "localname": "CommonStockIssuedUponCashlessExerciseOfWarrantsShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponConversionOfConvertibleNotesPayableAndAccruedInterestShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of convertible notes payable and accrued interest, share" } } }, "localname": "CommonStockIssuedUponConversionOfConvertibleNotesPayableAndAccruedInterestShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponConversionOfConvertibleNotesPayableAndAccruedInterestValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of convertible notes payable and accrued interest, value" } } }, "localname": "CommonStockIssuedUponConversionOfConvertibleNotesPayableAndAccruedInterestValue", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedUponConversionOfDebtSettlementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of debt settlement, amount" } } }, "localname": "CommonStockIssuedUponConversionOfDebtSettlementAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedUponConversionOfDebtSettlementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of debt settlement, shares" } } }, "localname": "CommonStockIssuedUponConversionOfDebtSettlementShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponConversionOfNotesAndAccruedInterestAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of notes and accrued interest, amount" } } }, "localname": "CommonStockIssuedUponConversionOfNotesAndAccruedInterestAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedUponConversionOfNotesAndAccruedInterestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon conversion of notes and accrued interest, shares" } } }, "localname": "CommonStockIssuedUponConversionOfNotesAndAccruedInterestShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponExerciseOfWarrantsForCashAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued upon exercise of warrants for cash, amount" } } }, "localname": "CommonStockIssuedUponExerciseOfWarrantsForCashAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_CommonStockIssuedUponExerciseOfWarrantsForCashShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon exercise of warrants for cash, shares" } } }, "localname": "CommonStockIssuedUponExerciseOfWarrantsForCashShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockIssuedUponWarrantExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued upon warrant exercised" } } }, "localname": "CommonStockIssuedUponWarrantExercised", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockSharesIssuedUponCashlessExerciseOfOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock, shares issued upon cashless exercise of options" } } }, "localname": "CommonStockSharesIssuedUponCashlessExerciseOfOptions", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_CommonStockSharesIssuedUponConversionOfDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares issued upon conversion of debt" } } }, "localname": "CommonStockSharesIssuedUponConversionOfDebt", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Computer software [Member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://zrfy.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "zrfy_ConcentrationRiskPercentageOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Risk Free Rate", "verboseLabel": "Risk Free Rate" } } }, "localname": "ConcentrationRiskPercentageOne", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://zrfy.com/role/StockholdersDeficitDetails2", "http://zrfy.com/role/StockholdersDeficitDetails3" ], "xbrltype": "percentItemType" }, "zrfy_ConcentrationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentrations" } } }, "localname": "ConcentrationsPolicyTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "zrfy_ContingentObligationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent obligation, description" } } }, "localname": "ContingentObligationDescription", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_ContingentPaymentObligation": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contingent payment obligation" } } }, "localname": "ContingentPaymentObligation", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "zrfy_ContingentPaymentObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Payment Obligation" } } }, "localname": "ContingentPaymentObligationAbstract", "nsuri": "http://zrfy.com/20221231", "xbrltype": "stringItemType" }, "zrfy_ConvertableNotesPayableRelatedPartiesDisclosureTextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertable Notes Payable - Related Parties" } } }, "localname": "ConvertableNotesPayableRelatedPartiesDisclosureTextblock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableRelatedParties" ], "xbrltype": "textBlockItemType" }, "zrfy_ConvertibleNotePayableNetOfDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt discount" } } }, "localname": "ConvertibleNotePayableNetOfDiscount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_ConvertibleNotesDueToBankInDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "(a) Convertible notes due to AL-Bank" } } }, "localname": "ConvertibleNotesDueToBankInDefault", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_ConvertibleNotesPayableDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible notes payable, default" } } }, "localname": "ConvertibleNotesPayableDefault", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_ConvertibleNotesPayableRelatedParties": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible notes payable - related parties" } } }, "localname": "ConvertibleNotesPayableRelatedParties", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "zrfy_ConvertibleNotesPayableRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Related Parties" } } }, "localname": "ConvertibleNotesPayableRelatedPartiesAbstract", "nsuri": "http://zrfy.com/20221231", "xbrltype": "stringItemType" }, "zrfy_ConvertibleNotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Convertible Notes Payable]", "verboseLabel": "Convertible Notes Payable" } } }, "localname": "ConvertibleNotesPayableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "zrfy_ConvertibleNotesShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible notes" } } }, "localname": "ConvertibleNotesShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "zrfy_ConvertibleSeriesBPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Series B Preferred stock" } } }, "localname": "ConvertibleSeriesBPreferredStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "zrfy_CostOfRevenues": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of revenue" } } }, "localname": "CostOfRevenues", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "zrfy_Dart": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(a) DART/Citco Global, in default" } } }, "localname": "Dart", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_DebtDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Debt discount]", "terseLabel": "Debt discount", "verboseLabel": "Debt discount" } } }, "localname": "DebtDiscount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_DebtReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amount recieved" } } }, "localname": "DebtReceived", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_DeemedDividendToWarrantHolders": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Deemed dividend to warrant holders]", "verboseLabel": "Deemed dividend to warrant holders" } } }, "localname": "DeemedDividendToWarrantHolders", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_DescriptionOfMonthlyPaymentOnLoan": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Monthly payment on loan, description" } } }, "localname": "DescriptionOfMonthlyPaymentOnLoan", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_DescriptionOfOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating lease, description" } } }, "localname": "DescriptionOfOperatingLease", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_EarningPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "-Basic and diluted" } } }, "localname": "EarningPerShareBasicAndDiluted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "zrfy_EidLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EID Loan [Member]" } } }, "localname": "EidLoanMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_EstimatedFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Estimated fair value" } } }, "localname": "EstimatedFairValue", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_ExercisePriceRangePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share, Beginning balance" } } }, "localname": "ExercisePriceRangePerShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Exercise Price Range Per Share, Beginning balance]", "verboseLabel": "Exercise Price Range Per Share, Beginning balance" } } }, "localname": "ExercisePriceRangePerShareBeginningBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share, Ending balance" } } }, "localname": "ExercisePriceRangePerShareEndingBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareExercisableEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share Exercisable Ending balance", "verboseLabel": "Exercise Price Range Per Share Exercisable Ending balance" } } }, "localname": "ExercisePriceRangePerShareExercisableEndingBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price range per share, Granted", "verboseLabel": "Exercise Price Range Per Share ,Granted" } } }, "localname": "ExercisePriceRangePerShareGranted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareOutstandingEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share Outstanding Ending" } } }, "localname": "ExercisePriceRangePerShareOutstandingEnding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePriceRangePerShareWarrantActicityExercisableEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Exercise Price Range Per Share Exercisable Ending balance]", "verboseLabel": "Exercise Price Range Per Share Exercisable Ending balance" } } }, "localname": "ExercisePriceRangePerShareWarrantActicityExercisableEndingBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ExercisePricesFSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Exercise Prices Six [Member]]", "verboseLabel": "Exercise Prices Six [Member]" } } }, "localname": "ExercisePricesFSixMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Five [Member]" } } }, "localname": "ExercisePricesFiveMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Four [Member]" } } }, "localname": "ExercisePricesFourMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices One [Member]" } } }, "localname": "ExercisePricesOneMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Six [Member]" } } }, "localname": "ExercisePricesSixMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Three [Member]" } } }, "localname": "ExercisePricesThreeMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExercisePricesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Two [Member]" } } }, "localname": "ExercisePricesTwoMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_ExpectedDividendYield": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend Yield" } } }, "localname": "ExpectedDividendYield", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "percentItemType" }, "zrfy_ExtinguishedAsDebtSettlementObligationTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Extinguished as debt settlement obligation transaction" } } }, "localname": "ExtinguishedAsDebtSettlementObligationTransaction", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_ExtinguishmentOfDerivativeLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Extinguishment of derivative liabilities" } } }, "localname": "ExtinguishmentOfDerivativeLiabilities", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfCommonStockIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of common stock issued" } } }, "localname": "FairValueOfCommonStockIssued", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfCommonStockIssuedAsAFinancingCostAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of common stock issued as a financing cost, amount" } } }, "localname": "FairValueOfCommonStockIssuedAsAFinancingCostAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfCommonStockIssuedAsAFinancingCostShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value of common stock issued as a financing cost, shares" } } }, "localname": "FairValueOfCommonStockIssuedAsAFinancingCostShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_FairValueOfCommonStockIssuedForFinancingServices": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of common stock issued for financing services" } } }, "localname": "FairValueOfCommonStockIssuedForFinancingServices", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfDerivativeUponIssuanceOfConvertibleDebtRecordedAsDebtDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of derivative upon issuance of convertible debt recorded as debt discount" } } }, "localname": "FairValueOfDerivativeUponIssuanceOfConvertibleDebtRecordedAsDebtDiscount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfVestedOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of vested options" } } }, "localname": "FairValueOfVestedOptions", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfWarrantRecordedAsDebtDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of warrant recorded as debt discount" } } }, "localname": "FairValueOfWarrantRecordedAsDebtDiscount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfWarrantsGrantedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrants granted for services" } } }, "localname": "FairValueOfWarrantsGrantedForServices", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_FairValueOfWarrantsIssuedWithNotesPayableAccountedForAsDebtDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrants issued with notes payable accounted for as debt discount" } } }, "localname": "FairValueOfWarrantsIssuedWithNotesPayableAccountedForAsDebtDiscount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_FebruaryTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "February 2021 [Member]" } } }, "localname": "FebruaryTwoThousandTwentyOneMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_FederalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal [Member]" } } }, "localname": "FederalMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_FilingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Date of filing" } } }, "localname": "FilingDate", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "dateItemType" }, "zrfy_FinancingObligationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing obligation description" } } }, "localname": "FinancingObligationDescription", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_FinancingObligationNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financing obligation" } } }, "localname": "FinancingObligationNet", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_GrantWarrantsForServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grant of Warrants For Servicesl [Member]" } } }, "localname": "GrantWarrantsForServicesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_IncomeTaxProvisionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Provision [Member]" } } }, "localname": "IncomeTaxProvisionMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "domainItemType" }, "zrfy_InitialPriceOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial price of preferred stock" } } }, "localname": "InitialPriceOfPreferredStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "zrfy_IntrinsicValueOfOutstandingOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Intrinsic value of outstanding options" } } }, "localname": "IntrinsicValueOfOutstandingOptions", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_IntrinsicValueOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Intrinsic value of warrants" } } }, "localname": "IntrinsicValueOfWarrants", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_IssuanceOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stocks [Member]" } } }, "localname": "IssuanceOfCommonStockMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_IssueNotesDiscountAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Original issue discounts" } } }, "localname": "IssueNotesDiscountAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_IssuedSharesOfStockWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issued shares of stock warrants granted" } } }, "localname": "IssuedSharesOfStockWarrantsGranted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_LegalFeesTheFirstGrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gross proceeds" } } }, "localname": "LegalFeesTheFirstGrossProceeds", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_LessValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less valuation allowance" } } }, "localname": "LessValuationAllowance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "zrfy_LiabilityCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilityCurrentAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "zrfy_LitigationFundingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation funding agreement [Member]" } } }, "localname": "LitigationFundingAgreementMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_LoanBorrowedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loan borrowed amount" } } }, "localname": "LoanBorrowedAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_LossOnExtinguishmentOfDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "[Loss on extinguishment of debt]", "verboseLabel": "Loss on extinguishment of debt" } } }, "localname": "LossOnExtinguishmentOfDebt", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "zrfy_LossOnExtinguishmentOfDebtNet": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss on extinguishment of debt, net" } } }, "localname": "LossOnExtinguishmentOfDebtNet", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "zrfy_MaturityPeriodOfIssuableNotes": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes payable issue maturity date" } } }, "localname": "MaturityPeriodOfIssuableNotes", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_MaximumsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Maximum [Member]]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumsMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_MinimumsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Minimum [Member]]", "verboseLabel": "Minimum [Member]" } } }, "localname": "MinimumsMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails", "http://zrfy.com/role/StockholdersDeficitDetails", "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_NetChangeInTheFairValueOfDerivativeLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net change in the fair value of derivative liabilities" } } }, "localname": "NetChangeInTheFairValueOfDerivativeLiabilities", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_NetLossPerCommonShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per common share" } } }, "localname": "NetLossPerCommonShareAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "zrfy_Note7ContingentPaymentObligation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Contingent Payment Obligation]", "verboseLabel": "Contingent Payment Obligation" } } }, "localname": "Note7ContingentPaymentObligation", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligation" ], "xbrltype": "textBlockItemType" }, "zrfy_NotePayableEidLoan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(c) Note payable-EID loan" } } }, "localname": "NotePayableEidLoan", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotePayableIssuanceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description about issuance of note payable" } } }, "localname": "NotePayableIssuanceDescription", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_NotePayablePrincipalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Principal payment" } } }, "localname": "NotePayablePrincipalAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_NotePayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note Payable Two [Member]" } } }, "localname": "NotePayableTwoMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_NotesPayableDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable, default" } } }, "localname": "NotesPayableDefault", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableInDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "(a) Notes payable- $1,639,000 - in default" } } }, "localname": "NotesPayableInDefault", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableInDefaultone": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(e) Notes payable - in default" } } }, "localname": "NotesPayableInDefaultone", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableIssuedByBlockSafeInDefault": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(b) Notes payable issued by BST - in default" } } }, "localname": "NotesPayableIssuedByBlockSafeInDefault", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableJuly": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(f) Notes payable - July 2022" } } }, "localname": "NotesPayableJuly", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable [Member]" } } }, "localname": "NotesPayableMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_NotesPayableOctober": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "(d) Notes payable - October 2022" } } }, "localname": "NotesPayableOctober", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableOutstandingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Notes payable, outstanding balance]", "verboseLabel": "Notes payable, outstanding balance" } } }, "localname": "NotesPayableOutstandingBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_NotesPayableRelatedPartiestabletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable - Related Parties" } } }, "localname": "NotesPayableRelatedPartiestabletextblock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableRelatedParties" ], "xbrltype": "textBlockItemType" }, "zrfy_NotesPayableSecured": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Outstanding secured notes payable" } } }, "localname": "NotesPayableSecured", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_NovemberTwentyZeroTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November 2020 [Member]" } } }, "localname": "NovemberTwentyZeroTwentyMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_NumberOfOptionsSharesBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number of Options Shares, Beginning balance]", "periodStartLabel": "Number of Options Shares, Beginning balance" } } }, "localname": "NumberOfOptionsSharesBeginningBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfOptionsSharesEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Shares, Ending balance" } } }, "localname": "NumberOfOptionsSharesEndingBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfOptionsSharesExercisableEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Shares exercisable Ending" } } }, "localname": "NumberOfOptionsSharesExercisableEnding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfWarrantExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Warrants exercised" } } }, "localname": "NumberOfWarrantExercised", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfWarrantsExercisableEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants exercisable Ending" } } }, "localname": "NumberOfWarrantsExercisableEnding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfWarrantsExercisedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants Exercised" } } }, "localname": "NumberOfWarrantsExercisedShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "zrfy_NumberOfWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants Granted" } } }, "localname": "NumberOfWarrantsGranted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "zrfy_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_OneNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Note [Member]" } } }, "localname": "OneNoteMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc Five [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncFiveMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc Four [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncFourMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc One [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncOneMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc Six [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncSixMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc Three [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncThreeMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OnstreamMediaCorporationVZerifyIncTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onstream Media Corporation V Zerify Inc Two [Member]" } } }, "localname": "OnstreamMediaCorporationVZerifyIncTwoMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_OperatingLeasetextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Operating Lease]", "verboseLabel": "Operating Lease" } } }, "localname": "OperatingLeasetextblock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLease" ], "xbrltype": "textBlockItemType" }, "zrfy_OptionExercisableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option Exercisable [Member]" } } }, "localname": "OptionExercisableMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_OptionExercisablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Option Exercisable [Member]]", "verboseLabel": "Option Exercisable [Member]" } } }, "localname": "OptionExercisablesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_OptionsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Outstanding [Member]" } } }, "localname": "OptionsOutstandingMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails1" ], "xbrltype": "domainItemType" }, "zrfy_OptionsToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options to purchase common stock" } } }, "localname": "OptionsToPurchaseCommonStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "zrfy_OtherInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Information" } } }, "localname": "OtherInformationAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLeaseDetails" ], "xbrltype": "stringItemType" }, "zrfy_OwnershipInterestHeldByCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership interest held by company" } } }, "localname": "OwnershipInterestHeldByCompany", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_OwnershipInterestHeldByOfficers": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership interest held by three executive officers" } } }, "localname": "OwnershipInterestHeldByOfficers", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_PreferredStockSharesDesignated": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock, shares designated" } } }, "localname": "PreferredStockSharesDesignated", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_PrincipalPaymentsOfPromissoryNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Principal payments of promissory notes" } } }, "localname": "PrincipalPaymentsOfPromissoryNotes", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_PrivatePlacementCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Private placement costs" } } }, "localname": "PrivatePlacementCost", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "zrfy_PrivatePlacementUnderRuleRegulationDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Under Rule Regulation D [Member]" } } }, "localname": "PrivatePlacementUnderRuleRegulationDMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_PromissoryNoteIssuedToUnrelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory note issued to unrelated parties" } } }, "localname": "PromissoryNoteIssuedToUnrelatedParties", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_PromissoryNoteVariousPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory note - various parties [Member]" } } }, "localname": "PromissoryNoteVariousPartiesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_PurchaseSharesOfCommonStockForFinancingServices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase shares of common stock for financing services" } } }, "localname": "PurchaseSharesOfCommonStockForFinancingServices", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_PurchasedPromissoryNoteAggregatePrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchased promissory note aggregate principal amount" } } }, "localname": "PurchasedPromissoryNoteAggregatePrincipalAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_QualifiedRegulationAOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Qualified Regulation A Offering [Member]" } } }, "localname": "QualifiedRegulationAOfferingMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_RepaymentOfConvertibleNotesPayableRelatedParties": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Repayment of convertible notes payable-related parties]", "negatedLabel": "Repayment of convertible notes payable-related parties" } } }, "localname": "RepaymentOfConvertibleNotesPayableRelatedParties", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_RepaymentPenaltyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repayment penalty percentage" } } }, "localname": "RepaymentPenaltyPercentage", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_RepurchaseOfCommonStockAndWarrantsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Repurchase of common stock and warrants, amount" } } }, "localname": "RepurchaseOfCommonStockAndWarrantsAmount", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "zrfy_RepurchaseOfCommonStockAndWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase of common stock and warrants, shares" } } }, "localname": "RepurchaseOfCommonStockAndWarrantsShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "zrfy_RevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Member]" } } }, "localname": "RevenuesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_SaleLeasebackTransactionMonthlyRentalPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Monyhly payment" } } }, "localname": "SaleLeasebackTransactionMonthlyRentalPayment", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_SalesDeacreasedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales deacreased percentage" } } }, "localname": "SalesDeacreasedPercentage", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_ScheduleGrantsOfWarrantsOnIssuanceOfNotePayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule grants of warrants on issuance of note Payable" } } }, "localname": "ScheduleGrantsOfWarrantsOnIssuanceOfNotePayableTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfGrantOfWarrantsForServicesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of grant of warrants for services" } } }, "localname": "ScheduleOfGrantOfWarrantsForServicesTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfMaturitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of maturities" } } }, "localname": "ScheduleOfMaturitiesTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLeaseTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment, stated at cost, less accumulated depreciation" } } }, "localname": "ScheduleOfPropertyAndEquipmentLessAccumulatedDepreciationTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfStockWarrantsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock warrants activity" } } }, "localname": "ScheduleOfStockWarrantsActivityTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfStockWarrantsOutstandingAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants outstanding and exercisable" } } }, "localname": "ScheduleOfStockWarrantsOutstandingAndExercisableTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of supplemental balance sheet information" } } }, "localname": "ScheduleOfSupplementalBalanceSheetInformationTableTextBlock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OperatingLeaseTables" ], "xbrltype": "textBlockItemType" }, "zrfy_ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Onstream Media Corporation cases and their filing dates" } } }, "localname": "ScheduleofonstreamMediaCorporationCasesAndTheirFilingDatesTabletextblock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/CommitmentAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "zrfy_SecuredNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Secured notes payable" } } }, "localname": "SecuredNotesPayable", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_SeriesAPreferredStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock" } } }, "localname": "SeriesAPreferredStocksMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "zrfy_SeriesBPreferredStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock" } } }, "localname": "SeriesBPreferredStocksMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "zrfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValues": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price]", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValues", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "perShareItemType" }, "zrfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options Shares, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "sharesItemType" }, "zrfy_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationInPeriodWeightedAverageExercisePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price 1]", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationInPeriodWeightedAverageExercisePriceAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "stringItemType" }, "zrfy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisedOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share, Exercised" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisedOptions", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangePerShareExpirationsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Per Share, Canceled/Expired" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangePerShareExpirationsInPeriod", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_SharesIssuedForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares issued for cash" } } }, "localname": "SharesIssuedForCash", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_SharesIssuedForCashValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for cash value" } } }, "localname": "SharesIssuedForCashValue", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_SharesIssuranceForCashValueDirectFeesAndCommission": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for cash value, direct fees and commission" } } }, "localname": "SharesIssuranceForCashValueDirectFeesAndCommission", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_SharesOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares of warrants" } } }, "localname": "SharesOfWarrants", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "zrfy_StateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State [Member]" } } }, "localname": "StateMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_StateTaxNetOfFederalBenefit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State tax, net of federal benefit" } } }, "localname": "StateTaxNetOfFederalBenefit", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "percentItemType" }, "zrfy_StockBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock-based compensation" } } }, "localname": "StockBasedCompensation", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "zrfy_StockCompensationExpenseAdditional": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock compensation expense, Additional" } } }, "localname": "StockCompensationExpenseAdditional", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_StockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Price" } } }, "localname": "StockPrice", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/DerivativeFinancialInstrumentsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_StockholderEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Stockholders' Deficit]", "verboseLabel": "Stockholders' Deficit" } } }, "localname": "StockholderEquityAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "zrfy_TheriumIncAndVGLCapitalLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Therium Inc. and VGL Capital, LLC [Member]" } } }, "localname": "TheriumIncAndVGLCapitalLLCMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ContingentPaymentObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_ThreeCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three customer [Member]" } } }, "localname": "ThreeCustomerMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_TokensIssuedToUnrelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Tokens issued to unrelated parties" } } }, "localname": "TokensIssuedToUnrelatedParties", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_Total": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Total 1]", "verboseLabel": "Total" } } }, "localname": "Total", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "zrfy_TotalConvertibleNotesPrincipalOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total convertible notes principal outstanding" } } }, "localname": "TotalConvertibleNotesPrincipalOutstanding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_TotalLossPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Total]", "verboseLabel": "Total" } } }, "localname": "TotalLossPerShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "zrfy_TotalNotesPayablePrincipalOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total notes payable principal outstanding" } } }, "localname": "TotalNotesPayablePrincipalOutstanding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "zrfy_TwentyOneOctoberTwentyZeroTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October, 21 2010 [Member]" } } }, "localname": "TwentyOneOctoberTwentyZeroTenMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_TwentyZeroFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2005 [Member]" } } }, "localname": "TwentyZeroFiveMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_TwentyZeroFiveThroughTwentyZeroFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2005 Through 2007 [Member]" } } }, "localname": "TwentyZeroFiveThroughTwentyZeroFiveMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_TwoCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two customer [Member]" } } }, "localname": "TwoCustomerMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_UnsecuredConvertibleNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unsecured Convertible Notes Payable [Member]" } } }, "localname": "UnsecuredConvertibleNotesPayableMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/VieFinancingObligationDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_UnsecuredNotesPayableInDefaultAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unsecured notes payable-in default" } } }, "localname": "UnsecuredNotesPayableInDefaultAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "zrfy_VariableInterestEntityBalanceOfAccountsPayablesAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "VIE Balance of Accounts Payables and Accrued Liabilities" } } }, "localname": "VariableInterestEntityBalanceOfAccountsPayablesAndAccruedLiabilities", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_VariableInterestEntityNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable VIE" } } }, "localname": "VariableInterestEntityNotesPayable", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "zrfy_VestedExercisablePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vested, exercisable price" } } }, "localname": "VestedExercisablePrice", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "zrfy_VieFinancingObligation": { "auth_ref": [], "calculation": { "http://zrfy.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "VIE Financing obligation" } } }, "localname": "VieFinancingObligation", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "zrfy_VolatilityRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volatility rate" } } }, "localname": "VolatilityRate", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_WalleyeOpportunitiesMasterFundLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Walleye Opportunities Master Fund Ltd [Member]" } } }, "localname": "WalleyeOpportunitiesMasterFundLtdMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_WarrantExercisedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercised, share" } } }, "localname": "WarrantExercisedShare", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_WarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Four [Member]" } } }, "localname": "WarrantFourMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantHolderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Holder [Member]" } } }, "localname": "WarrantHolderMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_WarrantInMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "localname": "WarrantInMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantNotePayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Note Payable [Member]" } } }, "localname": "WarrantNotePayableMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails3", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock purchase of warrant" } } }, "localname": "WarrantPurchase", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_WarrantServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Services [Member]" } } }, "localname": "WarrantServicesMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails2" ], "xbrltype": "domainItemType" }, "zrfy_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantsExercisableExpireTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable expire term" } } }, "localname": "WarrantsExercisableExpireTerm", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "durationItemType" }, "zrfy_WarrantsExercisablePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable price" } } }, "localname": "WarrantsExercisablePrice", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "zrfy_WarrantsFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Warrant Total [Member]]", "verboseLabel": "Warrant Total [Member]" } } }, "localname": "WarrantsFourMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "domainItemType" }, "zrfy_WarrantsIssuedToPurchaseCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to purchase common shares" } } }, "localname": "WarrantsIssuedToPurchaseCommonShares", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_WarrantsIssuedToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to purchase common stock" } } }, "localname": "WarrantsIssuedToPurchaseCommonStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "zrfy_WarrantsIssuedToPurchaseCommonStockExercisablePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to purchase common stock exercisable price" } } }, "localname": "WarrantsIssuedToPurchaseCommonStockExercisablePrice", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "zrfy_WarrantsIssuedToPurchaseCommonStockExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to purchase common stock expiration period" } } }, "localname": "WarrantsIssuedToPurchaseCommonStockExpirationPeriod", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "zrfy_WarrantsIssuedWithConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrants issued with convertible notes" } } }, "localname": "WarrantsIssuedWithConvertibleNotes", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "zrfy_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Total [Member]", "verboseLabel": "Warrant Total [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1", "http://zrfy.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "zrfy_WarrantsOutstandingAndExercisableNumberOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Outstanding" } } }, "localname": "WarrantsOutstandingAndExercisableNumberOutstanding", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails1" ], "xbrltype": "sharesItemType" }, "zrfy_WarrantsToPurchaseCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to purchase common stock" } } }, "localname": "WarrantsToPurchaseCommonStock", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "zrfy_WeightedAverageCommonSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageCommonSharesOutstandingAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "zrfy_WeightedAverageDiscountRatesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discount rate" } } }, "localname": "WeightedAverageDiscountRatesPercent", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "zrfy_WeightedAverageExercisePriceBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Beginning Balance" } } }, "localname": "WeightedAverageExercisePriceBeginningBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisePriceExercisableEndingBalacce": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Exercisable Ending Balacce]", "verboseLabel": "Weighted Average Exercise Price Exercisable Ending Balacce" } } }, "localname": "WeightedAverageExercisePriceExercisableEndingBalacce", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisePriceExercisableWarrantActivityEndingBalacce": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Exercisable Ending Balacce" } } }, "localname": "WeightedAverageExercisePriceExercisableWarrantActivityEndingBalacce", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price, Granted]", "verboseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "WeightedAverageExercisePriceGranted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisePriceOutstandingEndingBalacce": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Outstanding Ending Balacce" } } }, "localname": "WeightedAverageExercisePriceOutstandingEndingBalacce", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisePriceOutstandingStockOptionEndingBalacce": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Outstanding Ending Balacce]", "verboseLabel": "Weighted Average Exercise Price Outstanding Ending Balacce" } } }, "localname": "WeightedAverageExercisePriceOutstandingStockOptionEndingBalacce", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageExercisesPriceBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercises Price Beginning Balance" } } }, "localname": "WeightedAverageExercisesPriceBeginningBalance", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "perShareItemType" }, "zrfy_WeightedAverageNumberOfShareOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock options" } } }, "localname": "WeightedAverageNumberOfShareOutstandingAbstract", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/StockOptionsDetails" ], "xbrltype": "stringItemType" }, "zrfy_WeightedAverageNumberOfSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[-Basic and diluted]", "verboseLabel": "-Basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDiluted", "nsuri": "http://zrfy.com/20221231", "presentation": [ "http://zrfy.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "825", "URI": "https://asc.fasb.org/topic&trid=2134543", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=84167750&loc=d3e42232-110370", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r458": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r459": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r461": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r462": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r463": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r464": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r465": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 85 0001477932-23-002547-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-23-002547-xbrl.zip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᭕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end